#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Gender Dimorphism of Brain Reward System Volumes in Alcoholism
#Text=The brain's reward network has been reported to be smaller in alcoholic men compared to nonalcoholic men, but little is known about the volumes of reward regions in alcoholic women.
1-1	0-6	Gender	_	
1-2	7-17	Dimorphism	_	
1-3	18-20	of	_	
1-4	21-26	Brain	_	
1-5	27-33	Reward	_	
1-6	34-40	System	_	
1-7	41-48	Volumes	_	
1-8	49-51	in	_	
1-9	52-62	Alcoholism	_	
1-10	63-66	The	_	
1-11	67-74	brain's	_	
1-12	75-81	reward	_	
1-13	82-89	network	_	
1-14	90-93	has	_	
1-15	94-98	been	_	
1-16	99-107	reported	_	
1-17	108-110	to	_	
1-18	111-113	be	_	
1-19	114-121	smaller	_	
1-20	122-124	in	_	
1-21	125-134	alcoholic	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
1-22	135-138	men	_	
1-23	139-147	compared	_	
1-24	148-150	to	_	
1-25	151-163	nonalcoholic	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
1-26	164-167	men	_	
1-27	167-168	,	_	
1-28	169-172	but	_	
1-29	173-179	little	_	
1-30	180-182	is	_	
1-31	183-188	known	_	
1-32	189-194	about	_	
1-33	195-198	the	_	
1-34	199-206	volumes	_	
1-35	207-209	of	_	
1-36	210-216	reward	_	
1-37	217-224	regions	_	
1-38	225-227	in	_	
1-39	228-237	alcoholic	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
1-40	238-243	women	_	
1-41	243-244	.	_	

#Text=Morphometric analyses were performed on magnetic resonance brain scans of 60 long-term chronic alcoholics (ALC; 30 men) and 60 nonalcoholic controls (NC; 29 men).
2-1	245-257	Morphometric	_	
2-2	258-266	analyses	_	
2-3	267-271	were	_	
2-4	272-281	performed	_	
2-5	282-284	on	_	
2-6	285-293	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[1]	
2-7	294-303	resonance	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[1]	
2-8	304-309	brain	_	
2-9	310-315	scans	_	
2-10	316-318	of	_	
2-11	319-321	60	_	
2-12	322-331	long-term	_	
2-13	332-339	chronic	_	
2-14	340-350	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
2-15	351-352	(	_	
2-16	352-355	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
2-17	355-356	;	_	
2-18	357-359	30	_	
2-19	360-363	men	_	
2-20	363-364	)	_	
2-21	365-368	and	_	
2-22	369-371	60	_	
2-23	372-384	nonalcoholic	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
2-24	385-393	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[2]	
2-25	394-395	(	_	
2-26	395-397	NC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
2-27	397-398	;	_	
2-28	399-401	29	_	
2-29	402-405	men	_	
2-30	405-406	)	_	
2-31	406-407	.	_	

#Text=We derived volumes of total brain, and cortical and subcortical reward-related structures including the dorsolateral prefrontal (DLPFC), orbitofrontal, and cingulate cortices, and the temporal pole, insula, amygdala, hippocampus, nucleus accumbens septi (NAc), and ventral diencephalon (VDC).
3-1	408-410	We	_	
3-2	411-418	derived	_	
3-3	419-426	volumes	_	
3-4	427-429	of	_	
3-5	430-435	total	_	
3-6	436-441	brain	_	
3-7	441-442	,	_	
3-8	443-446	and	_	
3-9	447-455	cortical	_	
3-10	456-459	and	_	
3-11	460-471	subcortical	_	
3-12	472-486	reward-related	_	
3-13	487-497	structures	_	
3-14	498-507	including	_	
3-15	508-511	the	_	
3-16	512-524	dorsolateral	_	
3-17	525-535	prefrontal	_	
3-18	536-537	(	_	
3-19	537-542	DLPFC	_	
3-20	542-543	)	_	
3-21	543-544	,	_	
3-22	545-558	orbitofrontal	_	
3-23	558-559	,	_	
3-24	560-563	and	_	
3-25	564-573	cingulate	_	
3-26	574-582	cortices	_	
3-27	582-583	,	_	
3-28	584-587	and	_	
3-29	588-591	the	_	
3-30	592-600	temporal	_	
3-31	601-605	pole	_	
3-32	605-606	,	_	
3-33	607-613	insula	_	
3-34	613-614	,	_	
3-35	615-623	amygdala	_	
3-36	623-624	,	_	
3-37	625-636	hippocampus	_	
3-38	636-637	,	_	
3-39	638-645	nucleus	_	
3-40	646-655	accumbens	_	
3-41	656-661	septi	_	
3-42	662-663	(	_	
3-43	663-666	NAc	_	
3-44	666-667	)	_	
3-45	667-668	,	_	
3-46	669-672	and	_	
3-47	673-680	ventral	_	
3-48	681-693	diencephalon	_	
3-49	694-695	(	_	
3-50	695-698	VDC	_	
3-51	698-699	)	_	
3-52	699-700	.	_	

#Text=We examined the relationships of the volumetric findings to drinking history.
4-1	701-703	We	_	
4-2	704-712	examined	_	
4-3	713-716	the	_	
4-4	717-730	relationships	_	
4-5	731-733	of	_	
4-6	734-737	the	_	
4-7	738-748	volumetric	_	
4-8	749-757	findings	_	
4-9	758-760	to	_	
4-10	761-769	drinking	_	
4-11	770-777	history	_	
4-12	777-778	.	_	

#Text=Analyses revealed a significant gender interaction for the association between alcoholism and total reward network volumes, with ALC men having smaller reward volumes than NC men and ALC women having larger reward volumes than NC women.
5-1	779-787	Analyses	_	
5-2	788-796	revealed	_	
5-3	797-798	a	_	
5-4	799-810	significant	_	
5-5	811-817	gender	_	
5-6	818-829	interaction	_	
5-7	830-833	for	_	
5-8	834-837	the	_	
5-9	838-849	association	_	
5-10	850-857	between	_	
5-11	858-868	alcoholism	_	
5-12	869-872	and	_	
5-13	873-878	total	_	
5-14	879-885	reward	_	
5-15	886-893	network	_	
5-16	894-901	volumes	_	
5-17	901-902	,	_	
5-18	903-907	with	_	
5-19	908-911	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
5-20	912-915	men	_	
5-21	916-922	having	_	
5-22	923-930	smaller	_	
5-23	931-937	reward	_	
5-24	938-945	volumes	_	
5-25	946-950	than	_	
5-26	951-953	NC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
5-27	954-957	men	_	
5-28	958-961	and	_	
5-29	962-965	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
5-30	966-971	women	_	
5-31	972-978	having	_	
5-32	979-985	larger	_	
5-33	986-992	reward	_	
5-34	993-1000	volumes	_	
5-35	1001-1005	than	_	
5-36	1006-1008	NC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
5-37	1009-1014	women	_	
5-38	1014-1015	.	_	

#Text=Analyses of a priori subregions revealed a similar pattern of reward volume differences with significant gender interactions for DLPFC and VDC.
6-1	1016-1024	Analyses	_	
6-2	1025-1027	of	_	
6-3	1028-1029	a	_	
6-4	1030-1036	priori	_	
6-5	1037-1047	subregions	_	
6-6	1048-1056	revealed	_	
6-7	1057-1058	a	_	
6-8	1059-1066	similar	_	
6-9	1067-1074	pattern	_	
6-10	1075-1077	of	_	
6-11	1078-1084	reward	_	
6-12	1085-1091	volume	_	
6-13	1092-1103	differences	_	
6-14	1104-1108	with	_	
6-15	1109-1120	significant	_	
6-16	1121-1127	gender	_	
6-17	1128-1140	interactions	_	
6-18	1141-1144	for	_	
6-19	1145-1150	DLPFC	_	
6-20	1151-1154	and	_	
6-21	1155-1158	VDC	_	
6-22	1158-1159	.	_	

#Text=Overall, the volume of the cerebral ventricles in ALC participants was negatively associated with duration of abstinence, suggesting decline in atrophy over time.
#Text=1.
7-1	1160-1167	Overall	_	
7-2	1167-1168	,	_	
7-3	1169-1172	the	_	
7-4	1173-1179	volume	_	
7-5	1180-1182	of	_	
7-6	1183-1186	the	_	
7-7	1187-1195	cerebral	_	
7-8	1196-1206	ventricles	_	
7-9	1207-1209	in	_	
7-10	1210-1213	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
7-11	1214-1226	participants	_	
7-12	1227-1230	was	_	
7-13	1231-1241	negatively	_	
7-14	1242-1252	associated	_	
7-15	1253-1257	with	_	
7-16	1258-1266	duration	_	
7-17	1267-1269	of	_	
7-18	1270-1280	abstinence	_	
7-19	1280-1281	,	_	
7-20	1282-1292	suggesting	_	
7-21	1293-1300	decline	_	
7-22	1301-1303	in	_	
7-23	1304-1311	atrophy	_	
7-24	1312-1316	over	_	
7-25	1317-1321	time	_	
7-26	1321-1322	.	_	
7-27	1323-1324	1	_	
7-28	1324-1325	.	_	

#Text=Introduction
#Text=Identification of gender differences in association with Alcohol Use Disorder (referred to hereafter as “alcoholism”) has sparked controversy regarding the extent of cerebral and neuropsychological pathology, but little research exists to inform this debate.
8-1	1326-1338	Introduction	_	
8-2	1339-1353	Identification	_	
8-3	1354-1356	of	_	
8-4	1357-1363	gender	_	
8-5	1364-1375	differences	_	
8-6	1376-1378	in	_	
8-7	1379-1390	association	_	
8-8	1391-1395	with	_	
8-9	1396-1403	Alcohol	_	
8-10	1404-1407	Use	_	
8-11	1408-1416	Disorder	_	
8-12	1417-1418	(	_	
8-13	1418-1426	referred	_	
8-14	1427-1429	to	_	
8-15	1430-1439	hereafter	_	
8-16	1440-1442	as	_	
8-17	1443-1444	“	_	
8-18	1444-1454	alcoholism	_	
8-19	1454-1455	”	_	
8-20	1455-1456	)	_	
8-21	1457-1460	has	_	
8-22	1461-1468	sparked	_	
8-23	1469-1480	controversy	_	
8-24	1481-1490	regarding	_	
8-25	1491-1494	the	_	
8-26	1495-1501	extent	_	
8-27	1502-1504	of	_	
8-28	1505-1513	cerebral	_	
8-29	1514-1517	and	_	
8-30	1518-1536	neuropsychological	_	
8-31	1537-1546	pathology	_	
8-32	1546-1547	,	_	
8-33	1548-1551	but	_	
8-34	1552-1558	little	_	
8-35	1559-1567	research	_	
8-36	1568-1574	exists	_	
8-37	1575-1577	to	_	
8-38	1578-1584	inform	_	
8-39	1585-1589	this	_	
8-40	1590-1596	debate	_	
8-41	1596-1597	.	_	

#Text=Independent neuropathological processes may distinguish the residual effects of alcoholism on women from those on men, and neuroimaging provides insight into how brain structures are differentially affected with abstinence.
9-1	1598-1609	Independent	_	
9-2	1610-1627	neuropathological	_	
9-3	1628-1637	processes	_	
9-4	1638-1641	may	_	
9-5	1642-1653	distinguish	_	
9-6	1654-1657	the	_	
9-7	1658-1666	residual	_	
9-8	1667-1674	effects	_	
9-9	1675-1677	of	_	
9-10	1678-1688	alcoholism	_	
9-11	1689-1691	on	_	
9-12	1692-1697	women	_	
9-13	1698-1702	from	_	
9-14	1703-1708	those	_	
9-15	1709-1711	on	_	
9-16	1712-1715	men	_	
9-17	1715-1716	,	_	
9-18	1717-1720	and	_	
9-19	1721-1733	neuroimaging	_	
9-20	1734-1742	provides	_	
9-21	1743-1750	insight	_	
9-22	1751-1755	into	_	
9-23	1756-1759	how	_	
9-24	1760-1765	brain	_	
9-25	1766-1776	structures	_	
9-26	1777-1780	are	_	
9-27	1781-1795	differentially	_	
9-28	1796-1804	affected	_	
9-29	1805-1809	with	_	
9-30	1810-1820	abstinence	_	
9-31	1820-1821	.	_	

#Text=Importantly, care should be taken not to confound the long-term neuropsychological sequelae of alcoholism with the responses to acute intoxication, or other health consequences associated with ongoing heavy alcohol consumption.
10-1	1822-1833	Importantly	_	
10-2	1833-1834	,	_	
10-3	1835-1839	care	_	
10-4	1840-1846	should	_	
10-5	1847-1849	be	_	
10-6	1850-1855	taken	_	
10-7	1856-1859	not	_	
10-8	1860-1862	to	_	
10-9	1863-1871	confound	_	
10-10	1872-1875	the	_	
10-11	1876-1885	long-term	_	
10-12	1886-1904	neuropsychological	_	
10-13	1905-1913	sequelae	_	
10-14	1914-1916	of	_	
10-15	1917-1927	alcoholism	_	
10-16	1928-1932	with	_	
10-17	1933-1936	the	_	
10-18	1937-1946	responses	_	
10-19	1947-1949	to	_	
10-20	1950-1955	acute	_	
10-21	1956-1968	intoxication	_	
10-22	1968-1969	,	_	
10-23	1970-1972	or	_	
10-24	1973-1978	other	_	
10-25	1979-1985	health	_	
10-26	1986-1998	consequences	_	
10-27	1999-2009	associated	_	
10-28	2010-2014	with	_	
10-29	2015-2022	ongoing	_	
10-30	2023-2028	heavy	_	
10-31	2029-2036	alcohol	_	
10-32	2037-2048	consumption	_	
10-33	2048-2049	.	_	

#Text=These confounding factors can be mitigated by comparing men and women after long periods of abstinence.
11-1	2050-2055	These	_	
11-2	2056-2067	confounding	_	
11-3	2068-2075	factors	_	
11-4	2076-2079	can	_	
11-5	2080-2082	be	_	
11-6	2083-2092	mitigated	_	
11-7	2093-2095	by	_	
11-8	2096-2105	comparing	_	
11-9	2106-2109	men	_	
11-10	2110-2113	and	_	
11-11	2114-2119	women	_	
11-12	2120-2125	after	_	
11-13	2126-2130	long	_	
11-14	2131-2138	periods	_	
11-15	2139-2141	of	_	
11-16	2142-2152	abstinence	_	
11-17	2152-2153	.	_	

#Text=The few studies examining the relationship between gender and long-term alcoholism pathology have produced conflicting results, especially in terms of specific effects on the brains of women.
12-1	2154-2157	The	_	
12-2	2158-2161	few	_	
12-3	2162-2169	studies	_	
12-4	2170-2179	examining	_	
12-5	2180-2183	the	_	
12-6	2184-2196	relationship	_	
12-7	2197-2204	between	_	
12-8	2205-2211	gender	_	
12-9	2212-2215	and	_	
12-10	2216-2225	long-term	_	
12-11	2226-2236	alcoholism	_	
12-12	2237-2246	pathology	_	
12-13	2247-2251	have	_	
12-14	2252-2260	produced	_	
12-15	2261-2272	conflicting	_	
12-16	2273-2280	results	_	
12-17	2280-2281	,	_	
12-18	2282-2292	especially	_	
12-19	2293-2295	in	_	
12-20	2296-2301	terms	_	
12-21	2302-2304	of	_	
12-22	2305-2313	specific	_	
12-23	2314-2321	effects	_	
12-24	2322-2324	on	_	
12-25	2325-2328	the	_	
12-26	2329-2335	brains	_	
12-27	2336-2338	of	_	
12-28	2339-2344	women	_	
12-29	2344-2345	.	_	

#Text=Using structural magnetic resonance imaging (MRI), Pfefferbaum and colleagues found less brain shrinkage among alcoholic women than among alcoholic men.
13-1	2346-2351	Using	_	
13-2	2352-2362	structural	_	
13-3	2363-2371	magnetic	_	
13-4	2372-2381	resonance	_	
13-5	2382-2389	imaging	_	
13-6	2390-2391	(	_	
13-7	2391-2394	MRI	_	
13-8	2394-2395	)	_	
13-9	2395-2396	,	_	
13-10	2397-2408	Pfefferbaum	_	
13-11	2409-2412	and	_	
13-12	2413-2423	colleagues	_	
13-13	2424-2429	found	_	
13-14	2430-2434	less	_	
13-15	2435-2440	brain	_	
13-16	2441-2450	shrinkage	_	
13-17	2451-2456	among	_	
13-18	2457-2466	alcoholic	_	
13-19	2467-2472	women	_	
13-20	2473-2477	than	_	
13-21	2478-2483	among	_	
13-22	2484-2493	alcoholic	_	
13-23	2494-2497	men	_	
13-24	2497-2498	.	_	

#Text=Kroft and colleagues found that the average ventricular volume in alcoholic women was within the typical range found in MRI studies of nonalcoholic women of similar ages.
14-1	2499-2504	Kroft	_	
14-2	2505-2508	and	_	
14-3	2509-2519	colleagues	_	
14-4	2520-2525	found	_	
14-5	2526-2530	that	_	
14-6	2531-2534	the	_	
14-7	2535-2542	average	_	
14-8	2543-2554	ventricular	_	
14-9	2555-2561	volume	_	
14-10	2562-2564	in	_	
14-11	2565-2574	alcoholic	_	
14-12	2575-2580	women	_	
14-13	2581-2584	was	_	
14-14	2585-2591	within	_	
14-15	2592-2595	the	_	
14-16	2596-2603	typical	_	
14-17	2604-2609	range	_	
14-18	2610-2615	found	_	
14-19	2616-2618	in	_	
14-20	2619-2622	MRI	_	
14-21	2623-2630	studies	_	
14-22	2631-2633	of	_	
14-23	2634-2646	nonalcoholic	_	
14-24	2647-2652	women	_	
14-25	2653-2655	of	_	
14-26	2656-2663	similar	_	
14-27	2664-2668	ages	_	
14-28	2668-2669	.	_	

#Text=However, Hommer and colleagues  found that the corpus callosum was smaller in alcoholic women than in alcoholic men and nonalcoholic control women; alcoholic men did not differ from nonalcoholic control men.
15-1	2670-2677	However	_	
15-2	2677-2678	,	_	
15-3	2679-2685	Hommer	_	
15-4	2686-2689	and	_	
15-5	2690-2700	colleagues	_	
15-6	2702-2707	found	_	
15-7	2708-2712	that	_	
15-8	2713-2716	the	_	
15-9	2717-2723	corpus	_	
15-10	2724-2732	callosum	_	
15-11	2733-2736	was	_	
15-12	2737-2744	smaller	_	
15-13	2745-2747	in	_	
15-14	2748-2757	alcoholic	_	
15-15	2758-2763	women	_	
15-16	2764-2768	than	_	
15-17	2769-2771	in	_	
15-18	2772-2781	alcoholic	_	
15-19	2782-2785	men	_	
15-20	2786-2789	and	_	
15-21	2790-2802	nonalcoholic	_	
15-22	2803-2810	control	_	
15-23	2811-2816	women	_	
15-24	2816-2817	;	_	
15-25	2818-2827	alcoholic	_	
15-26	2828-2831	men	_	
15-27	2832-2835	did	_	
15-28	2836-2839	not	_	
15-29	2840-2846	differ	_	
15-30	2847-2851	from	_	
15-31	2852-2864	nonalcoholic	_	
15-32	2865-2872	control	_	
15-33	2873-2876	men	_	
15-34	2876-2877	.	_	

#Text=Using computerized tomography scans to measure atrophy, Jacobson reported that alcoholic women presented with greater ventricular enlargement and widening of cortical sulci than nonalcoholic women, and Mann and colleagues found comparable degrees of brain atrophy in men and women despite shorter drinking histories in the women.
16-1	2878-2883	Using	_	
16-2	2884-2896	computerized	_	
16-3	2897-2907	tomography	_	
16-4	2908-2913	scans	_	
16-5	2914-2916	to	_	
16-6	2917-2924	measure	_	
16-7	2925-2932	atrophy	_	
16-8	2932-2933	,	_	
16-9	2934-2942	Jacobson	_	
16-10	2943-2951	reported	_	
16-11	2952-2956	that	_	
16-12	2957-2966	alcoholic	_	
16-13	2967-2972	women	_	
16-14	2973-2982	presented	_	
16-15	2983-2987	with	_	
16-16	2988-2995	greater	_	
16-17	2996-3007	ventricular	_	
16-18	3008-3019	enlargement	_	
16-19	3020-3023	and	_	
16-20	3024-3032	widening	_	
16-21	3033-3035	of	_	
16-22	3036-3044	cortical	_	
16-23	3045-3050	sulci	_	
16-24	3051-3055	than	_	
16-25	3056-3068	nonalcoholic	_	
16-26	3069-3074	women	_	
16-27	3074-3075	,	_	
16-28	3076-3079	and	_	
16-29	3080-3084	Mann	_	
16-30	3085-3088	and	_	
16-31	3089-3099	colleagues	_	
16-32	3100-3105	found	_	
16-33	3106-3116	comparable	_	
16-34	3117-3124	degrees	_	
16-35	3125-3127	of	_	
16-36	3128-3133	brain	_	
16-37	3134-3141	atrophy	_	
16-38	3142-3144	in	_	
16-39	3145-3148	men	_	
16-40	3149-3152	and	_	
16-41	3153-3158	women	_	
16-42	3159-3166	despite	_	
16-43	3167-3174	shorter	_	
16-44	3175-3183	drinking	_	
16-45	3184-3193	histories	_	
16-46	3194-3196	in	_	
16-47	3197-3200	the	_	
16-48	3201-3206	women	_	
16-49	3206-3207	.	_	

#Text=Therefore, to clarify these conflicting results, we sought to examine how different lengths of abstinence are related to brain morphometry, from relatively short- (four weeks) through long periods (many years).
17-1	3208-3217	Therefore	_	
17-2	3217-3218	,	_	
17-3	3219-3221	to	_	
17-4	3222-3229	clarify	_	
17-5	3230-3235	these	_	
17-6	3236-3247	conflicting	_	
17-7	3248-3255	results	_	
17-8	3255-3256	,	_	
17-9	3257-3259	we	_	
17-10	3260-3266	sought	_	
17-11	3267-3269	to	_	
17-12	3270-3277	examine	_	
17-13	3278-3281	how	_	
17-14	3282-3291	different	_	
17-15	3292-3299	lengths	_	
17-16	3300-3302	of	_	
17-17	3303-3313	abstinence	_	
17-18	3314-3317	are	_	
17-19	3318-3325	related	_	
17-20	3326-3328	to	_	
17-21	3329-3334	brain	_	
17-22	3335-3346	morphometry	_	
17-23	3346-3347	,	_	
17-24	3348-3352	from	_	
17-25	3353-3363	relatively	_	
17-26	3364-3369	short	_	
17-27	3369-3370	-	_	
17-28	3371-3372	(	_	
17-29	3372-3376	four	_	
17-30	3377-3382	weeks	_	
17-31	3382-3383	)	_	
17-32	3384-3391	through	_	
17-33	3392-3396	long	_	
17-34	3397-3404	periods	_	
17-35	3405-3406	(	_	
17-36	3406-3410	many	_	
17-37	3411-3416	years	_	
17-38	3416-3417	)	_	
17-39	3417-3418	.	_	

#Text=In other studies, Pfefferbaum and colleagues measured white matter brain microstructure in alcoholic women by using diffusion tensor imaging (DTI).
18-1	3419-3421	In	_	
18-2	3422-3427	other	_	
18-3	3428-3435	studies	_	
18-4	3435-3436	,	_	
18-5	3437-3448	Pfefferbaum	_	
18-6	3449-3452	and	_	
18-7	3453-3463	colleagues	_	
18-8	3464-3472	measured	_	
18-9	3473-3478	white	_	
18-10	3479-3485	matter	_	
18-11	3486-3491	brain	_	
18-12	3492-3506	microstructure	_	
18-13	3507-3509	in	_	
18-14	3510-3519	alcoholic	_	
18-15	3520-3525	women	_	
18-16	3526-3528	by	_	
18-17	3529-3534	using	_	
18-18	3535-3544	diffusion	_	
18-19	3545-3551	tensor	_	
18-20	3552-3559	imaging	_	
18-21	3560-3561	(	_	
18-22	3561-3564	DTI	_	
18-23	3564-3565	)	_	
18-24	3565-3566	.	_	

#Text=They noted cerebral white matter abnormalities in women alcoholics that were not observed with conventional MRI, suggesting that alcohol use by women is associated with white matter microstructural disruption that may antedate detection with the use of grosser measures of white matter volumetric loss .
19-1	3567-3571	They	_	
19-2	3572-3577	noted	_	
19-3	3578-3586	cerebral	_	
19-4	3587-3592	white	_	
19-5	3593-3599	matter	_	
19-6	3600-3613	abnormalities	_	
19-7	3614-3616	in	_	
19-8	3617-3622	women	_	
19-9	3623-3633	alcoholics	_	
19-10	3634-3638	that	_	
19-11	3639-3643	were	_	
19-12	3644-3647	not	_	
19-13	3648-3656	observed	_	
19-14	3657-3661	with	_	
19-15	3662-3674	conventional	_	
19-16	3675-3678	MRI	_	
19-17	3678-3679	,	_	
19-18	3680-3690	suggesting	_	
19-19	3691-3695	that	_	
19-20	3696-3703	alcohol	_	
19-21	3704-3707	use	_	
19-22	3708-3710	by	_	
19-23	3711-3716	women	_	
19-24	3717-3719	is	_	
19-25	3720-3730	associated	_	
19-26	3731-3735	with	_	
19-27	3736-3741	white	_	
19-28	3742-3748	matter	_	
19-29	3749-3764	microstructural	_	
19-30	3765-3775	disruption	_	
19-31	3776-3780	that	_	
19-32	3781-3784	may	_	
19-33	3785-3793	antedate	_	
19-34	3794-3803	detection	_	
19-35	3804-3808	with	_	
19-36	3809-3812	the	_	
19-37	3813-3816	use	_	
19-38	3817-3819	of	_	
19-39	3820-3827	grosser	_	
19-40	3828-3836	measures	_	
19-41	3837-3839	of	_	
19-42	3840-3845	white	_	
19-43	3846-3852	matter	_	
19-44	3853-3863	volumetric	_	
19-45	3864-3868	loss	_	
19-46	3869-3870	.	_	

#Text=They also found that fractional anisotropy changes showed gender differences, being more pronounced in the corpus callosum in men and more pronounced in the centrum semiovale in women.
20-1	3871-3875	They	_	
20-2	3876-3880	also	_	
20-3	3881-3886	found	_	
20-4	3887-3891	that	_	
20-5	3892-3902	fractional	_	
20-6	3903-3913	anisotropy	_	
20-7	3914-3921	changes	_	
20-8	3922-3928	showed	_	
20-9	3929-3935	gender	_	
20-10	3936-3947	differences	_	
20-11	3947-3948	,	_	
20-12	3949-3954	being	_	
20-13	3955-3959	more	_	
20-14	3960-3970	pronounced	_	
20-15	3971-3973	in	_	
20-16	3974-3977	the	_	
20-17	3978-3984	corpus	_	
20-18	3985-3993	callosum	_	
20-19	3994-3996	in	_	
20-20	3997-4000	men	_	
20-21	4001-4004	and	_	
20-22	4005-4009	more	_	
20-23	4010-4020	pronounced	_	
20-24	4021-4023	in	_	
20-25	4024-4027	the	_	
20-26	4028-4035	centrum	_	
20-27	4036-4045	semiovale	_	
20-28	4046-4048	in	_	
20-29	4049-4054	women	_	
20-30	4054-4055	.	_	

#Text=Additionally, Pfefferbaum and colleagues reported that, when matched for alcohol exposure, alcoholic women showed more DTI signs of white matter degradation than alcoholic men in several fiber bundles, and that alcoholic women with longer abstinence from alcohol had larger cortical white matter volumes.
21-1	4056-4068	Additionally	_	
21-2	4068-4069	,	_	
21-3	4070-4081	Pfefferbaum	_	
21-4	4082-4085	and	_	
21-5	4086-4096	colleagues	_	
21-6	4097-4105	reported	_	
21-7	4106-4110	that	_	
21-8	4110-4111	,	_	
21-9	4112-4116	when	_	
21-10	4117-4124	matched	_	
21-11	4125-4128	for	_	
21-12	4129-4136	alcohol	_	
21-13	4137-4145	exposure	_	
21-14	4145-4146	,	_	
21-15	4147-4156	alcoholic	_	
21-16	4157-4162	women	_	
21-17	4163-4169	showed	_	
21-18	4170-4174	more	_	
21-19	4175-4178	DTI	_	
21-20	4179-4184	signs	_	
21-21	4185-4187	of	_	
21-22	4188-4193	white	_	
21-23	4194-4200	matter	_	
21-24	4201-4212	degradation	_	
21-25	4213-4217	than	_	
21-26	4218-4227	alcoholic	_	
21-27	4228-4231	men	_	
21-28	4232-4234	in	_	
21-29	4235-4242	several	_	
21-30	4243-4248	fiber	_	
21-31	4249-4256	bundles	_	
21-32	4256-4257	,	_	
21-33	4258-4261	and	_	
21-34	4262-4266	that	_	
21-35	4267-4276	alcoholic	_	
21-36	4277-4282	women	_	
21-37	4283-4287	with	_	
21-38	4288-4294	longer	_	
21-39	4295-4305	abstinence	_	
21-40	4306-4310	from	_	
21-41	4311-4318	alcohol	_	
21-42	4319-4322	had	_	
21-43	4323-4329	larger	_	
21-44	4330-4338	cortical	_	
21-45	4339-4344	white	_	
21-46	4345-4351	matter	_	
21-47	4352-4359	volumes	_	
21-48	4359-4360	.	_	

#Text=However, in a later study, Pfefferbaum et al. did not identify alcoholism-related differences in diffusion measures.
22-1	4361-4368	However	_	
22-2	4368-4369	,	_	
22-3	4370-4372	in	_	
22-4	4373-4374	a	_	
22-5	4375-4380	later	_	
22-6	4381-4386	study	_	
22-7	4386-4387	,	_	
22-8	4388-4399	Pfefferbaum	_	
22-9	4400-4402	et	_	
22-10	4403-4405	al	_	
22-11	4405-4406	.	_	
22-12	4407-4410	did	_	
22-13	4411-4414	not	_	
22-14	4415-4423	identify	_	
22-15	4424-4442	alcoholism-related	_	
22-16	4443-4454	differences	_	
22-17	4455-4457	in	_	
22-18	4458-4467	diffusion	_	
22-19	4468-4476	measures	_	
22-20	4476-4477	.	_	

#Text=Ruiz and colleagues found widespread white matter degradation in alcoholic women (in frontal, temporal, ventricular, and callosal regions) but only callosal degradation in men; women experienced faster callosal white matter recovery during abstinence.
23-1	4478-4482	Ruiz	_	
23-2	4483-4486	and	_	
23-3	4487-4497	colleagues	_	
23-4	4498-4503	found	_	
23-5	4504-4514	widespread	_	
23-6	4515-4520	white	_	
23-7	4521-4527	matter	_	
23-8	4528-4539	degradation	_	
23-9	4540-4542	in	_	
23-10	4543-4552	alcoholic	_	
23-11	4553-4558	women	_	
23-12	4559-4560	(	_	
23-13	4560-4562	in	_	
23-14	4563-4570	frontal	_	
23-15	4570-4571	,	_	
23-16	4572-4580	temporal	_	
23-17	4580-4581	,	_	
23-18	4582-4593	ventricular	_	
23-19	4593-4594	,	_	
23-20	4595-4598	and	_	
23-21	4599-4607	callosal	_	
23-22	4608-4615	regions	_	
23-23	4615-4616	)	_	
23-24	4617-4620	but	_	
23-25	4621-4625	only	_	
23-26	4626-4634	callosal	_	
23-27	4635-4646	degradation	_	
23-28	4647-4649	in	_	
23-29	4650-4653	men	_	
23-30	4653-4654	;	_	
23-31	4655-4660	women	_	
23-32	4661-4672	experienced	_	
23-33	4673-4679	faster	_	
23-34	4680-4688	callosal	_	
23-35	4689-4694	white	_	
23-36	4695-4701	matter	_	
23-37	4702-4710	recovery	_	
23-38	4711-4717	during	_	
23-39	4718-4728	abstinence	_	
23-40	4728-4729	.	_	

#Text=However, another study using magnetic resonance spectroscopy (MRS) to compare alcoholic men and women found that in frontal lobe gray matter, but not frontal lobe white matter, alcoholic women had a significantly greater deficit in concentrations of N-acetylaspartate (a marker for neuronal integrity) than alcoholic men.
24-1	4730-4737	However	_	
24-2	4737-4738	,	_	
24-3	4739-4746	another	_	
24-4	4747-4752	study	_	
24-5	4753-4758	using	_	
24-6	4759-4767	magnetic	_	
24-7	4768-4777	resonance	_	
24-8	4778-4790	spectroscopy	_	
24-9	4791-4792	(	_	
24-10	4792-4795	MRS	_	
24-11	4795-4796	)	_	
24-12	4797-4799	to	_	
24-13	4800-4807	compare	_	
24-14	4808-4817	alcoholic	_	
24-15	4818-4821	men	_	
24-16	4822-4825	and	_	
24-17	4826-4831	women	_	
24-18	4832-4837	found	_	
24-19	4838-4842	that	_	
24-20	4843-4845	in	_	
24-21	4846-4853	frontal	_	
24-22	4854-4858	lobe	_	
24-23	4859-4863	gray	_	
24-24	4864-4870	matter	_	
24-25	4870-4871	,	_	
24-26	4872-4875	but	_	
24-27	4876-4879	not	_	
24-28	4880-4887	frontal	_	
24-29	4888-4892	lobe	_	
24-30	4893-4898	white	_	
24-31	4899-4905	matter	_	
24-32	4905-4906	,	_	
24-33	4907-4916	alcoholic	_	
24-34	4917-4922	women	_	
24-35	4923-4926	had	_	
24-36	4927-4928	a	_	
24-37	4929-4942	significantly	_	
24-38	4943-4950	greater	_	
24-39	4951-4958	deficit	_	
24-40	4959-4961	in	_	
24-41	4962-4976	concentrations	_	
24-42	4977-4979	of	_	
24-43	4980-4997	N-acetylaspartate	_	
24-44	4998-4999	(	_	
24-45	4999-5000	a	_	
24-46	5001-5007	marker	_	
24-47	5008-5011	for	_	
24-48	5012-5020	neuronal	_	
24-49	5021-5030	integrity	_	
24-50	5030-5031	)	_	
24-51	5032-5036	than	_	
24-52	5037-5046	alcoholic	_	
24-53	5047-5050	men	_	
24-54	5050-5051	.	_	

#Text=The MRS findings are consistent with the suggestion by Hommer and colleagues that gray matter damage distinguishes alcoholic women and men to a greater extent than white matter damage.
25-1	5052-5055	The	_	
25-2	5056-5059	MRS	_	
25-3	5060-5068	findings	_	
25-4	5069-5072	are	_	
25-5	5073-5083	consistent	_	
25-6	5084-5088	with	_	
25-7	5089-5092	the	_	
25-8	5093-5103	suggestion	_	
25-9	5104-5106	by	_	
25-10	5107-5113	Hommer	_	
25-11	5114-5117	and	_	
25-12	5118-5128	colleagues	_	
25-13	5129-5133	that	_	
25-14	5134-5138	gray	_	
25-15	5139-5145	matter	_	
25-16	5146-5152	damage	_	
25-17	5153-5166	distinguishes	_	
25-18	5167-5176	alcoholic	_	
25-19	5177-5182	women	_	
25-20	5183-5186	and	_	
25-21	5187-5190	men	_	
25-22	5191-5193	to	_	
25-23	5194-5195	a	_	
25-24	5196-5203	greater	_	
25-25	5204-5210	extent	_	
25-26	5211-5215	than	_	
25-27	5216-5221	white	_	
25-28	5222-5228	matter	_	
25-29	5229-5235	damage	_	
25-30	5235-5236	.	_	

#Text=These discrepant findings necessitate non-directional hypotheses when considering differences between alcoholic men and women not only in total gray matter, white matter, and ventricular volumes, but also in the total “extended reward and oversight system” and its component subregions.
26-1	5237-5242	These	_	
26-2	5243-5253	discrepant	_	
26-3	5254-5262	findings	_	
26-4	5263-5274	necessitate	_	
26-5	5275-5290	non-directional	_	
26-6	5291-5301	hypotheses	_	
26-7	5302-5306	when	_	
26-8	5307-5318	considering	_	
26-9	5319-5330	differences	_	
26-10	5331-5338	between	_	
26-11	5339-5348	alcoholic	_	
26-12	5349-5352	men	_	
26-13	5353-5356	and	_	
26-14	5357-5362	women	_	
26-15	5363-5366	not	_	
26-16	5367-5371	only	_	
26-17	5372-5374	in	_	
26-18	5375-5380	total	_	
26-19	5381-5385	gray	_	
26-20	5386-5392	matter	_	
26-21	5392-5393	,	_	
26-22	5394-5399	white	_	
26-23	5400-5406	matter	_	
26-24	5406-5407	,	_	
26-25	5408-5411	and	_	
26-26	5412-5423	ventricular	_	
26-27	5424-5431	volumes	_	
26-28	5431-5432	,	_	
26-29	5433-5436	but	_	
26-30	5437-5441	also	_	
26-31	5442-5444	in	_	
26-32	5445-5448	the	_	
26-33	5449-5454	total	_	
26-34	5455-5456	“	_	
26-35	5456-5464	extended	_	
26-36	5465-5471	reward	_	
26-37	5472-5475	and	_	
26-38	5476-5485	oversight	_	
26-39	5486-5492	system	_	
26-40	5492-5493	”	_	
26-41	5494-5497	and	_	
26-42	5498-5501	its	_	
26-43	5502-5511	component	_	
26-44	5512-5522	subregions	_	
26-45	5522-5523	.	_	

#Text=Emotional, memory, and motivational abnormalities in Alcohol Use Disorder are associated with changes in the mesocorticolimbic system, a complex multi-functional network responsive to positive and negative reinforcement.
27-1	5524-5533	Emotional	_	
27-2	5533-5534	,	_	
27-3	5535-5541	memory	_	
27-4	5541-5542	,	_	
27-5	5543-5546	and	_	
27-6	5547-5559	motivational	_	
27-7	5560-5573	abnormalities	_	
27-8	5574-5576	in	_	
27-9	5577-5584	Alcohol	_	
27-10	5585-5588	Use	_	
27-11	5589-5597	Disorder	_	
27-12	5598-5601	are	_	
27-13	5602-5612	associated	_	
27-14	5613-5617	with	_	
27-15	5618-5625	changes	_	
27-16	5626-5628	in	_	
27-17	5629-5632	the	_	
27-18	5633-5650	mesocorticolimbic	_	
27-19	5651-5657	system	_	
27-20	5657-5658	,	_	
27-21	5659-5660	a	_	
27-22	5661-5668	complex	_	
27-23	5669-5685	multi-functional	_	
27-24	5686-5693	network	_	
27-25	5694-5704	responsive	_	
27-26	5705-5707	to	_	
27-27	5708-5716	positive	_	
27-28	5717-5720	and	_	
27-29	5721-5729	negative	_	
27-30	5730-5743	reinforcement	_	
27-31	5743-5744	.	_	

#Text=Principal components of the mesocorticolimbic reward circuit include the amygdala, hippocampus, nucleus accumbens septi (NAc; part of the ventral striatum), and ventral diencephalon (VDC; including basal forebrain, hypothalamus, sublenticular extended amygdala, mammillary bodies, and a large portion of the ventral tegmentum area), and cortical areas with modulating and oversight functions, such as the dorsolateral prefronatal cortex (DLPFC), orbitofrontal, temporal pole, subcallosal, and cingulate cortices, parahippocampal gyri, and the insula (; ).
28-1	5745-5754	Principal	_	
28-2	5755-5765	components	_	
28-3	5766-5768	of	_	
28-4	5769-5772	the	_	
28-5	5773-5790	mesocorticolimbic	_	
28-6	5791-5797	reward	_	
28-7	5798-5805	circuit	_	
28-8	5806-5813	include	_	
28-9	5814-5817	the	_	
28-10	5818-5826	amygdala	_	
28-11	5826-5827	,	_	
28-12	5828-5839	hippocampus	_	
28-13	5839-5840	,	_	
28-14	5841-5848	nucleus	_	
28-15	5849-5858	accumbens	_	
28-16	5859-5864	septi	_	
28-17	5865-5866	(	_	
28-18	5866-5869	NAc	_	
28-19	5869-5870	;	_	
28-20	5871-5875	part	_	
28-21	5876-5878	of	_	
28-22	5879-5882	the	_	
28-23	5883-5890	ventral	_	
28-24	5891-5899	striatum	_	
28-25	5899-5900	)	_	
28-26	5900-5901	,	_	
28-27	5902-5905	and	_	
28-28	5906-5913	ventral	_	
28-29	5914-5926	diencephalon	_	
28-30	5927-5928	(	_	
28-31	5928-5931	VDC	_	
28-32	5931-5932	;	_	
28-33	5933-5942	including	_	
28-34	5943-5948	basal	_	
28-35	5949-5958	forebrain	_	
28-36	5958-5959	,	_	
28-37	5960-5972	hypothalamus	_	
28-38	5972-5973	,	_	
28-39	5974-5987	sublenticular	_	
28-40	5988-5996	extended	_	
28-41	5997-6005	amygdala	_	
28-42	6005-6006	,	_	
28-43	6007-6017	mammillary	_	
28-44	6018-6024	bodies	_	
28-45	6024-6025	,	_	
28-46	6026-6029	and	_	
28-47	6030-6031	a	_	
28-48	6032-6037	large	_	
28-49	6038-6045	portion	_	
28-50	6046-6048	of	_	
28-51	6049-6052	the	_	
28-52	6053-6060	ventral	_	
28-53	6061-6070	tegmentum	_	
28-54	6071-6075	area	_	
28-55	6075-6076	)	_	
28-56	6076-6077	,	_	
28-57	6078-6081	and	_	
28-58	6082-6090	cortical	_	
28-59	6091-6096	areas	_	
28-60	6097-6101	with	_	
28-61	6102-6112	modulating	_	
28-62	6113-6116	and	_	
28-63	6117-6126	oversight	_	
28-64	6127-6136	functions	_	
28-65	6136-6137	,	_	
28-66	6138-6142	such	_	
28-67	6143-6145	as	_	
28-68	6146-6149	the	_	
28-69	6150-6162	dorsolateral	_	
28-70	6163-6174	prefronatal	_	
28-71	6175-6181	cortex	_	
28-72	6182-6183	(	_	
28-73	6183-6188	DLPFC	_	
28-74	6188-6189	)	_	
28-75	6189-6190	,	_	
28-76	6191-6204	orbitofrontal	_	
28-77	6204-6205	,	_	
28-78	6206-6214	temporal	_	
28-79	6215-6219	pole	_	
28-80	6219-6220	,	_	
28-81	6221-6232	subcallosal	_	
28-82	6232-6233	,	_	
28-83	6234-6237	and	_	
28-84	6238-6247	cingulate	_	
28-85	6248-6256	cortices	_	
28-86	6256-6257	,	_	
28-87	6258-6273	parahippocampal	_	
28-88	6274-6278	gyri	_	
28-89	6278-6279	,	_	
28-90	6280-6283	and	_	
28-91	6284-6287	the	_	
28-92	6288-6294	insula	_	
28-93	6295-6296	(	_	
28-94	6296-6297	;	_	
28-95	6298-6299	)	_	
28-96	6299-6300	.	_	

#Text=Collectively, this cortical/subcortical circuitry is referred to as the extended reward and oversight system or the reward network.
29-1	6301-6313	Collectively	_	
29-2	6313-6314	,	_	
29-3	6315-6319	this	_	
29-4	6320-6328	cortical	_	
29-5	6328-6329	/	_	
29-6	6329-6340	subcortical	_	
29-7	6341-6350	circuitry	_	
29-8	6351-6353	is	_	
29-9	6354-6362	referred	_	
29-10	6363-6365	to	_	
29-11	6366-6368	as	_	
29-12	6369-6372	the	_	
29-13	6373-6381	extended	_	
29-14	6382-6388	reward	_	
29-15	6389-6392	and	_	
29-16	6393-6402	oversight	_	
29-17	6403-6409	system	_	
29-18	6410-6412	or	_	
29-19	6413-6416	the	_	
29-20	6417-6423	reward	_	
29-21	6424-6431	network	_	
29-22	6431-6432	.	_	

#Text=The brain's reward system is a critical component of the brain disease model of addiction.
30-1	6433-6436	The	_	
30-2	6437-6444	brain's	_	
30-3	6445-6451	reward	_	
30-4	6452-6458	system	_	
30-5	6459-6461	is	_	
30-6	6462-6463	a	_	
30-7	6464-6472	critical	_	
30-8	6473-6482	component	_	
30-9	6483-6485	of	_	
30-10	6486-6489	the	_	
30-11	6490-6495	brain	_	
30-12	6496-6503	disease	_	
30-13	6504-6509	model	_	
30-14	6510-6512	of	_	
30-15	6513-6522	addiction	_	
30-16	6522-6523	.	_	

#Text=Moreover, Alcohol Use Disorder has been associated with abnormalities in the reward system, but alcoholic women were not included in the research.
31-1	6524-6532	Moreover	_	
31-2	6532-6533	,	_	
31-3	6534-6541	Alcohol	_	
31-4	6542-6545	Use	_	
31-5	6546-6554	Disorder	_	
31-6	6555-6558	has	_	
31-7	6559-6563	been	_	
31-8	6564-6574	associated	_	
31-9	6575-6579	with	_	
31-10	6580-6593	abnormalities	_	
31-11	6594-6596	in	_	
31-12	6597-6600	the	_	
31-13	6601-6607	reward	_	
31-14	6608-6614	system	_	
31-15	6614-6615	,	_	
31-16	6616-6619	but	_	
31-17	6620-6629	alcoholic	_	
31-18	6630-6635	women	_	
31-19	6636-6640	were	_	
31-20	6641-6644	not	_	
31-21	6645-6653	included	_	
31-22	6654-6656	in	_	
31-23	6657-6660	the	_	
31-24	6661-6669	research	_	
31-25	6669-6670	.	_	

#Text=Since there are known differences in the ways in which alcoholism affects men and women, it is essential to disclose these differences, especially with regard to damage in brain systems involved in addiction.
32-1	6671-6676	Since	_	
32-2	6677-6682	there	_	
32-3	6683-6686	are	_	
32-4	6687-6692	known	_	
32-5	6693-6704	differences	_	
32-6	6705-6707	in	_	
32-7	6708-6711	the	_	
32-8	6712-6716	ways	_	
32-9	6717-6719	in	_	
32-10	6720-6725	which	_	
32-11	6726-6736	alcoholism	_	
32-12	6737-6744	affects	_	
32-13	6745-6748	men	_	
32-14	6749-6752	and	_	
32-15	6753-6758	women	_	
32-16	6758-6759	,	_	
32-17	6760-6762	it	_	
32-18	6763-6765	is	_	
32-19	6766-6775	essential	_	
32-20	6776-6778	to	_	
32-21	6779-6787	disclose	_	
32-22	6788-6793	these	_	
32-23	6794-6805	differences	_	
32-24	6805-6806	,	_	
32-25	6807-6817	especially	_	
32-26	6818-6822	with	_	
32-27	6823-6829	regard	_	
32-28	6830-6832	to	_	
32-29	6833-6839	damage	_	
32-30	6840-6842	in	_	
32-31	6843-6848	brain	_	
32-32	6849-6856	systems	_	
32-33	6857-6865	involved	_	
32-34	6866-6868	in	_	
32-35	6869-6878	addiction	_	
32-36	6878-6879	.	_	

#Text=The present study directly addresses that concern, with the hopes of customizing individualized treatment and prevention strategies required by precision medicine.
33-1	6880-6883	The	_	
33-2	6884-6891	present	_	
33-3	6892-6897	study	_	
33-4	6898-6906	directly	_	
33-5	6907-6916	addresses	_	
33-6	6917-6921	that	_	
33-7	6922-6929	concern	_	
33-8	6929-6930	,	_	
33-9	6931-6935	with	_	
33-10	6936-6939	the	_	
33-11	6940-6945	hopes	_	
33-12	6946-6948	of	_	
33-13	6949-6960	customizing	_	
33-14	6961-6975	individualized	_	
33-15	6976-6985	treatment	_	
33-16	6986-6989	and	_	
33-17	6990-7000	prevention	_	
33-18	7001-7011	strategies	_	
33-19	7012-7020	required	_	
33-20	7021-7023	by	_	
33-21	7024-7033	precision	_	
33-22	7034-7042	medicine	_	
33-23	7042-7043	.	_	

#Text=Furthermore, abnormalities in this network not only have implications for clarifying the underlying etiology of addictions such as alcoholism, but also could differentially alter the course of treatment and recovery, by affecting sensitivity to feedback, evaluation of the consequences of one's behavior, and the ability to make economic, social, and health-related decisions.
34-1	7044-7055	Furthermore	_	
34-2	7055-7056	,	_	
34-3	7057-7070	abnormalities	_	
34-4	7071-7073	in	_	
34-5	7074-7078	this	_	
34-6	7079-7086	network	_	
34-7	7087-7090	not	_	
34-8	7091-7095	only	_	
34-9	7096-7100	have	_	
34-10	7101-7113	implications	_	
34-11	7114-7117	for	_	
34-12	7118-7128	clarifying	_	
34-13	7129-7132	the	_	
34-14	7133-7143	underlying	_	
34-15	7144-7152	etiology	_	
34-16	7153-7155	of	_	
34-17	7156-7166	addictions	_	
34-18	7167-7171	such	_	
34-19	7172-7174	as	_	
34-20	7175-7185	alcoholism	_	
34-21	7185-7186	,	_	
34-22	7187-7190	but	_	
34-23	7191-7195	also	_	
34-24	7196-7201	could	_	
34-25	7202-7216	differentially	_	
34-26	7217-7222	alter	_	
34-27	7223-7226	the	_	
34-28	7227-7233	course	_	
34-29	7234-7236	of	_	
34-30	7237-7246	treatment	_	
34-31	7247-7250	and	_	
34-32	7251-7259	recovery	_	
34-33	7259-7260	,	_	
34-34	7261-7263	by	_	
34-35	7264-7273	affecting	_	
34-36	7274-7285	sensitivity	_	
34-37	7286-7288	to	_	
34-38	7289-7297	feedback	_	
34-39	7297-7298	,	_	
34-40	7299-7309	evaluation	_	
34-41	7310-7312	of	_	
34-42	7313-7316	the	_	
34-43	7317-7329	consequences	_	
34-44	7330-7332	of	_	
34-45	7333-7338	one's	_	
34-46	7339-7347	behavior	_	
34-47	7347-7348	,	_	
34-48	7349-7352	and	_	
34-49	7353-7356	the	_	
34-50	7357-7364	ability	_	
34-51	7365-7367	to	_	
34-52	7368-7372	make	_	
34-53	7373-7381	economic	_	
34-54	7381-7382	,	_	
34-55	7383-7389	social	_	
34-56	7389-7390	,	_	
34-57	7391-7394	and	_	
34-58	7395-7409	health-related	_	
34-59	7410-7419	decisions	_	
34-60	7419-7420	.	_	

#Text=In alcoholics, mesocorticolimbic reward circuit regions previously studied with MRI have demonstrated structural changes with both atrophy and white matter damage (, ).
35-1	7421-7423	In	_	
35-2	7424-7434	alcoholics	_	
35-3	7434-7435	,	_	
35-4	7436-7453	mesocorticolimbic	_	
35-5	7454-7460	reward	_	
35-6	7461-7468	circuit	_	
35-7	7469-7476	regions	_	
35-8	7477-7487	previously	_	
35-9	7488-7495	studied	_	
35-10	7496-7500	with	_	
35-11	7501-7504	MRI	_	
35-12	7505-7509	have	_	
35-13	7510-7522	demonstrated	_	
35-14	7523-7533	structural	_	
35-15	7534-7541	changes	_	
35-16	7542-7546	with	_	
35-17	7547-7551	both	_	
35-18	7552-7559	atrophy	_	
35-19	7560-7563	and	_	
35-20	7564-7569	white	_	
35-21	7570-7576	matter	_	
35-22	7577-7583	damage	_	
35-23	7584-7585	(	_	
35-24	7585-7586	,	_	
35-25	7587-7588	)	_	
35-26	7588-7589	.	_	

#Text=The affected regions include not only the reward network as an interconnected system in its entirety, but also its specific component subregions.
36-1	7590-7593	The	_	
36-2	7594-7602	affected	_	
36-3	7603-7610	regions	_	
36-4	7611-7618	include	_	
36-5	7619-7622	not	_	
36-6	7623-7627	only	_	
36-7	7628-7631	the	_	
36-8	7632-7638	reward	_	
36-9	7639-7646	network	_	
36-10	7647-7649	as	_	
36-11	7650-7652	an	_	
36-12	7653-7667	interconnected	_	
36-13	7668-7674	system	_	
36-14	7675-7677	in	_	
36-15	7678-7681	its	_	
36-16	7682-7690	entirety	_	
36-17	7690-7691	,	_	
36-18	7692-7695	but	_	
36-19	7696-7700	also	_	
36-20	7701-7704	its	_	
36-21	7705-7713	specific	_	
36-22	7714-7723	component	_	
36-23	7724-7734	subregions	_	
36-24	7734-7735	.	_	

#Text=However, most studies have included only men.
37-1	7736-7743	However	_	
37-2	7743-7744	,	_	
37-3	7745-7749	most	_	
37-4	7750-7757	studies	_	
37-5	7758-7762	have	_	
37-6	7763-7771	included	_	
37-7	7772-7776	only	_	
37-8	7777-7780	men	_	
37-9	7780-7781	.	_	

#Text=We previously reported morphometric abnormalities in alcoholic men in the reward network.
38-1	7782-7784	We	_	
38-2	7785-7795	previously	_	
38-3	7796-7804	reported	_	
38-4	7805-7817	morphometric	_	
38-5	7818-7831	abnormalities	_	
38-6	7832-7834	in	_	
38-7	7835-7844	alcoholic	_	
38-8	7845-7848	men	_	
38-9	7849-7851	in	_	
38-10	7852-7855	the	_	
38-11	7856-7862	reward	_	
38-12	7863-7870	network	_	
38-13	7870-7871	.	_	

#Text=Using MRI in the present study, we analyzed brains of abstinent long-term chronic alcoholic (ALC) men and women and healthy nonalcoholic control (NC) men and women to test the hypothesis that there are gender differences with respect to the relationship of alcoholism to volumetric measures of the reward network.
39-1	7872-7877	Using	_	
39-2	7878-7881	MRI	_	
39-3	7882-7884	in	_	
39-4	7885-7888	the	_	
39-5	7889-7896	present	_	
39-6	7897-7902	study	_	
39-7	7902-7903	,	_	
39-8	7904-7906	we	_	
39-9	7907-7915	analyzed	_	
39-10	7916-7922	brains	_	
39-11	7923-7925	of	_	
39-12	7926-7935	abstinent	_	
39-13	7936-7945	long-term	_	
39-14	7946-7953	chronic	_	
39-15	7954-7963	alcoholic	_	
39-16	7964-7965	(	_	
39-17	7965-7968	ALC	_	
39-18	7968-7969	)	_	
39-19	7970-7973	men	_	
39-20	7974-7977	and	_	
39-21	7978-7983	women	_	
39-22	7984-7987	and	_	
39-23	7988-7995	healthy	_	
39-24	7996-8008	nonalcoholic	_	
39-25	8009-8016	control	_	
39-26	8017-8018	(	_	
39-27	8018-8020	NC	_	
39-28	8020-8021	)	_	
39-29	8022-8025	men	_	
39-30	8026-8029	and	_	
39-31	8030-8035	women	_	
39-32	8036-8038	to	_	
39-33	8039-8043	test	_	
39-34	8044-8047	the	_	
39-35	8048-8058	hypothesis	_	
39-36	8059-8063	that	_	
39-37	8064-8069	there	_	
39-38	8070-8073	are	_	
39-39	8074-8080	gender	_	
39-40	8081-8092	differences	_	
39-41	8093-8097	with	_	
39-42	8098-8105	respect	_	
39-43	8106-8108	to	_	
39-44	8109-8112	the	_	
39-45	8113-8125	relationship	_	
39-46	8126-8128	of	_	
39-47	8129-8139	alcoholism	_	
39-48	8140-8142	to	_	
39-49	8143-8153	volumetric	_	
39-50	8154-8162	measures	_	
39-51	8163-8165	of	_	
39-52	8166-8169	the	_	
39-53	8170-8176	reward	_	
39-54	8177-8184	network	_	
39-55	8184-8185	.	_	

#Text=We also explored relationships between volumetric alterations of the reward network and drinking history.
#Text=2.
40-1	8186-8188	We	_	
40-2	8189-8193	also	_	
40-3	8194-8202	explored	_	
40-4	8203-8216	relationships	_	
40-5	8217-8224	between	_	
40-6	8225-8235	volumetric	_	
40-7	8236-8247	alterations	_	
40-8	8248-8250	of	_	
40-9	8251-8254	the	_	
40-10	8255-8261	reward	_	
40-11	8262-8269	network	_	
40-12	8270-8273	and	_	
40-13	8274-8282	drinking	_	
40-14	8283-8290	history	_	
40-15	8290-8291	.	_	
40-16	8292-8293	2	_	
40-17	8293-8294	.	_	

#Text=Methods
#Text=2.1.
41-1	8295-8302	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod	
41-2	8303-8306	2.1	_	
41-3	8306-8307	.	_	

#Text=Subjects
#Text=Participants were right-handed (handedness as assessed in) men and women from the Boston area.
42-1	8308-8316	Subjects	_	
42-2	8317-8329	Participants	_	
42-3	8330-8334	were	_	
42-4	8335-8347	right-handed	_	
42-5	8348-8349	(	_	
42-6	8349-8359	handedness	_	
42-7	8360-8362	as	_	
42-8	8363-8371	assessed	_	
42-9	8372-8374	in	_	
42-10	8374-8375	)	_	
42-11	8376-8379	men	_	
42-12	8380-8383	and	_	
42-13	8384-8389	women	_	
42-14	8390-8394	from	_	
42-15	8395-8398	the	_	
42-16	8399-8405	Boston	_	
42-17	8406-8410	area	_	
42-18	8410-8411	.	_	

#Text=The study included 60 abstinent long-term chronic alcoholics (ALC; 30 men) and 60 nonalcoholic controls (NC; 29 men) (Table 1).
43-1	8412-8415	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-2	8416-8421	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-3	8422-8430	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-4	8431-8433	60	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-5	8434-8443	abstinent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-6	8444-8453	long-term	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-7	8454-8461	chronic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-8	8462-8472	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[4]	
43-9	8473-8474	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-10	8474-8477	ALC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[5]	
43-11	8477-8478	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-12	8479-8481	30	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-13	8482-8485	men	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-14	8485-8486	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-15	8487-8490	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-16	8491-8493	60	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-17	8494-8506	nonalcoholic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
43-18	8507-8515	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
43-19	8516-8517	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-20	8517-8519	NC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[7]	
43-21	8519-8520	;	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-22	8521-8523	29	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-23	8524-8527	men	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-24	8527-8528	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-25	8529-8530	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-26	8530-8535	Table	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-27	8536-8537	1	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-28	8537-8538	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
43-29	8538-8539	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	

#Text=Nine of the ALC men and eight of the NC men were added to the sample of men who had participated in our prior research .
44-1	8540-8544	Nine	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-2	8545-8547	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-3	8548-8551	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-4	8552-8555	ALC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[9]	
44-5	8556-8559	men	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-6	8560-8563	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-7	8564-8569	eight	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-8	8570-8572	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-9	8573-8576	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-10	8577-8579	NC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[10]	
44-11	8580-8583	men	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-12	8584-8588	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-13	8589-8594	added	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-14	8595-8597	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-15	8598-8601	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-16	8602-8608	sample	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-17	8609-8611	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-18	8612-8615	men	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-19	8616-8619	who	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-20	8620-8623	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-21	8624-8636	participated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-22	8637-8639	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-23	8640-8643	our	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-24	8644-8649	prior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-25	8650-8658	research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	
44-26	8659-8660	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[8]	

#Text=The ALC men and women were selected to have similar drinking history profiles.
45-1	8661-8664	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
45-2	8665-8668	ALC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]|http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[12]	
45-3	8669-8672	men	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
45-4	8673-8676	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
45-5	8677-8682	women	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
45-6	8683-8687	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
45-7	8688-8696	selected	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
45-8	8697-8699	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
45-9	8700-8704	have	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
45-10	8705-8712	similar	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
45-11	8713-8721	drinking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
45-12	8722-8729	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
45-13	8730-8738	profiles	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	
45-14	8738-8739	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[11]	

#Text=Participation was solicited from newspaper and web-based advertisements and from Boston University Medical Center, Boston Veterans Affairs (VA) Healthcare System, and VA after-care programs.
46-1	8740-8753	Participation	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-2	8754-8757	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-3	8758-8767	solicited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-4	8768-8772	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-5	8773-8782	newspaper	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-6	8783-8786	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-7	8787-8796	web-based	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-8	8797-8811	advertisements	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-9	8812-8815	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-10	8816-8820	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-11	8821-8827	Boston	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-12	8828-8838	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-13	8839-8846	Medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-14	8847-8853	Center	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-15	8853-8854	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-16	8855-8861	Boston	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-17	8862-8870	Veterans	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-18	8871-8878	Affairs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-19	8879-8880	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-20	8880-8882	VA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-21	8882-8883	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-22	8884-8894	Healthcare	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-23	8895-8901	System	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-24	8901-8902	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-25	8903-8906	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-26	8907-8909	VA	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-27	8910-8920	after-care	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-28	8921-8929	programs	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	
46-29	8929-8930	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]	

#Text=The Institutional Review Boards of the participating institutions approved this study.
47-1	8931-8934	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-2	8935-8948	Institutional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-3	8949-8955	Review	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-4	8956-8962	Boards	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-5	8963-8965	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-6	8966-8969	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-7	8970-8983	participating	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-8	8984-8996	institutions	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-9	8997-9005	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-10	9006-9010	this	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-11	9011-9016	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	
47-12	9016-9017	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[14]	

#Text=Informed consent was obtained prior to neuropsychological testing and scanning.
48-1	9018-9026	Informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-2	9027-9034	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-3	9035-9038	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-4	9039-9047	obtained	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-5	9048-9053	prior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-6	9054-9056	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-7	9057-9075	neuropsychological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-8	9076-9083	testing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-9	9084-9087	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-10	9088-9096	scanning	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	
48-11	9096-9097	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[15]	

#Text=Participants were reimbursed for time and travel expenses.
49-1	9098-9110	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
49-2	9111-9115	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
49-3	9116-9126	reimbursed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
49-4	9127-9130	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
49-5	9131-9135	time	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
49-6	9136-9139	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
49-7	9140-9146	travel	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
49-8	9147-9155	expenses	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	
49-9	9155-9156	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[16]	

#Text=Neurobehavioral and psychiatric evaluations typically required from six to nine hours over two or more days.
50-1	9157-9172	Neurobehavioral	_	
50-2	9173-9176	and	_	
50-3	9177-9188	psychiatric	_	
50-4	9189-9200	evaluations	_	
50-5	9201-9210	typically	_	
50-6	9211-9219	required	_	
50-7	9220-9224	from	_	
50-8	9225-9228	six	_	
50-9	9229-9231	to	_	
50-10	9232-9236	nine	_	
50-11	9237-9242	hours	_	
50-12	9243-9247	over	_	
50-13	9248-9251	two	_	
50-14	9252-9254	or	_	
50-15	9255-9259	more	_	
50-16	9260-9264	days	_	
50-17	9264-9265	.	_	

#Text=Participants had frequent breaks as needed.
#Text=2.2.
51-1	9266-9278	Participants	_	
51-2	9279-9282	had	_	
51-3	9283-9291	frequent	_	
51-4	9292-9298	breaks	_	
51-5	9299-9301	as	_	
51-6	9302-9308	needed	_	
51-7	9308-9309	.	_	
51-8	9310-9313	2.2	_	
51-9	9313-9314	.	_	

#Text=Clinical Evaluation and Neuropsychological Assessment
#Text=Participants underwent a medical history interview and vision testing, plus a series of questionnaires (e.g., handedness, medical history, alcohol and drug use) to ensure they met inclusion criteria.
52-1	9315-9323	Clinical	_	
52-2	9324-9334	Evaluation	_	
52-3	9335-9338	and	_	
52-4	9339-9357	Neuropsychological	_	
52-5	9358-9368	Assessment	_	
52-6	9369-9381	Participants	_	
52-7	9382-9391	underwent	_	
52-8	9392-9393	a	_	
52-9	9394-9401	medical	_	
52-10	9402-9409	history	_	
52-11	9410-9419	interview	_	
52-12	9420-9423	and	_	
52-13	9424-9430	vision	_	
52-14	9431-9438	testing	_	
52-15	9438-9439	,	_	
52-16	9440-9444	plus	_	
52-17	9445-9446	a	_	
52-18	9447-9453	series	_	
52-19	9454-9456	of	_	
52-20	9457-9471	questionnaires	_	
52-21	9472-9473	(	_	
52-22	9473-9476	e.g	_	
52-23	9476-9477	.	_	
52-24	9477-9478	,	_	
52-25	9479-9489	handedness	_	
52-26	9489-9490	,	_	
52-27	9491-9498	medical	_	
52-28	9499-9506	history	_	
52-29	9506-9507	,	_	
52-30	9508-9515	alcohol	_	
52-31	9516-9519	and	_	
52-32	9520-9524	drug	_	
52-33	9525-9528	use	_	
52-34	9528-9529	)	_	
52-35	9530-9532	to	_	
52-36	9533-9539	ensure	_	
52-37	9540-9544	they	_	
52-38	9545-9548	met	_	
52-39	9549-9558	inclusion	_	
52-40	9559-9567	criteria	_	
52-41	9567-9568	.	_	

#Text=Participants performed a computer assisted, shortened version of the Diagnostic Interview Schedule that provides lifetime psychiatric diagnoses according to DSM-IV criteria.
53-1	9569-9581	Participants	_	
53-2	9582-9591	performed	_	
53-3	9592-9593	a	_	
53-4	9594-9602	computer	_	
53-5	9603-9611	assisted	_	
53-6	9611-9612	,	_	
53-7	9613-9622	shortened	_	
53-8	9623-9630	version	_	
53-9	9631-9633	of	_	
53-10	9634-9637	the	_	
53-11	9638-9648	Diagnostic	_	
53-12	9649-9658	Interview	_	
53-13	9659-9667	Schedule	_	
53-14	9668-9672	that	_	
53-15	9673-9681	provides	_	
53-16	9682-9690	lifetime	_	
53-17	9691-9702	psychiatric	_	
53-18	9703-9712	diagnoses	_	
53-19	9713-9722	according	_	
53-20	9723-9725	to	_	
53-21	9726-9732	DSM-IV	_	
53-22	9733-9741	criteria	_	
53-23	9741-9742	.	_	

#Text=Participants were excluded from further participation if any source (DIS scores, hospital records, referrals, or personal interviews) indicated that English was not one of their first languages, or if they had any of the following: corrected visual acuity worse than 20/50 in both eyes; Korsakoff's syndrome; HIV; cirrhosis; major head injury with loss of consciousness greater than 30 minutes unrelated to alcoholism; stroke; epilepsy or seizures unrelated to alcoholism; schizophrenia; Hamilton Rating Scale for Depression (HRSD) score over 16; electroconvulsive therapy; history of drug use once per week or more within the past four years (except for one ALC woman who had not smoked marijuana within the past six months, and one ALC man who had not used cocaine within the past eight months).
54-1	9743-9755	Participants	_	
54-2	9756-9760	were	_	
54-3	9761-9769	excluded	_	
54-4	9770-9774	from	_	
54-5	9775-9782	further	_	
54-6	9783-9796	participation	_	
54-7	9797-9799	if	_	
54-8	9800-9803	any	_	
54-9	9804-9810	source	_	
54-10	9811-9812	(	_	
54-11	9812-9815	DIS	_	
54-12	9816-9822	scores	_	
54-13	9822-9823	,	_	
54-14	9824-9832	hospital	_	
54-15	9833-9840	records	_	
54-16	9840-9841	,	_	
54-17	9842-9851	referrals	_	
54-18	9851-9852	,	_	
54-19	9853-9855	or	_	
54-20	9856-9864	personal	_	
54-21	9865-9875	interviews	_	
54-22	9875-9876	)	_	
54-23	9877-9886	indicated	_	
54-24	9887-9891	that	_	
54-25	9892-9899	English	_	
54-26	9900-9903	was	_	
54-27	9904-9907	not	_	
54-28	9908-9911	one	_	
54-29	9912-9914	of	_	
54-30	9915-9920	their	_	
54-31	9921-9926	first	_	
54-32	9927-9936	languages	_	
54-33	9936-9937	,	_	
54-34	9938-9940	or	_	
54-35	9941-9943	if	_	
54-36	9944-9948	they	_	
54-37	9949-9952	had	_	
54-38	9953-9956	any	_	
54-39	9957-9959	of	_	
54-40	9960-9963	the	_	
54-41	9964-9973	following	_	
54-42	9973-9974	:	_	
54-43	9975-9984	corrected	_	
54-44	9985-9991	visual	_	
54-45	9992-9998	acuity	_	
54-46	9999-10004	worse	_	
54-47	10005-10009	than	_	
54-48	10010-10012	20	_	
54-49	10012-10013	/	_	
54-50	10013-10015	50	_	
54-51	10016-10018	in	_	
54-52	10019-10023	both	_	
54-53	10024-10028	eyes	_	
54-54	10028-10029	;	_	
54-55	10030-10041	Korsakoff's	_	
54-56	10042-10050	syndrome	_	
54-57	10050-10051	;	_	
54-58	10052-10055	HIV	_	
54-59	10055-10056	;	_	
54-60	10057-10066	cirrhosis	_	
54-61	10066-10067	;	_	
54-62	10068-10073	major	_	
54-63	10074-10078	head	_	
54-64	10079-10085	injury	_	
54-65	10086-10090	with	_	
54-66	10091-10095	loss	_	
54-67	10096-10098	of	_	
54-68	10099-10112	consciousness	_	
54-69	10113-10120	greater	_	
54-70	10121-10125	than	_	
54-71	10126-10128	30	_	
54-72	10129-10136	minutes	_	
54-73	10137-10146	unrelated	_	
54-74	10147-10149	to	_	
54-75	10150-10160	alcoholism	_	
54-76	10160-10161	;	_	
54-77	10162-10168	stroke	_	
54-78	10168-10169	;	_	
54-79	10170-10178	epilepsy	_	
54-80	10179-10181	or	_	
54-81	10182-10190	seizures	_	
54-82	10191-10200	unrelated	_	
54-83	10201-10203	to	_	
54-84	10204-10214	alcoholism	_	
54-85	10214-10215	;	_	
54-86	10216-10229	schizophrenia	_	
54-87	10229-10230	;	_	
54-88	10231-10239	Hamilton	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[17]	
54-89	10240-10246	Rating	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[17]	
54-90	10247-10252	Scale	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[17]	
54-91	10253-10256	for	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[17]	
54-92	10257-10267	Depression	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[17]	
54-93	10268-10269	(	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[17]	
54-94	10269-10273	HRSD	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[17]	
54-95	10273-10274	)	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale[17]	
54-96	10275-10280	score	_	
54-97	10281-10285	over	_	
54-98	10286-10288	16	_	
54-99	10288-10289	;	_	
54-100	10290-10307	electroconvulsive	_	
54-101	10308-10315	therapy	_	
54-102	10315-10316	;	_	
54-103	10317-10324	history	_	
54-104	10325-10327	of	_	
54-105	10328-10332	drug	_	
54-106	10333-10336	use	_	
54-107	10337-10341	once	_	
54-108	10342-10345	per	_	
54-109	10346-10350	week	_	
54-110	10351-10353	or	_	
54-111	10354-10358	more	_	
54-112	10359-10365	within	_	
54-113	10366-10369	the	_	
54-114	10370-10374	past	_	
54-115	10375-10379	four	_	
54-116	10380-10385	years	_	
54-117	10386-10387	(	_	
54-118	10387-10393	except	_	
54-119	10394-10397	for	_	
54-120	10398-10401	one	_	
54-121	10402-10405	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
54-122	10406-10411	woman	_	
54-123	10412-10415	who	_	
54-124	10416-10419	had	_	
54-125	10420-10423	not	_	
54-126	10424-10430	smoked	_	
54-127	10431-10440	marijuana	_	
54-128	10441-10447	within	_	
54-129	10448-10451	the	_	
54-130	10452-10456	past	_	
54-131	10457-10460	six	_	
54-132	10461-10467	months	_	
54-133	10467-10468	,	_	
54-134	10469-10472	and	_	
54-135	10473-10476	one	_	
54-136	10477-10480	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
54-137	10481-10484	man	_	
54-138	10485-10488	who	_	
54-139	10489-10492	had	_	
54-140	10493-10496	not	_	
54-141	10497-10501	used	_	
54-142	10502-10509	cocaine	_	
54-143	10510-10516	within	_	
54-144	10517-10520	the	_	
54-145	10521-10525	past	_	
54-146	10526-10531	eight	_	
54-147	10532-10538	months	_	
54-148	10538-10539	)	_	
54-149	10539-10540	.	_	

#Text=A number of participants were taking medications for a variety of conditions, had used drugs earlier than four years before enrollment, or had a potentially confounding medical history.
55-1	10541-10542	A	_	
55-2	10543-10549	number	_	
55-3	10550-10552	of	_	
55-4	10553-10565	participants	_	
55-5	10566-10570	were	_	
55-6	10571-10577	taking	_	
55-7	10578-10589	medications	_	
55-8	10590-10593	for	_	
55-9	10594-10595	a	_	
55-10	10596-10603	variety	_	
55-11	10604-10606	of	_	
55-12	10607-10617	conditions	_	
55-13	10617-10618	,	_	
55-14	10619-10622	had	_	
55-15	10623-10627	used	_	
55-16	10628-10633	drugs	_	
55-17	10634-10641	earlier	_	
55-18	10642-10646	than	_	
55-19	10647-10651	four	_	
55-20	10652-10657	years	_	
55-21	10658-10664	before	_	
55-22	10665-10675	enrollment	_	
55-23	10675-10676	,	_	
55-24	10677-10679	or	_	
55-25	10680-10683	had	_	
55-26	10684-10685	a	_	
55-27	10686-10697	potentially	_	
55-28	10698-10709	confounding	_	
55-29	10710-10717	medical	_	
55-30	10718-10725	history	_	
55-31	10725-10726	.	_	

#Text=Therefore, in analyses of the results, a subgroup of 85 participants (31 ALC; 54 NC) was created consisting of “unconfounded” participants who were not currently taking psychotropic medications, and reported never using illicit drugs more than once a week.
56-1	10727-10736	Therefore	_	
56-2	10736-10737	,	_	
56-3	10738-10740	in	_	
56-4	10741-10749	analyses	_	
56-5	10750-10752	of	_	
56-6	10753-10756	the	_	
56-7	10757-10764	results	_	
56-8	10764-10765	,	_	
56-9	10766-10767	a	_	
56-10	10768-10776	subgroup	_	
56-11	10777-10779	of	_	
56-12	10780-10782	85	_	
56-13	10783-10795	participants	_	
56-14	10796-10797	(	_	
56-15	10797-10799	31	_	
56-16	10800-10803	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
56-17	10803-10804	;	_	
56-18	10805-10807	54	_	
56-19	10808-10810	NC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
56-20	10810-10811	)	_	
56-21	10812-10815	was	_	
56-22	10816-10823	created	_	
56-23	10824-10834	consisting	_	
56-24	10835-10837	of	_	
56-25	10838-10839	“	_	
56-26	10839-10851	unconfounded	_	
56-27	10851-10852	”	_	
56-28	10853-10865	participants	_	
56-29	10866-10869	who	_	
56-30	10870-10874	were	_	
56-31	10875-10878	not	_	
56-32	10879-10888	currently	_	
56-33	10889-10895	taking	_	
56-34	10896-10908	psychotropic	_	
56-35	10909-10920	medications	_	
56-36	10920-10921	,	_	
56-37	10922-10925	and	_	
56-38	10926-10934	reported	_	
56-39	10935-10940	never	_	
56-40	10941-10946	using	_	
56-41	10947-10954	illicit	_	
56-42	10955-10960	drugs	_	
56-43	10961-10965	more	_	
56-44	10966-10970	than	_	
56-45	10971-10975	once	_	
56-46	10976-10977	a	_	
56-47	10978-10982	week	_	
56-48	10982-10983	.	_	

#Text=Additionally, that subgroup was restricted to individuals for whom no source indicated: hepatitis; an HRSD score over 13; or any of the following disorders: major depressive, bipolar I or II, schizoaffective, schizophreniform, or generalized anxiety.
57-1	10984-10996	Additionally	_	
57-2	10996-10997	,	_	
57-3	10998-11002	that	_	
57-4	11003-11011	subgroup	_	
57-5	11012-11015	was	_	
57-6	11016-11026	restricted	_	
57-7	11027-11029	to	_	
57-8	11030-11041	individuals	_	
57-9	11042-11045	for	_	
57-10	11046-11050	whom	_	
57-11	11051-11053	no	_	
57-12	11054-11060	source	_	
57-13	11061-11070	indicated	_	
57-14	11070-11071	:	_	
57-15	11072-11081	hepatitis	_	
57-16	11081-11082	;	_	
57-17	11083-11085	an	_	
57-18	11086-11090	HRSD	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale	
57-19	11091-11096	score	_	
57-20	11097-11101	over	_	
57-21	11102-11104	13	_	
57-22	11104-11105	;	_	
57-23	11106-11108	or	_	
57-24	11109-11112	any	_	
57-25	11113-11115	of	_	
57-26	11116-11119	the	_	
57-27	11120-11129	following	_	
57-28	11130-11139	disorders	_	
57-29	11139-11140	:	_	
57-30	11141-11146	major	_	
57-31	11147-11157	depressive	_	
57-32	11157-11158	,	_	
57-33	11159-11166	bipolar	_	
57-34	11167-11168	I	_	
57-35	11169-11171	or	_	
57-36	11172-11174	II	_	
57-37	11174-11175	,	_	
57-38	11176-11191	schizoaffective	_	
57-39	11191-11192	,	_	
57-40	11193-11209	schizophreniform	_	
57-41	11209-11210	,	_	
57-42	11211-11213	or	_	
57-43	11214-11225	generalized	_	
57-44	11226-11233	anxiety	_	
57-45	11233-11234	.	_	

#Text=Analyses of the results from the “unconfounded” subgroup of participants were consistent with those as reported in the text for the total sample.
58-1	11235-11243	Analyses	_	
58-2	11244-11246	of	_	
58-3	11247-11250	the	_	
58-4	11251-11258	results	_	
58-5	11259-11263	from	_	
58-6	11264-11267	the	_	
58-7	11268-11269	“	_	
58-8	11269-11281	unconfounded	_	
58-9	11281-11282	”	_	
58-10	11283-11291	subgroup	_	
58-11	11292-11294	of	_	
58-12	11295-11307	participants	_	
58-13	11308-11312	were	_	
58-14	11313-11323	consistent	_	
58-15	11324-11328	with	_	
58-16	11329-11334	those	_	
58-17	11335-11337	as	_	
58-18	11338-11346	reported	_	
58-19	11347-11349	in	_	
58-20	11350-11353	the	_	
58-21	11354-11358	text	_	
58-22	11359-11362	for	_	
58-23	11363-11366	the	_	
58-24	11367-11372	total	_	
58-25	11373-11379	sample	_	
58-26	11379-11380	.	_	

#Text=Participants received a structured interview regarding their drinking patterns, including length of sobriety (LOS) and duration of heavy drinking (DHD), i.e., more than 21 drinks per week (one drink: 355 ml beer, 148 ml wine, or 44 ml hard liquor).
59-1	11381-11393	Participants	_	
59-2	11394-11402	received	_	
59-3	11403-11404	a	_	
59-4	11405-11415	structured	_	
59-5	11416-11425	interview	_	
59-6	11426-11435	regarding	_	
59-7	11436-11441	their	_	
59-8	11442-11450	drinking	_	
59-9	11451-11459	patterns	_	
59-10	11459-11460	,	_	
59-11	11461-11470	including	_	
59-12	11471-11477	length	_	
59-13	11478-11480	of	_	
59-14	11481-11489	sobriety	_	
59-15	11490-11491	(	_	
59-16	11491-11494	LOS	_	
59-17	11494-11495	)	_	
59-18	11496-11499	and	_	
59-19	11500-11508	duration	_	
59-20	11509-11511	of	_	
59-21	11512-11517	heavy	_	
59-22	11518-11526	drinking	_	
59-23	11527-11528	(	_	
59-24	11528-11531	DHD	_	
59-25	11531-11532	)	_	
59-26	11532-11533	,	_	
59-27	11534-11537	i.e	_	
59-28	11537-11538	.	_	
59-29	11538-11539	,	_	
59-30	11540-11544	more	_	
59-31	11545-11549	than	_	
59-32	11550-11552	21	_	
59-33	11553-11559	drinks	_	
59-34	11560-11563	per	_	
59-35	11564-11568	week	_	
59-36	11569-11570	(	_	
59-37	11570-11573	one	_	
59-38	11574-11579	drink	_	
59-39	11579-11580	:	_	
59-40	11581-11584	355	_	
59-41	11585-11587	ml	_	
59-42	11588-11592	beer	_	
59-43	11592-11593	,	_	
59-44	11594-11597	148	_	
59-45	11598-11600	ml	_	
59-46	11601-11605	wine	_	
59-47	11605-11606	,	_	
59-48	11607-11609	or	_	
59-49	11610-11612	44	_	
59-50	11613-11615	ml	_	
59-51	11616-11620	hard	_	
59-52	11621-11627	liquor	_	
59-53	11627-11628	)	_	
59-54	11628-11629	.	_	

#Text=At-risk drinking is considered to be more than three drinks per week.
60-1	11630-11637	At-risk	_	
60-2	11638-11646	drinking	_	
60-3	11647-11649	is	_	
60-4	11650-11660	considered	_	
60-5	11661-11663	to	_	
60-6	11664-11666	be	_	
60-7	11667-11671	more	_	
60-8	11672-11676	than	_	
60-9	11677-11682	three	_	
60-10	11683-11689	drinks	_	
60-11	11690-11693	per	_	
60-12	11694-11698	week	_	
60-13	11698-11699	.	_	

#Text=Additionally, a Quantity Frequency Index which factors the amount, type, and frequency of alcohol usage (roughly corresponding to number of daily drinks, DD) over the last six months (for the NC participants), or over the six months preceding cessation of drinking (for the ALC participants), was calculated for each participant.
61-1	11700-11712	Additionally	_	
61-2	11712-11713	,	_	
61-3	11714-11715	a	_	
61-4	11716-11724	Quantity	_	
61-5	11725-11734	Frequency	_	
61-6	11735-11740	Index	_	
61-7	11741-11746	which	_	
61-8	11747-11754	factors	_	
61-9	11755-11758	the	_	
61-10	11759-11765	amount	_	
61-11	11765-11766	,	_	
61-12	11767-11771	type	_	
61-13	11771-11772	,	_	
61-14	11773-11776	and	_	
61-15	11777-11786	frequency	_	
61-16	11787-11789	of	_	
61-17	11790-11797	alcohol	_	
61-18	11798-11803	usage	_	
61-19	11804-11805	(	_	
61-20	11805-11812	roughly	_	
61-21	11813-11826	corresponding	_	
61-22	11827-11829	to	_	
61-23	11830-11836	number	_	
61-24	11837-11839	of	_	
61-25	11840-11845	daily	_	
61-26	11846-11852	drinks	_	
61-27	11852-11853	,	_	
61-28	11854-11856	DD	_	
61-29	11856-11857	)	_	
61-30	11858-11862	over	_	
61-31	11863-11866	the	_	
61-32	11867-11871	last	_	
61-33	11872-11875	six	_	
61-34	11876-11882	months	_	
61-35	11883-11884	(	_	
61-36	11884-11887	for	_	
61-37	11888-11891	the	_	
61-38	11892-11894	NC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder	
61-39	11895-11907	participants	_	
61-40	11907-11908	)	_	
61-41	11908-11909	,	_	
61-42	11910-11912	or	_	
61-43	11913-11917	over	_	
61-44	11918-11921	the	_	
61-45	11922-11925	six	_	
61-46	11926-11932	months	_	
61-47	11933-11942	preceding	_	
61-48	11943-11952	cessation	_	
61-49	11953-11955	of	_	
61-50	11956-11964	drinking	_	
61-51	11965-11966	(	_	
61-52	11966-11969	for	_	
61-53	11970-11973	the	_	
61-54	11974-11977	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
61-55	11978-11990	participants	_	
61-56	11990-11991	)	_	
61-57	11991-11992	,	_	
61-58	11993-11996	was	_	
61-59	11997-12007	calculated	_	
61-60	12008-12011	for	_	
61-61	12012-12016	each	_	
61-62	12017-12028	participant	_	
61-63	12028-12029	.	_	

#Text=Subjects also were asked about family history of alcoholism (see Supplemental Table 1).
62-1	12030-12038	Subjects	_	
62-2	12039-12043	also	_	
62-3	12044-12048	were	_	
62-4	12049-12054	asked	_	
62-5	12055-12060	about	_	
62-6	12061-12067	family	_	
62-7	12068-12075	history	_	
62-8	12076-12078	of	_	
62-9	12079-12089	alcoholism	_	
62-10	12090-12091	(	_	
62-11	12091-12094	see	_	
62-12	12095-12107	Supplemental	_	
62-13	12108-12113	Table	_	
62-14	12114-12115	1	_	
62-15	12115-12116	)	_	
62-16	12116-12117	.	_	

#Text=The ALC participants met DSM-IV criteria for alcohol abuse or dependence and drank heavily for a period of at least five years in their lives; they had abstained from alcohol for at least four weeks prior to testing (range of abstinence: four weeks to 38 years), except for one ALC woman and two ALC men with shorter sobriety periods and who were excluded from the unconfounded subgroup.
63-1	12118-12121	The	_	
63-2	12122-12125	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
63-3	12126-12138	participants	_	
63-4	12139-12142	met	_	
63-5	12143-12149	DSM-IV	_	
63-6	12150-12158	criteria	_	
63-7	12159-12162	for	_	
63-8	12163-12170	alcohol	_	
63-9	12171-12176	abuse	_	
63-10	12177-12179	or	_	
63-11	12180-12190	dependence	_	
63-12	12191-12194	and	_	
63-13	12195-12200	drank	_	
63-14	12201-12208	heavily	_	
63-15	12209-12212	for	_	
63-16	12213-12214	a	_	
63-17	12215-12221	period	_	
63-18	12222-12224	of	_	
63-19	12225-12227	at	_	
63-20	12228-12233	least	_	
63-21	12234-12238	five	_	
63-22	12239-12244	years	_	
63-23	12245-12247	in	_	
63-24	12248-12253	their	_	
63-25	12254-12259	lives	_	
63-26	12259-12260	;	_	
63-27	12261-12265	they	_	
63-28	12266-12269	had	_	
63-29	12270-12279	abstained	_	
63-30	12280-12284	from	_	
63-31	12285-12292	alcohol	_	
63-32	12293-12296	for	_	
63-33	12297-12299	at	_	
63-34	12300-12305	least	_	
63-35	12306-12310	four	_	
63-36	12311-12316	weeks	_	
63-37	12317-12322	prior	_	
63-38	12323-12325	to	_	
63-39	12326-12333	testing	_	
63-40	12334-12335	(	_	
63-41	12335-12340	range	_	
63-42	12341-12343	of	_	
63-43	12344-12354	abstinence	_	
63-44	12354-12355	:	_	
63-45	12356-12360	four	_	
63-46	12361-12366	weeks	_	
63-47	12367-12369	to	_	
63-48	12370-12372	38	_	
63-49	12373-12378	years	_	
63-50	12378-12379	)	_	
63-51	12379-12380	,	_	
63-52	12381-12387	except	_	
63-53	12388-12391	for	_	
63-54	12392-12395	one	_	
63-55	12396-12399	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
63-56	12400-12405	woman	_	
63-57	12406-12409	and	_	
63-58	12410-12413	two	_	
63-59	12414-12417	ALC	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse	
63-60	12418-12421	men	_	
63-61	12422-12426	with	_	
63-62	12427-12434	shorter	_	
63-63	12435-12443	sobriety	_	
63-64	12444-12451	periods	_	
63-65	12452-12455	and	_	
63-66	12456-12459	who	_	
63-67	12460-12464	were	_	
63-68	12465-12473	excluded	_	
63-69	12474-12478	from	_	
63-70	12479-12482	the	_	
63-71	12483-12495	unconfounded	_	
63-72	12496-12504	subgroup	_	
63-73	12504-12505	.	_	

#Text=Length of sobriety was ascertained with several comprehensive interviews over multiple testing sessions, in which the date of last drink was obtained and examined for consistency across sessions.
64-1	12506-12512	Length	_	
64-2	12513-12515	of	_	
64-3	12516-12524	sobriety	_	
64-4	12525-12528	was	_	
64-5	12529-12540	ascertained	_	
64-6	12541-12545	with	_	
64-7	12546-12553	several	_	
64-8	12554-12567	comprehensive	_	
64-9	12568-12578	interviews	_	
64-10	12579-12583	over	_	
64-11	12584-12592	multiple	_	
64-12	12593-12600	testing	_	
64-13	12601-12609	sessions	_	
64-14	12609-12610	,	_	
64-15	12611-12613	in	_	
64-16	12614-12619	which	_	
64-17	12620-12623	the	_	
64-18	12624-12628	date	_	
64-19	12629-12631	of	_	
64-20	12632-12636	last	_	
64-21	12637-12642	drink	_	
64-22	12643-12646	was	_	
64-23	12647-12655	obtained	_	
64-24	12656-12659	and	_	
64-25	12660-12668	examined	_	
64-26	12669-12672	for	_	
64-27	12673-12684	consistency	_	
64-28	12685-12691	across	_	
64-29	12692-12700	sessions	_	
64-30	12700-12701	.	_	

#Text=Alcoholic men and women did not differ by DD, DHD, or LOS.
65-1	12702-12711	Alcoholic	_	
65-2	12712-12715	men	_	
65-3	12716-12719	and	_	
65-4	12720-12725	women	_	
65-5	12726-12729	did	_	
65-6	12730-12733	not	_	
65-7	12734-12740	differ	_	
65-8	12741-12743	by	_	
65-9	12744-12746	DD	_	
65-10	12746-12747	,	_	
65-11	12748-12751	DHD	_	
65-12	12751-12752	,	_	
65-13	12753-12755	or	_	
65-14	12756-12759	LOS	_	
65-15	12759-12760	.	_	

#Text=Tests of intelligence, memory, and affect were administered, including the Wechsler Adult Intelligence Scale, Third Edition (WAIS-III) for Full-Scale IQ (FSIQ), Verbal IQ (VIQ), Performance IQ (PIQ), and Working Memory Index (WMI); the Wechsler Memory Scale, Third Edition (WMS-III) for Delayed Memory; the HRSD for depression; and the Multiple Affect Adjective Check List (MAACL) for anxiety.
#Text=2.3.
66-1	12761-12766	Tests	_	
66-2	12767-12769	of	_	
66-3	12770-12782	intelligence	_	
66-4	12782-12783	,	_	
66-5	12784-12790	memory	_	
66-6	12790-12791	,	_	
66-7	12792-12795	and	_	
66-8	12796-12802	affect	_	
66-9	12803-12807	were	_	
66-10	12808-12820	administered	_	
66-11	12820-12821	,	_	
66-12	12822-12831	including	_	
66-13	12832-12835	the	_	
66-14	12836-12844	Wechsler	*[18]	
66-15	12845-12850	Adult	*[18]	
66-16	12851-12863	Intelligence	*[18]	
66-17	12864-12869	Scale	*[18]	
66-18	12869-12870	,	_	
66-19	12871-12876	Third	_	
66-20	12877-12884	Edition	_	
66-21	12885-12886	(	_	
66-22	12886-12894	WAIS-III	_	
66-23	12894-12895	)	_	
66-24	12896-12899	for	_	
66-25	12900-12910	Full-Scale	_	
66-26	12911-12913	IQ	_	
66-27	12914-12915	(	_	
66-28	12915-12919	FSIQ	_	
66-29	12919-12920	)	_	
66-30	12920-12921	,	_	
66-31	12922-12928	Verbal	_	
66-32	12929-12931	IQ	_	
66-33	12932-12933	(	_	
66-34	12933-12936	VIQ	_	
66-35	12936-12937	)	_	
66-36	12937-12938	,	_	
66-37	12939-12950	Performance	_	
66-38	12951-12953	IQ	_	
66-39	12954-12955	(	_	
66-40	12955-12958	PIQ	_	
66-41	12958-12959	)	_	
66-42	12959-12960	,	_	
66-43	12961-12964	and	_	
66-44	12965-12972	Working	_	
66-45	12973-12979	Memory	_	
66-46	12980-12985	Index	_	
66-47	12986-12987	(	_	
66-48	12987-12990	WMI	_	
66-49	12990-12991	)	_	
66-50	12991-12992	;	_	
66-51	12993-12996	the	_	
66-52	12997-13005	Wechsler	_	
66-53	13006-13012	Memory	_	
66-54	13013-13018	Scale	_	
66-55	13018-13019	,	_	
66-56	13020-13025	Third	_	
66-57	13026-13033	Edition	_	
66-58	13034-13035	(	_	
66-59	13035-13042	WMS-III	_	
66-60	13042-13043	)	_	
66-61	13044-13047	for	_	
66-62	13048-13055	Delayed	_	
66-63	13056-13062	Memory	_	
66-64	13062-13063	;	_	
66-65	13064-13067	the	_	
66-66	13068-13072	HRSD	http://maven.renci.org/NeuroBridge/neurobridge#DepressionRatingScale	
66-67	13073-13076	for	_	
66-68	13077-13087	depression	_	
66-69	13087-13088	;	_	
66-70	13089-13092	and	_	
66-71	13093-13096	the	_	
66-72	13097-13105	Multiple	_	
66-73	13106-13112	Affect	_	
66-74	13113-13122	Adjective	_	
66-75	13123-13128	Check	_	
66-76	13129-13133	List	_	
66-77	13134-13135	(	_	
66-78	13135-13140	MAACL	_	
66-79	13140-13141	)	_	
66-80	13142-13145	for	_	
66-81	13146-13153	anxiety	_	
66-82	13153-13154	.	_	
66-83	13155-13158	2.3	_	
66-84	13158-13159	.	_	

#Text=MRI acquisition
#Text=MRI scans were obtained on a Siemens 3-Tesla TIM Trio scanner with an 8-channel head coil (Siemens Medical Solutions USA, Inc., Malvern, Pennsylvania).
67-1	13160-13163	MRI	_	
67-2	13164-13175	acquisition	_	
67-3	13176-13179	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
67-4	13180-13185	scans	_	
67-5	13186-13190	were	_	
67-6	13191-13199	obtained	_	
67-7	13200-13202	on	_	
67-8	13203-13204	a	_	
67-9	13205-13212	Siemens	_	
67-10	13213-13214	3	_	
67-11	13214-13215	-	_	
67-12	13215-13220	Tesla	_	
67-13	13221-13224	TIM	_	
67-14	13225-13229	Trio	_	
67-15	13230-13237	scanner	_	
67-16	13238-13242	with	_	
67-17	13243-13245	an	_	
67-18	13246-13247	8	_	
67-19	13247-13248	-	_	
67-20	13248-13255	channel	_	
67-21	13256-13260	head	_	
67-22	13261-13265	coil	_	
67-23	13266-13267	(	_	
67-24	13267-13274	Siemens	_	
67-25	13275-13282	Medical	_	
67-26	13283-13292	Solutions	_	
67-27	13293-13296	USA	_	
67-28	13296-13297	,	_	
67-29	13298-13301	Inc	_	
67-30	13301-13302	.	_	
67-31	13302-13303	,	_	
67-32	13304-13311	Malvern	_	
67-33	13311-13312	,	_	
67-34	13313-13325	Pennsylvania	_	
67-35	13325-13326	)	_	
67-36	13326-13327	.	_	

#Text=Image acquisitions included sagittal scout and two T1-weighted MP-RAGE series for volumetric analysis: TR=2530ms, TE=3.39ms, TI=1100ms, flip-angle=7°, Field-of-View=256, slice-thickness=1.33mm, number-of-slices=128 contiguous, sagittal images of the entire brain, matrix=256×256, number-of-excitations=2.
68-1	13328-13333	Image	_	
68-2	13334-13346	acquisitions	_	
68-3	13347-13355	included	_	
68-4	13356-13364	sagittal	_	
68-5	13365-13370	scout	_	
68-6	13371-13374	and	_	
68-7	13375-13378	two	_	
68-8	13379-13381	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[19]	
68-9	13381-13382	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[19]	
68-10	13382-13390	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[19]	
68-11	13391-13398	MP-RAGE	_	
68-12	13399-13405	series	_	
68-13	13406-13409	for	_	
68-14	13410-13420	volumetric	_	
68-15	13421-13429	analysis	_	
68-16	13429-13430	:	_	
68-17	13431-13433	TR	_	
68-18	13433-13434	=	_	
68-19	13434-13440	2530ms	_	
68-20	13440-13441	,	_	
68-21	13442-13444	TE	_	
68-22	13444-13445	=	_	
68-23	13445-13451	3.39ms	_	
68-24	13451-13452	,	_	
68-25	13453-13455	TI	_	
68-26	13455-13456	=	_	
68-27	13456-13462	1100ms	_	
68-28	13462-13463	,	_	
68-29	13464-13474	flip-angle	_	
68-30	13474-13475	=	_	
68-31	13475-13476	7	_	
68-32	13476-13477	°	_	
68-33	13477-13478	,	_	
68-34	13479-13492	Field-of-View	_	
68-35	13492-13493	=	_	
68-36	13493-13496	256	_	
68-37	13496-13497	,	_	
68-38	13498-13513	slice-thickness	_	
68-39	13513-13514	=	_	
68-40	13514-13520	1.33mm	_	
68-41	13520-13521	,	_	
68-42	13522-13538	number-of-slices	_	
68-43	13538-13539	=	_	
68-44	13539-13542	128	_	
68-45	13543-13553	contiguous	_	
68-46	13553-13554	,	_	
68-47	13555-13563	sagittal	_	
68-48	13564-13570	images	_	
68-49	13571-13573	of	_	
68-50	13574-13577	the	_	
68-51	13578-13584	entire	_	
68-52	13585-13590	brain	_	
68-53	13590-13591	,	_	
68-54	13592-13598	matrix	_	
68-55	13598-13599	=	_	
68-56	13599-13602	256	_	
68-57	13602-13603	×	_	
68-58	13603-13606	256	_	
68-59	13606-13607	,	_	
68-60	13608-13629	number-of-excitations	_	
68-61	13629-13630	=	_	
68-62	13630-13631	2	_	
68-63	13631-13632	.	_	

#Text=The two MP-RAGE series were averaged, then the averaged series was re-sliced in a standard coronal three-dimensional brain coordinate system.
69-1	13633-13636	The	_	
69-2	13637-13640	two	_	
69-3	13641-13648	MP-RAGE	_	
69-4	13649-13655	series	_	
69-5	13656-13660	were	_	
69-6	13661-13669	averaged	_	
69-7	13669-13670	,	_	
69-8	13671-13675	then	_	
69-9	13676-13679	the	_	
69-10	13680-13688	averaged	_	
69-11	13689-13695	series	_	
69-12	13696-13699	was	_	
69-13	13700-13709	re-sliced	_	
69-14	13710-13712	in	_	
69-15	13713-13714	a	_	
69-16	13715-13723	standard	_	
69-17	13724-13731	coronal	_	
69-18	13732-13749	three-dimensional	_	
69-19	13750-13755	brain	_	
69-20	13756-13766	coordinate	_	
69-21	13767-13773	system	_	
69-22	13773-13774	.	_	

#Text=Images were re-formatted to standard spatial orientation, but not rescaled in size.
#Text=2.4.
70-1	13775-13781	Images	_	
70-2	13782-13786	were	_	
70-3	13787-13799	re-formatted	_	
70-4	13800-13802	to	_	
70-5	13803-13811	standard	_	
70-6	13812-13819	spatial	_	
70-7	13820-13831	orientation	_	
70-8	13831-13832	,	_	
70-9	13833-13836	but	_	
70-10	13837-13840	not	_	
70-11	13841-13849	rescaled	_	
70-12	13850-13852	in	_	
70-13	13853-13857	size	_	
70-14	13857-13858	.	_	
70-15	13859-13862	2.4	_	
70-16	13862-13863	.	_	

#Text=MRI morphometric analyses
#Text=Image analyses followed semi-automated procedures.
71-1	13864-13867	MRI	_	
71-2	13868-13880	morphometric	_	
71-3	13881-13889	analyses	_	
71-4	13890-13895	Image	_	
71-5	13896-13904	analyses	_	
71-6	13905-13913	followed	_	
71-7	13914-13928	semi-automated	_	
71-8	13929-13939	procedures	_	
71-9	13939-13940	.	_	

#Text=Images were inspected for gross abnormalities, and cortical gray matter, white matter, subcortical structures, and ventricles were manually segmented on T1-weighted images using a computer-assisted approach .
72-1	13941-13947	Images	_	
72-2	13948-13952	were	_	
72-3	13953-13962	inspected	_	
72-4	13963-13966	for	_	
72-5	13967-13972	gross	_	
72-6	13973-13986	abnormalities	_	
72-7	13986-13987	,	_	
72-8	13988-13991	and	_	
72-9	13992-14000	cortical	_	
72-10	14001-14005	gray	_	
72-11	14006-14012	matter	_	
72-12	14012-14013	,	_	
72-13	14014-14019	white	_	
72-14	14020-14026	matter	_	
72-15	14026-14027	,	_	
72-16	14028-14039	subcortical	_	
72-17	14040-14050	structures	_	
72-18	14050-14051	,	_	
72-19	14052-14055	and	_	
72-20	14056-14066	ventricles	_	
72-21	14067-14071	were	_	
72-22	14072-14080	manually	_	
72-23	14081-14090	segmented	_	
72-24	14091-14093	on	_	
72-25	14094-14096	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[20]	
72-26	14096-14097	-	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[20]	
72-27	14097-14105	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[20]	
72-28	14106-14112	images	_	
72-29	14113-14118	using	_	
72-30	14119-14120	a	_	
72-31	14121-14138	computer-assisted	_	
72-32	14139-14147	approach	_	
72-33	14148-14149	.	_	

#Text=Neocortex was subdivided further into parcellation units, involving a number of manual and computer-assisted operations.
73-1	14150-14159	Neocortex	_	
73-2	14160-14163	was	_	
73-3	14164-14174	subdivided	_	
73-4	14175-14182	further	_	
73-5	14183-14187	into	_	
73-6	14188-14200	parcellation	_	
73-7	14201-14206	units	_	
73-8	14206-14207	,	_	
73-9	14208-14217	involving	_	
73-10	14218-14219	a	_	
73-11	14220-14226	number	_	
73-12	14227-14229	of	_	
73-13	14230-14236	manual	_	
73-14	14237-14240	and	_	
73-15	14241-14258	computer-assisted	_	
73-16	14259-14269	operations	_	
73-17	14269-14270	.	_	

#Text=Cortical subregions of the reward network were derived: DLPFC (defined as the sum of the dorsolateral superior-frontal and middle-frontal gyri, approximating Brodmann areas 8, 9, and 46), insular, subcallosal, orbitofrontal, and cingulate cortices, parahippocampal gyrus, and temporal pole.
74-1	14271-14279	Cortical	_	
74-2	14280-14290	subregions	_	
74-3	14291-14293	of	_	
74-4	14294-14297	the	_	
74-5	14298-14304	reward	_	
74-6	14305-14312	network	_	
74-7	14313-14317	were	_	
74-8	14318-14325	derived	_	
74-9	14325-14326	:	_	
74-10	14327-14332	DLPFC	_	
74-11	14333-14334	(	_	
74-12	14334-14341	defined	_	
74-13	14342-14344	as	_	
74-14	14345-14348	the	_	
74-15	14349-14352	sum	_	
74-16	14353-14355	of	_	
74-17	14356-14359	the	_	
74-18	14360-14372	dorsolateral	_	
74-19	14373-14389	superior-frontal	_	
74-20	14390-14393	and	_	
74-21	14394-14408	middle-frontal	_	
74-22	14409-14413	gyri	_	
74-23	14413-14414	,	_	
74-24	14415-14428	approximating	_	
74-25	14429-14437	Brodmann	_	
74-26	14438-14443	areas	_	
74-27	14444-14445	8	_	
74-28	14445-14446	,	_	
74-29	14447-14448	9	_	
74-30	14448-14449	,	_	
74-31	14450-14453	and	_	
74-32	14454-14456	46	_	
74-33	14456-14457	)	_	
74-34	14457-14458	,	_	
74-35	14459-14466	insular	_	
74-36	14466-14467	,	_	
74-37	14468-14479	subcallosal	_	
74-38	14479-14480	,	_	
74-39	14481-14494	orbitofrontal	_	
74-40	14494-14495	,	_	
74-41	14496-14499	and	_	
74-42	14500-14509	cingulate	_	
74-43	14510-14518	cortices	_	
74-44	14518-14519	,	_	
74-45	14520-14535	parahippocampal	_	
74-46	14536-14541	gyrus	_	
74-47	14541-14542	,	_	
74-48	14543-14546	and	_	
74-49	14547-14555	temporal	_	
74-50	14556-14560	pole	_	
74-51	14560-14561	.	_	

#Text=Gray matter subcortical structures in the reward network included NAc, amygdala, hippocampus, and VDC.
75-1	14562-14566	Gray	_	
75-2	14567-14573	matter	_	
75-3	14574-14585	subcortical	_	
75-4	14586-14596	structures	_	
75-5	14597-14599	in	_	
75-6	14600-14603	the	_	
75-7	14604-14610	reward	_	
75-8	14611-14618	network	_	
75-9	14619-14627	included	_	
75-10	14628-14631	NAc	_	
75-11	14631-14632	,	_	
75-12	14633-14641	amygdala	_	
75-13	14641-14642	,	_	
75-14	14643-14654	hippocampus	_	
75-15	14654-14655	,	_	
75-16	14656-14659	and	_	
75-17	14660-14663	VDC	_	
75-18	14663-14664	.	_	

#Text=For volumetric comparisons to reward network regions, we included analyses of sensory cortex (cuneus) and subcortical (dorsal striatum) regions.
76-1	14665-14668	For	_	
76-2	14669-14679	volumetric	_	
76-3	14680-14691	comparisons	_	
76-4	14692-14694	to	_	
76-5	14695-14701	reward	_	
76-6	14702-14709	network	_	
76-7	14710-14717	regions	_	
76-8	14717-14718	,	_	
76-9	14719-14721	we	_	
76-10	14722-14730	included	_	
76-11	14731-14739	analyses	_	
76-12	14740-14742	of	_	
76-13	14743-14750	sensory	_	
76-14	14751-14757	cortex	_	
76-15	14758-14759	(	_	
76-16	14759-14765	cuneus	_	
76-17	14765-14766	)	_	
76-18	14767-14770	and	_	
76-19	14771-14782	subcortical	_	
76-20	14783-14784	(	_	
76-21	14784-14790	dorsal	_	
76-22	14791-14799	striatum	_	
76-23	14799-14800	)	_	
76-24	14801-14808	regions	_	
76-25	14808-14809	.	_	

#Text=Segmentation and cortical parcellation were supervised by our neuroanatomist (NM).
77-1	14810-14822	Segmentation	_	
77-2	14823-14826	and	_	
77-3	14827-14835	cortical	_	
77-4	14836-14848	parcellation	_	
77-5	14849-14853	were	_	
77-6	14854-14864	supervised	_	
77-7	14865-14867	by	_	
77-8	14868-14871	our	_	
77-9	14872-14886	neuroanatomist	_	
77-10	14887-14888	(	_	
77-11	14888-14890	NM	_	
77-12	14890-14891	)	_	
77-13	14891-14892	.	_	

#Text=Blindness to group assignment was maintained during analyses.
78-1	14893-14902	Blindness	_	
78-2	14903-14905	to	_	
78-3	14906-14911	group	_	
78-4	14912-14922	assignment	_	
78-5	14923-14926	was	_	
78-6	14927-14937	maintained	_	
78-7	14938-14944	during	_	
78-8	14945-14953	analyses	_	
78-9	14953-14954	.	_	

#Text=High inter-rater and intra-rater reliability of these methods have been established (; ; ).
79-1	14955-14959	High	_	
79-2	14960-14971	inter-rater	_	
79-3	14972-14975	and	_	
79-4	14976-14987	intra-rater	_	
79-5	14988-14999	reliability	_	
79-6	15000-15002	of	_	
79-7	15003-15008	these	_	
79-8	15009-15016	methods	_	
79-9	15017-15021	have	_	
79-10	15022-15026	been	_	
79-11	15027-15038	established	_	
79-12	15039-15040	(	_	
79-13	15040-15041	;	_	
79-14	15042-15043	;	_	
79-15	15044-15045	)	_	
79-16	15045-15046	.	_	

#Text=Estimated total intracranial volume was obtained using FreeSurfer 5.3, an automated procedure.
80-1	15047-15056	Estimated	_	
80-2	15057-15062	total	_	
80-3	15063-15075	intracranial	_	
80-4	15076-15082	volume	_	
80-5	15083-15086	was	_	
80-6	15087-15095	obtained	_	
80-7	15096-15101	using	_	
80-8	15102-15112	FreeSurfer	_	
80-9	15113-15116	5.3	_	
80-10	15116-15117	,	_	
80-11	15118-15120	an	_	
80-12	15121-15130	automated	_	
80-13	15131-15140	procedure	_	
80-14	15140-15141	.	_	

#Text=A primary purpose of our study was to determine sex differences in the brain's reward system in individuals with Alcohol Use Disorder.
81-1	15142-15143	A	_	
81-2	15144-15151	primary	_	
81-3	15152-15159	purpose	_	
81-4	15160-15162	of	_	
81-5	15163-15166	our	_	
81-6	15167-15172	study	_	
81-7	15173-15176	was	_	
81-8	15177-15179	to	_	
81-9	15180-15189	determine	_	
81-10	15190-15193	sex	_	
81-11	15194-15205	differences	_	
81-12	15206-15208	in	_	
81-13	15209-15212	the	_	
81-14	15213-15220	brain's	_	
81-15	15221-15227	reward	_	
81-16	15228-15234	system	_	
81-17	15235-15237	in	_	
81-18	15238-15249	individuals	_	
81-19	15250-15254	with	_	
81-20	15255-15262	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[21]	
81-21	15263-15266	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[21]	
81-22	15267-15275	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[21]	
81-23	15275-15276	.	_	

#Text=We chose to use a semi-automated observer-assisted method to measure the reward volume and its components, rather than more automated techniques, for two primary reasons.
82-1	15277-15279	We	_	
82-2	15280-15285	chose	_	
82-3	15286-15288	to	_	
82-4	15289-15292	use	_	
82-5	15293-15294	a	_	
82-6	15295-15309	semi-automated	_	
82-7	15310-15327	observer-assisted	_	
82-8	15328-15334	method	_	
82-9	15335-15337	to	_	
82-10	15338-15345	measure	_	
82-11	15346-15349	the	_	
82-12	15350-15356	reward	_	
82-13	15357-15363	volume	_	
82-14	15364-15367	and	_	
82-15	15368-15371	its	_	
82-16	15372-15382	components	_	
82-17	15382-15383	,	_	
82-18	15384-15390	rather	_	
82-19	15391-15395	than	_	
82-20	15396-15400	more	_	
82-21	15401-15410	automated	_	
82-22	15411-15421	techniques	_	
82-23	15421-15422	,	_	
82-24	15423-15426	for	_	
82-25	15427-15430	two	_	
82-26	15431-15438	primary	_	
82-27	15439-15446	reasons	_	
82-28	15446-15447	.	_	

#Text=Firstly, we have previously published a comparison between the method used in the current project and the automated Freesurfer method, in which we identified the trade-offs for each approach.
83-1	15448-15455	Firstly	_	
83-2	15455-15456	,	_	
83-3	15457-15459	we	_	
83-4	15460-15464	have	_	
83-5	15465-15475	previously	_	
83-6	15476-15485	published	_	
83-7	15486-15487	a	_	
83-8	15488-15498	comparison	_	
83-9	15499-15506	between	_	
83-10	15507-15510	the	_	
83-11	15511-15517	method	_	
83-12	15518-15522	used	_	
83-13	15523-15525	in	_	
83-14	15526-15529	the	_	
83-15	15530-15537	current	_	
83-16	15538-15545	project	_	
83-17	15546-15549	and	_	
83-18	15550-15553	the	_	
83-19	15554-15563	automated	_	
83-20	15564-15574	Freesurfer	_	
83-21	15575-15581	method	_	
83-22	15581-15582	,	_	
83-23	15583-15585	in	_	
83-24	15586-15591	which	_	
83-25	15592-15594	we	_	
83-26	15595-15605	identified	_	
83-27	15606-15609	the	_	
83-28	15610-15620	trade-offs	_	
83-29	15621-15624	for	_	
83-30	15625-15629	each	_	
83-31	15630-15638	approach	_	
83-32	15638-15639	.	_	

#Text=Specifically, the advantages of using fully automated methods such as FreeSurfer are speed and low cost, and thus may be preferable for some studies.
84-1	15640-15652	Specifically	_	
84-2	15652-15653	,	_	
84-3	15654-15657	the	_	
84-4	15658-15668	advantages	_	
84-5	15669-15671	of	_	
84-6	15672-15677	using	_	
84-7	15678-15683	fully	_	
84-8	15684-15693	automated	_	
84-9	15694-15701	methods	_	
84-10	15702-15706	such	_	
84-11	15707-15709	as	_	
84-12	15710-15720	FreeSurfer	_	
84-13	15721-15724	are	_	
84-14	15725-15730	speed	_	
84-15	15731-15734	and	_	
84-16	15735-15738	low	_	
84-17	15739-15743	cost	_	
84-18	15743-15744	,	_	
84-19	15745-15748	and	_	
84-20	15749-15753	thus	_	
84-21	15754-15757	may	_	
84-22	15758-15760	be	_	
84-23	15761-15771	preferable	_	
84-24	15772-15775	for	_	
84-25	15776-15780	some	_	
84-26	15781-15788	studies	_	
84-27	15788-15789	.	_	

#Text=In fact, we did use FreeSurfer in the present study for measuring estimated total intracranial volume.
85-1	15790-15792	In	_	
85-2	15793-15797	fact	_	
85-3	15797-15798	,	_	
85-4	15799-15801	we	_	
85-5	15802-15805	did	_	
85-6	15806-15809	use	_	
85-7	15810-15820	FreeSurfer	_	
85-8	15821-15823	in	_	
85-9	15824-15827	the	_	
85-10	15828-15835	present	_	
85-11	15836-15841	study	_	
85-12	15842-15845	for	_	
85-13	15846-15855	measuring	_	
85-14	15856-15865	estimated	_	
85-15	15866-15871	total	_	
85-16	15872-15884	intracranial	_	
85-17	15885-15891	volume	_	
85-18	15891-15892	.	_	

#Text=However, automated measures are more prone to coregistration problems, atlasing misalignment, and other artifacts, and are not as accurate, particularly for measuring the small regions in the reward system.
86-1	15893-15900	However	_	
86-2	15900-15901	,	_	
86-3	15902-15911	automated	_	
86-4	15912-15920	measures	_	
86-5	15921-15924	are	_	
86-6	15925-15929	more	_	
86-7	15930-15935	prone	_	
86-8	15936-15938	to	_	
86-9	15939-15953	coregistration	_	
86-10	15954-15962	problems	_	
86-11	15962-15963	,	_	
86-12	15964-15972	atlasing	_	
86-13	15973-15985	misalignment	_	
86-14	15985-15986	,	_	
86-15	15987-15990	and	_	
86-16	15991-15996	other	_	
86-17	15997-16006	artifacts	_	
86-18	16006-16007	,	_	
86-19	16008-16011	and	_	
86-20	16012-16015	are	_	
86-21	16016-16019	not	_	
86-22	16020-16022	as	_	
86-23	16023-16031	accurate	_	
86-24	16031-16032	,	_	
86-25	16033-16045	particularly	_	
86-26	16046-16049	for	_	
86-27	16050-16059	measuring	_	
86-28	16060-16063	the	_	
86-29	16064-16069	small	_	
86-30	16070-16077	regions	_	
86-31	16078-16080	in	_	
86-32	16081-16084	the	_	
86-33	16085-16091	reward	_	
86-34	16092-16098	system	_	
86-35	16098-16099	.	_	

#Text=By comparison, the method used in the present study is the gold standard for neuroanatomic accuracy, and ensures precision and reliability in measuring regional brain networks.
87-1	16100-16102	By	_	
87-2	16103-16113	comparison	_	
87-3	16113-16114	,	_	
87-4	16115-16118	the	_	
87-5	16119-16125	method	_	
87-6	16126-16130	used	_	
87-7	16131-16133	in	_	
87-8	16134-16137	the	_	
87-9	16138-16145	present	_	
87-10	16146-16151	study	_	
87-11	16152-16154	is	_	
87-12	16155-16158	the	_	
87-13	16159-16163	gold	_	
87-14	16164-16172	standard	_	
87-15	16173-16176	for	_	
87-16	16177-16190	neuroanatomic	_	
87-17	16191-16199	accuracy	_	
87-18	16199-16200	,	_	
87-19	16201-16204	and	_	
87-20	16205-16212	ensures	_	
87-21	16213-16222	precision	_	
87-22	16223-16226	and	_	
87-23	16227-16238	reliability	_	
87-24	16239-16241	in	_	
87-25	16242-16251	measuring	_	
87-26	16252-16260	regional	_	
87-27	16261-16266	brain	_	
87-28	16267-16275	networks	_	
87-29	16275-16276	.	_	

#Text=Secondly, since we had previously observed and reported abnormalities in the reward system of men with Alcohol Use Disorder, we wanted to use the same semi-automated MRI methods as in that prior report, to ensure consistency across studies.
#Text=2.5.
88-1	16277-16285	Secondly	_	
88-2	16285-16286	,	_	
88-3	16287-16292	since	_	
88-4	16293-16295	we	_	
88-5	16296-16299	had	_	
88-6	16300-16310	previously	_	
88-7	16311-16319	observed	_	
88-8	16320-16323	and	_	
88-9	16324-16332	reported	_	
88-10	16333-16346	abnormalities	_	
88-11	16347-16349	in	_	
88-12	16350-16353	the	_	
88-13	16354-16360	reward	_	
88-14	16361-16367	system	_	
88-15	16368-16370	of	_	
88-16	16371-16374	men	_	
88-17	16375-16379	with	_	
88-18	16380-16387	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[22]	
88-19	16388-16391	Use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[22]	
88-20	16392-16400	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse[22]	
88-21	16400-16401	,	_	
88-22	16402-16404	we	_	
88-23	16405-16411	wanted	_	
88-24	16412-16414	to	_	
88-25	16415-16418	use	_	
88-26	16419-16422	the	_	
88-27	16423-16427	same	_	
88-28	16428-16442	semi-automated	_	
88-29	16443-16446	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging	
88-30	16447-16454	methods	_	
88-31	16455-16457	as	_	
88-32	16458-16460	in	_	
88-33	16461-16465	that	_	
88-34	16466-16471	prior	_	
88-35	16472-16478	report	_	
88-36	16478-16479	,	_	
88-37	16480-16482	to	_	
88-38	16483-16489	ensure	_	
88-39	16490-16501	consistency	_	
88-40	16502-16508	across	_	
88-41	16509-16516	studies	_	
88-42	16516-16517	.	_	
88-43	16518-16521	2.5	_	
88-44	16521-16522	.	_	

#Text=Statistical analyses
#Text=Statistical analyses were performed using JMP Pro software (version 11, SAS Institute, Inc., Cary, NC).
89-1	16523-16534	Statistical	_	
89-2	16535-16543	analyses	_	
89-3	16544-16555	Statistical	_	
89-4	16556-16564	analyses	_	
89-5	16565-16569	were	_	
89-6	16570-16579	performed	_	
89-7	16580-16585	using	_	
89-8	16586-16589	JMP	_	
89-9	16590-16593	Pro	_	
89-10	16594-16602	software	_	
89-11	16603-16604	(	_	
89-12	16604-16611	version	_	
89-13	16612-16614	11	_	
89-14	16614-16615	,	_	
89-15	16616-16619	SAS	_	
89-16	16620-16629	Institute	_	
89-17	16629-16630	,	_	
89-18	16631-16634	Inc	_	
89-19	16634-16635	.	_	
89-20	16635-16636	,	_	
89-21	16637-16641	Cary	_	
89-22	16641-16642	,	_	
89-23	16643-16645	NC	_	
89-24	16645-16646	)	_	
89-25	16646-16647	.	_	

#Text=We applied a multi-level data analysis approach.
90-1	16648-16650	We	_	
90-2	16651-16658	applied	_	
90-3	16659-16660	a	_	
90-4	16661-16672	multi-level	_	
90-5	16673-16677	data	_	
90-6	16678-16686	analysis	_	
90-7	16687-16695	approach	_	
90-8	16695-16696	.	_	

#Text=First, global volumetric brain measures (cm3) were assessed to determine if there were alcoholism-related or gender-related differences in brain, cerebrum, cortical gray matter, cerebral white matter, or ventricular volumes.
91-1	16697-16702	First	_	
91-2	16702-16703	,	_	
91-3	16704-16710	global	_	
91-4	16711-16721	volumetric	_	
91-5	16722-16727	brain	_	
91-6	16728-16736	measures	_	
91-7	16737-16738	(	_	
91-8	16738-16741	cm3	_	
91-9	16741-16742	)	_	
91-10	16743-16747	were	_	
91-11	16748-16756	assessed	_	
91-12	16757-16759	to	_	
91-13	16760-16769	determine	_	
91-14	16770-16772	if	_	
91-15	16773-16778	there	_	
91-16	16779-16783	were	_	
91-17	16784-16802	alcoholism-related	_	
91-18	16803-16805	or	_	
91-19	16806-16820	gender-related	_	
91-20	16821-16832	differences	_	
91-21	16833-16835	in	_	
91-22	16836-16841	brain	_	
91-23	16841-16842	,	_	
91-24	16843-16851	cerebrum	_	
91-25	16851-16852	,	_	
91-26	16853-16861	cortical	_	
91-27	16862-16866	gray	_	
91-28	16867-16873	matter	_	
91-29	16873-16874	,	_	
91-30	16875-16883	cerebral	_	
91-31	16884-16889	white	_	
91-32	16890-16896	matter	_	
91-33	16896-16897	,	_	
91-34	16898-16900	or	_	
91-35	16901-16912	ventricular	_	
91-36	16913-16920	volumes	_	
91-37	16920-16921	.	_	

#Text=Second, we assessed the reward network as a whole (sum of all reward network regions) to determine whether the entire reward network specifically was affected in alcoholism.
92-1	16922-16928	Second	_	
92-2	16928-16929	,	_	
92-3	16930-16932	we	_	
92-4	16933-16941	assessed	_	
92-5	16942-16945	the	_	
92-6	16946-16952	reward	_	
92-7	16953-16960	network	_	
92-8	16961-16963	as	_	
92-9	16964-16965	a	_	
92-10	16966-16971	whole	_	
92-11	16972-16973	(	_	
92-12	16973-16976	sum	_	
92-13	16977-16979	of	_	
92-14	16980-16983	all	_	
92-15	16984-16990	reward	_	
92-16	16991-16998	network	_	
92-17	16999-17006	regions	_	
92-18	17006-17007	)	_	
92-19	17008-17010	to	_	
92-20	17011-17020	determine	_	
92-21	17021-17028	whether	_	
92-22	17029-17032	the	_	
92-23	17033-17039	entire	_	
92-24	17040-17046	reward	_	
92-25	17047-17054	network	_	
92-26	17055-17067	specifically	_	
92-27	17068-17071	was	_	
92-28	17072-17080	affected	_	
92-29	17081-17083	in	_	
92-30	17084-17094	alcoholism	_	
92-31	17094-17095	.	_	

#Text=Third, we analyzed the individual component regions previously identified to be important in addiction and reward (see Figure 1).
93-1	17096-17101	Third	_	
93-2	17101-17102	,	_	
93-3	17103-17105	we	_	
93-4	17106-17114	analyzed	_	
93-5	17115-17118	the	_	
93-6	17119-17129	individual	_	
93-7	17130-17139	component	_	
93-8	17140-17147	regions	_	
93-9	17148-17158	previously	_	
93-10	17159-17169	identified	_	
93-11	17170-17172	to	_	
93-12	17173-17175	be	_	
93-13	17176-17185	important	_	
93-14	17186-17188	in	_	
93-15	17189-17198	addiction	_	
93-16	17199-17202	and	_	
93-17	17203-17209	reward	_	
93-18	17210-17211	(	_	
93-19	17211-17214	see	_	
93-20	17215-17221	Figure	_	
93-21	17222-17223	1	_	
93-22	17223-17224	)	_	
93-23	17224-17225	.	_	

#Text=Because each region has been independently established in the literature as an area of interest, and because we limited the analyses to a small set of hypothesis-driven regions, each analysis was considered a separate research question, mitigating the need for multiple comparison correction (; but see).
94-1	17226-17233	Because	_	
94-2	17234-17238	each	_	
94-3	17239-17245	region	_	
94-4	17246-17249	has	_	
94-5	17250-17254	been	_	
94-6	17255-17268	independently	_	
94-7	17269-17280	established	_	
94-8	17281-17283	in	_	
94-9	17284-17287	the	_	
94-10	17288-17298	literature	_	
94-11	17299-17301	as	_	
94-12	17302-17304	an	_	
94-13	17305-17309	area	_	
94-14	17310-17312	of	_	
94-15	17313-17321	interest	_	
94-16	17321-17322	,	_	
94-17	17323-17326	and	_	
94-18	17327-17334	because	_	
94-19	17335-17337	we	_	
94-20	17338-17345	limited	_	
94-21	17346-17349	the	_	
94-22	17350-17358	analyses	_	
94-23	17359-17361	to	_	
94-24	17362-17363	a	_	
94-25	17364-17369	small	_	
94-26	17370-17373	set	_	
94-27	17374-17376	of	_	
94-28	17377-17394	hypothesis-driven	_	
94-29	17395-17402	regions	_	
94-30	17402-17403	,	_	
94-31	17404-17408	each	_	
94-32	17409-17417	analysis	_	
94-33	17418-17421	was	_	
94-34	17422-17432	considered	_	
94-35	17433-17434	a	_	
94-36	17435-17443	separate	_	
94-37	17444-17452	research	_	
94-38	17453-17461	question	_	
94-39	17461-17462	,	_	
94-40	17463-17473	mitigating	_	
94-41	17474-17477	the	_	
94-42	17478-17482	need	_	
94-43	17483-17486	for	_	
94-44	17487-17495	multiple	_	
94-45	17496-17506	comparison	_	
94-46	17507-17517	correction	_	
94-47	17518-17519	(	_	
94-48	17519-17520	;	_	
94-49	17521-17524	but	_	
94-50	17525-17528	see	_	
94-51	17528-17529	)	_	
94-52	17529-17530	.	_	

#Text=To reduce the number of comparisons, and thus Type I errors, the left and right hemispheric volumes were summed.
95-1	17531-17533	To	_	
95-2	17534-17540	reduce	_	
95-3	17541-17544	the	_	
95-4	17545-17551	number	_	
95-5	17552-17554	of	_	
95-6	17555-17566	comparisons	_	
95-7	17566-17567	,	_	
95-8	17568-17571	and	_	
95-9	17572-17576	thus	_	
95-10	17577-17581	Type	_	
95-11	17582-17583	I	_	
95-12	17584-17590	errors	_	
95-13	17590-17591	,	_	
95-14	17592-17595	the	_	
95-15	17596-17600	left	_	
95-16	17601-17604	and	_	
95-17	17605-17610	right	_	
95-18	17611-17622	hemispheric	_	
95-19	17623-17630	volumes	_	
95-20	17631-17635	were	_	
95-21	17636-17642	summed	_	
95-22	17642-17643	.	_	

#Text=In order to identify brain regions disproportionately affected by alcoholism exceeding generalized effects on the cerebrum, we normalized the total reward region, component reward subregions, and comparison regions by determining percentages of each region relative to total cerebral volume for each subject.
96-1	17644-17646	In	_	
96-2	17647-17652	order	_	
96-3	17653-17655	to	_	
96-4	17656-17664	identify	_	
96-5	17665-17670	brain	_	
96-6	17671-17678	regions	_	
96-7	17679-17697	disproportionately	_	
96-8	17698-17706	affected	_	
96-9	17707-17709	by	_	
96-10	17710-17720	alcoholism	_	
96-11	17721-17730	exceeding	_	
96-12	17731-17742	generalized	_	
96-13	17743-17750	effects	_	
96-14	17751-17753	on	_	
96-15	17754-17757	the	_	
96-16	17758-17766	cerebrum	_	
96-17	17766-17767	,	_	
96-18	17768-17770	we	_	
96-19	17771-17781	normalized	_	
96-20	17782-17785	the	_	
96-21	17786-17791	total	_	
96-22	17792-17798	reward	_	
96-23	17799-17805	region	_	
96-24	17805-17806	,	_	
96-25	17807-17816	component	_	
96-26	17817-17823	reward	_	
96-27	17824-17834	subregions	_	
96-28	17834-17835	,	_	
96-29	17836-17839	and	_	
96-30	17840-17850	comparison	_	
96-31	17851-17858	regions	_	
96-32	17859-17861	by	_	
96-33	17862-17873	determining	_	
96-34	17874-17885	percentages	_	
96-35	17886-17888	of	_	
96-36	17889-17893	each	_	
96-37	17894-17900	region	_	
96-38	17901-17909	relative	_	
96-39	17910-17912	to	_	
96-40	17913-17918	total	_	
96-41	17919-17927	cerebral	_	
96-42	17928-17934	volume	_	
96-43	17935-17938	for	_	
96-44	17939-17943	each	_	
96-45	17944-17951	subject	_	
96-46	17951-17952	.	_	

#Text=Of note, we also computed analogous regional volumes as a percentage of intracranial volume (Supplemental Tables 2 and 5) in order to measure the subregions relative to cranial size, and also report the raw regional volumes (Supplemental Table 3).
97-1	17953-17955	Of	_	
97-2	17956-17960	note	_	
97-3	17960-17961	,	_	
97-4	17962-17964	we	_	
97-5	17965-17969	also	_	
97-6	17970-17978	computed	_	
97-7	17979-17988	analogous	_	
97-8	17989-17997	regional	_	
97-9	17998-18005	volumes	_	
97-10	18006-18008	as	_	
97-11	18009-18010	a	_	
97-12	18011-18021	percentage	_	
97-13	18022-18024	of	_	
97-14	18025-18037	intracranial	_	
97-15	18038-18044	volume	_	
97-16	18045-18046	(	_	
97-17	18046-18058	Supplemental	_	
97-18	18059-18065	Tables	_	
97-19	18066-18067	2	_	
97-20	18068-18071	and	_	
97-21	18072-18073	5	_	
97-22	18073-18074	)	_	
97-23	18075-18077	in	_	
97-24	18078-18083	order	_	
97-25	18084-18086	to	_	
97-26	18087-18094	measure	_	
97-27	18095-18098	the	_	
97-28	18099-18109	subregions	_	
97-29	18110-18118	relative	_	
97-30	18119-18121	to	_	
97-31	18122-18129	cranial	_	
97-32	18130-18134	size	_	
97-33	18134-18135	,	_	
97-34	18136-18139	and	_	
97-35	18140-18144	also	_	
97-36	18145-18151	report	_	
97-37	18152-18155	the	_	
97-38	18156-18159	raw	_	
97-39	18160-18168	regional	_	
97-40	18169-18176	volumes	_	
97-41	18177-18178	(	_	
97-42	18178-18190	Supplemental	_	
97-43	18191-18196	Table	_	
97-44	18197-18198	3	_	
97-45	18198-18199	)	_	
97-46	18199-18200	.	_	

#Text=The results of the raw volume analyses were similar to analyses of proportional volumes, with the expected exception that men have larger heads (and brains) than women.
98-1	18201-18204	The	_	
98-2	18205-18212	results	_	
98-3	18213-18215	of	_	
98-4	18216-18219	the	_	
98-5	18220-18223	raw	_	
98-6	18224-18230	volume	_	
98-7	18231-18239	analyses	_	
98-8	18240-18244	were	_	
98-9	18245-18252	similar	_	
98-10	18253-18255	to	_	
98-11	18256-18264	analyses	_	
98-12	18265-18267	of	_	
98-13	18268-18280	proportional	_	
98-14	18281-18288	volumes	_	
98-15	18288-18289	,	_	
98-16	18290-18294	with	_	
98-17	18295-18298	the	_	
98-18	18299-18307	expected	_	
98-19	18308-18317	exception	_	
98-20	18318-18322	that	_	
98-21	18323-18326	men	_	
98-22	18327-18331	have	_	
98-23	18332-18338	larger	_	
98-24	18339-18344	heads	_	
98-25	18345-18346	(	_	
98-26	18346-18349	and	_	
98-27	18350-18356	brains	_	
98-28	18356-18357	)	_	
98-29	18358-18362	than	_	
98-30	18363-18368	women	_	
98-31	18368-18369	.	_	

#Text=We applied linear regression analyses (covaried for age) to assess the relationships between global and reward subregion volumes as predicted by age, alcoholism, gender, and the alcoholism by gender interaction.
99-1	18370-18372	We	_	
99-2	18373-18380	applied	_	
99-3	18381-18387	linear	_	
99-4	18388-18398	regression	_	
99-5	18399-18407	analyses	_	
99-6	18408-18409	(	_	
99-7	18409-18417	covaried	_	
99-8	18418-18421	for	_	
99-9	18422-18425	age	_	
99-10	18425-18426	)	_	
99-11	18427-18429	to	_	
99-12	18430-18436	assess	_	
99-13	18437-18440	the	_	
99-14	18441-18454	relationships	_	
99-15	18455-18462	between	_	
99-16	18463-18469	global	_	
99-17	18470-18473	and	_	
99-18	18474-18480	reward	_	
99-19	18481-18490	subregion	_	
99-20	18491-18498	volumes	_	
99-21	18499-18501	as	_	
99-22	18502-18511	predicted	_	
99-23	18512-18514	by	_	
99-24	18515-18518	age	_	
99-25	18518-18519	,	_	
99-26	18520-18530	alcoholism	_	
99-27	18530-18531	,	_	
99-28	18532-18538	gender	_	
99-29	18538-18539	,	_	
99-30	18540-18543	and	_	
99-31	18544-18547	the	_	
99-32	18548-18558	alcoholism	_	
99-33	18559-18561	by	_	
99-34	18562-18568	gender	_	
99-35	18569-18580	interaction	_	
99-36	18580-18581	.	_	

#Text=Then, among alcoholics alone, models were constructed for each region, as predicted by age, gender, drinking history (i.e., DHD, DD, or LOS), and the interaction of each drinking history measure with gender.
100-1	18582-18586	Then	_	
100-2	18586-18587	,	_	
100-3	18588-18593	among	_	
100-4	18594-18604	alcoholics	_	
100-5	18605-18610	alone	_	
100-6	18610-18611	,	_	
100-7	18612-18618	models	_	
100-8	18619-18623	were	_	
100-9	18624-18635	constructed	_	
100-10	18636-18639	for	_	
100-11	18640-18644	each	_	
100-12	18645-18651	region	_	
100-13	18651-18652	,	_	
100-14	18653-18655	as	_	
100-15	18656-18665	predicted	_	
100-16	18666-18668	by	_	
100-17	18669-18672	age	_	
100-18	18672-18673	,	_	
100-19	18674-18680	gender	_	
100-20	18680-18681	,	_	
100-21	18682-18690	drinking	_	
100-22	18691-18698	history	_	
100-23	18699-18700	(	_	
100-24	18700-18703	i.e	_	
100-25	18703-18704	.	_	
100-26	18704-18705	,	_	
100-27	18706-18709	DHD	_	
100-28	18709-18710	,	_	
100-29	18711-18713	DD	_	
100-30	18713-18714	,	_	
100-31	18715-18717	or	_	
100-32	18718-18721	LOS	_	
100-33	18721-18722	)	_	
100-34	18722-18723	,	_	
100-35	18724-18727	and	_	
100-36	18728-18731	the	_	
100-37	18732-18743	interaction	_	
100-38	18744-18746	of	_	
100-39	18747-18751	each	_	
100-40	18752-18760	drinking	_	
100-41	18761-18768	history	_	
100-42	18769-18776	measure	_	
100-43	18777-18781	with	_	
100-44	18782-18788	gender	_	
100-45	18788-18789	.	_	

#Text=Based upon a discrepancy in the literature regarding gender differences in relation to alcoholism-related brain abnormalities, non-directional statistical procedures (i.e., two-tailed tests) were necessary when examining the brain volumes of interest.
101-1	18790-18795	Based	_	
101-2	18796-18800	upon	_	
101-3	18801-18802	a	_	
101-4	18803-18814	discrepancy	_	
101-5	18815-18817	in	_	
101-6	18818-18821	the	_	
101-7	18822-18832	literature	_	
101-8	18833-18842	regarding	_	
101-9	18843-18849	gender	_	
101-10	18850-18861	differences	_	
101-11	18862-18864	in	_	
101-12	18865-18873	relation	_	
101-13	18874-18876	to	_	
101-14	18877-18895	alcoholism-related	_	
101-15	18896-18901	brain	_	
101-16	18902-18915	abnormalities	_	
101-17	18915-18916	,	_	
101-18	18917-18932	non-directional	_	
101-19	18933-18944	statistical	_	
101-20	18945-18955	procedures	_	
101-21	18956-18957	(	_	
101-22	18957-18960	i.e	_	
101-23	18960-18961	.	_	
101-24	18961-18962	,	_	
101-25	18963-18973	two-tailed	_	
101-26	18974-18979	tests	_	
101-27	18979-18980	)	_	
101-28	18981-18985	were	_	
101-29	18986-18995	necessary	_	
101-30	18996-19000	when	_	
101-31	19001-19010	examining	_	
101-32	19011-19014	the	_	
101-33	19015-19020	brain	_	
101-34	19021-19028	volumes	_	
101-35	19029-19031	of	_	
101-36	19032-19040	interest	_	
101-37	19040-19041	.	_	

#Text=In all significant statistical analyses, the data from participants were removed if Cook's D exceeded 1, to account for participants with disproportionate influence.
102-1	19042-19044	In	_	
102-2	19045-19048	all	_	
102-3	19049-19060	significant	_	
102-4	19061-19072	statistical	_	
102-5	19073-19081	analyses	_	
102-6	19081-19082	,	_	
102-7	19083-19086	the	_	
102-8	19087-19091	data	_	
102-9	19092-19096	from	_	
102-10	19097-19109	participants	_	
102-11	19110-19114	were	_	
102-12	19115-19122	removed	_	
102-13	19123-19125	if	_	
102-14	19126-19132	Cook's	_	
102-15	19133-19134	D	_	
102-16	19135-19143	exceeded	_	
102-17	19144-19145	1	_	
102-18	19145-19146	,	_	
102-19	19147-19149	to	_	
102-20	19150-19157	account	_	
102-21	19158-19161	for	_	
102-22	19162-19174	participants	_	
102-23	19175-19179	with	_	
102-24	19180-19196	disproportionate	_	
102-25	19197-19206	influence	_	
102-26	19206-19207	.	_	

#Text=This procedure resulted in the removal of one ALC woman for the relationship of LOS to ventricular volume.
103-1	19208-19212	This	_	
103-2	19213-19222	procedure	_	
103-3	19223-19231	resulted	_	
103-4	19232-19234	in	_	
103-5	19235-19238	the	_	
103-6	19239-19246	removal	_	
103-7	19247-19249	of	_	
103-8	19250-19253	one	_	
103-9	19254-19257	ALC	_	
103-10	19258-19263	woman	_	
103-11	19264-19267	for	_	
103-12	19268-19271	the	_	
103-13	19272-19284	relationship	_	
103-14	19285-19287	of	_	
103-15	19288-19291	LOS	_	
103-16	19292-19294	to	_	
103-17	19295-19306	ventricular	_	
103-18	19307-19313	volume	_	
103-19	19313-19314	.	_	

#Text=Direct comparisons within subgroups according to gender (men vs. women) and group (ALC vs.
104-1	19315-19321	Direct	_	
104-2	19322-19333	comparisons	_	
104-3	19334-19340	within	_	
104-4	19341-19350	subgroups	_	
104-5	19351-19360	according	_	
104-6	19361-19363	to	_	
104-7	19364-19370	gender	_	
104-8	19371-19372	(	_	
104-9	19372-19375	men	_	
104-10	19376-19378	vs	_	
104-11	19378-19379	.	_	
104-12	19380-19385	women	_	
104-13	19385-19386	)	_	
104-14	19387-19390	and	_	
104-15	19391-19396	group	_	
104-16	19397-19398	(	_	
104-17	19398-19401	ALC	_	
104-18	19402-19404	vs	_	
104-19	19404-19405	.	_	

#Text=NC) were conducted to shed light on the results of significant interactions.
105-1	19406-19408	NC	_	
105-2	19408-19409	)	_	
105-3	19410-19414	were	_	
105-4	19415-19424	conducted	_	
105-5	19425-19427	to	_	
105-6	19428-19432	shed	_	
105-7	19433-19438	light	_	
105-8	19439-19441	on	_	
105-9	19442-19445	the	_	
105-10	19446-19453	results	_	
105-11	19454-19456	of	_	
105-12	19457-19468	significant	_	
105-13	19469-19481	interactions	_	
105-14	19481-19482	.	_	

#Text=Likewise, analyses of drinking variables are reported within the gender subgroups.
#Text=3.
106-1	19483-19491	Likewise	_	
106-2	19491-19492	,	_	
106-3	19493-19501	analyses	_	
106-4	19502-19504	of	_	
106-5	19505-19513	drinking	_	
106-6	19514-19523	variables	_	
106-7	19524-19527	are	_	
106-8	19528-19536	reported	_	
106-9	19537-19543	within	_	
106-10	19544-19547	the	_	
106-11	19548-19554	gender	_	
106-12	19555-19564	subgroups	_	
106-13	19564-19565	.	_	
106-14	19566-19567	3	_	
106-15	19567-19568	.	_	

#Text=Results
#Text=3.1.
107-1	19569-19576	Results	_	
107-2	19577-19580	3.1	_	
107-3	19580-19581	.	_	

#Text=Subjects
#Text=Table 1 provides information about the participants.
108-1	19582-19590	Subjects	_	
108-2	19591-19596	Table	_	
108-3	19597-19598	1	_	
108-4	19599-19607	provides	_	
108-5	19608-19619	information	_	
108-6	19620-19625	about	_	
108-7	19626-19629	the	_	
108-8	19630-19642	participants	_	
108-9	19642-19643	.	_	

#Text=The regression models examining interactions between group (NC vs.
109-1	19644-19647	The	_	
109-2	19648-19658	regression	_	
109-3	19659-19665	models	_	
109-4	19666-19675	examining	_	
109-5	19676-19688	interactions	_	
109-6	19689-19696	between	_	
109-7	19697-19702	group	_	
109-8	19703-19704	(	_	
109-9	19704-19706	NC	_	
109-10	19707-19709	vs	_	
109-11	19709-19710	.	_	

#Text=ALC) and gender (men vs. women) were not significant for any of the demographic, drinking, or neuropsychological variables.
110-1	19711-19714	ALC	_	
110-2	19714-19715	)	_	
110-3	19716-19719	and	_	
110-4	19720-19726	gender	_	
110-5	19727-19728	(	_	
110-6	19728-19731	men	_	
110-7	19732-19734	vs	_	
110-8	19734-19735	.	_	
110-9	19736-19741	women	_	
110-10	19741-19742	)	_	
110-11	19743-19747	were	_	
110-12	19748-19751	not	_	
110-13	19752-19763	significant	_	
110-14	19764-19767	for	_	
110-15	19768-19771	any	_	
110-16	19772-19774	of	_	
110-17	19775-19778	the	_	
110-18	19779-19790	demographic	_	
110-19	19790-19791	,	_	
110-20	19792-19800	drinking	_	
110-21	19800-19801	,	_	
110-22	19802-19804	or	_	
110-23	19805-19823	neuropsychological	_	
110-24	19824-19833	variables	_	
110-25	19833-19834	.	_	

#Text=With the exception of drinking variables, education, and HRSD scores, the NC and ALC groups did not differ.
111-1	19835-19839	With	_	
111-2	19840-19843	the	_	
111-3	19844-19853	exception	_	
111-4	19854-19856	of	_	
111-5	19857-19865	drinking	_	
111-6	19866-19875	variables	_	
111-7	19875-19876	,	_	
111-8	19877-19886	education	_	
111-9	19886-19887	,	_	
111-10	19888-19891	and	_	
111-11	19892-19896	HRSD	_	
111-12	19897-19903	scores	_	
111-13	19903-19904	,	_	
111-14	19905-19908	the	_	
111-15	19909-19911	NC	_	
111-16	19912-19915	and	_	
111-17	19916-19919	ALC	_	
111-18	19920-19926	groups	_	
111-19	19927-19930	did	_	
111-20	19931-19934	not	_	
111-21	19935-19941	differ	_	
111-22	19941-19942	.	_	

#Text=The average level of education for ALC participants was 1.1 years lower (t(117.8) = 2.67, p < 0.01), and the average HRSD scores were 2.5 points higher in ALC participants (t(79.1) = 4.16, p < 0.001).
112-1	19943-19946	The	_	
112-2	19947-19954	average	_	
112-3	19955-19960	level	_	
112-4	19961-19963	of	_	
112-5	19964-19973	education	_	
112-6	19974-19977	for	_	
112-7	19978-19981	ALC	_	
112-8	19982-19994	participants	_	
112-9	19995-19998	was	_	
112-10	19999-20002	1.1	_	
112-11	20003-20008	years	_	
112-12	20009-20014	lower	_	
112-13	20015-20016	(	_	
112-14	20016-20017	t	_	
112-15	20017-20018	(	_	
112-16	20018-20023	117.8	_	
112-17	20023-20024	)	_	
112-18	20025-20026	=	_	
112-19	20027-20031	2.67	_	
112-20	20031-20032	,	_	
112-21	20033-20034	p	_	
112-22	20035-20036	<	_	
112-23	20037-20041	0.01	_	
112-24	20041-20042	)	_	
112-25	20042-20043	,	_	
112-26	20044-20047	and	_	
112-27	20048-20051	the	_	
112-28	20052-20059	average	_	
112-29	20060-20064	HRSD	_	
112-30	20065-20071	scores	_	
112-31	20072-20076	were	_	
112-32	20077-20080	2.5	_	
112-33	20081-20087	points	_	
112-34	20088-20094	higher	_	
112-35	20095-20097	in	_	
112-36	20098-20101	ALC	_	
112-37	20102-20114	participants	_	
112-38	20115-20116	(	_	
112-39	20116-20117	t	_	
112-40	20117-20118	(	_	
112-41	20118-20122	79.1	_	
112-42	20122-20123	)	_	
112-43	20124-20125	=	_	
112-44	20126-20130	4.16	_	
112-45	20130-20131	,	_	
112-46	20132-20133	p	_	
112-47	20134-20135	<	_	
112-48	20136-20141	0.001	_	
112-49	20141-20142	)	_	
112-50	20142-20143	.	_	

#Text=The significant results revealed by the main morphometric analyses remained significant after covarying for education and HRSD.
#Text=3.2.
113-1	20144-20147	The	_	
113-2	20148-20159	significant	_	
113-3	20160-20167	results	_	
113-4	20168-20176	revealed	_	
113-5	20177-20179	by	_	
113-6	20180-20183	the	_	
113-7	20184-20188	main	_	
113-8	20189-20201	morphometric	_	
113-9	20202-20210	analyses	_	
113-10	20211-20219	remained	_	
113-11	20220-20231	significant	_	
113-12	20232-20237	after	_	
113-13	20238-20247	covarying	_	
113-14	20248-20251	for	_	
113-15	20252-20261	education	_	
113-16	20262-20265	and	_	
113-17	20266-20270	HRSD	_	
113-18	20270-20271	.	_	
113-19	20272-20275	3.2	_	
113-20	20275-20276	.	_	

#Text=Morphometric analyses
#Text=Table 2A shows that there were no significant main effects of alcoholism on the six global volumetric measures, nor were any of the alcoholism by gender interactions significant.
114-1	20277-20289	Morphometric	_	
114-2	20290-20298	analyses	_	
114-3	20299-20304	Table	_	
114-4	20305-20307	2A	_	
114-5	20308-20313	shows	_	
114-6	20314-20318	that	_	
114-7	20319-20324	there	_	
114-8	20325-20329	were	_	
114-9	20330-20332	no	_	
114-10	20333-20344	significant	_	
114-11	20345-20349	main	_	
114-12	20350-20357	effects	_	
114-13	20358-20360	of	_	
114-14	20361-20371	alcoholism	_	
114-15	20372-20374	on	_	
114-16	20375-20378	the	_	
114-17	20379-20382	six	_	
114-18	20383-20389	global	_	
114-19	20390-20400	volumetric	_	
114-20	20401-20409	measures	_	
114-21	20409-20410	,	_	
114-22	20411-20414	nor	_	
114-23	20415-20419	were	_	
114-24	20420-20423	any	_	
114-25	20424-20426	of	_	
114-26	20427-20430	the	_	
114-27	20431-20441	alcoholism	_	
114-28	20442-20444	by	_	
114-29	20445-20451	gender	_	
114-30	20452-20464	interactions	_	
114-31	20465-20476	significant	_	
114-32	20476-20477	.	_	

#Text=Table 2B and Figure 2 show that there was a significant alcoholism by gender interaction for total reward network volumes as a proportion of total cerebral volume (F(1,119) = 8.73, p < 0.01).
115-1	20478-20483	Table	_	
115-2	20484-20486	2B	_	
115-3	20487-20490	and	_	
115-4	20491-20497	Figure	_	
115-5	20498-20499	2	_	
115-6	20500-20504	show	_	
115-7	20505-20509	that	_	
115-8	20510-20515	there	_	
115-9	20516-20519	was	_	
115-10	20520-20521	a	_	
115-11	20522-20533	significant	_	
115-12	20534-20544	alcoholism	_	
115-13	20545-20547	by	_	
115-14	20548-20554	gender	_	
115-15	20555-20566	interaction	_	
115-16	20567-20570	for	_	
115-17	20571-20576	total	_	
115-18	20577-20583	reward	_	
115-19	20584-20591	network	_	
115-20	20592-20599	volumes	_	
115-21	20600-20602	as	_	
115-22	20603-20604	a	_	
115-23	20605-20615	proportion	_	
115-24	20616-20618	of	_	
115-25	20619-20624	total	_	
115-26	20625-20633	cerebral	_	
115-27	20634-20640	volume	_	
115-28	20641-20642	(	_	
115-29	20642-20643	F	_	
115-30	20643-20644	(	_	
115-31	20644-20649	1,119	_	
115-32	20649-20650	)	_	
115-33	20651-20652	=	_	
115-34	20653-20657	8.73	_	
115-35	20657-20658	,	_	
115-36	20659-20660	p	_	
115-37	20661-20662	<	_	
115-38	20663-20667	0.01	_	
115-39	20667-20668	)	_	
115-40	20668-20669	.	_	

#Text=The ALC men had 4.1% smaller reward region volumes than the NC men, while the ALC women had 4.4% larger reward region volumes than the NC women (although the comparison between the women subgroups was not significant).
116-1	20670-20673	The	_	
116-2	20674-20677	ALC	_	
116-3	20678-20681	men	_	
116-4	20682-20685	had	_	
116-5	20686-20690	4.1%	_	
116-6	20691-20698	smaller	_	
116-7	20699-20705	reward	_	
116-8	20706-20712	region	_	
116-9	20713-20720	volumes	_	
116-10	20721-20725	than	_	
116-11	20726-20729	the	_	
116-12	20730-20732	NC	_	
116-13	20733-20736	men	_	
116-14	20736-20737	,	_	
116-15	20738-20743	while	_	
116-16	20744-20747	the	_	
116-17	20748-20751	ALC	_	
116-18	20752-20757	women	_	
116-19	20758-20761	had	_	
116-20	20762-20766	4.4%	_	
116-21	20767-20773	larger	_	
116-22	20774-20780	reward	_	
116-23	20781-20787	region	_	
116-24	20788-20795	volumes	_	
116-25	20796-20800	than	_	
116-26	20801-20804	the	_	
116-27	20805-20807	NC	_	
116-28	20808-20813	women	_	
116-29	20814-20815	(	_	
116-30	20815-20823	although	_	
116-31	20824-20827	the	_	
116-32	20828-20838	comparison	_	
116-33	20839-20846	between	_	
116-34	20847-20850	the	_	
116-35	20851-20856	women	_	
116-36	20857-20866	subgroups	_	
116-37	20867-20870	was	_	
116-38	20871-20874	not	_	
116-39	20875-20886	significant	_	
116-40	20886-20887	)	_	
116-41	20887-20888	.	_	

#Text=In terms of reward subregions, there was a similar significant alcoholism by gender interaction for the DLPFC (F(1,119) = 9.46, p < 0.01).
117-1	20889-20891	In	_	
117-2	20892-20897	terms	_	
117-3	20898-20900	of	_	
117-4	20901-20907	reward	_	
117-5	20908-20918	subregions	_	
117-6	20918-20919	,	_	
117-7	20920-20925	there	_	
117-8	20926-20929	was	_	
117-9	20930-20931	a	_	
117-10	20932-20939	similar	_	
117-11	20940-20951	significant	_	
117-12	20952-20962	alcoholism	_	
117-13	20963-20965	by	_	
117-14	20966-20972	gender	_	
117-15	20973-20984	interaction	_	
117-16	20985-20988	for	_	
117-17	20989-20992	the	_	
117-18	20993-20998	DLPFC	_	
117-19	20999-21000	(	_	
117-20	21000-21001	F	_	
117-21	21001-21002	(	_	
117-22	21002-21007	1,119	_	
117-23	21007-21008	)	_	
117-24	21009-21010	=	_	
117-25	21011-21015	9.46	_	
117-26	21015-21016	,	_	
117-27	21017-21018	p	_	
117-28	21019-21020	<	_	
117-29	21021-21025	0.01	_	
117-30	21025-21026	)	_	
117-31	21026-21027	.	_	

#Text=The ALC men had 9.0% smaller DLPFC volumes than the NC men, while the ALC women had 13.6% larger DLPFC volumes than the NC women (although the comparison between the subgroups of men was not significant).
118-1	21028-21031	The	_	
118-2	21032-21035	ALC	_	
118-3	21036-21039	men	_	
118-4	21040-21043	had	_	
118-5	21044-21048	9.0%	_	
118-6	21049-21056	smaller	_	
118-7	21057-21062	DLPFC	_	
118-8	21063-21070	volumes	_	
118-9	21071-21075	than	_	
118-10	21076-21079	the	_	
118-11	21080-21082	NC	_	
118-12	21083-21086	men	_	
118-13	21086-21087	,	_	
118-14	21088-21093	while	_	
118-15	21094-21097	the	_	
118-16	21098-21101	ALC	_	
118-17	21102-21107	women	_	
118-18	21108-21111	had	_	
118-19	21112-21117	13.6%	_	
118-20	21118-21124	larger	_	
118-21	21125-21130	DLPFC	_	
118-22	21131-21138	volumes	_	
118-23	21139-21143	than	_	
118-24	21144-21147	the	_	
118-25	21148-21150	NC	_	
118-26	21151-21156	women	_	
118-27	21157-21158	(	_	
118-28	21158-21166	although	_	
118-29	21167-21170	the	_	
118-30	21171-21181	comparison	_	
118-31	21182-21189	between	_	
118-32	21190-21193	the	_	
118-33	21194-21203	subgroups	_	
118-34	21204-21206	of	_	
118-35	21207-21210	men	_	
118-36	21211-21214	was	_	
118-37	21215-21218	not	_	
118-38	21219-21230	significant	_	
118-39	21230-21231	)	_	
118-40	21231-21232	.	_	

#Text=There was also a significant alcoholism by gender interaction for the VDC (F(1,119) = 5.83, p < 0.05).
119-1	21233-21238	There	_	
119-2	21239-21242	was	_	
119-3	21243-21247	also	_	
119-4	21248-21249	a	_	
119-5	21250-21261	significant	_	
119-6	21262-21272	alcoholism	_	
119-7	21273-21275	by	_	
119-8	21276-21282	gender	_	
119-9	21283-21294	interaction	_	
119-10	21295-21298	for	_	
119-11	21299-21302	the	_	
119-12	21303-21306	VDC	_	
119-13	21307-21308	(	_	
119-14	21308-21309	F	_	
119-15	21309-21310	(	_	
119-16	21310-21315	1,119	_	
119-17	21315-21316	)	_	
119-18	21317-21318	=	_	
119-19	21319-21323	5.83	_	
119-20	21323-21324	,	_	
119-21	21325-21326	p	_	
119-22	21327-21328	<	_	
119-23	21329-21333	0.05	_	
119-24	21333-21334	)	_	
119-25	21334-21335	.	_	

#Text=The ALC men had 4.7% smaller VDC volumes than the NC men, while the ALC women had 5.1% larger VDC volumes than the NC women; here, neither comparison was significant by itself.
120-1	21336-21339	The	_	
120-2	21340-21343	ALC	_	
120-3	21344-21347	men	_	
120-4	21348-21351	had	_	
120-5	21352-21356	4.7%	_	
120-6	21357-21364	smaller	_	
120-7	21365-21368	VDC	_	
120-8	21369-21376	volumes	_	
120-9	21377-21381	than	_	
120-10	21382-21385	the	_	
120-11	21386-21388	NC	_	
120-12	21389-21392	men	_	
120-13	21392-21393	,	_	
120-14	21394-21399	while	_	
120-15	21400-21403	the	_	
120-16	21404-21407	ALC	_	
120-17	21408-21413	women	_	
120-18	21414-21417	had	_	
120-19	21418-21422	5.1%	_	
120-20	21423-21429	larger	_	
120-21	21430-21433	VDC	_	
120-22	21434-21441	volumes	_	
120-23	21442-21446	than	_	
120-24	21447-21450	the	_	
120-25	21451-21453	NC	_	
120-26	21454-21459	women	_	
120-27	21459-21460	;	_	
120-28	21461-21465	here	_	
120-29	21465-21466	,	_	
120-30	21467-21474	neither	_	
120-31	21475-21485	comparison	_	
120-32	21486-21489	was	_	
120-33	21490-21501	significant	_	
120-34	21502-21504	by	_	
120-35	21505-21511	itself	_	
120-36	21511-21512	.	_	

#Text=No other reward subregion volumes exhibited significant alcoholism by gender interaction effects, and there were no significant main effects of alcoholism on subregions.
121-1	21513-21515	No	_	
121-2	21516-21521	other	_	
121-3	21522-21528	reward	_	
121-4	21529-21538	subregion	_	
121-5	21539-21546	volumes	_	
121-6	21547-21556	exhibited	_	
121-7	21557-21568	significant	_	
121-8	21569-21579	alcoholism	_	
121-9	21580-21582	by	_	
121-10	21583-21589	gender	_	
121-11	21590-21601	interaction	_	
121-12	21602-21609	effects	_	
121-13	21609-21610	,	_	
121-14	21611-21614	and	_	
121-15	21615-21620	there	_	
121-16	21621-21625	were	_	
121-17	21626-21628	no	_	
121-18	21629-21640	significant	_	
121-19	21641-21645	main	_	
121-20	21646-21653	effects	_	
121-21	21654-21656	of	_	
121-22	21657-21667	alcoholism	_	
121-23	21668-21670	on	_	
121-24	21671-21681	subregions	_	
121-25	21681-21682	.	_	

#Text=As expected for the comparison region (dorsal striatum and cuneus), there were no significant alcoholism by gender interactions or significant main effects of alcoholism on volumes.
#Text=3.3.
122-1	21683-21685	As	_	
122-2	21686-21694	expected	_	
122-3	21695-21698	for	_	
122-4	21699-21702	the	_	
122-5	21703-21713	comparison	_	
122-6	21714-21720	region	_	
122-7	21721-21722	(	_	
122-8	21722-21728	dorsal	_	
122-9	21729-21737	striatum	_	
122-10	21738-21741	and	_	
122-11	21742-21748	cuneus	_	
122-12	21748-21749	)	_	
122-13	21749-21750	,	_	
122-14	21751-21756	there	_	
122-15	21757-21761	were	_	
122-16	21762-21764	no	_	
122-17	21765-21776	significant	_	
122-18	21777-21787	alcoholism	_	
122-19	21788-21790	by	_	
122-20	21791-21797	gender	_	
122-21	21798-21810	interactions	_	
122-22	21811-21813	or	_	
122-23	21814-21825	significant	_	
122-24	21826-21830	main	_	
122-25	21831-21838	effects	_	
122-26	21839-21841	of	_	
122-27	21842-21852	alcoholism	_	
122-28	21853-21855	on	_	
122-29	21856-21863	volumes	_	
122-30	21863-21864	.	_	
122-31	21865-21868	3.3	_	
122-32	21868-21869	.	_	

#Text=Imaging measures in relation to drinking variables
#Text=The relationships between drinking variables (DD, DHD, and LOS) and brain volumes were examined in ALC men and women.
123-1	21870-21877	Imaging	_	
123-2	21878-21886	measures	_	
123-3	21887-21889	in	_	
123-4	21890-21898	relation	_	
123-5	21899-21901	to	_	
123-6	21902-21910	drinking	_	
123-7	21911-21920	variables	_	
123-8	21921-21924	The	_	
123-9	21925-21938	relationships	_	
123-10	21939-21946	between	_	
123-11	21947-21955	drinking	_	
123-12	21956-21965	variables	_	
123-13	21966-21967	(	_	
123-14	21967-21969	DD	_	
123-15	21969-21970	,	_	
123-16	21971-21974	DHD	_	
123-17	21974-21975	,	_	
123-18	21976-21979	and	_	
123-19	21980-21983	LOS	_	
123-20	21983-21984	)	_	
123-21	21985-21988	and	_	
123-22	21989-21994	brain	_	
123-23	21995-22002	volumes	_	
123-24	22003-22007	were	_	
123-25	22008-22016	examined	_	
123-26	22017-22019	in	_	
123-27	22020-22023	ALC	_	
123-28	22024-22027	men	_	
123-29	22028-22031	and	_	
123-30	22032-22037	women	_	
123-31	22037-22038	.	_	

#Text=Significant results can be found in Figure 3 and in Table 3, which provides 95% confidence intervals and partial r2 for each region.
124-1	22039-22050	Significant	_	
124-2	22051-22058	results	_	
124-3	22059-22062	can	_	
124-4	22063-22065	be	_	
124-5	22066-22071	found	_	
124-6	22072-22074	in	_	
124-7	22075-22081	Figure	_	
124-8	22082-22083	3	_	
124-9	22084-22087	and	_	
124-10	22088-22090	in	_	
124-11	22091-22096	Table	_	
124-12	22097-22098	3	_	
124-13	22098-22099	,	_	
124-14	22100-22105	which	_	
124-15	22106-22114	provides	_	
124-16	22115-22118	95%	_	
124-17	22119-22129	confidence	_	
124-18	22130-22139	intervals	_	
124-19	22140-22143	and	_	
124-20	22144-22151	partial	_	
124-21	22152-22154	r2	_	
124-22	22155-22158	for	_	
124-23	22159-22163	each	_	
124-24	22164-22170	region	_	
124-25	22170-22171	.	_	

#Text=Supplemental Table 4 expands upon Table 3.
#Text=3.3.1 Daily Drinks
#Text=Table 3a shows that there were significant main effects of DD on total cerebrum volume, which was 0.36% higher per daily drink, and cerebral cortex volume, which was 0.38% higher per daily drink.
125-1	22172-22184	Supplemental	_	
125-2	22185-22190	Table	_	
125-3	22191-22192	4	_	
125-4	22193-22200	expands	_	
125-5	22201-22205	upon	_	
125-6	22206-22211	Table	_	
125-7	22212-22213	3	_	
125-8	22213-22214	.	_	
125-9	22215-22220	3.3.1	_	
125-10	22221-22226	Daily	_	
125-11	22227-22233	Drinks	_	
125-12	22234-22239	Table	_	
125-13	22240-22242	3a	_	
125-14	22243-22248	shows	_	
125-15	22249-22253	that	_	
125-16	22254-22259	there	_	
125-17	22260-22264	were	_	
125-18	22265-22276	significant	_	
125-19	22277-22281	main	_	
125-20	22282-22289	effects	_	
125-21	22290-22292	of	_	
125-22	22293-22295	DD	_	
125-23	22296-22298	on	_	
125-24	22299-22304	total	_	
125-25	22305-22313	cerebrum	_	
125-26	22314-22320	volume	_	
125-27	22320-22321	,	_	
125-28	22322-22327	which	_	
125-29	22328-22331	was	_	
125-30	22332-22337	0.36%	_	
125-31	22338-22344	higher	_	
125-32	22345-22348	per	_	
125-33	22349-22354	daily	_	
125-34	22355-22360	drink	_	
125-35	22360-22361	,	_	
125-36	22362-22365	and	_	
125-37	22366-22374	cerebral	_	
125-38	22375-22381	cortex	_	
125-39	22382-22388	volume	_	
125-40	22388-22389	,	_	
125-41	22390-22395	which	_	
125-42	22396-22399	was	_	
125-43	22400-22405	0.38%	_	
125-44	22406-22412	higher	_	
125-45	22413-22416	per	_	
125-46	22417-22422	daily	_	
125-47	22423-22428	drink	_	
125-48	22428-22429	.	_	

#Text=These effects were consistent with those observed for the alcoholic women (partial r2 values for women were 0.11 and 0.10 respectively, whereas r2 for men were 0.00 and 0.01 respectively).
126-1	22430-22435	These	_	
126-2	22436-22443	effects	_	
126-3	22444-22448	were	_	
126-4	22449-22459	consistent	_	
126-5	22460-22464	with	_	
126-6	22465-22470	those	_	
126-7	22471-22479	observed	_	
126-8	22480-22483	for	_	
126-9	22484-22487	the	_	
126-10	22488-22497	alcoholic	_	
126-11	22498-22503	women	_	
126-12	22504-22505	(	_	
126-13	22505-22512	partial	_	
126-14	22513-22515	r2	_	
126-15	22516-22522	values	_	
126-16	22523-22526	for	_	
126-17	22527-22532	women	_	
126-18	22533-22537	were	_	
126-19	22538-22542	0.11	_	
126-20	22543-22546	and	_	
126-21	22547-22551	0.10	_	
126-22	22552-22564	respectively	_	
126-23	22564-22565	,	_	
126-24	22566-22573	whereas	_	
126-25	22574-22576	r2	_	
126-26	22577-22580	for	_	
126-27	22581-22584	men	_	
126-28	22585-22589	were	_	
126-29	22590-22594	0.00	_	
126-30	22595-22598	and	_	
126-31	22599-22603	0.01	_	
126-32	22604-22616	respectively	_	
126-33	22616-22617	)	_	
126-34	22617-22618	.	_	

#Text=There also was a significant interaction between the effect of DD and gender on anterior cingulate cortex volume, with women exhibiting 0.93% lower volumes per daily drink, and men exhibiting 0.71% higher volumes per daily drink.
127-1	22619-22624	There	_	
127-2	22625-22629	also	_	
127-3	22630-22633	was	_	
127-4	22634-22635	a	_	
127-5	22636-22647	significant	_	
127-6	22648-22659	interaction	_	
127-7	22660-22667	between	_	
127-8	22668-22671	the	_	
127-9	22672-22678	effect	_	
127-10	22679-22681	of	_	
127-11	22682-22684	DD	_	
127-12	22685-22688	and	_	
127-13	22689-22695	gender	_	
127-14	22696-22698	on	_	
127-15	22699-22707	anterior	_	
127-16	22708-22717	cingulate	_	
127-17	22718-22724	cortex	_	
127-18	22725-22731	volume	_	
127-19	22731-22732	,	_	
127-20	22733-22737	with	_	
127-21	22738-22743	women	_	
127-22	22744-22754	exhibiting	_	
127-23	22755-22760	0.93%	_	
127-24	22761-22766	lower	_	
127-25	22767-22774	volumes	_	
127-26	22775-22778	per	_	
127-27	22779-22784	daily	_	
127-28	22785-22790	drink	_	
127-29	22790-22791	,	_	
127-30	22792-22795	and	_	
127-31	22796-22799	men	_	
127-32	22800-22810	exhibiting	_	
127-33	22811-22816	0.71%	_	
127-34	22817-22823	higher	_	
127-35	22824-22831	volumes	_	
127-36	22832-22835	per	_	
127-37	22836-22841	daily	_	
127-38	22842-22847	drink	_	
127-39	22847-22848	.	_	

#Text=For the alcoholic group, the volume of the hippocampus was 0.40% lower per daily drink.
128-1	22849-22852	For	_	
128-2	22853-22856	the	_	
128-3	22857-22866	alcoholic	_	
128-4	22867-22872	group	_	
128-5	22872-22873	,	_	
128-6	22874-22877	the	_	
128-7	22878-22884	volume	_	
128-8	22885-22887	of	_	
128-9	22888-22891	the	_	
128-10	22892-22903	hippocampus	_	
128-11	22904-22907	was	_	
128-12	22908-22913	0.40%	_	
128-13	22914-22919	lower	_	
128-14	22920-22923	per	_	
128-15	22924-22929	daily	_	
128-16	22930-22935	drink	_	
128-17	22935-22936	.	_	

#Text=No other main effects of alcoholism or interactions were significant.
#Text=3.3.2 Duration of Heavy Drinking
#Text=Table 3b shows that there was a significant interaction between the effect of DHD and gender (F(1,119) = 9.60, p < 0.01) on temporal pole volumes, with men exhibiting 0.84% lower volumes per year of heavy drinking, and women exhibiting 0.74% higher volumes per year of heavy drinking.
129-1	22937-22939	No	_	
129-2	22940-22945	other	_	
129-3	22946-22950	main	_	
129-4	22951-22958	effects	_	
129-5	22959-22961	of	_	
129-6	22962-22972	alcoholism	_	
129-7	22973-22975	or	_	
129-8	22976-22988	interactions	_	
129-9	22989-22993	were	_	
129-10	22994-23005	significant	_	
129-11	23005-23006	.	_	
129-12	23007-23012	3.3.2	_	
129-13	23013-23021	Duration	_	
129-14	23022-23024	of	_	
129-15	23025-23030	Heavy	_	
129-16	23031-23039	Drinking	_	
129-17	23040-23045	Table	_	
129-18	23046-23048	3b	_	
129-19	23049-23054	shows	_	
129-20	23055-23059	that	_	
129-21	23060-23065	there	_	
129-22	23066-23069	was	_	
129-23	23070-23071	a	_	
129-24	23072-23083	significant	_	
129-25	23084-23095	interaction	_	
129-26	23096-23103	between	_	
129-27	23104-23107	the	_	
129-28	23108-23114	effect	_	
129-29	23115-23117	of	_	
129-30	23118-23121	DHD	_	
129-31	23122-23125	and	_	
129-32	23126-23132	gender	_	
129-33	23133-23134	(	_	
129-34	23134-23135	F	_	
129-35	23135-23136	(	_	
129-36	23136-23141	1,119	_	
129-37	23141-23142	)	_	
129-38	23143-23144	=	_	
129-39	23145-23149	9.60	_	
129-40	23149-23150	,	_	
129-41	23151-23152	p	_	
129-42	23153-23154	<	_	
129-43	23155-23159	0.01	_	
129-44	23159-23160	)	_	
129-45	23161-23163	on	_	
129-46	23164-23172	temporal	_	
129-47	23173-23177	pole	_	
129-48	23178-23185	volumes	_	
129-49	23185-23186	,	_	
129-50	23187-23191	with	_	
129-51	23192-23195	men	_	
129-52	23196-23206	exhibiting	_	
129-53	23207-23212	0.84%	_	
129-54	23213-23218	lower	_	
129-55	23219-23226	volumes	_	
129-56	23227-23230	per	_	
129-57	23231-23235	year	_	
129-58	23236-23238	of	_	
129-59	23239-23244	heavy	_	
129-60	23245-23253	drinking	_	
129-61	23253-23254	,	_	
129-62	23255-23258	and	_	
129-63	23259-23264	women	_	
129-64	23265-23275	exhibiting	_	
129-65	23276-23281	0.74%	_	
129-66	23282-23288	higher	_	
129-67	23289-23296	volumes	_	
129-68	23297-23300	per	_	
129-69	23301-23305	year	_	
129-70	23306-23308	of	_	
129-71	23309-23314	heavy	_	
129-72	23315-23323	drinking	_	
129-73	23323-23324	.	_	

#Text=No main effects of DHD or other interactions were significant.
130-1	23325-23327	No	_	
130-2	23328-23332	main	_	
130-3	23333-23340	effects	_	
130-4	23341-23343	of	_	
130-5	23344-23347	DHD	_	
130-6	23348-23350	or	_	
130-7	23351-23356	other	_	
130-8	23357-23369	interactions	_	
130-9	23370-23374	were	_	
130-10	23375-23386	significant	_	
130-11	23386-23387	.	_	

#Text=Length of Sobriety
#Text=Table 3 shows that there was a significant main effect of LOS on total ventricular volume, which was 1.8% lower per year of sobriety, suggesting that atrophy declines with increasing duration of sobriety.
131-1	23388-23394	Length	_	
131-2	23395-23397	of	_	
131-3	23398-23406	Sobriety	_	
131-4	23407-23412	Table	_	
131-5	23413-23414	3	_	
131-6	23415-23420	shows	_	
131-7	23421-23425	that	_	
131-8	23426-23431	there	_	
131-9	23432-23435	was	_	
131-10	23436-23437	a	_	
131-11	23438-23449	significant	_	
131-12	23450-23454	main	_	
131-13	23455-23461	effect	_	
131-14	23462-23464	of	_	
131-15	23465-23468	LOS	_	
131-16	23469-23471	on	_	
131-17	23472-23477	total	_	
131-18	23478-23489	ventricular	_	
131-19	23490-23496	volume	_	
131-20	23496-23497	,	_	
131-21	23498-23503	which	_	
131-22	23504-23507	was	_	
131-23	23508-23512	1.8%	_	
131-24	23513-23518	lower	_	
131-25	23519-23522	per	_	
131-26	23523-23527	year	_	
131-27	23528-23530	of	_	
131-28	23531-23539	sobriety	_	
131-29	23539-23540	,	_	
131-30	23541-23551	suggesting	_	
131-31	23552-23556	that	_	
131-32	23557-23564	atrophy	_	
131-33	23565-23573	declines	_	
131-34	23574-23578	with	_	
131-35	23579-23589	increasing	_	
131-36	23590-23598	duration	_	
131-37	23599-23601	of	_	
131-38	23602-23610	sobriety	_	
131-39	23610-23611	.	_	

#Text=No other main effects of LOS and no interactions were significant.
#Text=4.
132-1	23612-23614	No	_	
132-2	23615-23620	other	_	
132-3	23621-23625	main	_	
132-4	23626-23633	effects	_	
132-5	23634-23636	of	_	
132-6	23637-23640	LOS	_	
132-7	23641-23644	and	_	
132-8	23645-23647	no	_	
132-9	23648-23660	interactions	_	
132-10	23661-23665	were	_	
132-11	23666-23677	significant	_	
132-12	23677-23678	.	_	
132-13	23679-23680	4	_	
132-14	23680-23681	.	_	

#Text=Discussion
#Text=4.1.
133-1	23682-23692	Discussion	_	
133-2	23693-23696	4.1	_	
133-3	23696-23697	.	_	

#Text=Findings
#Text=We investigated alcoholism-associated volumetric abnormalities disproportionately affecting the reward network, a cortical/subcortical circuit associated with reinforcement, punishment, and oversight of complex behaviors, including initiation and relapse of substance abuse.
134-1	23698-23706	Findings	_	
134-2	23707-23709	We	_	
134-3	23710-23722	investigated	_	
134-4	23723-23744	alcoholism-associated	_	
134-5	23745-23755	volumetric	_	
134-6	23756-23769	abnormalities	_	
134-7	23770-23788	disproportionately	_	
134-8	23789-23798	affecting	_	
134-9	23799-23802	the	_	
134-10	23803-23809	reward	_	
134-11	23810-23817	network	_	
134-12	23817-23818	,	_	
134-13	23819-23820	a	_	
134-14	23821-23829	cortical	_	
134-15	23829-23830	/	_	
134-16	23830-23841	subcortical	_	
134-17	23842-23849	circuit	_	
134-18	23850-23860	associated	_	
134-19	23861-23865	with	_	
134-20	23866-23879	reinforcement	_	
134-21	23879-23880	,	_	
134-22	23881-23891	punishment	_	
134-23	23891-23892	,	_	
134-24	23893-23896	and	_	
134-25	23897-23906	oversight	_	
134-26	23907-23909	of	_	
134-27	23910-23917	complex	_	
134-28	23918-23927	behaviors	_	
134-29	23927-23928	,	_	
134-30	23929-23938	including	_	
134-31	23939-23949	initiation	_	
134-32	23950-23953	and	_	
134-33	23954-23961	relapse	_	
134-34	23962-23964	of	_	
134-35	23965-23974	substance	_	
134-36	23975-23980	abuse	_	
134-37	23980-23981	.	_	

#Text=The results of the present study confirmed the findings of showing a smaller volume of the total reward system in ALC men than NC men.
135-1	23982-23985	The	_	
135-2	23986-23993	results	_	
135-3	23994-23996	of	_	
135-4	23997-24000	the	_	
135-5	24001-24008	present	_	
135-6	24009-24014	study	_	
135-7	24015-24024	confirmed	_	
135-8	24025-24028	the	_	
135-9	24029-24037	findings	_	
135-10	24038-24040	of	_	
135-11	24041-24048	showing	_	
135-12	24049-24050	a	_	
135-13	24051-24058	smaller	_	
135-14	24059-24065	volume	_	
135-15	24066-24068	of	_	
135-16	24069-24072	the	_	
135-17	24073-24078	total	_	
135-18	24079-24085	reward	_	
135-19	24086-24092	system	_	
135-20	24093-24095	in	_	
135-21	24096-24099	ALC	_	
135-22	24100-24103	men	_	
135-23	24104-24108	than	_	
135-24	24109-24111	NC	_	
135-25	24112-24115	men	_	
135-26	24115-24116	.	_	

#Text=Although reported that four component regions (DLPFC, insula, amygdala, and NAc) of the reward system were significantly smaller in ALC men than NC men, we observed similar, but not statistically significant, magnitudes of difference in the same regions.
136-1	24117-24125	Although	_	
136-2	24126-24134	reported	_	
136-3	24135-24139	that	_	
136-4	24140-24144	four	_	
136-5	24145-24154	component	_	
136-6	24155-24162	regions	_	
136-7	24163-24164	(	_	
136-8	24164-24169	DLPFC	_	
136-9	24169-24170	,	_	
136-10	24171-24177	insula	_	
136-11	24177-24178	,	_	
136-12	24179-24187	amygdala	_	
136-13	24187-24188	,	_	
136-14	24189-24192	and	_	
136-15	24193-24196	NAc	_	
136-16	24196-24197	)	_	
136-17	24198-24200	of	_	
136-18	24201-24204	the	_	
136-19	24205-24211	reward	_	
136-20	24212-24218	system	_	
136-21	24219-24223	were	_	
136-22	24224-24237	significantly	_	
136-23	24238-24245	smaller	_	
136-24	24246-24248	in	_	
136-25	24249-24252	ALC	_	
136-26	24253-24256	men	_	
136-27	24257-24261	than	_	
136-28	24262-24264	NC	_	
136-29	24265-24268	men	_	
136-30	24268-24269	,	_	
136-31	24270-24272	we	_	
136-32	24273-24281	observed	_	
136-33	24282-24289	similar	_	
136-34	24289-24290	,	_	
136-35	24291-24294	but	_	
136-36	24295-24298	not	_	
136-37	24299-24312	statistically	_	
136-38	24313-24324	significant	_	
136-39	24324-24325	,	_	
136-40	24326-24336	magnitudes	_	
136-41	24337-24339	of	_	
136-42	24340-24350	difference	_	
136-43	24351-24353	in	_	
136-44	24354-24357	the	_	
136-45	24358-24362	same	_	
136-46	24363-24370	regions	_	
136-47	24370-24371	.	_	

#Text=In any case, the primary aim of the present study was the identification of gender differences in association with Alcohol Use Disorder and brain reward volumes.
137-1	24372-24374	In	_	
137-2	24375-24378	any	_	
137-3	24379-24383	case	_	
137-4	24383-24384	,	_	
137-5	24385-24388	the	_	
137-6	24389-24396	primary	_	
137-7	24397-24400	aim	_	
137-8	24401-24403	of	_	
137-9	24404-24407	the	_	
137-10	24408-24415	present	_	
137-11	24416-24421	study	_	
137-12	24422-24425	was	_	
137-13	24426-24429	the	_	
137-14	24430-24444	identification	_	
137-15	24445-24447	of	_	
137-16	24448-24454	gender	_	
137-17	24455-24466	differences	_	
137-18	24467-24469	in	_	
137-19	24470-24481	association	_	
137-20	24482-24486	with	_	
137-21	24487-24494	Alcohol	_	
137-22	24495-24498	Use	_	
137-23	24499-24507	Disorder	_	
137-24	24508-24511	and	_	
137-25	24512-24517	brain	_	
137-26	24518-24524	reward	_	
137-27	24525-24532	volumes	_	
137-28	24532-24533	.	_	

#Text=We observed significant gender by alcoholism interactions for total reward network volumes, as well as DLPFC and VDC subregions.
138-1	24534-24536	We	_	
138-2	24537-24545	observed	_	
138-3	24546-24557	significant	_	
138-4	24558-24564	gender	_	
138-5	24565-24567	by	_	
138-6	24568-24578	alcoholism	_	
138-7	24579-24591	interactions	_	
138-8	24592-24595	for	_	
138-9	24596-24601	total	_	
138-10	24602-24608	reward	_	
138-11	24609-24616	network	_	
138-12	24617-24624	volumes	_	
138-13	24624-24625	,	_	
138-14	24626-24628	as	_	
138-15	24629-24633	well	_	
138-16	24634-24636	as	_	
138-17	24637-24642	DLPFC	_	
138-18	24643-24646	and	_	
138-19	24647-24650	VDC	_	
138-20	24651-24661	subregions	_	
138-21	24661-24662	.	_	

#Text=Importantly, our findings are particularly pertinent when considered within a larger body of research that considers gender and drinking history.
139-1	24663-24674	Importantly	_	
139-2	24674-24675	,	_	
139-3	24676-24679	our	_	
139-4	24680-24688	findings	_	
139-5	24689-24692	are	_	
139-6	24693-24705	particularly	_	
139-7	24706-24715	pertinent	_	
139-8	24716-24720	when	_	
139-9	24721-24731	considered	_	
139-10	24732-24738	within	_	
139-11	24739-24740	a	_	
139-12	24741-24747	larger	_	
139-13	24748-24752	body	_	
139-14	24753-24755	of	_	
139-15	24756-24764	research	_	
139-16	24765-24769	that	_	
139-17	24770-24779	considers	_	
139-18	24780-24786	gender	_	
139-19	24787-24790	and	_	
139-20	24791-24799	drinking	_	
139-21	24800-24807	history	_	
139-22	24807-24808	.	_	

#Text=We found dimorphic abnormalities in ALC men and women: Whereas the observed cerebral volume measures were smaller in ALC men compared to NC men, they were larger in ALC women compared to NC women.
140-1	24809-24811	We	_	
140-2	24812-24817	found	_	
140-3	24818-24827	dimorphic	_	
140-4	24828-24841	abnormalities	_	
140-5	24842-24844	in	_	
140-6	24845-24848	ALC	_	
140-7	24849-24852	men	_	
140-8	24853-24856	and	_	
140-9	24857-24862	women	_	
140-10	24862-24863	:	_	
140-11	24864-24871	Whereas	_	
140-12	24872-24875	the	_	
140-13	24876-24884	observed	_	
140-14	24885-24893	cerebral	_	
140-15	24894-24900	volume	_	
140-16	24901-24909	measures	_	
140-17	24910-24914	were	_	
140-18	24915-24922	smaller	_	
140-19	24923-24925	in	_	
140-20	24926-24929	ALC	_	
140-21	24930-24933	men	_	
140-22	24934-24942	compared	_	
140-23	24943-24945	to	_	
140-24	24946-24948	NC	_	
140-25	24949-24952	men	_	
140-26	24952-24953	,	_	
140-27	24954-24958	they	_	
140-28	24959-24963	were	_	
140-29	24964-24970	larger	_	
140-30	24971-24973	in	_	
140-31	24974-24977	ALC	_	
140-32	24978-24983	women	_	
140-33	24984-24992	compared	_	
140-34	24993-24995	to	_	
140-35	24996-24998	NC	_	
140-36	24999-25004	women	_	
140-37	25004-25005	.	_	

#Text=The DLPFC has rich connections with many reward regions (; ), and its oversight of limbic-paralimbic centers such as the VDC within the reward circuitry is crucial for normal cognitive and emotional functioning.
141-1	25006-25009	The	_	
141-2	25010-25015	DLPFC	_	
141-3	25016-25019	has	_	
141-4	25020-25024	rich	_	
141-5	25025-25036	connections	_	
141-6	25037-25041	with	_	
141-7	25042-25046	many	_	
141-8	25047-25053	reward	_	
141-9	25054-25061	regions	_	
141-10	25062-25063	(	_	
141-11	25063-25064	;	_	
141-12	25065-25066	)	_	
141-13	25066-25067	,	_	
141-14	25068-25071	and	_	
141-15	25072-25075	its	_	
141-16	25076-25085	oversight	_	
141-17	25086-25088	of	_	
141-18	25089-25106	limbic-paralimbic	_	
141-19	25107-25114	centers	_	
141-20	25115-25119	such	_	
141-21	25120-25122	as	_	
141-22	25123-25126	the	_	
141-23	25127-25130	VDC	_	
141-24	25131-25137	within	_	
141-25	25138-25141	the	_	
141-26	25142-25148	reward	_	
141-27	25149-25158	circuitry	_	
141-28	25159-25161	is	_	
141-29	25162-25169	crucial	_	
141-30	25170-25173	for	_	
141-31	25174-25180	normal	_	
141-32	25181-25190	cognitive	_	
141-33	25191-25194	and	_	
141-34	25195-25204	emotional	_	
141-35	25205-25216	functioning	_	
141-36	25216-25217	.	_	

#Text=Structural abnormalities in DLPFC and VDC associated with alcoholism would naturally disrupt the reward processing stream and disorganize these integrative functions.
142-1	25218-25228	Structural	_	
142-2	25229-25242	abnormalities	_	
142-3	25243-25245	in	_	
142-4	25246-25251	DLPFC	_	
142-5	25252-25255	and	_	
142-6	25256-25259	VDC	_	
142-7	25260-25270	associated	_	
142-8	25271-25275	with	_	
142-9	25276-25286	alcoholism	_	
142-10	25287-25292	would	_	
142-11	25293-25302	naturally	_	
142-12	25303-25310	disrupt	_	
142-13	25311-25314	the	_	
142-14	25315-25321	reward	_	
142-15	25322-25332	processing	_	
142-16	25333-25339	stream	_	
142-17	25340-25343	and	_	
142-18	25344-25355	disorganize	_	
142-19	25356-25361	these	_	
142-20	25362-25373	integrative	_	
142-21	25374-25383	functions	_	
142-22	25383-25384	.	_	

#Text=Our comparisons of imaging and drinking variables echoed this gender dimorphic effect.
143-1	25385-25388	Our	_	
143-2	25389-25400	comparisons	_	
143-3	25401-25403	of	_	
143-4	25404-25411	imaging	_	
143-5	25412-25415	and	_	
143-6	25416-25424	drinking	_	
143-7	25425-25434	variables	_	
143-8	25435-25441	echoed	_	
143-9	25442-25446	this	_	
143-10	25447-25453	gender	_	
143-11	25454-25463	dimorphic	_	
143-12	25464-25470	effect	_	
143-13	25470-25471	.	_	

#Text=That is, the temporal pole volume and duration of heavy drinking had an alcoholism by gender interaction with a negative relationship in alcoholic men, but a positive relationship in alcoholic women.
144-1	25472-25476	That	_	
144-2	25477-25479	is	_	
144-3	25479-25480	,	_	
144-4	25481-25484	the	_	
144-5	25485-25493	temporal	_	
144-6	25494-25498	pole	_	
144-7	25499-25505	volume	_	
144-8	25506-25509	and	_	
144-9	25510-25518	duration	_	
144-10	25519-25521	of	_	
144-11	25522-25527	heavy	_	
144-12	25528-25536	drinking	_	
144-13	25537-25540	had	_	
144-14	25541-25543	an	_	
144-15	25544-25554	alcoholism	_	
144-16	25555-25557	by	_	
144-17	25558-25564	gender	_	
144-18	25565-25576	interaction	_	
144-19	25577-25581	with	_	
144-20	25582-25583	a	_	
144-21	25584-25592	negative	_	
144-22	25593-25605	relationship	_	
144-23	25606-25608	in	_	
144-24	25609-25618	alcoholic	_	
144-25	25619-25622	men	_	
144-26	25622-25623	,	_	
144-27	25624-25627	but	_	
144-28	25628-25629	a	_	
144-29	25630-25638	positive	_	
144-30	25639-25651	relationship	_	
144-31	25652-25654	in	_	
144-32	25655-25664	alcoholic	_	
144-33	25665-25670	women	_	
144-34	25670-25671	.	_	

#Text=There also was a suggestion that global measures of cerebrum and cerebral cortex volumes were increased in relation to drinking severity (DD) for alcoholic women but not for alcoholic men.
145-1	25672-25677	There	_	
145-2	25678-25682	also	_	
145-3	25683-25686	was	_	
145-4	25687-25688	a	_	
145-5	25689-25699	suggestion	_	
145-6	25700-25704	that	_	
145-7	25705-25711	global	_	
145-8	25712-25720	measures	_	
145-9	25721-25723	of	_	
145-10	25724-25732	cerebrum	_	
145-11	25733-25736	and	_	
145-12	25737-25745	cerebral	_	
145-13	25746-25752	cortex	_	
145-14	25753-25760	volumes	_	
145-15	25761-25765	were	_	
145-16	25766-25775	increased	_	
145-17	25776-25778	in	_	
145-18	25779-25787	relation	_	
145-19	25788-25790	to	_	
145-20	25791-25799	drinking	_	
145-21	25800-25808	severity	_	
145-22	25809-25810	(	_	
145-23	25810-25812	DD	_	
145-24	25812-25813	)	_	
145-25	25814-25817	for	_	
145-26	25818-25827	alcoholic	_	
145-27	25828-25833	women	_	
145-28	25834-25837	but	_	
145-29	25838-25841	not	_	
145-30	25842-25845	for	_	
145-31	25846-25855	alcoholic	_	
145-32	25856-25859	men	_	
145-33	25859-25860	.	_	

#Text=The gender dimorphism that we observed in the total reward system, including its individual DLPFC and VDC subregions, would suggest that alcoholism in women has different risk factors, etiologies, or consequences than in men.
146-1	25861-25864	The	_	
146-2	25865-25871	gender	_	
146-3	25872-25882	dimorphism	_	
146-4	25883-25887	that	_	
146-5	25888-25890	we	_	
146-6	25891-25899	observed	_	
146-7	25900-25902	in	_	
146-8	25903-25906	the	_	
146-9	25907-25912	total	_	
146-10	25913-25919	reward	_	
146-11	25920-25926	system	_	
146-12	25926-25927	,	_	
146-13	25928-25937	including	_	
146-14	25938-25941	its	_	
146-15	25942-25952	individual	_	
146-16	25953-25958	DLPFC	_	
146-17	25959-25962	and	_	
146-18	25963-25966	VDC	_	
146-19	25967-25977	subregions	_	
146-20	25977-25978	,	_	
146-21	25979-25984	would	_	
146-22	25985-25992	suggest	_	
146-23	25993-25997	that	_	
146-24	25998-26008	alcoholism	_	
146-25	26009-26011	in	_	
146-26	26012-26017	women	_	
146-27	26018-26021	has	_	
146-28	26022-26031	different	_	
146-29	26032-26036	risk	_	
146-30	26037-26044	factors	_	
146-31	26044-26045	,	_	
146-32	26046-26056	etiologies	_	
146-33	26056-26057	,	_	
146-34	26058-26060	or	_	
146-35	26061-26073	consequences	_	
146-36	26074-26078	than	_	
146-37	26079-26081	in	_	
146-38	26082-26085	men	_	
146-39	26085-26086	.	_	

#Text=While it is reasonable to surmise that long-term alcohol abuse might cause decreased reward volumes in men, it is unlikely that long-term alcohol abuse leads to increased reward volumes in women, or that drinking severity and duration causes increases in brain volume measures in women.
147-1	26087-26092	While	_	
147-2	26093-26095	it	_	
147-3	26096-26098	is	_	
147-4	26099-26109	reasonable	_	
147-5	26110-26112	to	_	
147-6	26113-26120	surmise	_	
147-7	26121-26125	that	_	
147-8	26126-26135	long-term	_	
147-9	26136-26143	alcohol	_	
147-10	26144-26149	abuse	_	
147-11	26150-26155	might	_	
147-12	26156-26161	cause	_	
147-13	26162-26171	decreased	_	
147-14	26172-26178	reward	_	
147-15	26179-26186	volumes	_	
147-16	26187-26189	in	_	
147-17	26190-26193	men	_	
147-18	26193-26194	,	_	
147-19	26195-26197	it	_	
147-20	26198-26200	is	_	
147-21	26201-26209	unlikely	_	
147-22	26210-26214	that	_	
147-23	26215-26224	long-term	_	
147-24	26225-26232	alcohol	_	
147-25	26233-26238	abuse	_	
147-26	26239-26244	leads	_	
147-27	26245-26247	to	_	
147-28	26248-26257	increased	_	
147-29	26258-26264	reward	_	
147-30	26265-26272	volumes	_	
147-31	26273-26275	in	_	
147-32	26276-26281	women	_	
147-33	26281-26282	,	_	
147-34	26283-26285	or	_	
147-35	26286-26290	that	_	
147-36	26291-26299	drinking	_	
147-37	26300-26308	severity	_	
147-38	26309-26312	and	_	
147-39	26313-26321	duration	_	
147-40	26322-26328	causes	_	
147-41	26329-26338	increases	_	
147-42	26339-26341	in	_	
147-43	26342-26347	brain	_	
147-44	26348-26354	volume	_	
147-45	26355-26363	measures	_	
147-46	26364-26366	in	_	
147-47	26367-26372	women	_	
147-48	26372-26373	.	_	

#Text=A more likely explanation, we believe, is that alcoholic women begin with larger reward volumes, and that the reward system volume gender dimorphism is a reflection of a phenotypic distinction that may be related to differing underlying neuroanatomical and neurobehavioral discrepancies in risk factors or in gender-based motivation to seek alcohol.
148-1	26374-26375	A	_	
148-2	26376-26380	more	_	
148-3	26381-26387	likely	_	
148-4	26388-26399	explanation	_	
148-5	26399-26400	,	_	
148-6	26401-26403	we	_	
148-7	26404-26411	believe	_	
148-8	26411-26412	,	_	
148-9	26413-26415	is	_	
148-10	26416-26420	that	_	
148-11	26421-26430	alcoholic	_	
148-12	26431-26436	women	_	
148-13	26437-26442	begin	_	
148-14	26443-26447	with	_	
148-15	26448-26454	larger	_	
148-16	26455-26461	reward	_	
148-17	26462-26469	volumes	_	
148-18	26469-26470	,	_	
148-19	26471-26474	and	_	
148-20	26475-26479	that	_	
148-21	26480-26483	the	_	
148-22	26484-26490	reward	_	
148-23	26491-26497	system	_	
148-24	26498-26504	volume	_	
148-25	26505-26511	gender	_	
148-26	26512-26522	dimorphism	_	
148-27	26523-26525	is	_	
148-28	26526-26527	a	_	
148-29	26528-26538	reflection	_	
148-30	26539-26541	of	_	
148-31	26542-26543	a	_	
148-32	26544-26554	phenotypic	_	
148-33	26555-26566	distinction	_	
148-34	26567-26571	that	_	
148-35	26572-26575	may	_	
148-36	26576-26578	be	_	
148-37	26579-26586	related	_	
148-38	26587-26589	to	_	
148-39	26590-26599	differing	_	
148-40	26600-26610	underlying	_	
148-41	26611-26626	neuroanatomical	_	
148-42	26627-26630	and	_	
148-43	26631-26646	neurobehavioral	_	
148-44	26647-26660	discrepancies	_	
148-45	26661-26663	in	_	
148-46	26664-26668	risk	_	
148-47	26669-26676	factors	_	
148-48	26677-26679	or	_	
148-49	26680-26682	in	_	
148-50	26683-26695	gender-based	_	
148-51	26696-26706	motivation	_	
148-52	26707-26709	to	_	
148-53	26710-26714	seek	_	
148-54	26715-26722	alcohol	_	
148-55	26722-26723	.	_	

#Text=For example, a study by supports the view of pre-existing risk factors contributing to our observed gender differences in the brain's reward system.
149-1	26724-26727	For	_	
149-2	26728-26735	example	_	
149-3	26735-26736	,	_	
149-4	26737-26738	a	_	
149-5	26739-26744	study	_	
149-6	26745-26747	by	_	
149-7	26748-26756	supports	_	
149-8	26757-26760	the	_	
149-9	26761-26765	view	_	
149-10	26766-26768	of	_	
149-11	26769-26781	pre-existing	_	
149-12	26782-26786	risk	_	
149-13	26787-26794	factors	_	
149-14	26795-26807	contributing	_	
149-15	26808-26810	to	_	
149-16	26811-26814	our	_	
149-17	26815-26823	observed	_	
149-18	26824-26830	gender	_	
149-19	26831-26842	differences	_	
149-20	26843-26845	in	_	
149-21	26846-26849	the	_	
149-22	26850-26857	brain's	_	
149-23	26858-26864	reward	_	
149-24	26865-26871	system	_	
149-25	26871-26872	.	_	

#Text=Findings from that study showed gender differences in brain structure early in the course of drinking that may preexist in younger populations, with female drinkers having thicker cortices than same sex controls, and male drinkers having thinner cortices.
150-1	26873-26881	Findings	_	
150-2	26882-26886	from	_	
150-3	26887-26891	that	_	
150-4	26892-26897	study	_	
150-5	26898-26904	showed	_	
150-6	26905-26911	gender	_	
150-7	26912-26923	differences	_	
150-8	26924-26926	in	_	
150-9	26927-26932	brain	_	
150-10	26933-26942	structure	_	
150-11	26943-26948	early	_	
150-12	26949-26951	in	_	
150-13	26952-26955	the	_	
150-14	26956-26962	course	_	
150-15	26963-26965	of	_	
150-16	26966-26974	drinking	_	
150-17	26975-26979	that	_	
150-18	26980-26983	may	_	
150-19	26984-26992	preexist	_	
150-20	26993-26995	in	_	
150-21	26996-27003	younger	_	
150-22	27004-27015	populations	_	
150-23	27015-27016	,	_	
150-24	27017-27021	with	_	
150-25	27022-27028	female	_	
150-26	27029-27037	drinkers	_	
150-27	27038-27044	having	_	
150-28	27045-27052	thicker	_	
150-29	27053-27061	cortices	_	
150-30	27062-27066	than	_	
150-31	27067-27071	same	_	
150-32	27072-27075	sex	_	
150-33	27076-27084	controls	_	
150-34	27084-27085	,	_	
150-35	27086-27089	and	_	
150-36	27090-27094	male	_	
150-37	27095-27103	drinkers	_	
150-38	27104-27110	having	_	
150-39	27111-27118	thinner	_	
150-40	27119-27127	cortices	_	
150-41	27127-27128	.	_	

#Text=The influence of gonadal and stress hormones also can contribute to differences in the brains of alcoholic men and women, and these hormones have been shown to modulate the action of reward circuitry in particular.
151-1	27129-27132	The	_	
151-2	27133-27142	influence	_	
151-3	27143-27145	of	_	
151-4	27146-27153	gonadal	_	
151-5	27154-27157	and	_	
151-6	27158-27164	stress	_	
151-7	27165-27173	hormones	_	
151-8	27174-27178	also	_	
151-9	27179-27182	can	_	
151-10	27183-27193	contribute	_	
151-11	27194-27196	to	_	
151-12	27197-27208	differences	_	
151-13	27209-27211	in	_	
151-14	27212-27215	the	_	
151-15	27216-27222	brains	_	
151-16	27223-27225	of	_	
151-17	27226-27235	alcoholic	_	
151-18	27236-27239	men	_	
151-19	27240-27243	and	_	
151-20	27244-27249	women	_	
151-21	27249-27250	,	_	
151-22	27251-27254	and	_	
151-23	27255-27260	these	_	
151-24	27261-27269	hormones	_	
151-25	27270-27274	have	_	
151-26	27275-27279	been	_	
151-27	27280-27285	shown	_	
151-28	27286-27288	to	_	
151-29	27289-27297	modulate	_	
151-30	27298-27301	the	_	
151-31	27302-27308	action	_	
151-32	27309-27311	of	_	
151-33	27312-27318	reward	_	
151-34	27319-27328	circuitry	_	
151-35	27329-27331	in	_	
151-36	27332-27342	particular	_	
151-37	27342-27343	.	_	

#Text=Evidence for or against the notion of gender-based motivation to drink, would require large prospective studies over many years, such as those currently in progress1.
152-1	27344-27352	Evidence	_	
152-2	27353-27356	for	_	
152-3	27357-27359	or	_	
152-4	27360-27367	against	_	
152-5	27368-27371	the	_	
152-6	27372-27378	notion	_	
152-7	27379-27381	of	_	
152-8	27382-27394	gender-based	_	
152-9	27395-27405	motivation	_	
152-10	27406-27408	to	_	
152-11	27409-27414	drink	_	
152-12	27414-27415	,	_	
152-13	27416-27421	would	_	
152-14	27422-27429	require	_	
152-15	27430-27435	large	_	
152-16	27436-27447	prospective	_	
152-17	27448-27455	studies	_	
152-18	27456-27460	over	_	
152-19	27461-27465	many	_	
152-20	27466-27471	years	_	
152-21	27471-27472	,	_	
152-22	27473-27477	such	_	
152-23	27478-27480	as	_	
152-24	27481-27486	those	_	
152-25	27487-27496	currently	_	
152-26	27497-27499	in	_	
152-27	27500-27509	progress1	_	
152-28	27509-27510	.	_	

#Text=Nonetheless, alcoholic men and women are known to have differing neuropsychological and neurobehavioral profiles: alcoholic men, in aggregate, are more likely to have anti-social characteristics, whereas alcoholic women are more likely to have heightened anxiety co-morbidity.
153-1	27511-27522	Nonetheless	_	
153-2	27522-27523	,	_	
153-3	27524-27533	alcoholic	_	
153-4	27534-27537	men	_	
153-5	27538-27541	and	_	
153-6	27542-27547	women	_	
153-7	27548-27551	are	_	
153-8	27552-27557	known	_	
153-9	27558-27560	to	_	
153-10	27561-27565	have	_	
153-11	27566-27575	differing	_	
153-12	27576-27594	neuropsychological	_	
153-13	27595-27598	and	_	
153-14	27599-27614	neurobehavioral	_	
153-15	27615-27623	profiles	_	
153-16	27623-27624	:	_	
153-17	27625-27634	alcoholic	_	
153-18	27635-27638	men	_	
153-19	27638-27639	,	_	
153-20	27640-27642	in	_	
153-21	27643-27652	aggregate	_	
153-22	27652-27653	,	_	
153-23	27654-27657	are	_	
153-24	27658-27662	more	_	
153-25	27663-27669	likely	_	
153-26	27670-27672	to	_	
153-27	27673-27677	have	_	
153-28	27678-27689	anti-social	_	
153-29	27690-27705	characteristics	_	
153-30	27705-27706	,	_	
153-31	27707-27714	whereas	_	
153-32	27715-27724	alcoholic	_	
153-33	27725-27730	women	_	
153-34	27731-27734	are	_	
153-35	27735-27739	more	_	
153-36	27740-27746	likely	_	
153-37	27747-27749	to	_	
153-38	27750-27754	have	_	
153-39	27755-27765	heightened	_	
153-40	27766-27773	anxiety	_	
153-41	27774-27786	co-morbidity	_	
153-42	27786-27787	.	_	

#Text=In addition, alcohol has paradoxical effects of acting as a stimulant and mood-enhancer in some individuals, and in others, as a relaxant and anxiety-reducer.
154-1	27788-27790	In	_	
154-2	27791-27799	addition	_	
154-3	27799-27800	,	_	
154-4	27801-27808	alcohol	_	
154-5	27809-27812	has	_	
154-6	27813-27824	paradoxical	_	
154-7	27825-27832	effects	_	
154-8	27833-27835	of	_	
154-9	27836-27842	acting	_	
154-10	27843-27845	as	_	
154-11	27846-27847	a	_	
154-12	27848-27857	stimulant	_	
154-13	27858-27861	and	_	
154-14	27862-27875	mood-enhancer	_	
154-15	27876-27878	in	_	
154-16	27879-27883	some	_	
154-17	27884-27895	individuals	_	
154-18	27895-27896	,	_	
154-19	27897-27900	and	_	
154-20	27901-27903	in	_	
154-21	27904-27910	others	_	
154-22	27910-27911	,	_	
154-23	27912-27914	as	_	
154-24	27915-27916	a	_	
154-25	27917-27925	relaxant	_	
154-26	27926-27929	and	_	
154-27	27930-27945	anxiety-reducer	_	
154-28	27945-27946	.	_	

#Text=Thus, it may be that the neuroanatomical differences reported in the current study could potentially reflect an underlying gender difference in neuropsychological factors of motivational risk to developing alcoholism.
155-1	27947-27951	Thus	_	
155-2	27951-27952	,	_	
155-3	27953-27955	it	_	
155-4	27956-27959	may	_	
155-5	27960-27962	be	_	
155-6	27963-27967	that	_	
155-7	27968-27971	the	_	
155-8	27972-27987	neuroanatomical	_	
155-9	27988-27999	differences	_	
155-10	28000-28008	reported	_	
155-11	28009-28011	in	_	
155-12	28012-28015	the	_	
155-13	28016-28023	current	_	
155-14	28024-28029	study	_	
155-15	28030-28035	could	_	
155-16	28036-28047	potentially	_	
155-17	28048-28055	reflect	_	
155-18	28056-28058	an	_	
155-19	28059-28069	underlying	_	
155-20	28070-28076	gender	_	
155-21	28077-28087	difference	_	
155-22	28088-28090	in	_	
155-23	28091-28109	neuropsychological	_	
155-24	28110-28117	factors	_	
155-25	28118-28120	of	_	
155-26	28121-28133	motivational	_	
155-27	28134-28138	risk	_	
155-28	28139-28141	to	_	
155-29	28142-28152	developing	_	
155-30	28153-28163	alcoholism	_	
155-31	28163-28164	.	_	

#Text=However, caution is urged in that these data suggest only an aggregate dimorphism, and that there is substantial overlap between genders in both neuroanatomical and psychobehavioral effects.
156-1	28165-28172	However	_	
156-2	28172-28173	,	_	
156-3	28174-28181	caution	_	
156-4	28182-28184	is	_	
156-5	28185-28190	urged	_	
156-6	28191-28193	in	_	
156-7	28194-28198	that	_	
156-8	28199-28204	these	_	
156-9	28205-28209	data	_	
156-10	28210-28217	suggest	_	
156-11	28218-28222	only	_	
156-12	28223-28225	an	_	
156-13	28226-28235	aggregate	_	
156-14	28236-28246	dimorphism	_	
156-15	28246-28247	,	_	
156-16	28248-28251	and	_	
156-17	28252-28256	that	_	
156-18	28257-28262	there	_	
156-19	28263-28265	is	_	
156-20	28266-28277	substantial	_	
156-21	28278-28285	overlap	_	
156-22	28286-28293	between	_	
156-23	28294-28301	genders	_	
156-24	28302-28304	in	_	
156-25	28305-28309	both	_	
156-26	28310-28325	neuroanatomical	_	
156-27	28326-28329	and	_	
156-28	28330-28346	psychobehavioral	_	
156-29	28347-28354	effects	_	
156-30	28354-28355	.	_	

#Text=Furthermore, we found that the structural impact of alcoholism was specific to the reward network.
157-1	28356-28367	Furthermore	_	
157-2	28367-28368	,	_	
157-3	28369-28371	we	_	
157-4	28372-28377	found	_	
157-5	28378-28382	that	_	
157-6	28383-28386	the	_	
157-7	28387-28397	structural	_	
157-8	28398-28404	impact	_	
157-9	28405-28407	of	_	
157-10	28408-28418	alcoholism	_	
157-11	28419-28422	was	_	
157-12	28423-28431	specific	_	
157-13	28432-28434	to	_	
157-14	28435-28438	the	_	
157-15	28439-28445	reward	_	
157-16	28446-28453	network	_	
157-17	28453-28454	.	_	

#Text=We did not observe significant alcoholism by gender interactions or alcoholism main effects in global brain and gray matter, or in cuneus or dorsal striatum comparison regions.
158-1	28455-28457	We	_	
158-2	28458-28461	did	_	
158-3	28462-28465	not	_	
158-4	28466-28473	observe	_	
158-5	28474-28485	significant	_	
158-6	28486-28496	alcoholism	_	
158-7	28497-28499	by	_	
158-8	28500-28506	gender	_	
158-9	28507-28519	interactions	_	
158-10	28520-28522	or	_	
158-11	28523-28533	alcoholism	_	
158-12	28534-28538	main	_	
158-13	28539-28546	effects	_	
158-14	28547-28549	in	_	
158-15	28550-28556	global	_	
158-16	28557-28562	brain	_	
158-17	28563-28566	and	_	
158-18	28567-28571	gray	_	
158-19	28572-28578	matter	_	
158-20	28578-28579	,	_	
158-21	28580-28582	or	_	
158-22	28583-28585	in	_	
158-23	28586-28592	cuneus	_	
158-24	28593-28595	or	_	
158-25	28596-28602	dorsal	_	
158-26	28603-28611	striatum	_	
158-27	28612-28622	comparison	_	
158-28	28623-28630	regions	_	
158-29	28630-28631	.	_	

#Text=Prior structural neuroimaging studies in alcoholism have reported volumetric reductions in cerebral cortex, white matter, and cerebellum, but these studies have yielded variable results.
159-1	28632-28637	Prior	_	
159-2	28638-28648	structural	_	
159-3	28649-28661	neuroimaging	_	
159-4	28662-28669	studies	_	
159-5	28670-28672	in	_	
159-6	28673-28683	alcoholism	_	
159-7	28684-28688	have	_	
159-8	28689-28697	reported	_	
159-9	28698-28708	volumetric	_	
159-10	28709-28719	reductions	_	
159-11	28720-28722	in	_	
159-12	28723-28731	cerebral	_	
159-13	28732-28738	cortex	_	
159-14	28738-28739	,	_	
159-15	28740-28745	white	_	
159-16	28746-28752	matter	_	
159-17	28752-28753	,	_	
159-18	28754-28757	and	_	
159-19	28758-28768	cerebellum	_	
159-20	28768-28769	,	_	
159-21	28770-28773	but	_	
159-22	28774-28779	these	_	
159-23	28780-28787	studies	_	
159-24	28788-28792	have	_	
159-25	28793-28800	yielded	_	
159-26	28801-28809	variable	_	
159-27	28810-28817	results	_	
159-28	28817-28818	.	_	

#Text=An important factor contributing to this variability is length of abstinence.
160-1	28819-28821	An	_	
160-2	28822-28831	important	_	
160-3	28832-28838	factor	_	
160-4	28839-28851	contributing	_	
160-5	28852-28854	to	_	
160-6	28855-28859	this	_	
160-7	28860-28871	variability	_	
160-8	28872-28874	is	_	
160-9	28875-28881	length	_	
160-10	28882-28884	of	_	
160-11	28885-28895	abstinence	_	
160-12	28895-28896	.	_	

#Text=One study found that alcoholics showed recovery of cortical gray matter, sulcal, and lateral ventricular volumes as early as a month into sobriety, as well as reduction in third ventricular volume with continued abstinence as early as one year.
161-1	28897-28900	One	_	
161-2	28901-28906	study	_	
161-3	28907-28912	found	_	
161-4	28913-28917	that	_	
161-5	28918-28928	alcoholics	_	
161-6	28929-28935	showed	_	
161-7	28936-28944	recovery	_	
161-8	28945-28947	of	_	
161-9	28948-28956	cortical	_	
161-10	28957-28961	gray	_	
161-11	28962-28968	matter	_	
161-12	28968-28969	,	_	
161-13	28970-28976	sulcal	_	
161-14	28976-28977	,	_	
161-15	28978-28981	and	_	
161-16	28982-28989	lateral	_	
161-17	28990-29001	ventricular	_	
161-18	29002-29009	volumes	_	
161-19	29010-29012	as	_	
161-20	29013-29018	early	_	
161-21	29019-29021	as	_	
161-22	29022-29023	a	_	
161-23	29024-29029	month	_	
161-24	29030-29034	into	_	
161-25	29035-29043	sobriety	_	
161-26	29043-29044	,	_	
161-27	29045-29047	as	_	
161-28	29048-29052	well	_	
161-29	29053-29055	as	_	
161-30	29056-29065	reduction	_	
161-31	29066-29068	in	_	
161-32	29069-29074	third	_	
161-33	29075-29086	ventricular	_	
161-34	29087-29093	volume	_	
161-35	29094-29098	with	_	
161-36	29099-29108	continued	_	
161-37	29109-29119	abstinence	_	
161-38	29120-29122	as	_	
161-39	29123-29128	early	_	
161-40	29129-29131	as	_	
161-41	29132-29135	one	_	
161-42	29136-29140	year	_	
161-43	29140-29141	.	_	

#Text=In another study, baseline atrophy in abstinent alcoholics was reversed following eight months of sobriety.
162-1	29142-29144	In	_	
162-2	29145-29152	another	_	
162-3	29153-29158	study	_	
162-4	29158-29159	,	_	
162-5	29160-29168	baseline	_	
162-6	29169-29176	atrophy	_	
162-7	29177-29179	in	_	
162-8	29180-29189	abstinent	_	
162-9	29190-29200	alcoholics	_	
162-10	29201-29204	was	_	
162-11	29205-29213	reversed	_	
162-12	29214-29223	following	_	
162-13	29224-29229	eight	_	
162-14	29230-29236	months	_	
162-15	29237-29239	of	_	
162-16	29240-29248	sobriety	_	
162-17	29248-29249	.	_	

#Text=In yet another study examining longitudinal cortical gray matter and ventricular changes in alcoholics and controls over a five-year period, alcoholics demonstrated faster gray matter volume loss than controls.
163-1	29250-29252	In	_	
163-2	29253-29256	yet	_	
163-3	29257-29264	another	_	
163-4	29265-29270	study	_	
163-5	29271-29280	examining	_	
163-6	29281-29293	longitudinal	_	
163-7	29294-29302	cortical	_	
163-8	29303-29307	gray	_	
163-9	29308-29314	matter	_	
163-10	29315-29318	and	_	
163-11	29319-29330	ventricular	_	
163-12	29331-29338	changes	_	
163-13	29339-29341	in	_	
163-14	29342-29352	alcoholics	_	
163-15	29353-29356	and	_	
163-16	29357-29365	controls	_	
163-17	29366-29370	over	_	
163-18	29371-29372	a	_	
163-19	29373-29382	five-year	_	
163-20	29383-29389	period	_	
163-21	29389-29390	,	_	
163-22	29391-29401	alcoholics	_	
163-23	29402-29414	demonstrated	_	
163-24	29415-29421	faster	_	
163-25	29422-29426	gray	_	
163-26	29427-29433	matter	_	
163-27	29434-29440	volume	_	
163-28	29441-29445	loss	_	
163-29	29446-29450	than	_	
163-30	29451-29459	controls	_	
163-31	29459-29460	.	_	

#Text=However, alcoholics who maintained sobriety showed ventricular enlargement comparable to that of controls, and the authors suggested that continued alcohol abuse leads to progressive brain tissue volume shrinkage.
164-1	29461-29468	However	_	
164-2	29468-29469	,	_	
164-3	29470-29480	alcoholics	_	
164-4	29481-29484	who	_	
164-5	29485-29495	maintained	_	
164-6	29496-29504	sobriety	_	
164-7	29505-29511	showed	_	
164-8	29512-29523	ventricular	_	
164-9	29524-29535	enlargement	_	
164-10	29536-29546	comparable	_	
164-11	29547-29549	to	_	
164-12	29550-29554	that	_	
164-13	29555-29557	of	_	
164-14	29558-29566	controls	_	
164-15	29566-29567	,	_	
164-16	29568-29571	and	_	
164-17	29572-29575	the	_	
164-18	29576-29583	authors	_	
164-19	29584-29593	suggested	_	
164-20	29594-29598	that	_	
164-21	29599-29608	continued	_	
164-22	29609-29616	alcohol	_	
164-23	29617-29622	abuse	_	
164-24	29623-29628	leads	_	
164-25	29629-29631	to	_	
164-26	29632-29643	progressive	_	
164-27	29644-29649	brain	_	
164-28	29650-29656	tissue	_	
164-29	29657-29663	volume	_	
164-30	29664-29673	shrinkage	_	
164-31	29673-29674	.	_	

#Text=In the present study, the average LOS of the ALC group was 6.3 years, with a maximum of 37.8 years, and this duration of abstinence may explain the similarity of the ALC and NC groups in overall brain volume, as LOS significantly correlated with lower ventricular volumes.
165-1	29675-29677	In	_	
165-2	29678-29681	the	_	
165-3	29682-29689	present	_	
165-4	29690-29695	study	_	
165-5	29695-29696	,	_	
165-6	29697-29700	the	_	
165-7	29701-29708	average	_	
165-8	29709-29712	LOS	_	
165-9	29713-29715	of	_	
165-10	29716-29719	the	_	
165-11	29720-29723	ALC	_	
165-12	29724-29729	group	_	
165-13	29730-29733	was	_	
165-14	29734-29737	6.3	_	
165-15	29738-29743	years	_	
165-16	29743-29744	,	_	
165-17	29745-29749	with	_	
165-18	29750-29751	a	_	
165-19	29752-29759	maximum	_	
165-20	29760-29762	of	_	
165-21	29763-29767	37.8	_	
165-22	29768-29773	years	_	
165-23	29773-29774	,	_	
165-24	29775-29778	and	_	
165-25	29779-29783	this	_	
165-26	29784-29792	duration	_	
165-27	29793-29795	of	_	
165-28	29796-29806	abstinence	_	
165-29	29807-29810	may	_	
165-30	29811-29818	explain	_	
165-31	29819-29822	the	_	
165-32	29823-29833	similarity	_	
165-33	29834-29836	of	_	
165-34	29837-29840	the	_	
165-35	29841-29844	ALC	_	
165-36	29845-29848	and	_	
165-37	29849-29851	NC	_	
165-38	29852-29858	groups	_	
165-39	29859-29861	in	_	
165-40	29862-29869	overall	_	
165-41	29870-29875	brain	_	
165-42	29876-29882	volume	_	
165-43	29882-29883	,	_	
165-44	29884-29886	as	_	
165-45	29887-29890	LOS	_	
165-46	29891-29904	significantly	_	
165-47	29905-29915	correlated	_	
165-48	29916-29920	with	_	
165-49	29921-29926	lower	_	
165-50	29927-29938	ventricular	_	
165-51	29939-29946	volumes	_	
165-52	29946-29947	.	_	

#Text=There was a negative correlation between hippocampus volume and drinking severity, which was reflected in both genders.
166-1	29948-29953	There	_	
166-2	29954-29957	was	_	
166-3	29958-29959	a	_	
166-4	29960-29968	negative	_	
166-5	29969-29980	correlation	_	
166-6	29981-29988	between	_	
166-7	29989-30000	hippocampus	_	
166-8	30001-30007	volume	_	
166-9	30008-30011	and	_	
166-10	30012-30020	drinking	_	
166-11	30021-30029	severity	_	
166-12	30029-30030	,	_	
166-13	30031-30036	which	_	
166-14	30037-30040	was	_	
166-15	30041-30050	reflected	_	
166-16	30051-30053	in	_	
166-17	30054-30058	both	_	
166-18	30059-30066	genders	_	
166-19	30066-30067	.	_	

#Text=The hippocampus is known to be highly sensitive to the neurotoxic effects of alcohol, so this finding may reflect the sensitivity of hippocampus to alcoholism-related damage in both genders.
167-1	30068-30071	The	_	
167-2	30072-30083	hippocampus	_	
167-3	30084-30086	is	_	
167-4	30087-30092	known	_	
167-5	30093-30095	to	_	
167-6	30096-30098	be	_	
167-7	30099-30105	highly	_	
167-8	30106-30115	sensitive	_	
167-9	30116-30118	to	_	
167-10	30119-30122	the	_	
167-11	30123-30133	neurotoxic	_	
167-12	30134-30141	effects	_	
167-13	30142-30144	of	_	
167-14	30145-30152	alcohol	_	
167-15	30152-30153	,	_	
167-16	30154-30156	so	_	
167-17	30157-30161	this	_	
167-18	30162-30169	finding	_	
167-19	30170-30173	may	_	
167-20	30174-30181	reflect	_	
167-21	30182-30185	the	_	
167-22	30186-30197	sensitivity	_	
167-23	30198-30200	of	_	
167-24	30201-30212	hippocampus	_	
167-25	30213-30215	to	_	
167-26	30216-30234	alcoholism-related	_	
167-27	30235-30241	damage	_	
167-28	30242-30244	in	_	
167-29	30245-30249	both	_	
167-30	30250-30257	genders	_	
167-31	30257-30258	.	_	

#Text=The anterior cingulate relationship with daily drinks displayed a gender interaction that varied from the other gender dimorphic effects described above, with women showing smaller volumes and men showing larger volumes with more daily drinks.
168-1	30259-30262	The	_	
168-2	30263-30271	anterior	_	
168-3	30272-30281	cingulate	_	
168-4	30282-30294	relationship	_	
168-5	30295-30299	with	_	
168-6	30300-30305	daily	_	
168-7	30306-30312	drinks	_	
168-8	30313-30322	displayed	_	
168-9	30323-30324	a	_	
168-10	30325-30331	gender	_	
168-11	30332-30343	interaction	_	
168-12	30344-30348	that	_	
168-13	30349-30355	varied	_	
168-14	30356-30360	from	_	
168-15	30361-30364	the	_	
168-16	30365-30370	other	_	
168-17	30371-30377	gender	_	
168-18	30378-30387	dimorphic	_	
168-19	30388-30395	effects	_	
168-20	30396-30405	described	_	
168-21	30406-30411	above	_	
168-22	30411-30412	,	_	
168-23	30413-30417	with	_	
168-24	30418-30423	women	_	
168-25	30424-30431	showing	_	
168-26	30432-30439	smaller	_	
168-27	30440-30447	volumes	_	
168-28	30448-30451	and	_	
168-29	30452-30455	men	_	
168-30	30456-30463	showing	_	
168-31	30464-30470	larger	_	
168-32	30471-30478	volumes	_	
168-33	30479-30483	with	_	
168-34	30484-30488	more	_	
168-35	30489-30494	daily	_	
168-36	30495-30501	drinks	_	
168-37	30501-30502	.	_	

#Text=Finally, ventricular volume was inversely related to length of sobriety, thereby confirming both the deleterious cerebral effects of chronic alcoholism and the potential for improvement in brain structural deficits following abstinence.
#Text=4.2.
169-1	30503-30510	Finally	_	
169-2	30510-30511	,	_	
169-3	30512-30523	ventricular	_	
169-4	30524-30530	volume	_	
169-5	30531-30534	was	_	
169-6	30535-30544	inversely	_	
169-7	30545-30552	related	_	
169-8	30553-30555	to	_	
169-9	30556-30562	length	_	
169-10	30563-30565	of	_	
169-11	30566-30574	sobriety	_	
169-12	30574-30575	,	_	
169-13	30576-30583	thereby	_	
169-14	30584-30594	confirming	_	
169-15	30595-30599	both	_	
169-16	30600-30603	the	_	
169-17	30604-30615	deleterious	_	
169-18	30616-30624	cerebral	_	
169-19	30625-30632	effects	_	
169-20	30633-30635	of	_	
169-21	30636-30643	chronic	_	
169-22	30644-30654	alcoholism	_	
169-23	30655-30658	and	_	
169-24	30659-30662	the	_	
169-25	30663-30672	potential	_	
169-26	30673-30676	for	_	
169-27	30677-30688	improvement	_	
169-28	30689-30691	in	_	
169-29	30692-30697	brain	_	
169-30	30698-30708	structural	_	
169-31	30709-30717	deficits	_	
169-32	30718-30727	following	_	
169-33	30728-30738	abstinence	_	
169-34	30738-30739	.	_	
169-35	30740-30743	4.2	_	
169-36	30743-30744	.	_	

#Text=Limitations
#Text=Despite the clear alcoholism by gender volumetric effects observed in the present study, there were several limitations.
170-1	30745-30756	Limitations	_	
170-2	30757-30764	Despite	_	
170-3	30765-30768	the	_	
170-4	30769-30774	clear	_	
170-5	30775-30785	alcoholism	_	
170-6	30786-30788	by	_	
170-7	30789-30795	gender	_	
170-8	30796-30806	volumetric	_	
170-9	30807-30814	effects	_	
170-10	30815-30823	observed	_	
170-11	30824-30826	in	_	
170-12	30827-30830	the	_	
170-13	30831-30838	present	_	
170-14	30839-30844	study	_	
170-15	30844-30845	,	_	
170-16	30846-30851	there	_	
170-17	30852-30856	were	_	
170-18	30857-30864	several	_	
170-19	30865-30876	limitations	_	
170-20	30876-30877	.	_	

#Text=First, although the average level of education for ALC participants was 1.1 years lower than NC participants, and the average HRSD scores were 2.5 points higher in ALC participants, both groups had completed high school, and the mean HRSD scores were below 4.0 for both groups (individuals scoring above 20 can be considered depressed).
171-1	30878-30883	First	_	
171-2	30883-30884	,	_	
171-3	30885-30893	although	_	
171-4	30894-30897	the	_	
171-5	30898-30905	average	_	
171-6	30906-30911	level	_	
171-7	30912-30914	of	_	
171-8	30915-30924	education	_	
171-9	30925-30928	for	_	
171-10	30929-30932	ALC	_	
171-11	30933-30945	participants	_	
171-12	30946-30949	was	_	
171-13	30950-30953	1.1	_	
171-14	30954-30959	years	_	
171-15	30960-30965	lower	_	
171-16	30966-30970	than	_	
171-17	30971-30973	NC	_	
171-18	30974-30986	participants	_	
171-19	30986-30987	,	_	
171-20	30988-30991	and	_	
171-21	30992-30995	the	_	
171-22	30996-31003	average	_	
171-23	31004-31008	HRSD	_	
171-24	31009-31015	scores	_	
171-25	31016-31020	were	_	
171-26	31021-31024	2.5	_	
171-27	31025-31031	points	_	
171-28	31032-31038	higher	_	
171-29	31039-31041	in	_	
171-30	31042-31045	ALC	_	
171-31	31046-31058	participants	_	
171-32	31058-31059	,	_	
171-33	31060-31064	both	_	
171-34	31065-31071	groups	_	
171-35	31072-31075	had	_	
171-36	31076-31085	completed	_	
171-37	31086-31090	high	_	
171-38	31091-31097	school	_	
171-39	31097-31098	,	_	
171-40	31099-31102	and	_	
171-41	31103-31106	the	_	
171-42	31107-31111	mean	_	
171-43	31112-31116	HRSD	_	
171-44	31117-31123	scores	_	
171-45	31124-31128	were	_	
171-46	31129-31134	below	_	
171-47	31135-31138	4.0	_	
171-48	31139-31142	for	_	
171-49	31143-31147	both	_	
171-50	31148-31154	groups	_	
171-51	31155-31156	(	_	
171-52	31156-31167	individuals	_	
171-53	31168-31175	scoring	_	
171-54	31176-31181	above	_	
171-55	31182-31184	20	_	
171-56	31185-31188	can	_	
171-57	31189-31191	be	_	
171-58	31192-31202	considered	_	
171-59	31203-31212	depressed	_	
171-60	31212-31213	)	_	
171-61	31213-31214	.	_	

#Text=Moreover, any participants with HRSD scores above 16 were excluded entirely.
172-1	31215-31223	Moreover	_	
172-2	31223-31224	,	_	
172-3	31225-31228	any	_	
172-4	31229-31241	participants	_	
172-5	31242-31246	with	_	
172-6	31247-31251	HRSD	_	
172-7	31252-31258	scores	_	
172-8	31259-31264	above	_	
172-9	31265-31267	16	_	
172-10	31268-31272	were	_	
172-11	31273-31281	excluded	_	
172-12	31282-31290	entirely	_	
172-13	31290-31291	.	_	

#Text=More importantly, the significant results revealed by the main morphometric analyses remained significant after covarying for education and HRSD.
173-1	31292-31296	More	_	
173-2	31297-31308	importantly	_	
173-3	31308-31309	,	_	
173-4	31310-31313	the	_	
173-5	31314-31325	significant	_	
173-6	31326-31333	results	_	
173-7	31334-31342	revealed	_	
173-8	31343-31345	by	_	
173-9	31346-31349	the	_	
173-10	31350-31354	main	_	
173-11	31355-31367	morphometric	_	
173-12	31368-31376	analyses	_	
173-13	31377-31385	remained	_	
173-14	31386-31397	significant	_	
173-15	31398-31403	after	_	
173-16	31404-31413	covarying	_	
173-17	31414-31417	for	_	
173-18	31418-31427	education	_	
173-19	31428-31431	and	_	
173-20	31432-31436	HRSD	_	
173-21	31436-31437	.	_	

#Text=Second, we did not restrict study recruitment to ALC participants with a strong family history of alcohol dependence, and the morphometric alterations we observed may be more distinct in families with a high prevalence of alcoholism (that is, family history may be associated with pre-existing differences in reward system volumes).
174-1	31438-31444	Second	_	
174-2	31444-31445	,	_	
174-3	31446-31448	we	_	
174-4	31449-31452	did	_	
174-5	31453-31456	not	_	
174-6	31457-31465	restrict	_	
174-7	31466-31471	study	_	
174-8	31472-31483	recruitment	_	
174-9	31484-31486	to	_	
174-10	31487-31490	ALC	_	
174-11	31491-31503	participants	_	
174-12	31504-31508	with	_	
174-13	31509-31510	a	_	
174-14	31511-31517	strong	_	
174-15	31518-31524	family	_	
174-16	31525-31532	history	_	
174-17	31533-31535	of	_	
174-18	31536-31543	alcohol	_	
174-19	31544-31554	dependence	_	
174-20	31554-31555	,	_	
174-21	31556-31559	and	_	
174-22	31560-31563	the	_	
174-23	31564-31576	morphometric	_	
174-24	31577-31588	alterations	_	
174-25	31589-31591	we	_	
174-26	31592-31600	observed	_	
174-27	31601-31604	may	_	
174-28	31605-31607	be	_	
174-29	31608-31612	more	_	
174-30	31613-31621	distinct	_	
174-31	31622-31624	in	_	
174-32	31625-31633	families	_	
174-33	31634-31638	with	_	
174-34	31639-31640	a	_	
174-35	31641-31645	high	_	
174-36	31646-31656	prevalence	_	
174-37	31657-31659	of	_	
174-38	31660-31670	alcoholism	_	
174-39	31671-31672	(	_	
174-40	31672-31676	that	_	
174-41	31677-31679	is	_	
174-42	31679-31680	,	_	
174-43	31681-31687	family	_	
174-44	31688-31695	history	_	
174-45	31696-31699	may	_	
174-46	31700-31702	be	_	
174-47	31703-31713	associated	_	
174-48	31714-31718	with	_	
174-49	31719-31731	pre-existing	_	
174-50	31732-31743	differences	_	
174-51	31744-31746	in	_	
174-52	31747-31753	reward	_	
174-53	31754-31760	system	_	
174-54	31761-31768	volumes	_	
174-55	31768-31769	)	_	
174-56	31769-31770	.	_	

#Text=Third, this study used a cross-sectional approach.
175-1	31771-31776	Third	_	
175-2	31776-31777	,	_	
175-3	31778-31782	this	_	
175-4	31783-31788	study	_	
175-5	31789-31793	used	_	
175-6	31794-31795	a	_	
175-7	31796-31811	cross-sectional	_	
175-8	31812-31820	approach	_	
175-9	31820-31821	.	_	

#Text=This approach prevented us from determining whether the relationships we observed predated the onset of heavy drinking (and thus could be considered risk factors for alcoholism) or were actually consequences of heavy drinking.
176-1	31822-31826	This	_	
176-2	31827-31835	approach	_	
176-3	31836-31845	prevented	_	
176-4	31846-31848	us	_	
176-5	31849-31853	from	_	
176-6	31854-31865	determining	_	
176-7	31866-31873	whether	_	
176-8	31874-31877	the	_	
176-9	31878-31891	relationships	_	
176-10	31892-31894	we	_	
176-11	31895-31903	observed	_	
176-12	31904-31912	predated	_	
176-13	31913-31916	the	_	
176-14	31917-31922	onset	_	
176-15	31923-31925	of	_	
176-16	31926-31931	heavy	_	
176-17	31932-31940	drinking	_	
176-18	31941-31942	(	_	
176-19	31942-31945	and	_	
176-20	31946-31950	thus	_	
176-21	31951-31956	could	_	
176-22	31957-31959	be	_	
176-23	31960-31970	considered	_	
176-24	31971-31975	risk	_	
176-25	31976-31983	factors	_	
176-26	31984-31987	for	_	
176-27	31988-31998	alcoholism	_	
176-28	31998-31999	)	_	
176-29	32000-32002	or	_	
176-30	32003-32007	were	_	
176-31	32008-32016	actually	_	
176-32	32017-32029	consequences	_	
176-33	32030-32032	of	_	
176-34	32033-32038	heavy	_	
176-35	32039-32047	drinking	_	
176-36	32047-32048	.	_	

#Text=Nevertheless, the present findings expanded upon results found in male participants by Makris and colleagues by showing gender dimorphic alcoholism-related abnormalities.
177-1	32049-32061	Nevertheless	_	
177-2	32061-32062	,	_	
177-3	32063-32066	the	_	
177-4	32067-32074	present	_	
177-5	32075-32083	findings	_	
177-6	32084-32092	expanded	_	
177-7	32093-32097	upon	_	
177-8	32098-32105	results	_	
177-9	32106-32111	found	_	
177-10	32112-32114	in	_	
177-11	32115-32119	male	_	
177-12	32120-32132	participants	_	
177-13	32133-32135	by	_	
177-14	32136-32142	Makris	_	
177-15	32143-32146	and	_	
177-16	32147-32157	colleagues	_	
177-17	32158-32160	by	_	
177-18	32161-32168	showing	_	
177-19	32169-32175	gender	_	
177-20	32176-32185	dimorphic	_	
177-21	32186-32204	alcoholism-related	_	
177-22	32205-32218	abnormalities	_	
177-23	32218-32219	.	_	

#Text=Finally, because we examined numerous subregions of the reward system (Table 2), thereby increasing the study's vulnerability to a Type I error, we performed additional analyses with a false discovery rate multiple comparison correction procedure  for the 13 reward subregions.
178-1	32220-32227	Finally	_	
178-2	32227-32228	,	_	
178-3	32229-32236	because	_	
178-4	32237-32239	we	_	
178-5	32240-32248	examined	_	
178-6	32249-32257	numerous	_	
178-7	32258-32268	subregions	_	
178-8	32269-32271	of	_	
178-9	32272-32275	the	_	
178-10	32276-32282	reward	_	
178-11	32283-32289	system	_	
178-12	32290-32291	(	_	
178-13	32291-32296	Table	_	
178-14	32297-32298	2	_	
178-15	32298-32299	)	_	
178-16	32299-32300	,	_	
178-17	32301-32308	thereby	_	
178-18	32309-32319	increasing	_	
178-19	32320-32323	the	_	
178-20	32324-32331	study's	_	
178-21	32332-32345	vulnerability	_	
178-22	32346-32348	to	_	
178-23	32349-32350	a	_	
178-24	32351-32355	Type	_	
178-25	32356-32357	I	_	
178-26	32358-32363	error	_	
178-27	32363-32364	,	_	
178-28	32365-32367	we	_	
178-29	32368-32377	performed	_	
178-30	32378-32388	additional	_	
178-31	32389-32397	analyses	_	
178-32	32398-32402	with	_	
178-33	32403-32404	a	_	
178-34	32405-32410	false	_	
178-35	32411-32420	discovery	_	
178-36	32421-32425	rate	_	
178-37	32426-32434	multiple	_	
178-38	32435-32445	comparison	_	
178-39	32446-32456	correction	_	
178-40	32457-32466	procedure	_	
178-41	32468-32471	for	_	
178-42	32472-32475	the	_	
178-43	32476-32478	13	_	
178-44	32479-32485	reward	_	
178-45	32486-32496	subregions	_	
178-46	32496-32497	.	_	

#Text=Despite this procedure's increasing the chance of making a Type II error, significant results were unchanged for the group by gender interaction involving the DLPFC, as well as for differences within the ALC group for the posterior parahippocampal gyrus and temporal pole, and for gender differences within the NC group for the temporal pole.
179-1	32498-32505	Despite	_	
179-2	32506-32510	this	_	
179-3	32511-32522	procedure's	_	
179-4	32523-32533	increasing	_	
179-5	32534-32537	the	_	
179-6	32538-32544	chance	_	
179-7	32545-32547	of	_	
179-8	32548-32554	making	_	
179-9	32555-32556	a	_	
179-10	32557-32561	Type	_	
179-11	32562-32564	II	_	
179-12	32565-32570	error	_	
179-13	32570-32571	,	_	
179-14	32572-32583	significant	_	
179-15	32584-32591	results	_	
179-16	32592-32596	were	_	
179-17	32597-32606	unchanged	_	
179-18	32607-32610	for	_	
179-19	32611-32614	the	_	
179-20	32615-32620	group	_	
179-21	32621-32623	by	_	
179-22	32624-32630	gender	_	
179-23	32631-32642	interaction	_	
179-24	32643-32652	involving	_	
179-25	32653-32656	the	_	
179-26	32657-32662	DLPFC	_	
179-27	32662-32663	,	_	
179-28	32664-32666	as	_	
179-29	32667-32671	well	_	
179-30	32672-32674	as	_	
179-31	32675-32678	for	_	
179-32	32679-32690	differences	_	
179-33	32691-32697	within	_	
179-34	32698-32701	the	_	
179-35	32702-32705	ALC	_	
179-36	32706-32711	group	_	
179-37	32712-32715	for	_	
179-38	32716-32719	the	_	
179-39	32720-32729	posterior	_	
179-40	32730-32745	parahippocampal	_	
179-41	32746-32751	gyrus	_	
179-42	32752-32755	and	_	
179-43	32756-32764	temporal	_	
179-44	32765-32769	pole	_	
179-45	32769-32770	,	_	
179-46	32771-32774	and	_	
179-47	32775-32778	for	_	
179-48	32779-32785	gender	_	
179-49	32786-32797	differences	_	
179-50	32798-32804	within	_	
179-51	32805-32808	the	_	
179-52	32809-32811	NC	_	
179-53	32812-32817	group	_	
179-54	32818-32821	for	_	
179-55	32822-32825	the	_	
179-56	32826-32834	temporal	_	
179-57	32835-32839	pole	_	
179-58	32839-32840	.	_	

#Text=However, no relationships among the 13 reward subregions and the drinking variables (DD, DHD, or LOS) remained significant.
180-1	32841-32848	However	_	
180-2	32848-32849	,	_	
180-3	32850-32852	no	_	
180-4	32853-32866	relationships	_	
180-5	32867-32872	among	_	
180-6	32873-32876	the	_	
180-7	32877-32879	13	_	
180-8	32880-32886	reward	_	
180-9	32887-32897	subregions	_	
180-10	32898-32901	and	_	
180-11	32902-32905	the	_	
180-12	32906-32914	drinking	_	
180-13	32915-32924	variables	_	
180-14	32925-32926	(	_	
180-15	32926-32928	DD	_	
180-16	32928-32929	,	_	
180-17	32930-32933	DHD	_	
180-18	32933-32934	,	_	
180-19	32935-32937	or	_	
180-20	32938-32941	LOS	_	
180-21	32941-32942	)	_	
180-22	32943-32951	remained	_	
180-23	32952-32963	significant	_	
180-24	32963-32964	.	_	

#Text=Nevertheless, it is important to note that our inclusion of each separate region was based upon independent findings derived from previously published reports, and the examination of each region represented an independent aim, although there is controversy regarding this justification.
181-1	32965-32977	Nevertheless	_	
181-2	32977-32978	,	_	
181-3	32979-32981	it	_	
181-4	32982-32984	is	_	
181-5	32985-32994	important	_	
181-6	32995-32997	to	_	
181-7	32998-33002	note	_	
181-8	33003-33007	that	_	
181-9	33008-33011	our	_	
181-10	33012-33021	inclusion	_	
181-11	33022-33024	of	_	
181-12	33025-33029	each	_	
181-13	33030-33038	separate	_	
181-14	33039-33045	region	_	
181-15	33046-33049	was	_	
181-16	33050-33055	based	_	
181-17	33056-33060	upon	_	
181-18	33061-33072	independent	_	
181-19	33073-33081	findings	_	
181-20	33082-33089	derived	_	
181-21	33090-33094	from	_	
181-22	33095-33105	previously	_	
181-23	33106-33115	published	_	
181-24	33116-33123	reports	_	
181-25	33123-33124	,	_	
181-26	33125-33128	and	_	
181-27	33129-33132	the	_	
181-28	33133-33144	examination	_	
181-29	33145-33147	of	_	
181-30	33148-33152	each	_	
181-31	33153-33159	region	_	
181-32	33160-33171	represented	_	
181-33	33172-33174	an	_	
181-34	33175-33186	independent	_	
181-35	33187-33190	aim	_	
181-36	33190-33191	,	_	
181-37	33192-33200	although	_	
181-38	33201-33206	there	_	
181-39	33207-33209	is	_	
181-40	33210-33221	controversy	_	
181-41	33222-33231	regarding	_	
181-42	33232-33236	this	_	
181-43	33237-33250	justification	_	
181-44	33250-33251	.	_	

#Text=Therefore, we reported the magnitudes of the effects — along with the confidence intervals, which reflect the probability levels — for each region we investigated.
182-1	33252-33261	Therefore	_	
182-2	33261-33262	,	_	
182-3	33263-33265	we	_	
182-4	33266-33274	reported	_	
182-5	33275-33278	the	_	
182-6	33279-33289	magnitudes	_	
182-7	33290-33292	of	_	
182-8	33293-33296	the	_	
182-9	33297-33304	effects	_	
182-10	33305-33306	—	_	
182-11	33307-33312	along	_	
182-12	33313-33317	with	_	
182-13	33318-33321	the	_	
182-14	33322-33332	confidence	_	
182-15	33333-33342	intervals	_	
182-16	33342-33343	,	_	
182-17	33344-33349	which	_	
182-18	33350-33357	reflect	_	
182-19	33358-33361	the	_	
182-20	33362-33373	probability	_	
182-21	33374-33380	levels	_	
182-22	33381-33382	—	_	
182-23	33383-33386	for	_	
182-24	33387-33391	each	_	
182-25	33392-33398	region	_	
182-26	33399-33401	we	_	
182-27	33402-33414	investigated	_	
182-28	33414-33415	.	_	

#Text=Such an approach is concordant with sophisticated Bayesian frameworks.
#Text=5.
183-1	33416-33420	Such	_	
183-2	33421-33423	an	_	
183-3	33424-33432	approach	_	
183-4	33433-33435	is	_	
183-5	33436-33446	concordant	_	
183-6	33447-33451	with	_	
183-7	33452-33465	sophisticated	_	
183-8	33466-33474	Bayesian	_	
183-9	33475-33485	frameworks	_	
183-10	33485-33486	.	_	
183-11	33487-33488	5	_	
183-12	33488-33489	.	_	

#Text=Conclusions
#Text=The present study considered the reward network as an interconnected and interrelated system, using statistical analyses that treated it as a unique group of subregions.
184-1	33490-33501	Conclusions	_	
184-2	33502-33505	The	_	
184-3	33506-33513	present	_	
184-4	33514-33519	study	_	
184-5	33520-33530	considered	_	
184-6	33531-33534	the	_	
184-7	33535-33541	reward	_	
184-8	33542-33549	network	_	
184-9	33550-33552	as	_	
184-10	33553-33555	an	_	
184-11	33556-33570	interconnected	_	
184-12	33571-33574	and	_	
184-13	33575-33587	interrelated	_	
184-14	33588-33594	system	_	
184-15	33594-33595	,	_	
184-16	33596-33601	using	_	
184-17	33602-33613	statistical	_	
184-18	33614-33622	analyses	_	
184-19	33623-33627	that	_	
184-20	33628-33635	treated	_	
184-21	33636-33638	it	_	
184-22	33639-33641	as	_	
184-23	33642-33643	a	_	
184-24	33644-33650	unique	_	
184-25	33651-33656	group	_	
184-26	33657-33659	of	_	
184-27	33660-33670	subregions	_	
184-28	33670-33671	.	_	

#Text=For the total extended reward and oversight system, as well as its DLPFC and VDC subregions, alcoholism was associated with smaller volumes in men; conversely, alcoholism was associated larger volumes in women, yielding a significant alcoholism by gender interaction.
185-1	33672-33675	For	_	
185-2	33676-33679	the	_	
185-3	33680-33685	total	_	
185-4	33686-33694	extended	_	
185-5	33695-33701	reward	_	
185-6	33702-33705	and	_	
185-7	33706-33715	oversight	_	
185-8	33716-33722	system	_	
185-9	33722-33723	,	_	
185-10	33724-33726	as	_	
185-11	33727-33731	well	_	
185-12	33732-33734	as	_	
185-13	33735-33738	its	_	
185-14	33739-33744	DLPFC	_	
185-15	33745-33748	and	_	
185-16	33749-33752	VDC	_	
185-17	33753-33763	subregions	_	
185-18	33763-33764	,	_	
185-19	33765-33775	alcoholism	_	
185-20	33776-33779	was	_	
185-21	33780-33790	associated	_	
185-22	33791-33795	with	_	
185-23	33796-33803	smaller	_	
185-24	33804-33811	volumes	_	
185-25	33812-33814	in	_	
185-26	33815-33818	men	_	
185-27	33818-33819	;	_	
185-28	33820-33830	conversely	_	
185-29	33830-33831	,	_	
185-30	33832-33842	alcoholism	_	
185-31	33843-33846	was	_	
185-32	33847-33857	associated	_	
185-33	33858-33864	larger	_	
185-34	33865-33872	volumes	_	
185-35	33873-33875	in	_	
185-36	33876-33881	women	_	
185-37	33881-33882	,	_	
185-38	33883-33891	yielding	_	
185-39	33892-33893	a	_	
185-40	33894-33905	significant	_	
185-41	33906-33916	alcoholism	_	
185-42	33917-33919	by	_	
185-43	33920-33926	gender	_	
185-44	33927-33938	interaction	_	
185-45	33938-33939	.	_	

#Text=These findings demonstrated gender differences in brain reward circuitry.
186-1	33940-33945	These	_	
186-2	33946-33954	findings	_	
186-3	33955-33967	demonstrated	_	
186-4	33968-33974	gender	_	
186-5	33975-33986	differences	_	
186-6	33987-33989	in	_	
186-7	33990-33995	brain	_	
186-8	33996-34002	reward	_	
186-9	34003-34012	circuitry	_	
186-10	34012-34013	.	_	

#Text=In terms of specific reward regions, alcoholism-associated changes were most apparent in DLPFC and VDC.
187-1	34014-34016	In	_	
187-2	34017-34022	terms	_	
187-3	34023-34025	of	_	
187-4	34026-34034	specific	_	
187-5	34035-34041	reward	_	
187-6	34042-34049	regions	_	
187-7	34049-34050	,	_	
187-8	34051-34072	alcoholism-associated	_	
187-9	34073-34080	changes	_	
187-10	34081-34085	were	_	
187-11	34086-34090	most	_	
187-12	34091-34099	apparent	_	
187-13	34100-34102	in	_	
187-14	34103-34108	DLPFC	_	
187-15	34109-34112	and	_	
187-16	34113-34116	VDC	_	
187-17	34116-34117	.	_	

#Text=The present study also connected reward network morphometry to drinking history, finding a number of effects and interactions.
188-1	34118-34121	The	_	
188-2	34122-34129	present	_	
188-3	34130-34135	study	_	
188-4	34136-34140	also	_	
188-5	34141-34150	connected	_	
188-6	34151-34157	reward	_	
188-7	34158-34165	network	_	
188-8	34166-34177	morphometry	_	
188-9	34178-34180	to	_	
188-10	34181-34189	drinking	_	
188-11	34190-34197	history	_	
188-12	34197-34198	,	_	
188-13	34199-34206	finding	_	
188-14	34207-34208	a	_	
188-15	34209-34215	number	_	
188-16	34216-34218	of	_	
188-17	34219-34226	effects	_	
188-18	34227-34230	and	_	
188-19	34231-34243	interactions	_	
188-20	34243-34244	.	_	

#Text=Additionally, total ventricular volume decreased in association with the number of years that alcoholics remained sober, suggesting significant recovery with abstinence.
189-1	34245-34257	Additionally	_	
189-2	34257-34258	,	_	
189-3	34259-34264	total	_	
189-4	34265-34276	ventricular	_	
189-5	34277-34283	volume	_	
189-6	34284-34293	decreased	_	
189-7	34294-34296	in	_	
189-8	34297-34308	association	_	
189-9	34309-34313	with	_	
189-10	34314-34317	the	_	
189-11	34318-34324	number	_	
189-12	34325-34327	of	_	
189-13	34328-34333	years	_	
189-14	34334-34338	that	_	
189-15	34339-34349	alcoholics	_	
189-16	34350-34358	remained	_	
189-17	34359-34364	sober	_	
189-18	34364-34365	,	_	
189-19	34366-34376	suggesting	_	
189-20	34377-34388	significant	_	
189-21	34389-34397	recovery	_	
189-22	34398-34402	with	_	
189-23	34403-34413	abstinence	_	
189-24	34413-34414	.	_	

#Text=Overall, the findings highlight the impact of alcoholism on the reward network, the potential for amelioration of structural deficits with sobriety, and differences based on gender.
190-1	34415-34422	Overall	_	
190-2	34422-34423	,	_	
190-3	34424-34427	the	_	
190-4	34428-34436	findings	_	
190-5	34437-34446	highlight	_	
190-6	34447-34450	the	_	
190-7	34451-34457	impact	_	
190-8	34458-34460	of	_	
190-9	34461-34471	alcoholism	_	
190-10	34472-34474	on	_	
190-11	34475-34478	the	_	
190-12	34479-34485	reward	_	
190-13	34486-34493	network	_	
190-14	34493-34494	,	_	
190-15	34495-34498	the	_	
190-16	34499-34508	potential	_	
190-17	34509-34512	for	_	
190-18	34513-34525	amelioration	_	
190-19	34526-34528	of	_	
190-20	34529-34539	structural	_	
190-21	34540-34548	deficits	_	
190-22	34549-34553	with	_	
190-23	34554-34562	sobriety	_	
190-24	34562-34563	,	_	
190-25	34564-34567	and	_	
190-26	34568-34579	differences	_	
190-27	34580-34585	based	_	
190-28	34586-34588	on	_	
190-29	34589-34595	gender	_	
190-30	34595-34596	.	_	

#Text=Further exploration of these relationships may aid in finding potential biological and psychological therapeutic targets.
191-1	34597-34604	Further	_	
191-2	34605-34616	exploration	_	
191-3	34617-34619	of	_	
191-4	34620-34625	these	_	
191-5	34626-34639	relationships	_	
191-6	34640-34643	may	_	
191-7	34644-34647	aid	_	
191-8	34648-34650	in	_	
191-9	34651-34658	finding	_	
191-10	34659-34668	potential	_	
191-11	34669-34679	biological	_	
191-12	34680-34683	and	_	
191-13	34684-34697	psychological	_	
191-14	34698-34709	therapeutic	_	
191-15	34710-34717	targets	_	
191-16	34717-34718	.	_	

#Text=Supplementary Material
#Text=The Adolescent Brain Cognitive Development [ABCD] USA Consortium Research Project
#Text=Conflicts of interest: None of the authors reported having any relevant biomedical financial interest or potential conflicts of interest.
192-1	34719-34732	Supplementary	_	
192-2	34733-34741	Material	_	
192-3	34742-34745	The	_	
192-4	34746-34756	Adolescent	_	
192-5	34757-34762	Brain	_	
192-6	34763-34772	Cognitive	_	
192-7	34773-34784	Development	_	
192-8	34785-34786	[	_	
192-9	34786-34790	ABCD	_	
192-10	34790-34791	]	_	
192-11	34792-34795	USA	_	
192-12	34796-34806	Consortium	_	
192-13	34807-34815	Research	_	
192-14	34816-34823	Project	_	
192-15	34824-34833	Conflicts	_	
192-16	34834-34836	of	_	
192-17	34837-34845	interest	_	
192-18	34845-34846	:	_	
192-19	34847-34851	None	_	
192-20	34852-34854	of	_	
192-21	34855-34858	the	_	
192-22	34859-34866	authors	_	
192-23	34867-34875	reported	_	
192-24	34876-34882	having	_	
192-25	34883-34886	any	_	
192-26	34887-34895	relevant	_	
192-27	34896-34906	biomedical	_	
192-28	34907-34916	financial	_	
192-29	34917-34925	interest	_	
192-30	34926-34928	or	_	
192-31	34929-34938	potential	_	
192-32	34939-34948	conflicts	_	
192-33	34949-34951	of	_	
192-34	34952-34960	interest	_	
192-35	34960-34961	.	_	

#Text=This is a PDF file of an unedited manuscript that has been accepted for publication.
193-1	34962-34966	This	_	
193-2	34967-34969	is	_	
193-3	34970-34971	a	_	
193-4	34972-34975	PDF	_	
193-5	34976-34980	file	_	
193-6	34981-34983	of	_	
193-7	34984-34986	an	_	
193-8	34987-34995	unedited	_	
193-9	34996-35006	manuscript	_	
193-10	35007-35011	that	_	
193-11	35012-35015	has	_	
193-12	35016-35020	been	_	
193-13	35021-35029	accepted	_	
193-14	35030-35033	for	_	
193-15	35034-35045	publication	_	
193-16	35045-35046	.	_	

#Text=As a service to our customers we are providing this early version of the manuscript.
194-1	35047-35049	As	_	
194-2	35050-35051	a	_	
194-3	35052-35059	service	_	
194-4	35060-35062	to	_	
194-5	35063-35066	our	_	
194-6	35067-35076	customers	_	
194-7	35077-35079	we	_	
194-8	35080-35083	are	_	
194-9	35084-35093	providing	_	
194-10	35094-35098	this	_	
194-11	35099-35104	early	_	
194-12	35105-35112	version	_	
194-13	35113-35115	of	_	
194-14	35116-35119	the	_	
194-15	35120-35130	manuscript	_	
194-16	35130-35131	.	_	

#Text=The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form.
195-1	35132-35135	The	_	
195-2	35136-35146	manuscript	_	
195-3	35147-35151	will	_	
195-4	35152-35159	undergo	_	
195-5	35160-35171	copyediting	_	
195-6	35171-35172	,	_	
195-7	35173-35184	typesetting	_	
195-8	35184-35185	,	_	
195-9	35186-35189	and	_	
195-10	35190-35196	review	_	
195-11	35197-35199	of	_	
195-12	35200-35203	the	_	
195-13	35204-35213	resulting	_	
195-14	35214-35219	proof	_	
195-15	35220-35226	before	_	
195-16	35227-35229	it	_	
195-17	35230-35232	is	_	
195-18	35233-35242	published	_	
195-19	35243-35245	in	_	
195-20	35246-35249	its	_	
195-21	35250-35255	final	_	
195-22	35256-35263	citable	_	
195-23	35264-35268	form	_	
195-24	35268-35269	.	_	

#Text=Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
196-1	35270-35276	Please	_	
196-2	35277-35281	note	_	
196-3	35282-35286	that	_	
196-4	35287-35293	during	_	
196-5	35294-35297	the	_	
196-6	35298-35308	production	_	
196-7	35309-35316	process	_	
196-8	35317-35323	errors	_	
196-9	35324-35327	may	_	
196-10	35328-35330	be	_	
196-11	35331-35341	discovered	_	
196-12	35342-35347	which	_	
196-13	35348-35353	could	_	
196-14	35354-35360	affect	_	
196-15	35361-35364	the	_	
196-16	35365-35372	content	_	
196-17	35372-35373	,	_	
196-18	35374-35377	and	_	
196-19	35378-35381	all	_	
196-20	35382-35387	legal	_	
196-21	35388-35399	disclaimers	_	
196-22	35400-35404	that	_	
196-23	35405-35410	apply	_	
196-24	35411-35413	to	_	
196-25	35414-35417	the	_	
196-26	35418-35425	journal	_	
196-27	35426-35433	pertain	_	
196-28	35433-35434	.	_	

#Text=Hippocampal volume in patients with alcohol dependence
#Text=New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata
#Text=
#Text=Connections underlying the synthesis of cognition, memory, and emotion in primate prefrontal cortices
#Text=Controlling the false discovery rate: A practical and powerful approach to multiple testing
#Text=Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome
#Text=Patterns of hand preference in a student population
#Text=
#Text=Deformation-based morphometry of brain changes in alcohol dependence and abstinence
#Text=
#Text=The human brain age 7–11 years: A volumetric analysis based on magnetic resonance images
#Text=MRI-based topographic parcellation of human neocortex: An anatomically specified method with estimate of reliability
#Text=Detection of influential observation in linear regression
#Text=In praise of tedious anatomy
#Text=Language-association cortex asymmetry in autism and specific language impairment
#Text=Gender differences and association between psychological stress and alcohol consumption: a systematic review
#Text=The young adult human brain: An MRI-based morphometric analysis
#Text=Automatically parcellating the human cerebral cortex
#Text=Whole brain segmentation
#Text=Planned hypothesis tests are not necessarily exempt from multiplicity adjustment
#Text=Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder
#Text=
#Text=Philosophy and the practice of Bayesian statistics
#Text=Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging
#Text=Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging
#Text=A rating scale for depression
#Text=Frontal white matter and cingulum diffusion tensor imaging deficits in alcoholism
#Text=The limbic lobe and its output channels: Implications for emotional functions and adaptive behavior
#Text=Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys
#Text=Male and female sensitivity to alcohol-induced brain damage
#Text=Decreased corpus callosum size among alcoholic women
#Text=Female alcoholics: A controlled CT brain scan and clinical study
#Text=Anatomic segmentation and volumetric calculations in nuclear magnetic resonance imaging
#Text=Brain ventricular size in female alcoholics: An MRI study
#Text=A volumetric MRI study of the hippocampus in Type 1 and 2 alcoholism
#Text=Cognitive neuroscience of emotional memory
#Text=Gender differences in the brain: Implications for the study of human alcoholism
#Text=Overlapping projections to the amygdala and striatum from auditory processing areas of the thalamus and cortex
#Text=Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear
#Text=Typologies of alcohol dependence.
197-1	35435-35446	Hippocampal	_	
197-2	35447-35453	volume	_	
197-3	35454-35456	in	_	
197-4	35457-35465	patients	_	
197-5	35466-35470	with	_	
197-6	35471-35478	alcohol	_	
197-7	35479-35489	dependence	_	
197-8	35490-35493	New	_	
197-9	35494-35506	perspectives	_	
197-10	35507-35509	in	_	
197-11	35510-35515	basal	_	
197-12	35516-35525	forebrain	_	
197-13	35526-35538	organization	_	
197-14	35539-35541	of	_	
197-15	35542-35549	special	_	
197-16	35550-35559	relevance	_	
197-17	35560-35563	for	_	
197-18	35564-35580	neuropsychiatric	_	
197-19	35581-35590	disorders	_	
197-20	35590-35591	:	_	
197-21	35592-35595	The	_	
197-22	35596-35611	striatopallidal	_	
197-23	35611-35612	,	_	
197-24	35613-35623	amygdaloid	_	
197-25	35623-35624	,	_	
197-26	35625-35628	and	_	
197-27	35629-35641	corticopetal	_	
197-28	35642-35652	components	_	
197-29	35653-35655	of	_	
197-30	35656-35666	substantia	_	
197-31	35667-35677	innominata	_	
197-32	35679-35690	Connections	_	
197-33	35691-35701	underlying	_	
197-34	35702-35705	the	_	
197-35	35706-35715	synthesis	_	
197-36	35716-35718	of	_	
197-37	35719-35728	cognition	_	
197-38	35728-35729	,	_	
197-39	35730-35736	memory	_	
197-40	35736-35737	,	_	
197-41	35738-35741	and	_	
197-42	35742-35749	emotion	_	
197-43	35750-35752	in	_	
197-44	35753-35760	primate	_	
197-45	35761-35771	prefrontal	_	
197-46	35772-35780	cortices	_	
197-47	35781-35792	Controlling	_	
197-48	35793-35796	the	_	
197-49	35797-35802	false	_	
197-50	35803-35812	discovery	_	
197-51	35813-35817	rate	_	
197-52	35817-35818	:	_	
197-53	35819-35820	A	_	
197-54	35821-35830	practical	_	
197-55	35831-35834	and	_	
197-56	35835-35843	powerful	_	
197-57	35844-35852	approach	_	
197-58	35853-35855	to	_	
197-59	35856-35864	multiple	_	
197-60	35865-35872	testing	_	
197-61	35873-35885	Relationship	_	
197-62	35886-35893	between	_	
197-63	35894-35906	dopaminergic	_	
197-64	35907-35924	neurotransmission	_	
197-65	35924-35925	,	_	
197-66	35926-35936	alcoholism	_	
197-67	35936-35937	,	_	
197-68	35938-35941	and	_	
197-69	35942-35948	reward	_	
197-70	35949-35959	deficiency	_	
197-71	35960-35968	syndrome	_	
197-72	35969-35977	Patterns	_	
197-73	35978-35980	of	_	
197-74	35981-35985	hand	_	
197-75	35986-35996	preference	_	
197-76	35997-35999	in	_	
197-77	36000-36001	a	_	
197-78	36002-36009	student	_	
197-79	36010-36020	population	_	
197-80	36022-36039	Deformation-based	_	
197-81	36040-36051	morphometry	_	
197-82	36052-36054	of	_	
197-83	36055-36060	brain	_	
197-84	36061-36068	changes	_	
197-85	36069-36071	in	_	
197-86	36072-36079	alcohol	_	
197-87	36080-36090	dependence	_	
197-88	36091-36094	and	_	
197-89	36095-36105	abstinence	_	
197-90	36107-36110	The	_	
197-91	36111-36116	human	_	
197-92	36117-36122	brain	_	
197-93	36123-36126	age	_	
197-94	36127-36128	7	_	
197-95	36128-36129	–	_	
197-96	36129-36131	11	_	
197-97	36132-36137	years	_	
197-98	36137-36138	:	_	
197-99	36139-36140	A	_	
197-100	36141-36151	volumetric	_	
197-101	36152-36160	analysis	_	
197-102	36161-36166	based	_	
197-103	36167-36169	on	_	
197-104	36170-36178	magnetic	_	
197-105	36179-36188	resonance	_	
197-106	36189-36195	images	_	
197-107	36196-36205	MRI-based	_	
197-108	36206-36217	topographic	_	
197-109	36218-36230	parcellation	_	
197-110	36231-36233	of	_	
197-111	36234-36239	human	_	
197-112	36240-36249	neocortex	_	
197-113	36249-36250	:	_	
197-114	36251-36253	An	_	
197-115	36254-36266	anatomically	_	
197-116	36267-36276	specified	_	
197-117	36277-36283	method	_	
197-118	36284-36288	with	_	
197-119	36289-36297	estimate	_	
197-120	36298-36300	of	_	
197-121	36301-36312	reliability	_	
197-122	36313-36322	Detection	_	
197-123	36323-36325	of	_	
197-124	36326-36337	influential	_	
197-125	36338-36349	observation	_	
197-126	36350-36352	in	_	
197-127	36353-36359	linear	_	
197-128	36360-36370	regression	_	
197-129	36371-36373	In	_	
197-130	36374-36380	praise	_	
197-131	36381-36383	of	_	
197-132	36384-36391	tedious	_	
197-133	36392-36399	anatomy	_	
197-134	36400-36420	Language-association	_	
197-135	36421-36427	cortex	_	
197-136	36428-36437	asymmetry	_	
197-137	36438-36440	in	_	
197-138	36441-36447	autism	_	
197-139	36448-36451	and	_	
197-140	36452-36460	specific	_	
197-141	36461-36469	language	_	
197-142	36470-36480	impairment	_	
197-143	36481-36487	Gender	_	
197-144	36488-36499	differences	_	
197-145	36500-36503	and	_	
197-146	36504-36515	association	_	
197-147	36516-36523	between	_	
197-148	36524-36537	psychological	_	
197-149	36538-36544	stress	_	
197-150	36545-36548	and	_	
197-151	36549-36556	alcohol	_	
197-152	36557-36568	consumption	_	
197-153	36568-36569	:	_	
197-154	36570-36571	a	_	
197-155	36572-36582	systematic	_	
197-156	36583-36589	review	_	
197-157	36590-36593	The	_	
197-158	36594-36599	young	_	
197-159	36600-36605	adult	_	
197-160	36606-36611	human	_	
197-161	36612-36617	brain	_	
197-162	36617-36618	:	_	
197-163	36619-36621	An	_	
197-164	36622-36631	MRI-based	_	
197-165	36632-36644	morphometric	_	
197-166	36645-36653	analysis	_	
197-167	36654-36667	Automatically	_	
197-168	36668-36680	parcellating	_	
197-169	36681-36684	the	_	
197-170	36685-36690	human	_	
197-171	36691-36699	cerebral	_	
197-172	36700-36706	cortex	_	
197-173	36707-36712	Whole	_	
197-174	36713-36718	brain	_	
197-175	36719-36731	segmentation	_	
197-176	36732-36739	Planned	_	
197-177	36740-36750	hypothesis	_	
197-178	36751-36756	tests	_	
197-179	36757-36760	are	_	
197-180	36761-36764	not	_	
197-181	36765-36776	necessarily	_	
197-182	36777-36783	exempt	_	
197-183	36784-36788	from	_	
197-184	36789-36801	multiplicity	_	
197-185	36802-36812	adjustment	_	
197-186	36813-36823	Structural	_	
197-187	36824-36829	brain	_	
197-188	36830-36838	magnetic	_	
197-189	36839-36848	resonance	_	
197-190	36849-36856	imaging	_	
197-191	36857-36859	of	_	
197-192	36860-36866	limbic	_	
197-193	36867-36870	and	_	
197-194	36871-36879	thalamic	_	
197-195	36880-36887	volumes	_	
197-196	36888-36890	in	_	
197-197	36891-36900	pediatric	_	
197-198	36901-36908	bipolar	_	
197-199	36909-36917	disorder	_	
197-200	36919-36929	Philosophy	_	
197-201	36930-36933	and	_	
197-202	36934-36937	the	_	
197-203	36938-36946	practice	_	
197-204	36947-36949	of	_	
197-205	36950-36958	Bayesian	_	
197-206	36959-36969	statistics	_	
197-207	36970-36978	Cortical	_	
197-208	36979-36992	abnormalities	_	
197-209	36993-36995	in	_	
197-210	36996-37009	schizophrenia	_	
197-211	37010-37020	identified	_	
197-212	37021-37023	by	_	
197-213	37024-37034	structural	_	
197-214	37035-37043	magnetic	_	
197-215	37044-37053	resonance	_	
197-216	37054-37061	imaging	_	
197-217	37062-37068	Normal	_	
197-218	37069-37075	sexual	_	
197-219	37076-37086	dimorphism	_	
197-220	37087-37089	of	_	
197-221	37090-37093	the	_	
197-222	37094-37099	adult	_	
197-223	37100-37105	human	_	
197-224	37106-37111	brain	_	
197-225	37112-37120	assessed	_	
197-226	37121-37123	by	_	
197-227	37124-37126	in	_	
197-228	37127-37131	vivo	_	
197-229	37132-37140	magnetic	_	
197-230	37141-37150	resonance	_	
197-231	37151-37158	imaging	_	
197-232	37159-37160	A	_	
197-233	37161-37167	rating	_	
197-234	37168-37173	scale	_	
197-235	37174-37177	for	_	
197-236	37178-37188	depression	_	
197-237	37189-37196	Frontal	_	
197-238	37197-37202	white	_	
197-239	37203-37209	matter	_	
197-240	37210-37213	and	_	
197-241	37214-37222	cingulum	_	
197-242	37223-37232	diffusion	_	
197-243	37233-37239	tensor	_	
197-244	37240-37247	imaging	_	
197-245	37248-37256	deficits	_	
197-246	37257-37259	in	_	
197-247	37260-37270	alcoholism	_	
197-248	37271-37274	The	_	
197-249	37275-37281	limbic	_	
197-250	37282-37286	lobe	_	
197-251	37287-37290	and	_	
197-252	37291-37294	its	_	
197-253	37295-37301	output	_	
197-254	37302-37310	channels	_	
197-255	37310-37311	:	_	
197-256	37312-37324	Implications	_	
197-257	37325-37328	for	_	
197-258	37329-37338	emotional	_	
197-259	37339-37348	functions	_	
197-260	37349-37352	and	_	
197-261	37353-37361	adaptive	_	
197-262	37362-37370	behavior	_	
197-263	37371-37384	Dissociations	_	
197-264	37385-37387	of	_	
197-265	37388-37396	cerebral	_	
197-266	37397-37403	cortex	_	
197-267	37403-37404	,	_	
197-268	37405-37416	subcortical	_	
197-269	37417-37420	and	_	
197-270	37421-37429	cerebral	_	
197-271	37430-37435	white	_	
197-272	37436-37442	matter	_	
197-273	37443-37450	volumes	_	
197-274	37451-37453	in	_	
197-275	37454-37462	autistic	_	
197-276	37463-37467	boys	_	
197-277	37468-37472	Male	_	
197-278	37473-37476	and	_	
197-279	37477-37483	female	_	
197-280	37484-37495	sensitivity	_	
197-281	37496-37498	to	_	
197-282	37499-37514	alcohol-induced	_	
197-283	37515-37520	brain	_	
197-284	37521-37527	damage	_	
197-285	37528-37537	Decreased	_	
197-286	37538-37544	corpus	_	
197-287	37545-37553	callosum	_	
197-288	37554-37558	size	_	
197-289	37559-37564	among	_	
197-290	37565-37574	alcoholic	_	
197-291	37575-37580	women	_	
197-292	37581-37587	Female	_	
197-293	37588-37598	alcoholics	_	
197-294	37598-37599	:	_	
197-295	37600-37601	A	_	
197-296	37602-37612	controlled	_	
197-297	37613-37615	CT	_	
197-298	37616-37621	brain	_	
197-299	37622-37626	scan	_	
197-300	37627-37630	and	_	
197-301	37631-37639	clinical	_	
197-302	37640-37645	study	_	
197-303	37646-37654	Anatomic	_	
197-304	37655-37667	segmentation	_	
197-305	37668-37671	and	_	
197-306	37672-37682	volumetric	_	
197-307	37683-37695	calculations	_	
197-308	37696-37698	in	_	
197-309	37699-37706	nuclear	_	
197-310	37707-37715	magnetic	_	
197-311	37716-37725	resonance	_	
197-312	37726-37733	imaging	_	
197-313	37734-37739	Brain	_	
197-314	37740-37751	ventricular	_	
197-315	37752-37756	size	_	
197-316	37757-37759	in	_	
197-317	37760-37766	female	_	
197-318	37767-37777	alcoholics	_	
197-319	37777-37778	:	_	
197-320	37779-37781	An	_	
197-321	37782-37785	MRI	_	
197-322	37786-37791	study	_	
197-323	37792-37793	A	_	
197-324	37794-37804	volumetric	_	
197-325	37805-37808	MRI	_	
197-326	37809-37814	study	_	
197-327	37815-37817	of	_	
197-328	37818-37821	the	_	
197-329	37822-37833	hippocampus	_	
197-330	37834-37836	in	_	
197-331	37837-37841	Type	_	
197-332	37842-37843	1	_	
197-333	37844-37847	and	_	
197-334	37848-37849	2	_	
197-335	37850-37860	alcoholism	_	
197-336	37861-37870	Cognitive	_	
197-337	37871-37883	neuroscience	_	
197-338	37884-37886	of	_	
197-339	37887-37896	emotional	_	
197-340	37897-37903	memory	_	
197-341	37904-37910	Gender	_	
197-342	37911-37922	differences	_	
197-343	37923-37925	in	_	
197-344	37926-37929	the	_	
197-345	37930-37935	brain	_	
197-346	37935-37936	:	_	
197-347	37937-37949	Implications	_	
197-348	37950-37953	for	_	
197-349	37954-37957	the	_	
197-350	37958-37963	study	_	
197-351	37964-37966	of	_	
197-352	37967-37972	human	_	
197-353	37973-37983	alcoholism	_	
197-354	37984-37995	Overlapping	_	
197-355	37996-38007	projections	_	
197-356	38008-38010	to	_	
197-357	38011-38014	the	_	
197-358	38015-38023	amygdala	_	
197-359	38024-38027	and	_	
197-360	38028-38036	striatum	_	
197-361	38037-38041	from	_	
197-362	38042-38050	auditory	_	
197-363	38051-38061	processing	_	
197-364	38062-38067	areas	_	
197-365	38068-38070	of	_	
197-366	38071-38074	the	_	
197-367	38075-38083	thalamus	_	
197-368	38084-38087	and	_	
197-369	38088-38094	cortex	_	
197-370	38095-38104	Different	_	
197-371	38105-38116	projections	_	
197-372	38117-38119	of	_	
197-373	38120-38123	the	_	
197-374	38124-38131	central	_	
197-375	38132-38142	amygdaloid	_	
197-376	38143-38150	nucleus	_	
197-377	38151-38158	mediate	_	
197-378	38159-38168	autonomic	_	
197-379	38169-38172	and	_	
197-380	38173-38183	behavioral	_	
197-381	38184-38194	correlates	_	
197-382	38195-38197	of	_	
197-383	38198-38209	conditioned	_	
197-384	38210-38214	fear	_	
197-385	38215-38225	Typologies	_	
197-386	38226-38228	of	_	
197-387	38229-38236	alcohol	_	
197-388	38237-38247	dependence	_	
197-389	38247-38248	.	_	

#Text=From Jellinek to genetics and beyond
#Text=Decreased absolute amygdala volume in cocaine addicts
#Text=MRI-based topographic parcellation of human cerebral white matter and nuclei
#Text=Decreased volume of the brain reward system in alcoholism
#Text=Neuroimaging of gender differences in alcohol dependence: Are women more vulnerable?
198-1	38249-38253	From	_	
198-2	38254-38262	Jellinek	_	
198-3	38263-38265	to	_	
198-4	38266-38274	genetics	_	
198-5	38275-38278	and	_	
198-6	38279-38285	beyond	_	
198-7	38286-38295	Decreased	_	
198-8	38296-38304	absolute	_	
198-9	38305-38313	amygdala	_	
198-10	38314-38320	volume	_	
198-11	38321-38323	in	_	
198-12	38324-38331	cocaine	_	
198-13	38332-38339	addicts	_	
198-14	38340-38349	MRI-based	_	
198-15	38350-38361	topographic	_	
198-16	38362-38374	parcellation	_	
198-17	38375-38377	of	_	
198-18	38378-38383	human	_	
198-19	38384-38392	cerebral	_	
198-20	38393-38398	white	_	
198-21	38399-38405	matter	_	
198-22	38406-38409	and	_	
198-23	38410-38416	nuclei	_	
198-24	38417-38426	Decreased	_	
198-25	38427-38433	volume	_	
198-26	38434-38436	of	_	
198-27	38437-38440	the	_	
198-28	38441-38446	brain	_	
198-29	38447-38453	reward	_	
198-30	38454-38460	system	_	
198-31	38461-38463	in	_	
198-32	38464-38474	alcoholism	_	
198-33	38475-38487	Neuroimaging	_	
198-34	38488-38490	of	_	
198-35	38491-38497	gender	_	
198-36	38498-38509	differences	_	
198-37	38510-38512	in	_	
198-38	38513-38520	alcohol	_	
198-39	38521-38531	dependence	_	
198-40	38531-38532	:	_	
198-41	38533-38536	Are	_	
198-42	38537-38542	women	_	
198-43	38543-38547	more	_	
198-44	38548-38558	vulnerable	_	
198-45	38558-38559	?	_	

#Text=Treatment of alcohol intoxication and alcohol withdrawal
#Text=The cognitive control of emotion
#Text=Genetic influences in emotional dysfunction and alcoholism-related brain damage
#Text=Alcohol: Effects on neurobehavioral functions and the brain
#Text=Brain volumetric measures in alcoholics: a comparison of two segmentation methods
#Text=Profiles of impaired, spared, and recovered neuropsychologic processes in alcoholism
#Text=Association pathways of the prefrontal cortex and functional observations
#Text=Frontal circuitry degradation marks healthy adult aging: Evidence from diffusion tensor imaging
#Text=Sex differences in the effects of alcohol on brain structure
#Text=Degradation of association and projection white matter systems in alcoholism detected with quantitative fiber tracking
#Text=Corpus callosum, pons, and cortical white matter in alcoholic women
#Text=Transcallosal white matter degradation detected with quantitative fiber tracking in alcoholic men and women: selective relations to dissociable functions
#Text=Microstructural but not macrostructural disruption of white matter in women with chronic alcoholism
#Text=Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics
#Text=A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval
#Text=Sex differences in acoustic startle responses and seizure thresholds between ethanol-withdrawn male and female rats
#Text=
#Text=Closing the gender gap: The case for gender-specific alcoholism research
#Text=Drinking history associations with regional white matter volumes in alcoholic men and women
#Text=Subcortical volumes in long-term abstinent alcoholics: Associations with psychiatric comorbidity
#Text=
#Text=Subcortical correlates of craving in recently abstinent alcoholic patients
#Text=Effects of alcoholism and gender on brain metabolism
#Text=Thalamic and amygdala–hippocampal volume reductions in first-degree relatives of patients with schizophrenia: An MRI-based morphometric analysis
#Text=Brain response to working memory over three years of adolescence: influence of initiating heavy drinking
#Text=Cerebellar volume decline in normal aging, alcoholism, and Korsakoff's syndrome: Relation to ataxia
#Text=Anterior hippocampal volume deficits in nonamnesic, aging chronic alcoholics
#Text=Effects of age and sex on volumes of the thalamus, pons, and cortex
#Text=Positron emission tomography imaging of the serotonin transporter in subjects with a history of alcoholism
#Text=
#Text=When to combine hypotheses and adjust for multiple tests
#Text=Neurobiologic advances from the brain disease model of addiction
#Text=Puberty, hormones, and sex differences in alcohol abuse and dependence
#Text=
#Text=
#Text=
#Text=Three-dimensional representation of the cortical and subcortical structures of
#Text=the brain's reward system.
199-1	38560-38569	Treatment	_	
199-2	38570-38572	of	_	
199-3	38573-38580	alcohol	_	
199-4	38581-38593	intoxication	_	
199-5	38594-38597	and	_	
199-6	38598-38605	alcohol	_	
199-7	38606-38616	withdrawal	_	
199-8	38617-38620	The	_	
199-9	38621-38630	cognitive	_	
199-10	38631-38638	control	_	
199-11	38639-38641	of	_	
199-12	38642-38649	emotion	_	
199-13	38650-38657	Genetic	_	
199-14	38658-38668	influences	_	
199-15	38669-38671	in	_	
199-16	38672-38681	emotional	_	
199-17	38682-38693	dysfunction	_	
199-18	38694-38697	and	_	
199-19	38698-38716	alcoholism-related	_	
199-20	38717-38722	brain	_	
199-21	38723-38729	damage	_	
199-22	38730-38737	Alcohol	_	
199-23	38737-38738	:	_	
199-24	38739-38746	Effects	_	
199-25	38747-38749	on	_	
199-26	38750-38765	neurobehavioral	_	
199-27	38766-38775	functions	_	
199-28	38776-38779	and	_	
199-29	38780-38783	the	_	
199-30	38784-38789	brain	_	
199-31	38790-38795	Brain	_	
199-32	38796-38806	volumetric	_	
199-33	38807-38815	measures	_	
199-34	38816-38818	in	_	
199-35	38819-38829	alcoholics	_	
199-36	38829-38830	:	_	
199-37	38831-38832	a	_	
199-38	38833-38843	comparison	_	
199-39	38844-38846	of	_	
199-40	38847-38850	two	_	
199-41	38851-38863	segmentation	_	
199-42	38864-38871	methods	_	
199-43	38872-38880	Profiles	_	
199-44	38881-38883	of	_	
199-45	38884-38892	impaired	_	
199-46	38892-38893	,	_	
199-47	38894-38900	spared	_	
199-48	38900-38901	,	_	
199-49	38902-38905	and	_	
199-50	38906-38915	recovered	_	
199-51	38916-38932	neuropsychologic	_	
199-52	38933-38942	processes	_	
199-53	38943-38945	in	_	
199-54	38946-38956	alcoholism	_	
199-55	38957-38968	Association	_	
199-56	38969-38977	pathways	_	
199-57	38978-38980	of	_	
199-58	38981-38984	the	_	
199-59	38985-38995	prefrontal	_	
199-60	38996-39002	cortex	_	
199-61	39003-39006	and	_	
199-62	39007-39017	functional	_	
199-63	39018-39030	observations	_	
199-64	39031-39038	Frontal	_	
199-65	39039-39048	circuitry	_	
199-66	39049-39060	degradation	_	
199-67	39061-39066	marks	_	
199-68	39067-39074	healthy	_	
199-69	39075-39080	adult	_	
199-70	39081-39086	aging	_	
199-71	39086-39087	:	_	
199-72	39088-39096	Evidence	_	
199-73	39097-39101	from	_	
199-74	39102-39111	diffusion	_	
199-75	39112-39118	tensor	_	
199-76	39119-39126	imaging	_	
199-77	39127-39130	Sex	_	
199-78	39131-39142	differences	_	
199-79	39143-39145	in	_	
199-80	39146-39149	the	_	
199-81	39150-39157	effects	_	
199-82	39158-39160	of	_	
199-83	39161-39168	alcohol	_	
199-84	39169-39171	on	_	
199-85	39172-39177	brain	_	
199-86	39178-39187	structure	_	
199-87	39188-39199	Degradation	_	
199-88	39200-39202	of	_	
199-89	39203-39214	association	_	
199-90	39215-39218	and	_	
199-91	39219-39229	projection	_	
199-92	39230-39235	white	_	
199-93	39236-39242	matter	_	
199-94	39243-39250	systems	_	
199-95	39251-39253	in	_	
199-96	39254-39264	alcoholism	_	
199-97	39265-39273	detected	_	
199-98	39274-39278	with	_	
199-99	39279-39291	quantitative	_	
199-100	39292-39297	fiber	_	
199-101	39298-39306	tracking	_	
199-102	39307-39313	Corpus	_	
199-103	39314-39322	callosum	_	
199-104	39322-39323	,	_	
199-105	39324-39328	pons	_	
199-106	39328-39329	,	_	
199-107	39330-39333	and	_	
199-108	39334-39342	cortical	_	
199-109	39343-39348	white	_	
199-110	39349-39355	matter	_	
199-111	39356-39358	in	_	
199-112	39359-39368	alcoholic	_	
199-113	39369-39374	women	_	
199-114	39375-39388	Transcallosal	_	
199-115	39389-39394	white	_	
199-116	39395-39401	matter	_	
199-117	39402-39413	degradation	_	
199-118	39414-39422	detected	_	
199-119	39423-39427	with	_	
199-120	39428-39440	quantitative	_	
199-121	39441-39446	fiber	_	
199-122	39447-39455	tracking	_	
199-123	39456-39458	in	_	
199-124	39459-39468	alcoholic	_	
199-125	39469-39472	men	_	
199-126	39473-39476	and	_	
199-127	39477-39482	women	_	
199-128	39482-39483	:	_	
199-129	39484-39493	selective	_	
199-130	39494-39503	relations	_	
199-131	39504-39506	to	_	
199-132	39507-39518	dissociable	_	
199-133	39519-39528	functions	_	
199-134	39529-39544	Microstructural	_	
199-135	39545-39548	but	_	
199-136	39549-39552	not	_	
199-137	39553-39568	macrostructural	_	
199-138	39569-39579	disruption	_	
199-139	39580-39582	of	_	
199-140	39583-39588	white	_	
199-141	39589-39595	matter	_	
199-142	39596-39598	in	_	
199-143	39599-39604	women	_	
199-144	39605-39609	with	_	
199-145	39610-39617	chronic	_	
199-146	39618-39628	alcoholism	_	
199-147	39629-39641	Longitudinal	_	
199-148	39642-39649	changes	_	
199-149	39650-39652	in	_	
199-150	39653-39661	magnetic	_	
199-151	39662-39671	resonance	_	
199-152	39672-39679	imaging	_	
199-153	39680-39685	brain	_	
199-154	39686-39693	volumes	_	
199-155	39694-39696	in	_	
199-156	39697-39706	abstinent	_	
199-157	39707-39710	and	_	
199-158	39711-39719	relapsed	_	
199-159	39720-39730	alcoholics	_	
199-160	39731-39732	A	_	
199-161	39733-39743	controlled	_	
199-162	39744-39749	study	_	
199-163	39750-39752	of	_	
199-164	39753-39761	cortical	_	
199-165	39762-39766	gray	_	
199-166	39767-39773	matter	_	
199-167	39774-39777	and	_	
199-168	39778-39789	ventricular	_	
199-169	39790-39797	changes	_	
199-170	39798-39800	in	_	
199-171	39801-39810	alcoholic	_	
199-172	39811-39814	men	_	
199-173	39815-39819	over	_	
199-174	39820-39821	a	_	
199-175	39822-39823	5	_	
199-176	39823-39824	-	_	
199-177	39824-39828	year	_	
199-178	39829-39837	interval	_	
199-179	39838-39841	Sex	_	
199-180	39842-39853	differences	_	
199-181	39854-39856	in	_	
199-182	39857-39865	acoustic	_	
199-183	39866-39873	startle	_	
199-184	39874-39883	responses	_	
199-185	39884-39887	and	_	
199-186	39888-39895	seizure	_	
199-187	39896-39906	thresholds	_	
199-188	39907-39914	between	_	
199-189	39915-39932	ethanol-withdrawn	_	
199-190	39933-39937	male	_	
199-191	39938-39941	and	_	
199-192	39942-39948	female	_	
199-193	39949-39953	rats	_	
199-194	39955-39962	Closing	_	
199-195	39963-39966	the	_	
199-196	39967-39973	gender	_	
199-197	39974-39977	gap	_	
199-198	39977-39978	:	_	
199-199	39979-39982	The	_	
199-200	39983-39987	case	_	
199-201	39988-39991	for	_	
199-202	39992-40007	gender-specific	_	
199-203	40008-40018	alcoholism	_	
199-204	40019-40027	research	_	
199-205	40028-40036	Drinking	_	
199-206	40037-40044	history	_	
199-207	40045-40057	associations	_	
199-208	40058-40062	with	_	
199-209	40063-40071	regional	_	
199-210	40072-40077	white	_	
199-211	40078-40084	matter	_	
199-212	40085-40092	volumes	_	
199-213	40093-40095	in	_	
199-214	40096-40105	alcoholic	_	
199-215	40106-40109	men	_	
199-216	40110-40113	and	_	
199-217	40114-40119	women	_	
199-218	40120-40131	Subcortical	_	
199-219	40132-40139	volumes	_	
199-220	40140-40142	in	_	
199-221	40143-40152	long-term	_	
199-222	40153-40162	abstinent	_	
199-223	40163-40173	alcoholics	_	
199-224	40173-40174	:	_	
199-225	40175-40187	Associations	_	
199-226	40188-40192	with	_	
199-227	40193-40204	psychiatric	_	
199-228	40205-40216	comorbidity	_	
199-229	40218-40229	Subcortical	_	
199-230	40230-40240	correlates	_	
199-231	40241-40243	of	_	
199-232	40244-40251	craving	_	
199-233	40252-40254	in	_	
199-234	40255-40263	recently	_	
199-235	40264-40273	abstinent	_	
199-236	40274-40283	alcoholic	_	
199-237	40284-40292	patients	_	
199-238	40293-40300	Effects	_	
199-239	40301-40303	of	_	
199-240	40304-40314	alcoholism	_	
199-241	40315-40318	and	_	
199-242	40319-40325	gender	_	
199-243	40326-40328	on	_	
199-244	40329-40334	brain	_	
199-245	40335-40345	metabolism	_	
199-246	40346-40354	Thalamic	_	
199-247	40355-40358	and	_	
199-248	40359-40379	amygdala–hippocampal	_	
199-249	40380-40386	volume	_	
199-250	40387-40397	reductions	_	
199-251	40398-40400	in	_	
199-252	40401-40413	first-degree	_	
199-253	40414-40423	relatives	_	
199-254	40424-40426	of	_	
199-255	40427-40435	patients	_	
199-256	40436-40440	with	_	
199-257	40441-40454	schizophrenia	_	
199-258	40454-40455	:	_	
199-259	40456-40458	An	_	
199-260	40459-40468	MRI-based	_	
199-261	40469-40481	morphometric	_	
199-262	40482-40490	analysis	_	
199-263	40491-40496	Brain	_	
199-264	40497-40505	response	_	
199-265	40506-40508	to	_	
199-266	40509-40516	working	_	
199-267	40517-40523	memory	_	
199-268	40524-40528	over	_	
199-269	40529-40534	three	_	
199-270	40535-40540	years	_	
199-271	40541-40543	of	_	
199-272	40544-40555	adolescence	_	
199-273	40555-40556	:	_	
199-274	40557-40566	influence	_	
199-275	40567-40569	of	_	
199-276	40570-40580	initiating	_	
199-277	40581-40586	heavy	_	
199-278	40587-40595	drinking	_	
199-279	40596-40606	Cerebellar	_	
199-280	40607-40613	volume	_	
199-281	40614-40621	decline	_	
199-282	40622-40624	in	_	
199-283	40625-40631	normal	_	
199-284	40632-40637	aging	_	
199-285	40637-40638	,	_	
199-286	40639-40649	alcoholism	_	
199-287	40649-40650	,	_	
199-288	40651-40654	and	_	
199-289	40655-40666	Korsakoff's	_	
199-290	40667-40675	syndrome	_	
199-291	40675-40676	:	_	
199-292	40677-40685	Relation	_	
199-293	40686-40688	to	_	
199-294	40689-40695	ataxia	_	
199-295	40696-40704	Anterior	_	
199-296	40705-40716	hippocampal	_	
199-297	40717-40723	volume	_	
199-298	40724-40732	deficits	_	
199-299	40733-40735	in	_	
199-300	40736-40746	nonamnesic	_	
199-301	40746-40747	,	_	
199-302	40748-40753	aging	_	
199-303	40754-40761	chronic	_	
199-304	40762-40772	alcoholics	_	
199-305	40773-40780	Effects	_	
199-306	40781-40783	of	_	
199-307	40784-40787	age	_	
199-308	40788-40791	and	_	
199-309	40792-40795	sex	_	
199-310	40796-40798	on	_	
199-311	40799-40806	volumes	_	
199-312	40807-40809	of	_	
199-313	40810-40813	the	_	
199-314	40814-40822	thalamus	_	
199-315	40822-40823	,	_	
199-316	40824-40828	pons	_	
199-317	40828-40829	,	_	
199-318	40830-40833	and	_	
199-319	40834-40840	cortex	_	
199-320	40841-40849	Positron	_	
199-321	40850-40858	emission	_	
199-322	40859-40869	tomography	_	
199-323	40870-40877	imaging	_	
199-324	40878-40880	of	_	
199-325	40881-40884	the	_	
199-326	40885-40894	serotonin	_	
199-327	40895-40906	transporter	_	
199-328	40907-40909	in	_	
199-329	40910-40918	subjects	_	
199-330	40919-40923	with	_	
199-331	40924-40925	a	_	
199-332	40926-40933	history	_	
199-333	40934-40936	of	_	
199-334	40937-40947	alcoholism	_	
199-335	40949-40953	When	_	
199-336	40954-40956	to	_	
199-337	40957-40964	combine	_	
199-338	40965-40975	hypotheses	_	
199-339	40976-40979	and	_	
199-340	40980-40986	adjust	_	
199-341	40987-40990	for	_	
199-342	40991-40999	multiple	_	
199-343	41000-41005	tests	_	
199-344	41006-41019	Neurobiologic	_	
199-345	41020-41028	advances	_	
199-346	41029-41033	from	_	
199-347	41034-41037	the	_	
199-348	41038-41043	brain	_	
199-349	41044-41051	disease	_	
199-350	41052-41057	model	_	
199-351	41058-41060	of	_	
199-352	41061-41070	addiction	_	
199-353	41071-41078	Puberty	_	
199-354	41078-41079	,	_	
199-355	41080-41088	hormones	_	
199-356	41088-41089	,	_	
199-357	41090-41093	and	_	
199-358	41094-41097	sex	_	
199-359	41098-41109	differences	_	
199-360	41110-41112	in	_	
199-361	41113-41120	alcohol	_	
199-362	41121-41126	abuse	_	
199-363	41127-41130	and	_	
199-364	41131-41141	dependence	_	
199-365	41145-41162	Three-dimensional	_	
199-366	41163-41177	representation	_	
199-367	41178-41180	of	_	
199-368	41181-41184	the	_	
199-369	41185-41193	cortical	_	
199-370	41194-41197	and	_	
199-371	41198-41209	subcortical	_	
199-372	41210-41220	structures	_	
199-373	41221-41223	of	_	
199-374	41224-41227	the	_	
199-375	41228-41235	brain's	_	
199-376	41236-41242	reward	_	
199-377	41243-41249	system	_	
199-378	41249-41250	.	_	

#Text=Image A shows a lateral view of the right
#Text=hemisphere.
200-1	41251-41256	Image	_	
200-2	41257-41258	A	_	
200-3	41259-41264	shows	_	
200-4	41265-41266	a	_	
200-5	41267-41274	lateral	_	
200-6	41275-41279	view	_	
200-7	41280-41282	of	_	
200-8	41283-41286	the	_	
200-9	41287-41292	right	_	
200-10	41293-41303	hemisphere	_	
200-11	41303-41304	.	_	

#Text=Images B and C show a medial view of the right hemisphere; image D
#Text=is an inferior view.
201-1	41305-41311	Images	_	
201-2	41312-41313	B	_	
201-3	41314-41317	and	_	
201-4	41318-41319	C	_	
201-5	41320-41324	show	_	
201-6	41325-41326	a	_	
201-7	41327-41333	medial	_	
201-8	41334-41338	view	_	
201-9	41339-41341	of	_	
201-10	41342-41345	the	_	
201-11	41346-41351	right	_	
201-12	41352-41362	hemisphere	_	
201-13	41362-41363	;	_	
201-14	41364-41369	image	_	
201-15	41370-41371	D	_	
201-16	41372-41374	is	_	
201-17	41375-41377	an	_	
201-18	41378-41386	inferior	_	
201-19	41387-41391	view	_	
201-20	41391-41392	.	_	

#Text=Each region has been justified as an independent a priori
#Text=analysis in previous literature that indicates involvement in alcoholism and
#Text=addiction: Amyg – amygdala (32; 35; 68), CGa – anterior
#Text=cingulate cortex (66; 69; 70), CGp – posterior cingulate cortex (71;
#Text=72), DLPFC – dorsolateral prefrontal cortex (35; 66; 69), FOC –
#Text=orbitofrontal cortex (73–75), Hipp – hippocampus (29; 30), INS
#Text=– insula (35; 66; 69; 70), NAc – nucleus accumbens septi (35),
#Text=PHa – anterior parahippocampal gyrus (76), PHp – posterior
#Text=parahippocampal gyrus (77), SC – subcallosal cortex (78), TP –
#Text=temporal pole (79), VDC – ventral diencephalon (not shown; composed of
#Text=the basal forebrain, hypothalamus, sublenticular extended amygdala, mammillary
#Text=bodies, and a large portion of the ventral tegmentum area) (80).
202-1	41393-41397	Each	_	
202-2	41398-41404	region	_	
202-3	41405-41408	has	_	
202-4	41409-41413	been	_	
202-5	41414-41423	justified	_	
202-6	41424-41426	as	_	
202-7	41427-41429	an	_	
202-8	41430-41441	independent	_	
202-9	41442-41443	a	_	
202-10	41444-41450	priori	_	
202-11	41451-41459	analysis	_	
202-12	41460-41462	in	_	
202-13	41463-41471	previous	_	
202-14	41472-41482	literature	_	
202-15	41483-41487	that	_	
202-16	41488-41497	indicates	_	
202-17	41498-41509	involvement	_	
202-18	41510-41512	in	_	
202-19	41513-41523	alcoholism	_	
202-20	41524-41527	and	_	
202-21	41528-41537	addiction	_	
202-22	41537-41538	:	_	
202-23	41539-41543	Amyg	_	
202-24	41544-41545	–	_	
202-25	41546-41554	amygdala	_	
202-26	41555-41556	(	_	
202-27	41556-41558	32	_	
202-28	41558-41559	;	_	
202-29	41560-41562	35	_	
202-30	41562-41563	;	_	
202-31	41564-41566	68	_	
202-32	41566-41567	)	_	
202-33	41567-41568	,	_	
202-34	41569-41572	CGa	_	
202-35	41573-41574	–	_	
202-36	41575-41583	anterior	_	
202-37	41584-41593	cingulate	_	
202-38	41594-41600	cortex	_	
202-39	41601-41602	(	_	
202-40	41602-41604	66	_	
202-41	41604-41605	;	_	
202-42	41606-41608	69	_	
202-43	41608-41609	;	_	
202-44	41610-41612	70	_	
202-45	41612-41613	)	_	
202-46	41613-41614	,	_	
202-47	41615-41618	CGp	_	
202-48	41619-41620	–	_	
202-49	41621-41630	posterior	_	
202-50	41631-41640	cingulate	_	
202-51	41641-41647	cortex	_	
202-52	41648-41649	(	_	
202-53	41649-41651	71	_	
202-54	41651-41652	;	_	
202-55	41653-41655	72	_	
202-56	41655-41656	)	_	
202-57	41656-41657	,	_	
202-58	41658-41663	DLPFC	_	
202-59	41664-41665	–	_	
202-60	41666-41678	dorsolateral	_	
202-61	41679-41689	prefrontal	_	
202-62	41690-41696	cortex	_	
202-63	41697-41698	(	_	
202-64	41698-41700	35	_	
202-65	41700-41701	;	_	
202-66	41702-41704	66	_	
202-67	41704-41705	;	_	
202-68	41706-41708	69	_	
202-69	41708-41709	)	_	
202-70	41709-41710	,	_	
202-71	41711-41714	FOC	_	
202-72	41715-41716	–	_	
202-73	41717-41730	orbitofrontal	_	
202-74	41731-41737	cortex	_	
202-75	41738-41739	(	_	
202-76	41739-41741	73	_	
202-77	41741-41742	–	_	
202-78	41742-41744	75	_	
202-79	41744-41745	)	_	
202-80	41745-41746	,	_	
202-81	41747-41751	Hipp	_	
202-82	41752-41753	–	_	
202-83	41754-41765	hippocampus	_	
202-84	41766-41767	(	_	
202-85	41767-41769	29	_	
202-86	41769-41770	;	_	
202-87	41771-41773	30	_	
202-88	41773-41774	)	_	
202-89	41774-41775	,	_	
202-90	41776-41779	INS	_	
202-91	41780-41781	–	_	
202-92	41782-41788	insula	_	
202-93	41789-41790	(	_	
202-94	41790-41792	35	_	
202-95	41792-41793	;	_	
202-96	41794-41796	66	_	
202-97	41796-41797	;	_	
202-98	41798-41800	69	_	
202-99	41800-41801	;	_	
202-100	41802-41804	70	_	
202-101	41804-41805	)	_	
202-102	41805-41806	,	_	
202-103	41807-41810	NAc	_	
202-104	41811-41812	–	_	
202-105	41813-41820	nucleus	_	
202-106	41821-41830	accumbens	_	
202-107	41831-41836	septi	_	
202-108	41837-41838	(	_	
202-109	41838-41840	35	_	
202-110	41840-41841	)	_	
202-111	41841-41842	,	_	
202-112	41843-41846	PHa	_	
202-113	41847-41848	–	_	
202-114	41849-41857	anterior	_	
202-115	41858-41873	parahippocampal	_	
202-116	41874-41879	gyrus	_	
202-117	41880-41881	(	_	
202-118	41881-41883	76	_	
202-119	41883-41884	)	_	
202-120	41884-41885	,	_	
202-121	41886-41889	PHp	_	
202-122	41890-41891	–	_	
202-123	41892-41901	posterior	_	
202-124	41902-41917	parahippocampal	_	
202-125	41918-41923	gyrus	_	
202-126	41924-41925	(	_	
202-127	41925-41927	77	_	
202-128	41927-41928	)	_	
202-129	41928-41929	,	_	
202-130	41930-41932	SC	_	
202-131	41933-41934	–	_	
202-132	41935-41946	subcallosal	_	
202-133	41947-41953	cortex	_	
202-134	41954-41955	(	_	
202-135	41955-41957	78	_	
202-136	41957-41958	)	_	
202-137	41958-41959	,	_	
202-138	41960-41962	TP	_	
202-139	41963-41964	–	_	
202-140	41965-41973	temporal	_	
202-141	41974-41978	pole	_	
202-142	41979-41980	(	_	
202-143	41980-41982	79	_	
202-144	41982-41983	)	_	
202-145	41983-41984	,	_	
202-146	41985-41988	VDC	_	
202-147	41989-41990	–	_	
202-148	41991-41998	ventral	_	
202-149	41999-42011	diencephalon	_	
202-150	42012-42013	(	_	
202-151	42013-42016	not	_	
202-152	42017-42022	shown	_	
202-153	42022-42023	;	_	
202-154	42024-42032	composed	_	
202-155	42033-42035	of	_	
202-156	42036-42039	the	_	
202-157	42040-42045	basal	_	
202-158	42046-42055	forebrain	_	
202-159	42055-42056	,	_	
202-160	42057-42069	hypothalamus	_	
202-161	42069-42070	,	_	
202-162	42071-42084	sublenticular	_	
202-163	42085-42093	extended	_	
202-164	42094-42102	amygdala	_	
202-165	42102-42103	,	_	
202-166	42104-42114	mammillary	_	
202-167	42115-42121	bodies	_	
202-168	42121-42122	,	_	
202-169	42123-42126	and	_	
202-170	42127-42128	a	_	
202-171	42129-42134	large	_	
202-172	42135-42142	portion	_	
202-173	42143-42145	of	_	
202-174	42146-42149	the	_	
202-175	42150-42157	ventral	_	
202-176	42158-42167	tegmentum	_	
202-177	42168-42172	area	_	
202-178	42172-42173	)	_	
202-179	42174-42175	(	_	
202-180	42175-42177	80	_	
202-181	42177-42178	)	_	
202-182	42178-42179	.	_	

#Text=Modified from
#Text=, with
#Text=permission.
203-1	42180-42188	Modified	_	
203-2	42189-42193	from	_	
203-3	42194-42195	,	_	
203-4	42196-42200	with	_	
203-5	42201-42211	permission	_	
203-6	42211-42212	.	_	

#Text=Reward volumes in alcoholic and nonalcoholic men and women.
204-1	42213-42219	Reward	_	
204-2	42220-42227	volumes	_	
204-3	42228-42230	in	_	
204-4	42231-42240	alcoholic	_	
204-5	42241-42244	and	_	
204-6	42245-42257	nonalcoholic	_	
204-7	42258-42261	men	_	
204-8	42262-42265	and	_	
204-9	42266-42271	women	_	
204-10	42271-42272	.	_	

#Text=Lower
#Text=alcoholism-related reward network volumes were observed for men, but increases
#Text=were observed for women.
205-1	42273-42278	Lower	_	
205-2	42279-42297	alcoholism-related	_	
205-3	42298-42304	reward	_	
205-4	42305-42312	network	_	
205-5	42313-42320	volumes	_	
205-6	42321-42325	were	_	
205-7	42326-42334	observed	_	
205-8	42335-42338	for	_	
205-9	42339-42342	men	_	
205-10	42342-42343	,	_	
205-11	42344-42347	but	_	
205-12	42348-42357	increases	_	
205-13	42358-42362	were	_	
205-14	42363-42371	observed	_	
205-15	42372-42375	for	_	
205-16	42376-42381	women	_	
205-17	42381-42382	.	_	

#Text=Boxplot whiskers represent the most extreme values
#Text=within double the interquartile range, and the middle band represents the
#Text=median.
206-1	42383-42390	Boxplot	_	
206-2	42391-42399	whiskers	_	
206-3	42400-42409	represent	_	
206-4	42410-42413	the	_	
206-5	42414-42418	most	_	
206-6	42419-42426	extreme	_	
206-7	42427-42433	values	_	
206-8	42434-42440	within	_	
206-9	42441-42447	double	_	
206-10	42448-42451	the	_	
206-11	42452-42465	interquartile	_	
206-12	42466-42471	range	_	
206-13	42471-42472	,	_	
206-14	42473-42476	and	_	
206-15	42477-42480	the	_	
206-16	42481-42487	middle	_	
206-17	42488-42492	band	_	
206-18	42493-42503	represents	_	
206-19	42504-42507	the	_	
206-20	42508-42514	median	_	
206-21	42514-42515	.	_	

#Text=There was one outlier, indicated by the red dot, and results did not
#Text=change when that value was removed.
207-1	42516-42521	There	_	
207-2	42522-42525	was	_	
207-3	42526-42529	one	_	
207-4	42530-42537	outlier	_	
207-5	42537-42538	,	_	
207-6	42539-42548	indicated	_	
207-7	42549-42551	by	_	
207-8	42552-42555	the	_	
207-9	42556-42559	red	_	
207-10	42560-42563	dot	_	
207-11	42563-42564	,	_	
207-12	42565-42568	and	_	
207-13	42569-42576	results	_	
207-14	42577-42580	did	_	
207-15	42581-42584	not	_	
207-16	42585-42591	change	_	
207-17	42592-42596	when	_	
207-18	42597-42601	that	_	
207-19	42602-42607	value	_	
207-20	42608-42611	was	_	
207-21	42612-42619	removed	_	
207-22	42619-42620	.	_	

#Text=Stars indicate significant differences
#Text=(p < 0.05).
208-1	42621-42626	Stars	_	
208-2	42627-42635	indicate	_	
208-3	42636-42647	significant	_	
208-4	42648-42659	differences	_	
208-5	42660-42661	(	_	
208-6	42661-42662	p	_	
208-7	42663-42664	<	_	
208-8	42665-42669	0.05	_	
208-9	42669-42670	)	_	
208-10	42670-42671	.	_	

#Text=Brain volumes in relation to drinking variables.
209-1	42672-42677	Brain	_	
209-2	42678-42685	volumes	_	
209-3	42686-42688	in	_	
209-4	42689-42697	relation	_	
209-5	42698-42700	to	_	
209-6	42701-42709	drinking	_	
209-7	42710-42719	variables	_	
209-8	42719-42720	.	_	

#Text=Brain volumes were significantly
#Text=associated with daily drinks, duration of heavy drinking, and length of
#Text=sobriety.
210-1	42721-42726	Brain	_	
210-2	42727-42734	volumes	_	
210-3	42735-42739	were	_	
210-4	42740-42753	significantly	_	
210-5	42754-42764	associated	_	
210-6	42765-42769	with	_	
210-7	42770-42775	daily	_	
210-8	42776-42782	drinks	_	
210-9	42782-42783	,	_	
210-10	42784-42792	duration	_	
210-11	42793-42795	of	_	
210-12	42796-42801	heavy	_	
210-13	42802-42810	drinking	_	
210-14	42810-42811	,	_	
210-15	42812-42815	and	_	
210-16	42816-42822	length	_	
210-17	42823-42825	of	_	
210-18	42826-42834	sobriety	_	
210-19	42834-42835	.	_	

#Text=These leverage plots (81) represent the relationships between the
#Text=specified drinking history variables and regional brain volumes, covaried for
#Text=age.
211-1	42836-42841	These	_	
211-2	42842-42850	leverage	_	
211-3	42851-42856	plots	_	
211-4	42857-42858	(	_	
211-5	42858-42860	81	_	
211-6	42860-42861	)	_	
211-7	42862-42871	represent	_	
211-8	42872-42875	the	_	
211-9	42876-42889	relationships	_	
211-10	42890-42897	between	_	
211-11	42898-42901	the	_	
211-12	42902-42911	specified	_	
211-13	42912-42920	drinking	_	
211-14	42921-42928	history	_	
211-15	42929-42938	variables	_	
211-16	42939-42942	and	_	
211-17	42943-42951	regional	_	
211-18	42952-42957	brain	_	
211-19	42958-42965	volumes	_	
211-20	42965-42966	,	_	
211-21	42967-42975	covaried	_	
211-22	42976-42979	for	_	
211-23	42980-42983	age	_	
211-24	42983-42984	.	_	

#Text=For the anterior cingulate cortex and the temporal pole, the gender
#Text=interactions were significant (p < 0.05), so the
#Text=relationships were calculated separately for ALC men and ALC women, and the
#Text=plots for men and women were overlaid.
212-1	42985-42988	For	_	
212-2	42989-42992	the	_	
212-3	42993-43001	anterior	_	
212-4	43002-43011	cingulate	_	
212-5	43012-43018	cortex	_	
212-6	43019-43022	and	_	
212-7	43023-43026	the	_	
212-8	43027-43035	temporal	_	
212-9	43036-43040	pole	_	
212-10	43040-43041	,	_	
212-11	43042-43045	the	_	
212-12	43046-43052	gender	_	
212-13	43053-43065	interactions	_	
212-14	43066-43070	were	_	
212-15	43071-43082	significant	_	
212-16	43083-43084	(	_	
212-17	43084-43085	p	_	
212-18	43086-43087	<	_	
212-19	43088-43092	0.05	_	
212-20	43092-43093	)	_	
212-21	43093-43094	,	_	
212-22	43095-43097	so	_	
212-23	43098-43101	the	_	
212-24	43102-43115	relationships	_	
212-25	43116-43120	were	_	
212-26	43121-43131	calculated	_	
212-27	43132-43142	separately	_	
212-28	43143-43146	for	_	
212-29	43147-43150	ALC	_	
212-30	43151-43154	men	_	
212-31	43155-43158	and	_	
212-32	43159-43162	ALC	_	
212-33	43163-43168	women	_	
212-34	43168-43169	,	_	
212-35	43170-43173	and	_	
212-36	43174-43177	the	_	
212-37	43178-43183	plots	_	
212-38	43184-43187	for	_	
212-39	43188-43191	men	_	
212-40	43192-43195	and	_	
212-41	43196-43201	women	_	
212-42	43202-43206	were	_	
212-43	43207-43215	overlaid	_	
212-44	43215-43216	.	_	

#Text=Red circles indicate ALC women; blue
#Text=triangles indicate ALC men.
213-1	43217-43220	Red	_	
213-2	43221-43228	circles	_	
213-3	43229-43237	indicate	_	
213-4	43238-43241	ALC	_	
213-5	43242-43247	women	_	
213-6	43247-43248	;	_	
213-7	43249-43253	blue	_	
213-8	43254-43263	triangles	_	
213-9	43264-43272	indicate	_	
213-10	43273-43276	ALC	_	
213-11	43277-43280	men	_	
213-12	43280-43281	.	_	

#Text=Regression lines and 95% confidence curves
#Text=of the slopes (dotted lines) are displayed.
214-1	43282-43292	Regression	_	
214-2	43293-43298	lines	_	
214-3	43299-43302	and	_	
214-4	43303-43306	95%	_	
214-5	43307-43317	confidence	_	
214-6	43318-43324	curves	_	
214-7	43325-43327	of	_	
214-8	43328-43331	the	_	
214-9	43332-43338	slopes	_	
214-10	43339-43340	(	_	
214-11	43340-43346	dotted	_	
214-12	43347-43352	lines	_	
214-13	43352-43353	)	_	
214-14	43354-43357	are	_	
214-15	43358-43367	displayed	_	
214-16	43367-43368	.	_	

#Text=Neuropsychological and drinking variables of the participants.
215-1	43369-43387	Neuropsychological	_	
215-2	43388-43391	and	_	
215-3	43392-43400	drinking	_	
215-4	43401-43410	variables	_	
215-5	43411-43413	of	_	
215-6	43414-43417	the	_	
215-7	43418-43430	participants	_	
215-8	43430-43431	.	_	

#Text=Mean values are
#Text=provided with standard deviations (SD).
216-1	43432-43436	Mean	_	
216-2	43437-43443	values	_	
216-3	43444-43447	are	_	
216-4	43448-43456	provided	_	
216-5	43457-43461	with	_	
216-6	43462-43470	standard	_	
216-7	43471-43481	deviations	_	
216-8	43482-43483	(	_	
216-9	43483-43485	SD	_	
216-10	43485-43486	)	_	
216-11	43486-43487	.	_	

#Text=Significant differences are presented in
#Text=bold text.
217-1	43488-43499	Significant	_	
217-2	43500-43511	differences	_	
217-3	43512-43515	are	_	
217-4	43516-43525	presented	_	
217-5	43526-43528	in	_	
217-6	43529-43533	bold	_	
217-7	43534-43538	text	_	
217-8	43538-43539	.	_	

#Text=Abbreviations: ALC = Alcoholic; NC = Nonalcoholic
#Text=Control; 95% CI = 95% confidence interval of the mean
#Text=difference between groups.
218-1	43540-43553	Abbreviations	_	
218-2	43553-43554	:	_	
218-3	43555-43558	ALC	_	
218-4	43559-43560	=	_	
218-5	43561-43570	Alcoholic	_	
218-6	43570-43571	;	_	
218-7	43572-43574	NC	_	
218-8	43575-43576	=	_	
218-9	43577-43589	Nonalcoholic	_	
218-10	43590-43597	Control	_	
218-11	43597-43598	;	_	
218-12	43599-43602	95%	_	
218-13	43603-43605	CI	_	
218-14	43606-43607	=	_	
218-15	43608-43611	95%	_	
218-16	43612-43622	confidence	_	
218-17	43623-43631	interval	_	
218-18	43632-43634	of	_	
218-19	43635-43638	the	_	
218-20	43639-43643	mean	_	
218-21	43644-43654	difference	_	
218-22	43655-43662	between	_	
218-23	43663-43669	groups	_	
218-24	43669-43670	.	_	

#Text=ALC Women (N=30)\tMen (N=30)\tNC Women (N=31)\tNC Men (N=29)\tNC - ALC\tNC Women - ALC Women\tNC Men -ALC Men\tALC Women – ALC Men\tNC Women – NC Men\t \t\t \t\t\tMean (SD)\tMean (SD)\tMean (SD)\tMean (SD)\t95% CI\t95% CI\t95% CI\t95% CI\t95% CI\t \tDemographic and Neuropsychological\t \tMeasures\tAge\t51.6 (9.8)\t51.8 (11.1)\t55.8 (13.8)\t51.9 (12.2)\t[-2.0, 6.5]\t[-1.9, 10.4]\t[-6.0, 6.2]\t[-5.6, 5.2]\t[-2.8, 10.7]\t \tEducation\t14.7 (2.5)\t13.9 (2.3)\t16.1 (2.3)\t14.7 (2)\t[0.3, 2.0]\t[0.2, 2.6]\t[-0.3, 1.9]\t[-0.4, 2.0]\t[0.3, 2.5]\t \tFSIQb\t108 (18.3)\t104.2 (11.4)\t111.3 (14.4)\t109.3 (10.3)\t[-0.8, 9.3]\t[-5.7, 10.0]\t[-0.7, 10.8]\t[-4.2, 11.8]\t[-4.4, 8.5]\t \tPIQc\t106.6 (18.5)\t100.4 (12.2)\t110.4 (15.3)\t106.9 (11.6)\t[-0.1, 10.7]\t[-5.0, 12.6]\t[0.3, 12.7]\t[-2.1, 14.4]\t[-3.6, 10.5]\t \tVIQd\t107.9 (17.9)\t106.8 (11.8)\t110.5 (14)\t109.9 (11.4)\t[-2.2, 7.9]\t[-5.8, 10.9]\t[-3.0, 9.1]\t[-6.8, 9.1]\t[-6.0, 7.3]\t \tWMIe\t105.9 (17)\t106.1 (13.2)\t108 (12.9)\t104.6 (9.9)\t[-4.5, 5.3]\t[-5.7, 10.0]\t[-7.6, 4.6]\t[-8.2, 7.8]\t[-2.5, 9.4]\t \tDelayed Memoryf\t117.6 (17)\t101 (11.5)\t116.8 (15.1)\t104.3 (13)\t[-4.1, 7.6]\t[-9.1, 7.6]\t[-3.1, 9.8]\t[9.0,\t \t24.2]\t[5.2,\t \t19.8]\t \tHRSDg\t3.45 (3.77)\t3.97 (4.7)\t1.52 (2.29)\t0.86 (1.15)\t[-3.7,\t \t-1.3]\t[-3.6,\t \t-0.3]\t[-4.9,\t \t-1.3]\t[-2.7, 1.7]\t[-0.3, 1.6]\t \tMAACL Anxietyh\t48.6 (15.2)\t46.1 (11.1)\t45.6 (14.3)\t43.6 (6.3)\t[-7.2, 1.8]\t[-10.6, 4.7]\t[-7.3, 2.3]\t[-4.6, 9.4]\t[-3.7, 7.7]\t \tDrinking Measures\tDaily Drinks (ounces ethanol per day)\t7.7 (6.8)\t11 (8.3)\t0.2 (0.3)\t0.3 (0.5)\t[-11.1,\t \t-7.1]\t[-10.1,\t \t-5.0]\t[-13.8,\t \t-7.6]\t[-7.3, 0.6]\t[-0.4, 0.1]\t \tDuration of Heavy Drinking (years)\t13 (6.3)\t16.6 (8.3)\t0 (0)\t0 (0)\t[-16.7,\t \t-12.9]\t[-15.4,\t \t-10.7]\t[-19.6,\t \t-13.5]\t[-7.3, 0.3]\tN/A\t \tLength of Sobriety (years)\t7.3 (9.3)\t5.2 (9.9)\tN/A (N/A)\tN/A (N/A)\tN/A\tN/A\tN/A\t[-2.9, 7.0]\tN/A\t \t
#Text=Neuropsychological scores were unavailable for 1 ALC woman, 1 ALC man, and 1
#Text=NC woman.
219-1	43673-43676	ALC	_	
219-2	43677-43682	Women	_	
219-3	43683-43684	(	_	
219-4	43684-43685	N	_	
219-5	43685-43686	=	_	
219-6	43686-43688	30	_	
219-7	43688-43689	)	_	
219-8	43690-43693	Men	_	
219-9	43694-43695	(	_	
219-10	43695-43696	N	_	
219-11	43696-43697	=	_	
219-12	43697-43699	30	_	
219-13	43699-43700	)	_	
219-14	43701-43703	NC	_	
219-15	43704-43709	Women	_	
219-16	43710-43711	(	_	
219-17	43711-43712	N	_	
219-18	43712-43713	=	_	
219-19	43713-43715	31	_	
219-20	43715-43716	)	_	
219-21	43717-43719	NC	_	
219-22	43720-43723	Men	_	
219-23	43724-43725	(	_	
219-24	43725-43726	N	_	
219-25	43726-43727	=	_	
219-26	43727-43729	29	_	
219-27	43729-43730	)	_	
219-28	43731-43733	NC	_	
219-29	43734-43735	-	_	
219-30	43736-43739	ALC	_	
219-31	43740-43742	NC	_	
219-32	43743-43748	Women	_	
219-33	43749-43750	-	_	
219-34	43751-43754	ALC	_	
219-35	43755-43760	Women	_	
219-36	43761-43763	NC	_	
219-37	43764-43767	Men	_	
219-38	43768-43769	-	_	
219-39	43769-43772	ALC	_	
219-40	43773-43776	Men	_	
219-41	43777-43780	ALC	_	
219-42	43781-43786	Women	_	
219-43	43787-43788	–	_	
219-44	43789-43792	ALC	_	
219-45	43793-43796	Men	_	
219-46	43797-43799	NC	_	
219-47	43800-43805	Women	_	
219-48	43806-43807	–	_	
219-49	43808-43810	NC	_	
219-50	43811-43814	Men	_	
219-51	43822-43826	Mean	_	
219-52	43827-43828	(	_	
219-53	43828-43830	SD	_	
219-54	43830-43831	)	_	
219-55	43832-43836	Mean	_	
219-56	43837-43838	(	_	
219-57	43838-43840	SD	_	
219-58	43840-43841	)	_	
219-59	43842-43846	Mean	_	
219-60	43847-43848	(	_	
219-61	43848-43850	SD	_	
219-62	43850-43851	)	_	
219-63	43852-43856	Mean	_	
219-64	43857-43858	(	_	
219-65	43858-43860	SD	_	
219-66	43860-43861	)	_	
219-67	43862-43865	95%	_	
219-68	43866-43868	CI	_	
219-69	43869-43872	95%	_	
219-70	43873-43875	CI	_	
219-71	43876-43879	95%	_	
219-72	43880-43882	CI	_	
219-73	43883-43886	95%	_	
219-74	43887-43889	CI	_	
219-75	43890-43893	95%	_	
219-76	43894-43896	CI	_	
219-77	43899-43910	Demographic	_	
219-78	43911-43914	and	_	
219-79	43915-43933	Neuropsychological	_	
219-80	43936-43944	Measures	_	
219-81	43945-43948	Age	_	
219-82	43949-43953	51.6	_	
219-83	43954-43955	(	_	
219-84	43955-43958	9.8	_	
219-85	43958-43959	)	_	
219-86	43960-43964	51.8	_	
219-87	43965-43966	(	_	
219-88	43966-43970	11.1	_	
219-89	43970-43971	)	_	
219-90	43972-43976	55.8	_	
219-91	43977-43978	(	_	
219-92	43978-43982	13.8	_	
219-93	43982-43983	)	_	
219-94	43984-43988	51.9	_	
219-95	43989-43990	(	_	
219-96	43990-43994	12.2	_	
219-97	43994-43995	)	_	
219-98	43996-43997	[	_	
219-99	43997-43998	-	_	
219-100	43998-44001	2.0	_	
219-101	44001-44002	,	_	
219-102	44003-44006	6.5	_	
219-103	44006-44007	]	_	
219-104	44008-44009	[	_	
219-105	44009-44010	-	_	
219-106	44010-44013	1.9	_	
219-107	44013-44014	,	_	
219-108	44015-44019	10.4	_	
219-109	44019-44020	]	_	
219-110	44021-44022	[	_	
219-111	44022-44023	-	_	
219-112	44023-44026	6.0	_	
219-113	44026-44027	,	_	
219-114	44028-44031	6.2	_	
219-115	44031-44032	]	_	
219-116	44033-44034	[	_	
219-117	44034-44035	-	_	
219-118	44035-44038	5.6	_	
219-119	44038-44039	,	_	
219-120	44040-44043	5.2	_	
219-121	44043-44044	]	_	
219-122	44045-44046	[	_	
219-123	44046-44047	-	_	
219-124	44047-44050	2.8	_	
219-125	44050-44051	,	_	
219-126	44052-44056	10.7	_	
219-127	44056-44057	]	_	
219-128	44060-44069	Education	_	
219-129	44070-44074	14.7	_	
219-130	44075-44076	(	_	
219-131	44076-44079	2.5	_	
219-132	44079-44080	)	_	
219-133	44081-44085	13.9	_	
219-134	44086-44087	(	_	
219-135	44087-44090	2.3	_	
219-136	44090-44091	)	_	
219-137	44092-44096	16.1	_	
219-138	44097-44098	(	_	
219-139	44098-44101	2.3	_	
219-140	44101-44102	)	_	
219-141	44103-44107	14.7	_	
219-142	44108-44109	(	_	
219-143	44109-44110	2	_	
219-144	44110-44111	)	_	
219-145	44112-44113	[	_	
219-146	44113-44116	0.3	_	
219-147	44116-44117	,	_	
219-148	44118-44121	2.0	_	
219-149	44121-44122	]	_	
219-150	44123-44124	[	_	
219-151	44124-44127	0.2	_	
219-152	44127-44128	,	_	
219-153	44129-44132	2.6	_	
219-154	44132-44133	]	_	
219-155	44134-44135	[	_	
219-156	44135-44136	-	_	
219-157	44136-44139	0.3	_	
219-158	44139-44140	,	_	
219-159	44141-44144	1.9	_	
219-160	44144-44145	]	_	
219-161	44146-44147	[	_	
219-162	44147-44148	-	_	
219-163	44148-44151	0.4	_	
219-164	44151-44152	,	_	
219-165	44153-44156	2.0	_	
219-166	44156-44157	]	_	
219-167	44158-44159	[	_	
219-168	44159-44162	0.3	_	
219-169	44162-44163	,	_	
219-170	44164-44167	2.5	_	
219-171	44167-44168	]	_	
219-172	44171-44176	FSIQb	_	
219-173	44177-44180	108	_	
219-174	44181-44182	(	_	
219-175	44182-44186	18.3	_	
219-176	44186-44187	)	_	
219-177	44188-44193	104.2	_	
219-178	44194-44195	(	_	
219-179	44195-44199	11.4	_	
219-180	44199-44200	)	_	
219-181	44201-44206	111.3	_	
219-182	44207-44208	(	_	
219-183	44208-44212	14.4	_	
219-184	44212-44213	)	_	
219-185	44214-44219	109.3	_	
219-186	44220-44221	(	_	
219-187	44221-44225	10.3	_	
219-188	44225-44226	)	_	
219-189	44227-44228	[	_	
219-190	44228-44229	-	_	
219-191	44229-44232	0.8	_	
219-192	44232-44233	,	_	
219-193	44234-44237	9.3	_	
219-194	44237-44238	]	_	
219-195	44239-44240	[	_	
219-196	44240-44241	-	_	
219-197	44241-44244	5.7	_	
219-198	44244-44245	,	_	
219-199	44246-44250	10.0	_	
219-200	44250-44251	]	_	
219-201	44252-44253	[	_	
219-202	44253-44254	-	_	
219-203	44254-44257	0.7	_	
219-204	44257-44258	,	_	
219-205	44259-44263	10.8	_	
219-206	44263-44264	]	_	
219-207	44265-44266	[	_	
219-208	44266-44267	-	_	
219-209	44267-44270	4.2	_	
219-210	44270-44271	,	_	
219-211	44272-44276	11.8	_	
219-212	44276-44277	]	_	
219-213	44278-44279	[	_	
219-214	44279-44280	-	_	
219-215	44280-44283	4.4	_	
219-216	44283-44284	,	_	
219-217	44285-44288	8.5	_	
219-218	44288-44289	]	_	
219-219	44292-44296	PIQc	_	
219-220	44297-44302	106.6	_	
219-221	44303-44304	(	_	
219-222	44304-44308	18.5	_	
219-223	44308-44309	)	_	
219-224	44310-44315	100.4	_	
219-225	44316-44317	(	_	
219-226	44317-44321	12.2	_	
219-227	44321-44322	)	_	
219-228	44323-44328	110.4	_	
219-229	44329-44330	(	_	
219-230	44330-44334	15.3	_	
219-231	44334-44335	)	_	
219-232	44336-44341	106.9	_	
219-233	44342-44343	(	_	
219-234	44343-44347	11.6	_	
219-235	44347-44348	)	_	
219-236	44349-44350	[	_	
219-237	44350-44351	-	_	
219-238	44351-44354	0.1	_	
219-239	44354-44355	,	_	
219-240	44356-44360	10.7	_	
219-241	44360-44361	]	_	
219-242	44362-44363	[	_	
219-243	44363-44364	-	_	
219-244	44364-44367	5.0	_	
219-245	44367-44368	,	_	
219-246	44369-44373	12.6	_	
219-247	44373-44374	]	_	
219-248	44375-44376	[	_	
219-249	44376-44379	0.3	_	
219-250	44379-44380	,	_	
219-251	44381-44385	12.7	_	
219-252	44385-44386	]	_	
219-253	44387-44388	[	_	
219-254	44388-44389	-	_	
219-255	44389-44392	2.1	_	
219-256	44392-44393	,	_	
219-257	44394-44398	14.4	_	
219-258	44398-44399	]	_	
219-259	44400-44401	[	_	
219-260	44401-44402	-	_	
219-261	44402-44405	3.6	_	
219-262	44405-44406	,	_	
219-263	44407-44411	10.5	_	
219-264	44411-44412	]	_	
219-265	44415-44419	VIQd	_	
219-266	44420-44425	107.9	_	
219-267	44426-44427	(	_	
219-268	44427-44431	17.9	_	
219-269	44431-44432	)	_	
219-270	44433-44438	106.8	_	
219-271	44439-44440	(	_	
219-272	44440-44444	11.8	_	
219-273	44444-44445	)	_	
219-274	44446-44451	110.5	_	
219-275	44452-44453	(	_	
219-276	44453-44455	14	_	
219-277	44455-44456	)	_	
219-278	44457-44462	109.9	_	
219-279	44463-44464	(	_	
219-280	44464-44468	11.4	_	
219-281	44468-44469	)	_	
219-282	44470-44471	[	_	
219-283	44471-44472	-	_	
219-284	44472-44475	2.2	_	
219-285	44475-44476	,	_	
219-286	44477-44480	7.9	_	
219-287	44480-44481	]	_	
219-288	44482-44483	[	_	
219-289	44483-44484	-	_	
219-290	44484-44487	5.8	_	
219-291	44487-44488	,	_	
219-292	44489-44493	10.9	_	
219-293	44493-44494	]	_	
219-294	44495-44496	[	_	
219-295	44496-44497	-	_	
219-296	44497-44500	3.0	_	
219-297	44500-44501	,	_	
219-298	44502-44505	9.1	_	
219-299	44505-44506	]	_	
219-300	44507-44508	[	_	
219-301	44508-44509	-	_	
219-302	44509-44512	6.8	_	
219-303	44512-44513	,	_	
219-304	44514-44517	9.1	_	
219-305	44517-44518	]	_	
219-306	44519-44520	[	_	
219-307	44520-44521	-	_	
219-308	44521-44524	6.0	_	
219-309	44524-44525	,	_	
219-310	44526-44529	7.3	_	
219-311	44529-44530	]	_	
219-312	44533-44537	WMIe	_	
219-313	44538-44543	105.9	_	
219-314	44544-44545	(	_	
219-315	44545-44547	17	_	
219-316	44547-44548	)	_	
219-317	44549-44554	106.1	_	
219-318	44555-44556	(	_	
219-319	44556-44560	13.2	_	
219-320	44560-44561	)	_	
219-321	44562-44565	108	_	
219-322	44566-44567	(	_	
219-323	44567-44571	12.9	_	
219-324	44571-44572	)	_	
219-325	44573-44578	104.6	_	
219-326	44579-44580	(	_	
219-327	44580-44583	9.9	_	
219-328	44583-44584	)	_	
219-329	44585-44586	[	_	
219-330	44586-44587	-	_	
219-331	44587-44590	4.5	_	
219-332	44590-44591	,	_	
219-333	44592-44595	5.3	_	
219-334	44595-44596	]	_	
219-335	44597-44598	[	_	
219-336	44598-44599	-	_	
219-337	44599-44602	5.7	_	
219-338	44602-44603	,	_	
219-339	44604-44608	10.0	_	
219-340	44608-44609	]	_	
219-341	44610-44611	[	_	
219-342	44611-44612	-	_	
219-343	44612-44615	7.6	_	
219-344	44615-44616	,	_	
219-345	44617-44620	4.6	_	
219-346	44620-44621	]	_	
219-347	44622-44623	[	_	
219-348	44623-44624	-	_	
219-349	44624-44627	8.2	_	
219-350	44627-44628	,	_	
219-351	44629-44632	7.8	_	
219-352	44632-44633	]	_	
219-353	44634-44635	[	_	
219-354	44635-44636	-	_	
219-355	44636-44639	2.5	_	
219-356	44639-44640	,	_	
219-357	44641-44644	9.4	_	
219-358	44644-44645	]	_	
219-359	44648-44655	Delayed	_	
219-360	44656-44663	Memoryf	_	
219-361	44664-44669	117.6	_	
219-362	44670-44671	(	_	
219-363	44671-44673	17	_	
219-364	44673-44674	)	_	
219-365	44675-44678	101	_	
219-366	44679-44680	(	_	
219-367	44680-44684	11.5	_	
219-368	44684-44685	)	_	
219-369	44686-44691	116.8	_	
219-370	44692-44693	(	_	
219-371	44693-44697	15.1	_	
219-372	44697-44698	)	_	
219-373	44699-44704	104.3	_	
219-374	44705-44706	(	_	
219-375	44706-44708	13	_	
219-376	44708-44709	)	_	
219-377	44710-44711	[	_	
219-378	44711-44712	-	_	
219-379	44712-44715	4.1	_	
219-380	44715-44716	,	_	
219-381	44717-44720	7.6	_	
219-382	44720-44721	]	_	
219-383	44722-44723	[	_	
219-384	44723-44724	-	_	
219-385	44724-44727	9.1	_	
219-386	44727-44728	,	_	
219-387	44729-44732	7.6	_	
219-388	44732-44733	]	_	
219-389	44734-44735	[	_	
219-390	44735-44736	-	_	
219-391	44736-44739	3.1	_	
219-392	44739-44740	,	_	
219-393	44741-44744	9.8	_	
219-394	44744-44745	]	_	
219-395	44746-44747	[	_	
219-396	44747-44750	9.0	_	
219-397	44750-44751	,	_	
219-398	44754-44758	24.2	_	
219-399	44758-44759	]	_	
219-400	44760-44761	[	_	
219-401	44761-44764	5.2	_	
219-402	44764-44765	,	_	
219-403	44768-44772	19.8	_	
219-404	44772-44773	]	_	
219-405	44776-44781	HRSDg	_	
219-406	44782-44786	3.45	_	
219-407	44787-44788	(	_	
219-408	44788-44792	3.77	_	
219-409	44792-44793	)	_	
219-410	44794-44798	3.97	_	
219-411	44799-44800	(	_	
219-412	44800-44803	4.7	_	
219-413	44803-44804	)	_	
219-414	44805-44809	1.52	_	
219-415	44810-44811	(	_	
219-416	44811-44815	2.29	_	
219-417	44815-44816	)	_	
219-418	44817-44821	0.86	_	
219-419	44822-44823	(	_	
219-420	44823-44827	1.15	_	
219-421	44827-44828	)	_	
219-422	44829-44830	[	_	
219-423	44830-44831	-	_	
219-424	44831-44834	3.7	_	
219-425	44834-44835	,	_	
219-426	44838-44839	-	_	
219-427	44839-44842	1.3	_	
219-428	44842-44843	]	_	
219-429	44844-44845	[	_	
219-430	44845-44846	-	_	
219-431	44846-44849	3.6	_	
219-432	44849-44850	,	_	
219-433	44853-44854	-	_	
219-434	44854-44857	0.3	_	
219-435	44857-44858	]	_	
219-436	44859-44860	[	_	
219-437	44860-44861	-	_	
219-438	44861-44864	4.9	_	
219-439	44864-44865	,	_	
219-440	44868-44869	-	_	
219-441	44869-44872	1.3	_	
219-442	44872-44873	]	_	
219-443	44874-44875	[	_	
219-444	44875-44876	-	_	
219-445	44876-44879	2.7	_	
219-446	44879-44880	,	_	
219-447	44881-44884	1.7	_	
219-448	44884-44885	]	_	
219-449	44886-44887	[	_	
219-450	44887-44888	-	_	
219-451	44888-44891	0.3	_	
219-452	44891-44892	,	_	
219-453	44893-44896	1.6	_	
219-454	44896-44897	]	_	
219-455	44900-44905	MAACL	_	
219-456	44906-44914	Anxietyh	_	
219-457	44915-44919	48.6	_	
219-458	44920-44921	(	_	
219-459	44921-44925	15.2	_	
219-460	44925-44926	)	_	
219-461	44927-44931	46.1	_	
219-462	44932-44933	(	_	
219-463	44933-44937	11.1	_	
219-464	44937-44938	)	_	
219-465	44939-44943	45.6	_	
219-466	44944-44945	(	_	
219-467	44945-44949	14.3	_	
219-468	44949-44950	)	_	
219-469	44951-44955	43.6	_	
219-470	44956-44957	(	_	
219-471	44957-44960	6.3	_	
219-472	44960-44961	)	_	
219-473	44962-44963	[	_	
219-474	44963-44964	-	_	
219-475	44964-44967	7.2	_	
219-476	44967-44968	,	_	
219-477	44969-44972	1.8	_	
219-478	44972-44973	]	_	
219-479	44974-44975	[	_	
219-480	44975-44976	-	_	
219-481	44976-44980	10.6	_	
219-482	44980-44981	,	_	
219-483	44982-44985	4.7	_	
219-484	44985-44986	]	_	
219-485	44987-44988	[	_	
219-486	44988-44989	-	_	
219-487	44989-44992	7.3	_	
219-488	44992-44993	,	_	
219-489	44994-44997	2.3	_	
219-490	44997-44998	]	_	
219-491	44999-45000	[	_	
219-492	45000-45001	-	_	
219-493	45001-45004	4.6	_	
219-494	45004-45005	,	_	
219-495	45006-45009	9.4	_	
219-496	45009-45010	]	_	
219-497	45011-45012	[	_	
219-498	45012-45013	-	_	
219-499	45013-45016	3.7	_	
219-500	45016-45017	,	_	
219-501	45018-45021	7.7	_	
219-502	45021-45022	]	_	
219-503	45025-45033	Drinking	_	
219-504	45034-45042	Measures	_	
219-505	45043-45048	Daily	_	
219-506	45049-45055	Drinks	_	
219-507	45056-45057	(	_	
219-508	45057-45063	ounces	_	
219-509	45064-45071	ethanol	_	
219-510	45072-45075	per	_	
219-511	45076-45079	day	_	
219-512	45079-45080	)	_	
219-513	45081-45084	7.7	_	
219-514	45085-45086	(	_	
219-515	45086-45089	6.8	_	
219-516	45089-45090	)	_	
219-517	45091-45093	11	_	
219-518	45094-45095	(	_	
219-519	45095-45098	8.3	_	
219-520	45098-45099	)	_	
219-521	45100-45103	0.2	_	
219-522	45104-45105	(	_	
219-523	45105-45108	0.3	_	
219-524	45108-45109	)	_	
219-525	45110-45113	0.3	_	
219-526	45114-45115	(	_	
219-527	45115-45118	0.5	_	
219-528	45118-45119	)	_	
219-529	45120-45121	[	_	
219-530	45121-45122	-	_	
219-531	45122-45126	11.1	_	
219-532	45126-45127	,	_	
219-533	45130-45131	-	_	
219-534	45131-45134	7.1	_	
219-535	45134-45135	]	_	
219-536	45136-45137	[	_	
219-537	45137-45138	-	_	
219-538	45138-45142	10.1	_	
219-539	45142-45143	,	_	
219-540	45146-45147	-	_	
219-541	45147-45150	5.0	_	
219-542	45150-45151	]	_	
219-543	45152-45153	[	_	
219-544	45153-45154	-	_	
219-545	45154-45158	13.8	_	
219-546	45158-45159	,	_	
219-547	45162-45163	-	_	
219-548	45163-45166	7.6	_	
219-549	45166-45167	]	_	
219-550	45168-45169	[	_	
219-551	45169-45170	-	_	
219-552	45170-45173	7.3	_	
219-553	45173-45174	,	_	
219-554	45175-45178	0.6	_	
219-555	45178-45179	]	_	
219-556	45180-45181	[	_	
219-557	45181-45182	-	_	
219-558	45182-45185	0.4	_	
219-559	45185-45186	,	_	
219-560	45187-45190	0.1	_	
219-561	45190-45191	]	_	
219-562	45194-45202	Duration	_	
219-563	45203-45205	of	_	
219-564	45206-45211	Heavy	_	
219-565	45212-45220	Drinking	_	
219-566	45221-45222	(	_	
219-567	45222-45227	years	_	
219-568	45227-45228	)	_	
219-569	45229-45231	13	_	
219-570	45232-45233	(	_	
219-571	45233-45236	6.3	_	
219-572	45236-45237	)	_	
219-573	45238-45242	16.6	_	
219-574	45243-45244	(	_	
219-575	45244-45247	8.3	_	
219-576	45247-45248	)	_	
219-577	45249-45250	0	_	
219-578	45251-45252	(	_	
219-579	45252-45253	0	_	
219-580	45253-45254	)	_	
219-581	45255-45256	0	_	
219-582	45257-45258	(	_	
219-583	45258-45259	0	_	
219-584	45259-45260	)	_	
219-585	45261-45262	[	_	
219-586	45262-45263	-	_	
219-587	45263-45267	16.7	_	
219-588	45267-45268	,	_	
219-589	45271-45272	-	_	
219-590	45272-45276	12.9	_	
219-591	45276-45277	]	_	
219-592	45278-45279	[	_	
219-593	45279-45280	-	_	
219-594	45280-45284	15.4	_	
219-595	45284-45285	,	_	
219-596	45288-45289	-	_	
219-597	45289-45293	10.7	_	
219-598	45293-45294	]	_	
219-599	45295-45296	[	_	
219-600	45296-45297	-	_	
219-601	45297-45301	19.6	_	
219-602	45301-45302	,	_	
219-603	45305-45306	-	_	
219-604	45306-45310	13.5	_	
219-605	45310-45311	]	_	
219-606	45312-45313	[	_	
219-607	45313-45314	-	_	
219-608	45314-45317	7.3	_	
219-609	45317-45318	,	_	
219-610	45319-45322	0.3	_	
219-611	45322-45323	]	_	
219-612	45324-45325	N	_	
219-613	45325-45326	/	_	
219-614	45326-45327	A	_	
219-615	45330-45336	Length	_	
219-616	45337-45339	of	_	
219-617	45340-45348	Sobriety	_	
219-618	45349-45350	(	_	
219-619	45350-45355	years	_	
219-620	45355-45356	)	_	
219-621	45357-45360	7.3	_	
219-622	45361-45362	(	_	
219-623	45362-45365	9.3	_	
219-624	45365-45366	)	_	
219-625	45367-45370	5.2	_	
219-626	45371-45372	(	_	
219-627	45372-45375	9.9	_	
219-628	45375-45376	)	_	
219-629	45377-45378	N	_	
219-630	45378-45379	/	_	
219-631	45379-45380	A	_	
219-632	45381-45382	(	_	
219-633	45382-45383	N	_	
219-634	45383-45384	/	_	
219-635	45384-45385	A	_	
219-636	45385-45386	)	_	
219-637	45387-45388	N	_	
219-638	45388-45389	/	_	
219-639	45389-45390	A	_	
219-640	45391-45392	(	_	
219-641	45392-45393	N	_	
219-642	45393-45394	/	_	
219-643	45394-45395	A	_	
219-644	45395-45396	)	_	
219-645	45397-45398	N	_	
219-646	45398-45399	/	_	
219-647	45399-45400	A	_	
219-648	45401-45402	N	_	
219-649	45402-45403	/	_	
219-650	45403-45404	A	_	
219-651	45405-45406	N	_	
219-652	45406-45407	/	_	
219-653	45407-45408	A	_	
219-654	45409-45410	[	_	
219-655	45410-45411	-	_	
219-656	45411-45414	2.9	_	
219-657	45414-45415	,	_	
219-658	45416-45419	7.0	_	
219-659	45419-45420	]	_	
219-660	45421-45422	N	_	
219-661	45422-45423	/	_	
219-662	45423-45424	A	_	
219-663	45428-45446	Neuropsychological	_	
219-664	45447-45453	scores	_	
219-665	45454-45458	were	_	
219-666	45459-45470	unavailable	_	
219-667	45471-45474	for	_	
219-668	45475-45476	1	_	
219-669	45477-45480	ALC	_	
219-670	45481-45486	woman	_	
219-671	45486-45487	,	_	
219-672	45488-45489	1	_	
219-673	45490-45493	ALC	_	
219-674	45494-45497	man	_	
219-675	45497-45498	,	_	
219-676	45499-45502	and	_	
219-677	45503-45504	1	_	
219-678	45505-45507	NC	_	
219-679	45508-45513	woman	_	
219-680	45513-45514	.	_	

#Text=The number of daily drinks was not obtained from 1 NC man.
220-1	45515-45518	The	_	
220-2	45519-45525	number	_	
220-3	45526-45528	of	_	
220-4	45529-45534	daily	_	
220-5	45535-45541	drinks	_	
220-6	45542-45545	was	_	
220-7	45546-45549	not	_	
220-8	45550-45558	obtained	_	
220-9	45559-45563	from	_	
220-10	45564-45565	1	_	
220-11	45566-45568	NC	_	
220-12	45569-45572	man	_	
220-13	45572-45573	.	_	

#Text=Wechsler Adult Intelligence Scale, Full Scale IQ.
221-1	45574-45582	Wechsler	_	
221-2	45583-45588	Adult	_	
221-3	45589-45601	Intelligence	_	
221-4	45602-45607	Scale	_	
221-5	45607-45608	,	_	
221-6	45609-45613	Full	_	
221-7	45614-45619	Scale	_	
221-8	45620-45622	IQ	_	
221-9	45622-45623	.	_	

#Text=Wechsler Adult Intelligence Scale, Performance IQ.
222-1	45624-45632	Wechsler	_	
222-2	45633-45638	Adult	_	
222-3	45639-45651	Intelligence	_	
222-4	45652-45657	Scale	_	
222-5	45657-45658	,	_	
222-6	45659-45670	Performance	_	
222-7	45671-45673	IQ	_	
222-8	45673-45674	.	_	

#Text=Wechsler Adult Intelligence Scale, Verbal IQ.
223-1	45675-45683	Wechsler	_	
223-2	45684-45689	Adult	_	
223-3	45690-45702	Intelligence	_	
223-4	45703-45708	Scale	_	
223-5	45708-45709	,	_	
223-6	45710-45716	Verbal	_	
223-7	45717-45719	IQ	_	
223-8	45719-45720	.	_	

#Text=Wechsler Adult Intelligence Scale, Working Memory Index.
224-1	45721-45729	Wechsler	_	
224-2	45730-45735	Adult	_	
224-3	45736-45748	Intelligence	_	
224-4	45749-45754	Scale	_	
224-5	45754-45755	,	_	
224-6	45756-45763	Working	_	
224-7	45764-45770	Memory	_	
224-8	45771-45776	Index	_	
224-9	45776-45777	.	_	

#Text=Wechsler Memory Scale, Delayed Memory.
225-1	45778-45786	Wechsler	_	
225-2	45787-45793	Memory	_	
225-3	45794-45799	Scale	_	
225-4	45799-45800	,	_	
225-5	45801-45808	Delayed	_	
225-6	45809-45815	Memory	_	
225-7	45815-45816	.	_	

#Text=Hamilton Rating Scale for Depression.
226-1	45817-45825	Hamilton	_	
226-2	45826-45832	Rating	_	
226-3	45833-45838	Scale	_	
226-4	45839-45842	for	_	
226-5	45843-45853	Depression	_	
226-6	45853-45854	.	_	

#Text=Multiple Affect Adjective Checklist, Anxiety.
227-1	45855-45863	Multiple	_	
227-2	45864-45870	Affect	_	
227-3	45871-45880	Adjective	_	
227-4	45881-45890	Checklist	_	
227-5	45890-45891	,	_	
227-6	45892-45899	Anxiety	_	
227-7	45899-45900	.	_	

#Text=Morphometric analyses.
228-1	45901-45913	Morphometric	_	
228-2	45914-45922	analyses	_	
228-3	45922-45923	.	_	

#Text=Table 2A shows values for the six global volumetric
#Text=regions (cm3).
229-1	45924-45929	Table	_	
229-2	45930-45932	2A	_	
229-3	45933-45938	shows	_	
229-4	45939-45945	values	_	
229-5	45946-45949	for	_	
229-6	45950-45953	the	_	
229-7	45954-45957	six	_	
229-8	45958-45964	global	_	
229-9	45965-45975	volumetric	_	
229-10	45976-45983	regions	_	
229-11	45984-45985	(	_	
229-12	45985-45988	cm3	_	
229-13	45988-45989	)	_	
229-14	45989-45990	.	_	

#Text=Table 2B shows values for the total reward system
#Text=volume, the 13 a priori subregions, and two comparison regions (percentage of
#Text=cerebrum).
230-1	45991-45996	Table	_	
230-2	45997-45999	2B	_	
230-3	46000-46005	shows	_	
230-4	46006-46012	values	_	
230-5	46013-46016	for	_	
230-6	46017-46020	the	_	
230-7	46021-46026	total	_	
230-8	46027-46033	reward	_	
230-9	46034-46040	system	_	
230-10	46041-46047	volume	_	
230-11	46047-46048	,	_	
230-12	46049-46052	the	_	
230-13	46053-46055	13	_	
230-14	46056-46057	a	_	
230-15	46058-46064	priori	_	
230-16	46065-46075	subregions	_	
230-17	46075-46076	,	_	
230-18	46077-46080	and	_	
230-19	46081-46084	two	_	
230-20	46085-46095	comparison	_	
230-21	46096-46103	regions	_	
230-22	46104-46105	(	_	
230-23	46105-46115	percentage	_	
230-24	46116-46118	of	_	
230-25	46119-46127	cerebrum	_	
230-26	46127-46128	)	_	
230-27	46128-46129	.	_	

#Text=Mean values are provided with standard deviations (SD).
231-1	46130-46134	Mean	_	
231-2	46135-46141	values	_	
231-3	46142-46145	are	_	
231-4	46146-46154	provided	_	
231-5	46155-46159	with	_	
231-6	46160-46168	standard	_	
231-7	46169-46179	deviations	_	
231-8	46180-46181	(	_	
231-9	46181-46183	SD	_	
231-10	46183-46184	)	_	
231-11	46184-46185	.	_	

#Text=Significant
#Text=differences (p < 0.05) are presented in bold text.
232-1	46186-46197	Significant	_	
232-2	46198-46209	differences	_	
232-3	46210-46211	(	_	
232-4	46211-46212	p	_	
232-5	46213-46214	<	_	
232-6	46215-46219	0.05	_	
232-7	46219-46220	)	_	
232-8	46221-46224	are	_	
232-9	46225-46234	presented	_	
232-10	46235-46237	in	_	
232-11	46238-46242	bold	_	
232-12	46243-46247	text	_	
232-13	46247-46248	.	_	

#Text=Abbreviations: ALC = Alcoholic; NC = Nonalcoholic Control;
#Text=95% CI = 95% confidence interval of the mean difference
#Text=between groups, expressed as the percentage of the mean volume for each of the
#Text=regions.
233-1	46249-46262	Abbreviations	_	
233-2	46262-46263	:	_	
233-3	46264-46267	ALC	_	
233-4	46268-46269	=	_	
233-5	46270-46279	Alcoholic	_	
233-6	46279-46280	;	_	
233-7	46281-46283	NC	_	
233-8	46284-46285	=	_	
233-9	46286-46298	Nonalcoholic	_	
233-10	46299-46306	Control	_	
233-11	46306-46307	;	_	
233-12	46308-46311	95%	_	
233-13	46312-46314	CI	_	
233-14	46315-46316	=	_	
233-15	46317-46320	95%	_	
233-16	46321-46331	confidence	_	
233-17	46332-46340	interval	_	
233-18	46341-46343	of	_	
233-19	46344-46347	the	_	
233-20	46348-46352	mean	_	
233-21	46353-46363	difference	_	
233-22	46364-46371	between	_	
233-23	46372-46378	groups	_	
233-24	46378-46379	,	_	
233-25	46380-46389	expressed	_	
233-26	46390-46392	as	_	
233-27	46393-46396	the	_	
233-28	46397-46407	percentage	_	
233-29	46408-46410	of	_	
233-30	46411-46414	the	_	
233-31	46415-46419	mean	_	
233-32	46420-46426	volume	_	
233-33	46427-46430	for	_	
233-34	46431-46435	each	_	
233-35	46436-46438	of	_	
233-36	46439-46442	the	_	
233-37	46443-46450	regions	_	
233-38	46450-46451	.	_	

#Text=ALC Women (N=30)\tALC Men (N=30)\tNC Women (N=31)\tNC Men (N=29)\tALC - NC\tALC Men - NC Men\tALC Women - NC Women\tALC Women - ALC Men\tNC Women - NC Men\t \t\t \t\t\tMean\t(SD)\tMean\t(SD)\tMean\t(SD)\tMean\t(SD)\t95% CI\t95% CI\t95% CI\t95% CI\t95% CI\t \t2A.
234-1	46454-46457	ALC	_	
234-2	46458-46463	Women	_	
234-3	46464-46465	(	_	
234-4	46465-46466	N	_	
234-5	46466-46467	=	_	
234-6	46467-46469	30	_	
234-7	46469-46470	)	_	
234-8	46471-46474	ALC	_	
234-9	46475-46478	Men	_	
234-10	46479-46480	(	_	
234-11	46480-46481	N	_	
234-12	46481-46482	=	_	
234-13	46482-46484	30	_	
234-14	46484-46485	)	_	
234-15	46486-46488	NC	_	
234-16	46489-46494	Women	_	
234-17	46495-46496	(	_	
234-18	46496-46497	N	_	
234-19	46497-46498	=	_	
234-20	46498-46500	31	_	
234-21	46500-46501	)	_	
234-22	46502-46504	NC	_	
234-23	46505-46508	Men	_	
234-24	46509-46510	(	_	
234-25	46510-46511	N	_	
234-26	46511-46512	=	_	
234-27	46512-46514	29	_	
234-28	46514-46515	)	_	
234-29	46516-46519	ALC	_	
234-30	46520-46521	-	_	
234-31	46522-46524	NC	_	
234-32	46525-46528	ALC	_	
234-33	46529-46532	Men	_	
234-34	46533-46534	-	_	
234-35	46535-46537	NC	_	
234-36	46538-46541	Men	_	
234-37	46542-46545	ALC	_	
234-38	46546-46551	Women	_	
234-39	46552-46553	-	_	
234-40	46554-46556	NC	_	
234-41	46557-46562	Women	_	
234-42	46563-46566	ALC	_	
234-43	46567-46572	Women	_	
234-44	46573-46574	-	_	
234-45	46575-46578	ALC	_	
234-46	46579-46582	Men	_	
234-47	46583-46585	NC	_	
234-48	46586-46591	Women	_	
234-49	46592-46593	-	_	
234-50	46594-46596	NC	_	
234-51	46597-46600	Men	_	
234-52	46608-46612	Mean	_	
234-53	46613-46614	(	_	
234-54	46614-46616	SD	_	
234-55	46616-46617	)	_	
234-56	46618-46622	Mean	_	
234-57	46623-46624	(	_	
234-58	46624-46626	SD	_	
234-59	46626-46627	)	_	
234-60	46628-46632	Mean	_	
234-61	46633-46634	(	_	
234-62	46634-46636	SD	_	
234-63	46636-46637	)	_	
234-64	46638-46642	Mean	_	
234-65	46643-46644	(	_	
234-66	46644-46646	SD	_	
234-67	46646-46647	)	_	
234-68	46648-46651	95%	_	
234-69	46652-46654	CI	_	
234-70	46655-46658	95%	_	
234-71	46659-46661	CI	_	
234-72	46662-46665	95%	_	
234-73	46666-46668	CI	_	
234-74	46669-46672	95%	_	
234-75	46673-46675	CI	_	
234-76	46676-46679	95%	_	
234-77	46680-46682	CI	_	
234-78	46685-46687	2A	_	
234-79	46687-46688	.	_	

#Text=Global Regions (cm3)\t\t\t\t\t\t\t\t\t\t\t\t\t\t \tEstimated Total Intracranial Volume\t1,445. 87\t(144.2 8)\t1,601. 03\t(127.8 9)\t1,376. 18\t(118.1 8)\t1,565. 87\t(146.3 3)\t[-1%,\t \t7%]\t[-2%,\t \t6%]\t[0%,\t \t9%]\t[-15%,\t \t-6%]\t[-16%,\t \t-7%]\t \tTotal Brain\t1,233. 57\t(129.4 6)\t1,327. 11\t(106.5 4)\t1,176. 31\t(116.2 4)\t1,302. 51\t(142.6 2)\t[-1%,\t \t7%]\t[-3%,\t \t6%]\t[-1%,\t \t9%]\t[-12%,\t \t-3%]\t[-14%,\t \t-4%]\t \tTotal Cerebrum\t1,073. 19\t(120.2 3)\t1,163. 87\t(94.24)\t1,025. 51\t(103.6 3)\t1,138. 77\t(122.8 6)\t[-1%,\t \t7%]\t[-2%,\t \t7%]\t[-2%,\t \t9%]\t[-13%,\t \t-3%]\t[-14%,\t \t-4%]\t \tTotal Cerebral Cortex\t579.71\t(66.38)\t607.07\t(61.32)\t550.02\t(56.66)\t599.67\t(64.44)\t[-1%,\t \t7%]\t[-4%,\t \t6%]\t[-1%,\t \t11%]\t[-10%,\t \t1%]\t[-13%,\t \t-2%]\t \tTotal Cerebral White Matter\t421.58\t(54.78)\t479.72\t(58.72)\t409.88\t(61.82)\t462.68\t(67.46)\t[-3%,\t \t8%]\t[-3%,\t \t10%]\t[-6%,\t \t9%]\t[-19%,\t \t-6%]\t[-17%,\t \t-3%]\t \tTotal Ventricular System\t24.89\t(20.03)\t27.58\t(10.21)\t20.80\t(7.80)\t26.79\t(14.70)\t[-5%,\t \t33%]\t[-19%,\t \t25%]\t[-6%,\t \t59%]\t[-39%,\t \t20%]\t[-55%,\t \t-9%]\t \t2B\tReward Regions (percentage of cerebrum)\t\t\t\t\t\t\t\t\t\t\t\t\t\t \tTotal Rewarda\t12.72\t(1.01)\t11.70\t(0.98)\t12.17\t(1.11)\t12.19\t(0.58)\t[-3%,\t \t3%]\t[-8%,\t \t-1%]\t[0%,\t \t9%]\t[4%,\t \t13%]\t[-4%,\t \t4%]\t \tDorsolateral Prefrontal Cortexa\t3.68\t(0.74)\t3.24\t(0.70)\t3.21\t(0.74)\t3.54\t(0.47)\t[-5%,\t \t10%]\t[-18%,\t \t0%]\t[2%,\t \t25%]\t[2%,\t \t23%]\t[-20%,\t \t0%]\t \tInsula\t1.28\t(0.11)\t1.21\t(0.12)\t1.29\t(0.15)\t1.25\t(0.07)\t[-5%,\t \t2%]\t[-7%,\t \t1%]\t[-5%,\t \t5%]\t[0%,\t \t10%]\t[-2%,\t \t7%]\t \tSubcallosal Cortex\t0.37\t(0.05)\t0.39\t(0.07)\t0.39\t(0.07)\t0.40\t(0.06)\t[-11%,\t \t1%]\t[-11%,\t \t6%]\t[-16%,\t \t1%]\t[-15%,\t \t1%]\t[-10%,\t \t7%]\t \tOrbitofrontal Cortex\t0.89\t(0.17)\t0.87\t(0.17)\t0.89\t(0.22)\t0.92\t(0.13)\t[-11%,\t \t4%]\t[-15%,\t \t3%]\t[-13%,\t \t10%]\t[-8%,\t \t12%]\t[-13%,\t \t7%]\t \tAnterior Cingulate Cortex\t1.06\t(0.20)\t1.05\t(0.22)\t1.13\t(0.18)\t1.04\t(0.23)\t[-9%,\t \t5%]\t[-10%,\t \t12%]\t[-15%,\t \t3%]\t[-9%,\t \t12%]\t[-3%,\t \t16%]\t \tPosterior Cingulate Cortex\t0.92\t(0.12)\t0.96\t(0.17)\t0.97\t(0.11)\t0.96\t(0.15)\t[-8%,\t \t2%]\t[-9%,\t \t9%]\t[-12%,\t \t1%]\t[-13%,\t \t3%]\t[-7%,\t \t8%]\t \tAnterior Parahippocampal Gyrus\t0.50\t(0.10)\t0.47\t(0.10)\t0.49\t(0.09)\t0.48\t(0.09)\t[-5%,\t \t8%]\t[-12%,\t \t8%]\t[-3%,\t \t15%]\t[-4%,\t \t16%]\t[-9%,\t \t9%]\t \tPosterior Parahippocampal Gyrus\t0.29\t(0.06)\t0.24\t(0.05)\t0.28\t(0.06)\t0.25\t(0.05)\t[-7%,\t \t9%]\t[-13%,\t \t9%]\t[-8%,\t \t15%]\t[6%,\t \t28%]\t[0%,\t \t23%]\t \tTemporal Pole\t1.84\t(0.25)\t1.48\t(0.20)\t1.68\t(0.28)\t1.48\t(0.22)\t[-2%,\t \t10%]\t[-7%,\t \t7%]\t[0%,\t \t16%]\t[14%,\t \t28%]\t[5%,\t \t22%]\t \tNucleus Accumbens Septi\t0.10\t(0.02)\t0.09\t(0.02)\t0.10\t(0.02)\t0.10\t(0.02)\t[-8%,\t \t5%]\t[-14%,\t \t6%]\t[-8%,\t \t11%]\t[-5%,\t \t16%]\t[-9%,\t \t10%]\t \tAmygdala\t0.27\t(0.03)\t0.26\t(0.04)\t0.27\t(0.04)\t0.27\t(0.05)\t[-8%,\t \t4%]\t[-16%,\t \t4%]\t[-5%,\t \t10%]\t[-1%,\t \t14%]\t[-12%,\t \t7%]\t \tHippocampus\t0.66\t(0.07)\t0.62\t(0.06)\t0.65\t(0.06)\t0.64\t(0.07)\t[-5%,\t \t3%]\t[-9%,\t \t2%]\t[-4%,\t \t6%]\t[1%,\t \t12%]\t[-4%,\t \t7%]\t \tVentral Diencephalona\t0.87\t(0.09)\t0.80\t(0.09)\t0.82\t(0.09)\t0.84\t(0.10)\t[-4%,\t \t4%]\t[-11%,\t \t1%]\t[0%,\t \t11%]\t[2%,\t \t13%]\t[-8%,\t \t4%]\t \tCuneus\t0.98\t(0.20)\t1.03\t(0.26)\t1.08\t(0.21)\t1.03\t(0.20)\t[-13%,\t \t3%]\t[-12%,\t \t12%]\t[-21%,\t \t0%]\t[-17%,\t \t6%]\t[-6%,\t \t14%]\t \tDorsal Striatum\t1.68\t(0.16)\t1.69\t(0.17)\t1.72\t(0.16)\t1.73\t(0.15)\t[-6%,\t \t0%]\t[-7%,\t \t2%]\t[-8%,\t \t2%]\t[-6%,\t \t3%]\t[-5%,\t \t5%]\t \t
#Text=Interaction significant for alcoholism by gender (p
#Text=< 0.05).
235-1	46689-46695	Global	_	
235-2	46696-46703	Regions	_	
235-3	46704-46705	(	_	
235-4	46705-46708	cm3	_	
235-5	46708-46709	)	_	
235-6	46725-46734	Estimated	_	
235-7	46735-46740	Total	_	
235-8	46741-46753	Intracranial	_	
235-9	46754-46760	Volume	_	
235-10	46761-46766	1,445	_	
235-11	46766-46767	.	_	
235-12	46768-46770	87	_	
235-13	46771-46772	(	_	
235-14	46772-46777	144.2	_	
235-15	46778-46779	8	_	
235-16	46779-46780	)	_	
235-17	46781-46786	1,601	_	
235-18	46786-46787	.	_	
235-19	46788-46790	03	_	
235-20	46791-46792	(	_	
235-21	46792-46797	127.8	_	
235-22	46798-46799	9	_	
235-23	46799-46800	)	_	
235-24	46801-46806	1,376	_	
235-25	46806-46807	.	_	
235-26	46808-46810	18	_	
235-27	46811-46812	(	_	
235-28	46812-46817	118.1	_	
235-29	46818-46819	8	_	
235-30	46819-46820	)	_	
235-31	46821-46826	1,565	_	
235-32	46826-46827	.	_	
235-33	46828-46830	87	_	
235-34	46831-46832	(	_	
235-35	46832-46837	146.3	_	
235-36	46838-46839	3	_	
235-37	46839-46840	)	_	
235-38	46841-46842	[	_	
235-39	46842-46843	-	_	
235-40	46843-46845	1%	_	
235-41	46845-46846	,	_	
235-42	46849-46851	7%	_	
235-43	46851-46852	]	_	
235-44	46853-46854	[	_	
235-45	46854-46855	-	_	
235-46	46855-46857	2%	_	
235-47	46857-46858	,	_	
235-48	46861-46863	6%	_	
235-49	46863-46864	]	_	
235-50	46865-46866	[	_	
235-51	46866-46868	0%	_	
235-52	46868-46869	,	_	
235-53	46872-46874	9%	_	
235-54	46874-46875	]	_	
235-55	46876-46877	[	_	
235-56	46877-46878	-	_	
235-57	46878-46881	15%	_	
235-58	46881-46882	,	_	
235-59	46885-46886	-	_	
235-60	46886-46888	6%	_	
235-61	46888-46889	]	_	
235-62	46890-46891	[	_	
235-63	46891-46892	-	_	
235-64	46892-46895	16%	_	
235-65	46895-46896	,	_	
235-66	46899-46900	-	_	
235-67	46900-46902	7%	_	
235-68	46902-46903	]	_	
235-69	46906-46911	Total	_	
235-70	46912-46917	Brain	_	
235-71	46918-46923	1,233	_	
235-72	46923-46924	.	_	
235-73	46925-46927	57	_	
235-74	46928-46929	(	_	
235-75	46929-46934	129.4	_	
235-76	46935-46936	6	_	
235-77	46936-46937	)	_	
235-78	46938-46943	1,327	_	
235-79	46943-46944	.	_	
235-80	46945-46947	11	_	
235-81	46948-46949	(	_	
235-82	46949-46954	106.5	_	
235-83	46955-46956	4	_	
235-84	46956-46957	)	_	
235-85	46958-46963	1,176	_	
235-86	46963-46964	.	_	
235-87	46965-46967	31	_	
235-88	46968-46969	(	_	
235-89	46969-46974	116.2	_	
235-90	46975-46976	4	_	
235-91	46976-46977	)	_	
235-92	46978-46983	1,302	_	
235-93	46983-46984	.	_	
235-94	46985-46987	51	_	
235-95	46988-46989	(	_	
235-96	46989-46994	142.6	_	
235-97	46995-46996	2	_	
235-98	46996-46997	)	_	
235-99	46998-46999	[	_	
235-100	46999-47000	-	_	
235-101	47000-47002	1%	_	
235-102	47002-47003	,	_	
235-103	47006-47008	7%	_	
235-104	47008-47009	]	_	
235-105	47010-47011	[	_	
235-106	47011-47012	-	_	
235-107	47012-47014	3%	_	
235-108	47014-47015	,	_	
235-109	47018-47020	6%	_	
235-110	47020-47021	]	_	
235-111	47022-47023	[	_	
235-112	47023-47024	-	_	
235-113	47024-47026	1%	_	
235-114	47026-47027	,	_	
235-115	47030-47032	9%	_	
235-116	47032-47033	]	_	
235-117	47034-47035	[	_	
235-118	47035-47036	-	_	
235-119	47036-47039	12%	_	
235-120	47039-47040	,	_	
235-121	47043-47044	-	_	
235-122	47044-47046	3%	_	
235-123	47046-47047	]	_	
235-124	47048-47049	[	_	
235-125	47049-47050	-	_	
235-126	47050-47053	14%	_	
235-127	47053-47054	,	_	
235-128	47057-47058	-	_	
235-129	47058-47060	4%	_	
235-130	47060-47061	]	_	
235-131	47064-47069	Total	_	
235-132	47070-47078	Cerebrum	_	
235-133	47079-47084	1,073	_	
235-134	47084-47085	.	_	
235-135	47086-47088	19	_	
235-136	47089-47090	(	_	
235-137	47090-47095	120.2	_	
235-138	47096-47097	3	_	
235-139	47097-47098	)	_	
235-140	47099-47104	1,163	_	
235-141	47104-47105	.	_	
235-142	47106-47108	87	_	
235-143	47109-47110	(	_	
235-144	47110-47115	94.24	_	
235-145	47115-47116	)	_	
235-146	47117-47122	1,025	_	
235-147	47122-47123	.	_	
235-148	47124-47126	51	_	
235-149	47127-47128	(	_	
235-150	47128-47133	103.6	_	
235-151	47134-47135	3	_	
235-152	47135-47136	)	_	
235-153	47137-47142	1,138	_	
235-154	47142-47143	.	_	
235-155	47144-47146	77	_	
235-156	47147-47148	(	_	
235-157	47148-47153	122.8	_	
235-158	47154-47155	6	_	
235-159	47155-47156	)	_	
235-160	47157-47158	[	_	
235-161	47158-47159	-	_	
235-162	47159-47161	1%	_	
235-163	47161-47162	,	_	
235-164	47165-47167	7%	_	
235-165	47167-47168	]	_	
235-166	47169-47170	[	_	
235-167	47170-47171	-	_	
235-168	47171-47173	2%	_	
235-169	47173-47174	,	_	
235-170	47177-47179	7%	_	
235-171	47179-47180	]	_	
235-172	47181-47182	[	_	
235-173	47182-47183	-	_	
235-174	47183-47185	2%	_	
235-175	47185-47186	,	_	
235-176	47189-47191	9%	_	
235-177	47191-47192	]	_	
235-178	47193-47194	[	_	
235-179	47194-47195	-	_	
235-180	47195-47198	13%	_	
235-181	47198-47199	,	_	
235-182	47202-47203	-	_	
235-183	47203-47205	3%	_	
235-184	47205-47206	]	_	
235-185	47207-47208	[	_	
235-186	47208-47209	-	_	
235-187	47209-47212	14%	_	
235-188	47212-47213	,	_	
235-189	47216-47217	-	_	
235-190	47217-47219	4%	_	
235-191	47219-47220	]	_	
235-192	47223-47228	Total	_	
235-193	47229-47237	Cerebral	_	
235-194	47238-47244	Cortex	_	
235-195	47245-47251	579.71	_	
235-196	47252-47253	(	_	
235-197	47253-47258	66.38	_	
235-198	47258-47259	)	_	
235-199	47260-47266	607.07	_	
235-200	47267-47268	(	_	
235-201	47268-47273	61.32	_	
235-202	47273-47274	)	_	
235-203	47275-47281	550.02	_	
235-204	47282-47283	(	_	
235-205	47283-47288	56.66	_	
235-206	47288-47289	)	_	
235-207	47290-47296	599.67	_	
235-208	47297-47298	(	_	
235-209	47298-47303	64.44	_	
235-210	47303-47304	)	_	
235-211	47305-47306	[	_	
235-212	47306-47307	-	_	
235-213	47307-47309	1%	_	
235-214	47309-47310	,	_	
235-215	47313-47315	7%	_	
235-216	47315-47316	]	_	
235-217	47317-47318	[	_	
235-218	47318-47319	-	_	
235-219	47319-47321	4%	_	
235-220	47321-47322	,	_	
235-221	47325-47327	6%	_	
235-222	47327-47328	]	_	
235-223	47329-47330	[	_	
235-224	47330-47331	-	_	
235-225	47331-47333	1%	_	
235-226	47333-47334	,	_	
235-227	47337-47340	11%	_	
235-228	47340-47341	]	_	
235-229	47342-47343	[	_	
235-230	47343-47344	-	_	
235-231	47344-47347	10%	_	
235-232	47347-47348	,	_	
235-233	47351-47353	1%	_	
235-234	47353-47354	]	_	
235-235	47355-47356	[	_	
235-236	47356-47357	-	_	
235-237	47357-47360	13%	_	
235-238	47360-47361	,	_	
235-239	47364-47365	-	_	
235-240	47365-47367	2%	_	
235-241	47367-47368	]	_	
235-242	47371-47376	Total	_	
235-243	47377-47385	Cerebral	_	
235-244	47386-47391	White	_	
235-245	47392-47398	Matter	_	
235-246	47399-47405	421.58	_	
235-247	47406-47407	(	_	
235-248	47407-47412	54.78	_	
235-249	47412-47413	)	_	
235-250	47414-47420	479.72	_	
235-251	47421-47422	(	_	
235-252	47422-47427	58.72	_	
235-253	47427-47428	)	_	
235-254	47429-47435	409.88	_	
235-255	47436-47437	(	_	
235-256	47437-47442	61.82	_	
235-257	47442-47443	)	_	
235-258	47444-47450	462.68	_	
235-259	47451-47452	(	_	
235-260	47452-47457	67.46	_	
235-261	47457-47458	)	_	
235-262	47459-47460	[	_	
235-263	47460-47461	-	_	
235-264	47461-47463	3%	_	
235-265	47463-47464	,	_	
235-266	47467-47469	8%	_	
235-267	47469-47470	]	_	
235-268	47471-47472	[	_	
235-269	47472-47473	-	_	
235-270	47473-47475	3%	_	
235-271	47475-47476	,	_	
235-272	47479-47482	10%	_	
235-273	47482-47483	]	_	
235-274	47484-47485	[	_	
235-275	47485-47486	-	_	
235-276	47486-47488	6%	_	
235-277	47488-47489	,	_	
235-278	47492-47494	9%	_	
235-279	47494-47495	]	_	
235-280	47496-47497	[	_	
235-281	47497-47498	-	_	
235-282	47498-47501	19%	_	
235-283	47501-47502	,	_	
235-284	47505-47506	-	_	
235-285	47506-47508	6%	_	
235-286	47508-47509	]	_	
235-287	47510-47511	[	_	
235-288	47511-47512	-	_	
235-289	47512-47515	17%	_	
235-290	47515-47516	,	_	
235-291	47519-47520	-	_	
235-292	47520-47522	3%	_	
235-293	47522-47523	]	_	
235-294	47526-47531	Total	_	
235-295	47532-47543	Ventricular	_	
235-296	47544-47550	System	_	
235-297	47551-47556	24.89	_	
235-298	47557-47558	(	_	
235-299	47558-47563	20.03	_	
235-300	47563-47564	)	_	
235-301	47565-47570	27.58	_	
235-302	47571-47572	(	_	
235-303	47572-47577	10.21	_	
235-304	47577-47578	)	_	
235-305	47579-47584	20.80	_	
235-306	47585-47586	(	_	
235-307	47586-47590	7.80	_	
235-308	47590-47591	)	_	
235-309	47592-47597	26.79	_	
235-310	47598-47599	(	_	
235-311	47599-47604	14.70	_	
235-312	47604-47605	)	_	
235-313	47606-47607	[	_	
235-314	47607-47608	-	_	
235-315	47608-47610	5%	_	
235-316	47610-47611	,	_	
235-317	47614-47617	33%	_	
235-318	47617-47618	]	_	
235-319	47619-47620	[	_	
235-320	47620-47621	-	_	
235-321	47621-47624	19%	_	
235-322	47624-47625	,	_	
235-323	47628-47631	25%	_	
235-324	47631-47632	]	_	
235-325	47633-47634	[	_	
235-326	47634-47635	-	_	
235-327	47635-47637	6%	_	
235-328	47637-47638	,	_	
235-329	47641-47644	59%	_	
235-330	47644-47645	]	_	
235-331	47646-47647	[	_	
235-332	47647-47648	-	_	
235-333	47648-47651	39%	_	
235-334	47651-47652	,	_	
235-335	47655-47658	20%	_	
235-336	47658-47659	]	_	
235-337	47660-47661	[	_	
235-338	47661-47662	-	_	
235-339	47662-47665	55%	_	
235-340	47665-47666	,	_	
235-341	47669-47670	-	_	
235-342	47670-47672	9%	_	
235-343	47672-47673	]	_	
235-344	47676-47678	2B	_	
235-345	47679-47685	Reward	_	
235-346	47686-47693	Regions	_	
235-347	47694-47695	(	_	
235-348	47695-47705	percentage	_	
235-349	47706-47708	of	_	
235-350	47709-47717	cerebrum	_	
235-351	47717-47718	)	_	
235-352	47734-47739	Total	_	
235-353	47740-47747	Rewarda	_	
235-354	47748-47753	12.72	_	
235-355	47754-47755	(	_	
235-356	47755-47759	1.01	_	
235-357	47759-47760	)	_	
235-358	47761-47766	11.70	_	
235-359	47767-47768	(	_	
235-360	47768-47772	0.98	_	
235-361	47772-47773	)	_	
235-362	47774-47779	12.17	_	
235-363	47780-47781	(	_	
235-364	47781-47785	1.11	_	
235-365	47785-47786	)	_	
235-366	47787-47792	12.19	_	
235-367	47793-47794	(	_	
235-368	47794-47798	0.58	_	
235-369	47798-47799	)	_	
235-370	47800-47801	[	_	
235-371	47801-47802	-	_	
235-372	47802-47804	3%	_	
235-373	47804-47805	,	_	
235-374	47808-47810	3%	_	
235-375	47810-47811	]	_	
235-376	47812-47813	[	_	
235-377	47813-47814	-	_	
235-378	47814-47816	8%	_	
235-379	47816-47817	,	_	
235-380	47820-47821	-	_	
235-381	47821-47823	1%	_	
235-382	47823-47824	]	_	
235-383	47825-47826	[	_	
235-384	47826-47828	0%	_	
235-385	47828-47829	,	_	
235-386	47832-47834	9%	_	
235-387	47834-47835	]	_	
235-388	47836-47837	[	_	
235-389	47837-47839	4%	_	
235-390	47839-47840	,	_	
235-391	47843-47846	13%	_	
235-392	47846-47847	]	_	
235-393	47848-47849	[	_	
235-394	47849-47850	-	_	
235-395	47850-47852	4%	_	
235-396	47852-47853	,	_	
235-397	47856-47858	4%	_	
235-398	47858-47859	]	_	
235-399	47862-47874	Dorsolateral	_	
235-400	47875-47885	Prefrontal	_	
235-401	47886-47893	Cortexa	_	
235-402	47894-47898	3.68	_	
235-403	47899-47900	(	_	
235-404	47900-47904	0.74	_	
235-405	47904-47905	)	_	
235-406	47906-47910	3.24	_	
235-407	47911-47912	(	_	
235-408	47912-47916	0.70	_	
235-409	47916-47917	)	_	
235-410	47918-47922	3.21	_	
235-411	47923-47924	(	_	
235-412	47924-47928	0.74	_	
235-413	47928-47929	)	_	
235-414	47930-47934	3.54	_	
235-415	47935-47936	(	_	
235-416	47936-47940	0.47	_	
235-417	47940-47941	)	_	
235-418	47942-47943	[	_	
235-419	47943-47944	-	_	
235-420	47944-47946	5%	_	
235-421	47946-47947	,	_	
235-422	47950-47953	10%	_	
235-423	47953-47954	]	_	
235-424	47955-47956	[	_	
235-425	47956-47957	-	_	
235-426	47957-47960	18%	_	
235-427	47960-47961	,	_	
235-428	47964-47966	0%	_	
235-429	47966-47967	]	_	
235-430	47968-47969	[	_	
235-431	47969-47971	2%	_	
235-432	47971-47972	,	_	
235-433	47975-47978	25%	_	
235-434	47978-47979	]	_	
235-435	47980-47981	[	_	
235-436	47981-47983	2%	_	
235-437	47983-47984	,	_	
235-438	47987-47990	23%	_	
235-439	47990-47991	]	_	
235-440	47992-47993	[	_	
235-441	47993-47994	-	_	
235-442	47994-47997	20%	_	
235-443	47997-47998	,	_	
235-444	48001-48003	0%	_	
235-445	48003-48004	]	_	
235-446	48007-48013	Insula	_	
235-447	48014-48018	1.28	_	
235-448	48019-48020	(	_	
235-449	48020-48024	0.11	_	
235-450	48024-48025	)	_	
235-451	48026-48030	1.21	_	
235-452	48031-48032	(	_	
235-453	48032-48036	0.12	_	
235-454	48036-48037	)	_	
235-455	48038-48042	1.29	_	
235-456	48043-48044	(	_	
235-457	48044-48048	0.15	_	
235-458	48048-48049	)	_	
235-459	48050-48054	1.25	_	
235-460	48055-48056	(	_	
235-461	48056-48060	0.07	_	
235-462	48060-48061	)	_	
235-463	48062-48063	[	_	
235-464	48063-48064	-	_	
235-465	48064-48066	5%	_	
235-466	48066-48067	,	_	
235-467	48070-48072	2%	_	
235-468	48072-48073	]	_	
235-469	48074-48075	[	_	
235-470	48075-48076	-	_	
235-471	48076-48078	7%	_	
235-472	48078-48079	,	_	
235-473	48082-48084	1%	_	
235-474	48084-48085	]	_	
235-475	48086-48087	[	_	
235-476	48087-48088	-	_	
235-477	48088-48090	5%	_	
235-478	48090-48091	,	_	
235-479	48094-48096	5%	_	
235-480	48096-48097	]	_	
235-481	48098-48099	[	_	
235-482	48099-48101	0%	_	
235-483	48101-48102	,	_	
235-484	48105-48108	10%	_	
235-485	48108-48109	]	_	
235-486	48110-48111	[	_	
235-487	48111-48112	-	_	
235-488	48112-48114	2%	_	
235-489	48114-48115	,	_	
235-490	48118-48120	7%	_	
235-491	48120-48121	]	_	
235-492	48124-48135	Subcallosal	_	
235-493	48136-48142	Cortex	_	
235-494	48143-48147	0.37	_	
235-495	48148-48149	(	_	
235-496	48149-48153	0.05	_	
235-497	48153-48154	)	_	
235-498	48155-48159	0.39	_	
235-499	48160-48161	(	_	
235-500	48161-48165	0.07	_	
235-501	48165-48166	)	_	
235-502	48167-48171	0.39	_	
235-503	48172-48173	(	_	
235-504	48173-48177	0.07	_	
235-505	48177-48178	)	_	
235-506	48179-48183	0.40	_	
235-507	48184-48185	(	_	
235-508	48185-48189	0.06	_	
235-509	48189-48190	)	_	
235-510	48191-48192	[	_	
235-511	48192-48193	-	_	
235-512	48193-48196	11%	_	
235-513	48196-48197	,	_	
235-514	48200-48202	1%	_	
235-515	48202-48203	]	_	
235-516	48204-48205	[	_	
235-517	48205-48206	-	_	
235-518	48206-48209	11%	_	
235-519	48209-48210	,	_	
235-520	48213-48215	6%	_	
235-521	48215-48216	]	_	
235-522	48217-48218	[	_	
235-523	48218-48219	-	_	
235-524	48219-48222	16%	_	
235-525	48222-48223	,	_	
235-526	48226-48228	1%	_	
235-527	48228-48229	]	_	
235-528	48230-48231	[	_	
235-529	48231-48232	-	_	
235-530	48232-48235	15%	_	
235-531	48235-48236	,	_	
235-532	48239-48241	1%	_	
235-533	48241-48242	]	_	
235-534	48243-48244	[	_	
235-535	48244-48245	-	_	
235-536	48245-48248	10%	_	
235-537	48248-48249	,	_	
235-538	48252-48254	7%	_	
235-539	48254-48255	]	_	
235-540	48258-48271	Orbitofrontal	_	
235-541	48272-48278	Cortex	_	
235-542	48279-48283	0.89	_	
235-543	48284-48285	(	_	
235-544	48285-48289	0.17	_	
235-545	48289-48290	)	_	
235-546	48291-48295	0.87	_	
235-547	48296-48297	(	_	
235-548	48297-48301	0.17	_	
235-549	48301-48302	)	_	
235-550	48303-48307	0.89	_	
235-551	48308-48309	(	_	
235-552	48309-48313	0.22	_	
235-553	48313-48314	)	_	
235-554	48315-48319	0.92	_	
235-555	48320-48321	(	_	
235-556	48321-48325	0.13	_	
235-557	48325-48326	)	_	
235-558	48327-48328	[	_	
235-559	48328-48329	-	_	
235-560	48329-48332	11%	_	
235-561	48332-48333	,	_	
235-562	48336-48338	4%	_	
235-563	48338-48339	]	_	
235-564	48340-48341	[	_	
235-565	48341-48342	-	_	
235-566	48342-48345	15%	_	
235-567	48345-48346	,	_	
235-568	48349-48351	3%	_	
235-569	48351-48352	]	_	
235-570	48353-48354	[	_	
235-571	48354-48355	-	_	
235-572	48355-48358	13%	_	
235-573	48358-48359	,	_	
235-574	48362-48365	10%	_	
235-575	48365-48366	]	_	
235-576	48367-48368	[	_	
235-577	48368-48369	-	_	
235-578	48369-48371	8%	_	
235-579	48371-48372	,	_	
235-580	48375-48378	12%	_	
235-581	48378-48379	]	_	
235-582	48380-48381	[	_	
235-583	48381-48382	-	_	
235-584	48382-48385	13%	_	
235-585	48385-48386	,	_	
235-586	48389-48391	7%	_	
235-587	48391-48392	]	_	
235-588	48395-48403	Anterior	_	
235-589	48404-48413	Cingulate	_	
235-590	48414-48420	Cortex	_	
235-591	48421-48425	1.06	_	
235-592	48426-48427	(	_	
235-593	48427-48431	0.20	_	
235-594	48431-48432	)	_	
235-595	48433-48437	1.05	_	
235-596	48438-48439	(	_	
235-597	48439-48443	0.22	_	
235-598	48443-48444	)	_	
235-599	48445-48449	1.13	_	
235-600	48450-48451	(	_	
235-601	48451-48455	0.18	_	
235-602	48455-48456	)	_	
235-603	48457-48461	1.04	_	
235-604	48462-48463	(	_	
235-605	48463-48467	0.23	_	
235-606	48467-48468	)	_	
235-607	48469-48470	[	_	
235-608	48470-48471	-	_	
235-609	48471-48473	9%	_	
235-610	48473-48474	,	_	
235-611	48477-48479	5%	_	
235-612	48479-48480	]	_	
235-613	48481-48482	[	_	
235-614	48482-48483	-	_	
235-615	48483-48486	10%	_	
235-616	48486-48487	,	_	
235-617	48490-48493	12%	_	
235-618	48493-48494	]	_	
235-619	48495-48496	[	_	
235-620	48496-48497	-	_	
235-621	48497-48500	15%	_	
235-622	48500-48501	,	_	
235-623	48504-48506	3%	_	
235-624	48506-48507	]	_	
235-625	48508-48509	[	_	
235-626	48509-48510	-	_	
235-627	48510-48512	9%	_	
235-628	48512-48513	,	_	
235-629	48516-48519	12%	_	
235-630	48519-48520	]	_	
235-631	48521-48522	[	_	
235-632	48522-48523	-	_	
235-633	48523-48525	3%	_	
235-634	48525-48526	,	_	
235-635	48529-48532	16%	_	
235-636	48532-48533	]	_	
235-637	48536-48545	Posterior	_	
235-638	48546-48555	Cingulate	_	
235-639	48556-48562	Cortex	_	
235-640	48563-48567	0.92	_	
235-641	48568-48569	(	_	
235-642	48569-48573	0.12	_	
235-643	48573-48574	)	_	
235-644	48575-48579	0.96	_	
235-645	48580-48581	(	_	
235-646	48581-48585	0.17	_	
235-647	48585-48586	)	_	
235-648	48587-48591	0.97	_	
235-649	48592-48593	(	_	
235-650	48593-48597	0.11	_	
235-651	48597-48598	)	_	
235-652	48599-48603	0.96	_	
235-653	48604-48605	(	_	
235-654	48605-48609	0.15	_	
235-655	48609-48610	)	_	
235-656	48611-48612	[	_	
235-657	48612-48613	-	_	
235-658	48613-48615	8%	_	
235-659	48615-48616	,	_	
235-660	48619-48621	2%	_	
235-661	48621-48622	]	_	
235-662	48623-48624	[	_	
235-663	48624-48625	-	_	
235-664	48625-48627	9%	_	
235-665	48627-48628	,	_	
235-666	48631-48633	9%	_	
235-667	48633-48634	]	_	
235-668	48635-48636	[	_	
235-669	48636-48637	-	_	
235-670	48637-48640	12%	_	
235-671	48640-48641	,	_	
235-672	48644-48646	1%	_	
235-673	48646-48647	]	_	
235-674	48648-48649	[	_	
235-675	48649-48650	-	_	
235-676	48650-48653	13%	_	
235-677	48653-48654	,	_	
235-678	48657-48659	3%	_	
235-679	48659-48660	]	_	
235-680	48661-48662	[	_	
235-681	48662-48663	-	_	
235-682	48663-48665	7%	_	
235-683	48665-48666	,	_	
235-684	48669-48671	8%	_	
235-685	48671-48672	]	_	
235-686	48675-48683	Anterior	_	
235-687	48684-48699	Parahippocampal	_	
235-688	48700-48705	Gyrus	_	
235-689	48706-48710	0.50	_	
235-690	48711-48712	(	_	
235-691	48712-48716	0.10	_	
235-692	48716-48717	)	_	
235-693	48718-48722	0.47	_	
235-694	48723-48724	(	_	
235-695	48724-48728	0.10	_	
235-696	48728-48729	)	_	
235-697	48730-48734	0.49	_	
235-698	48735-48736	(	_	
235-699	48736-48740	0.09	_	
235-700	48740-48741	)	_	
235-701	48742-48746	0.48	_	
235-702	48747-48748	(	_	
235-703	48748-48752	0.09	_	
235-704	48752-48753	)	_	
235-705	48754-48755	[	_	
235-706	48755-48756	-	_	
235-707	48756-48758	5%	_	
235-708	48758-48759	,	_	
235-709	48762-48764	8%	_	
235-710	48764-48765	]	_	
235-711	48766-48767	[	_	
235-712	48767-48768	-	_	
235-713	48768-48771	12%	_	
235-714	48771-48772	,	_	
235-715	48775-48777	8%	_	
235-716	48777-48778	]	_	
235-717	48779-48780	[	_	
235-718	48780-48781	-	_	
235-719	48781-48783	3%	_	
235-720	48783-48784	,	_	
235-721	48787-48790	15%	_	
235-722	48790-48791	]	_	
235-723	48792-48793	[	_	
235-724	48793-48794	-	_	
235-725	48794-48796	4%	_	
235-726	48796-48797	,	_	
235-727	48800-48803	16%	_	
235-728	48803-48804	]	_	
235-729	48805-48806	[	_	
235-730	48806-48807	-	_	
235-731	48807-48809	9%	_	
235-732	48809-48810	,	_	
235-733	48813-48815	9%	_	
235-734	48815-48816	]	_	
235-735	48819-48828	Posterior	_	
235-736	48829-48844	Parahippocampal	_	
235-737	48845-48850	Gyrus	_	
235-738	48851-48855	0.29	_	
235-739	48856-48857	(	_	
235-740	48857-48861	0.06	_	
235-741	48861-48862	)	_	
235-742	48863-48867	0.24	_	
235-743	48868-48869	(	_	
235-744	48869-48873	0.05	_	
235-745	48873-48874	)	_	
235-746	48875-48879	0.28	_	
235-747	48880-48881	(	_	
235-748	48881-48885	0.06	_	
235-749	48885-48886	)	_	
235-750	48887-48891	0.25	_	
235-751	48892-48893	(	_	
235-752	48893-48897	0.05	_	
235-753	48897-48898	)	_	
235-754	48899-48900	[	_	
235-755	48900-48901	-	_	
235-756	48901-48903	7%	_	
235-757	48903-48904	,	_	
235-758	48907-48909	9%	_	
235-759	48909-48910	]	_	
235-760	48911-48912	[	_	
235-761	48912-48913	-	_	
235-762	48913-48916	13%	_	
235-763	48916-48917	,	_	
235-764	48920-48922	9%	_	
235-765	48922-48923	]	_	
235-766	48924-48925	[	_	
235-767	48925-48926	-	_	
235-768	48926-48928	8%	_	
235-769	48928-48929	,	_	
235-770	48932-48935	15%	_	
235-771	48935-48936	]	_	
235-772	48937-48938	[	_	
235-773	48938-48940	6%	_	
235-774	48940-48941	,	_	
235-775	48944-48947	28%	_	
235-776	48947-48948	]	_	
235-777	48949-48950	[	_	
235-778	48950-48952	0%	_	
235-779	48952-48953	,	_	
235-780	48956-48959	23%	_	
235-781	48959-48960	]	_	
235-782	48963-48971	Temporal	_	
235-783	48972-48976	Pole	_	
235-784	48977-48981	1.84	_	
235-785	48982-48983	(	_	
235-786	48983-48987	0.25	_	
235-787	48987-48988	)	_	
235-788	48989-48993	1.48	_	
235-789	48994-48995	(	_	
235-790	48995-48999	0.20	_	
235-791	48999-49000	)	_	
235-792	49001-49005	1.68	_	
235-793	49006-49007	(	_	
235-794	49007-49011	0.28	_	
235-795	49011-49012	)	_	
235-796	49013-49017	1.48	_	
235-797	49018-49019	(	_	
235-798	49019-49023	0.22	_	
235-799	49023-49024	)	_	
235-800	49025-49026	[	_	
235-801	49026-49027	-	_	
235-802	49027-49029	2%	_	
235-803	49029-49030	,	_	
235-804	49033-49036	10%	_	
235-805	49036-49037	]	_	
235-806	49038-49039	[	_	
235-807	49039-49040	-	_	
235-808	49040-49042	7%	_	
235-809	49042-49043	,	_	
235-810	49046-49048	7%	_	
235-811	49048-49049	]	_	
235-812	49050-49051	[	_	
235-813	49051-49053	0%	_	
235-814	49053-49054	,	_	
235-815	49057-49060	16%	_	
235-816	49060-49061	]	_	
235-817	49062-49063	[	_	
235-818	49063-49066	14%	_	
235-819	49066-49067	,	_	
235-820	49070-49073	28%	_	
235-821	49073-49074	]	_	
235-822	49075-49076	[	_	
235-823	49076-49078	5%	_	
235-824	49078-49079	,	_	
235-825	49082-49085	22%	_	
235-826	49085-49086	]	_	
235-827	49089-49096	Nucleus	_	
235-828	49097-49106	Accumbens	_	
235-829	49107-49112	Septi	_	
235-830	49113-49117	0.10	_	
235-831	49118-49119	(	_	
235-832	49119-49123	0.02	_	
235-833	49123-49124	)	_	
235-834	49125-49129	0.09	_	
235-835	49130-49131	(	_	
235-836	49131-49135	0.02	_	
235-837	49135-49136	)	_	
235-838	49137-49141	0.10	_	
235-839	49142-49143	(	_	
235-840	49143-49147	0.02	_	
235-841	49147-49148	)	_	
235-842	49149-49153	0.10	_	
235-843	49154-49155	(	_	
235-844	49155-49159	0.02	_	
235-845	49159-49160	)	_	
235-846	49161-49162	[	_	
235-847	49162-49163	-	_	
235-848	49163-49165	8%	_	
235-849	49165-49166	,	_	
235-850	49169-49171	5%	_	
235-851	49171-49172	]	_	
235-852	49173-49174	[	_	
235-853	49174-49175	-	_	
235-854	49175-49178	14%	_	
235-855	49178-49179	,	_	
235-856	49182-49184	6%	_	
235-857	49184-49185	]	_	
235-858	49186-49187	[	_	
235-859	49187-49188	-	_	
235-860	49188-49190	8%	_	
235-861	49190-49191	,	_	
235-862	49194-49197	11%	_	
235-863	49197-49198	]	_	
235-864	49199-49200	[	_	
235-865	49200-49201	-	_	
235-866	49201-49203	5%	_	
235-867	49203-49204	,	_	
235-868	49207-49210	16%	_	
235-869	49210-49211	]	_	
235-870	49212-49213	[	_	
235-871	49213-49214	-	_	
235-872	49214-49216	9%	_	
235-873	49216-49217	,	_	
235-874	49220-49223	10%	_	
235-875	49223-49224	]	_	
235-876	49227-49235	Amygdala	_	
235-877	49236-49240	0.27	_	
235-878	49241-49242	(	_	
235-879	49242-49246	0.03	_	
235-880	49246-49247	)	_	
235-881	49248-49252	0.26	_	
235-882	49253-49254	(	_	
235-883	49254-49258	0.04	_	
235-884	49258-49259	)	_	
235-885	49260-49264	0.27	_	
235-886	49265-49266	(	_	
235-887	49266-49270	0.04	_	
235-888	49270-49271	)	_	
235-889	49272-49276	0.27	_	
235-890	49277-49278	(	_	
235-891	49278-49282	0.05	_	
235-892	49282-49283	)	_	
235-893	49284-49285	[	_	
235-894	49285-49286	-	_	
235-895	49286-49288	8%	_	
235-896	49288-49289	,	_	
235-897	49292-49294	4%	_	
235-898	49294-49295	]	_	
235-899	49296-49297	[	_	
235-900	49297-49298	-	_	
235-901	49298-49301	16%	_	
235-902	49301-49302	,	_	
235-903	49305-49307	4%	_	
235-904	49307-49308	]	_	
235-905	49309-49310	[	_	
235-906	49310-49311	-	_	
235-907	49311-49313	5%	_	
235-908	49313-49314	,	_	
235-909	49317-49320	10%	_	
235-910	49320-49321	]	_	
235-911	49322-49323	[	_	
235-912	49323-49324	-	_	
235-913	49324-49326	1%	_	
235-914	49326-49327	,	_	
235-915	49330-49333	14%	_	
235-916	49333-49334	]	_	
235-917	49335-49336	[	_	
235-918	49336-49337	-	_	
235-919	49337-49340	12%	_	
235-920	49340-49341	,	_	
235-921	49344-49346	7%	_	
235-922	49346-49347	]	_	
235-923	49350-49361	Hippocampus	_	
235-924	49362-49366	0.66	_	
235-925	49367-49368	(	_	
235-926	49368-49372	0.07	_	
235-927	49372-49373	)	_	
235-928	49374-49378	0.62	_	
235-929	49379-49380	(	_	
235-930	49380-49384	0.06	_	
235-931	49384-49385	)	_	
235-932	49386-49390	0.65	_	
235-933	49391-49392	(	_	
235-934	49392-49396	0.06	_	
235-935	49396-49397	)	_	
235-936	49398-49402	0.64	_	
235-937	49403-49404	(	_	
235-938	49404-49408	0.07	_	
235-939	49408-49409	)	_	
235-940	49410-49411	[	_	
235-941	49411-49412	-	_	
235-942	49412-49414	5%	_	
235-943	49414-49415	,	_	
235-944	49418-49420	3%	_	
235-945	49420-49421	]	_	
235-946	49422-49423	[	_	
235-947	49423-49424	-	_	
235-948	49424-49426	9%	_	
235-949	49426-49427	,	_	
235-950	49430-49432	2%	_	
235-951	49432-49433	]	_	
235-952	49434-49435	[	_	
235-953	49435-49436	-	_	
235-954	49436-49438	4%	_	
235-955	49438-49439	,	_	
235-956	49442-49444	6%	_	
235-957	49444-49445	]	_	
235-958	49446-49447	[	_	
235-959	49447-49449	1%	_	
235-960	49449-49450	,	_	
235-961	49453-49456	12%	_	
235-962	49456-49457	]	_	
235-963	49458-49459	[	_	
235-964	49459-49460	-	_	
235-965	49460-49462	4%	_	
235-966	49462-49463	,	_	
235-967	49466-49468	7%	_	
235-968	49468-49469	]	_	
235-969	49472-49479	Ventral	_	
235-970	49480-49493	Diencephalona	_	
235-971	49494-49498	0.87	_	
235-972	49499-49500	(	_	
235-973	49500-49504	0.09	_	
235-974	49504-49505	)	_	
235-975	49506-49510	0.80	_	
235-976	49511-49512	(	_	
235-977	49512-49516	0.09	_	
235-978	49516-49517	)	_	
235-979	49518-49522	0.82	_	
235-980	49523-49524	(	_	
235-981	49524-49528	0.09	_	
235-982	49528-49529	)	_	
235-983	49530-49534	0.84	_	
235-984	49535-49536	(	_	
235-985	49536-49540	0.10	_	
235-986	49540-49541	)	_	
235-987	49542-49543	[	_	
235-988	49543-49544	-	_	
235-989	49544-49546	4%	_	
235-990	49546-49547	,	_	
235-991	49550-49552	4%	_	
235-992	49552-49553	]	_	
235-993	49554-49555	[	_	
235-994	49555-49556	-	_	
235-995	49556-49559	11%	_	
235-996	49559-49560	,	_	
235-997	49563-49565	1%	_	
235-998	49565-49566	]	_	
235-999	49567-49568	[	_	
235-1000	49568-49570	0%	_	
235-1001	49570-49571	,	_	
235-1002	49574-49577	11%	_	
235-1003	49577-49578	]	_	
235-1004	49579-49580	[	_	
235-1005	49580-49582	2%	_	
235-1006	49582-49583	,	_	
235-1007	49586-49589	13%	_	
235-1008	49589-49590	]	_	
235-1009	49591-49592	[	_	
235-1010	49592-49593	-	_	
235-1011	49593-49595	8%	_	
235-1012	49595-49596	,	_	
235-1013	49599-49601	4%	_	
235-1014	49601-49602	]	_	
235-1015	49605-49611	Cuneus	_	
235-1016	49612-49616	0.98	_	
235-1017	49617-49618	(	_	
235-1018	49618-49622	0.20	_	
235-1019	49622-49623	)	_	
235-1020	49624-49628	1.03	_	
235-1021	49629-49630	(	_	
235-1022	49630-49634	0.26	_	
235-1023	49634-49635	)	_	
235-1024	49636-49640	1.08	_	
235-1025	49641-49642	(	_	
235-1026	49642-49646	0.21	_	
235-1027	49646-49647	)	_	
235-1028	49648-49652	1.03	_	
235-1029	49653-49654	(	_	
235-1030	49654-49658	0.20	_	
235-1031	49658-49659	)	_	
235-1032	49660-49661	[	_	
235-1033	49661-49662	-	_	
235-1034	49662-49665	13%	_	
235-1035	49665-49666	,	_	
235-1036	49669-49671	3%	_	
235-1037	49671-49672	]	_	
235-1038	49673-49674	[	_	
235-1039	49674-49675	-	_	
235-1040	49675-49678	12%	_	
235-1041	49678-49679	,	_	
235-1042	49682-49685	12%	_	
235-1043	49685-49686	]	_	
235-1044	49687-49688	[	_	
235-1045	49688-49689	-	_	
235-1046	49689-49692	21%	_	
235-1047	49692-49693	,	_	
235-1048	49696-49698	0%	_	
235-1049	49698-49699	]	_	
235-1050	49700-49701	[	_	
235-1051	49701-49702	-	_	
235-1052	49702-49705	17%	_	
235-1053	49705-49706	,	_	
235-1054	49709-49711	6%	_	
235-1055	49711-49712	]	_	
235-1056	49713-49714	[	_	
235-1057	49714-49715	-	_	
235-1058	49715-49717	6%	_	
235-1059	49717-49718	,	_	
235-1060	49721-49724	14%	_	
235-1061	49724-49725	]	_	
235-1062	49728-49734	Dorsal	_	
235-1063	49735-49743	Striatum	_	
235-1064	49744-49748	1.68	_	
235-1065	49749-49750	(	_	
235-1066	49750-49754	0.16	_	
235-1067	49754-49755	)	_	
235-1068	49756-49760	1.69	_	
235-1069	49761-49762	(	_	
235-1070	49762-49766	0.17	_	
235-1071	49766-49767	)	_	
235-1072	49768-49772	1.72	_	
235-1073	49773-49774	(	_	
235-1074	49774-49778	0.16	_	
235-1075	49778-49779	)	_	
235-1076	49780-49784	1.73	_	
235-1077	49785-49786	(	_	
235-1078	49786-49790	0.15	_	
235-1079	49790-49791	)	_	
235-1080	49792-49793	[	_	
235-1081	49793-49794	-	_	
235-1082	49794-49796	6%	_	
235-1083	49796-49797	,	_	
235-1084	49800-49802	0%	_	
235-1085	49802-49803	]	_	
235-1086	49804-49805	[	_	
235-1087	49805-49806	-	_	
235-1088	49806-49808	7%	_	
235-1089	49808-49809	,	_	
235-1090	49812-49814	2%	_	
235-1091	49814-49815	]	_	
235-1092	49816-49817	[	_	
235-1093	49817-49818	-	_	
235-1094	49818-49820	8%	_	
235-1095	49820-49821	,	_	
235-1096	49824-49826	2%	_	
235-1097	49826-49827	]	_	
235-1098	49828-49829	[	_	
235-1099	49829-49830	-	_	
235-1100	49830-49832	6%	_	
235-1101	49832-49833	,	_	
235-1102	49836-49838	3%	_	
235-1103	49838-49839	]	_	
235-1104	49840-49841	[	_	
235-1105	49841-49842	-	_	
235-1106	49842-49844	5%	_	
235-1107	49844-49845	,	_	
235-1108	49848-49850	5%	_	
235-1109	49850-49851	]	_	
235-1110	49855-49866	Interaction	_	
235-1111	49867-49878	significant	_	
235-1112	49879-49882	for	_	
235-1113	49883-49893	alcoholism	_	
235-1114	49894-49896	by	_	
235-1115	49897-49903	gender	_	
235-1116	49904-49905	(	_	
235-1117	49905-49906	p	_	
235-1118	49907-49908	<	_	
235-1119	49909-49913	0.05	_	
235-1120	49913-49914	)	_	
235-1121	49914-49915	.	_	

#Text=Significant relationships among volumes and drinking variables.
236-1	49916-49927	Significant	_	
236-2	49928-49941	relationships	_	
236-3	49942-49947	among	_	
236-4	49948-49955	volumes	_	
236-5	49956-49959	and	_	
236-6	49960-49968	drinking	_	
236-7	49969-49978	variables	_	
236-8	49978-49979	.	_	

#Text=Values for total
#Text=cerebrum, total cerebral cortex, and the total ventricular system were
#Text=calculated using raw volumes (cm3).
237-1	49980-49986	Values	_	
237-2	49987-49990	for	_	
237-3	49991-49996	total	_	
237-4	49997-50005	cerebrum	_	
237-5	50005-50006	,	_	
237-6	50007-50012	total	_	
237-7	50013-50021	cerebral	_	
237-8	50022-50028	cortex	_	
237-9	50028-50029	,	_	
237-10	50030-50033	and	_	
237-11	50034-50037	the	_	
237-12	50038-50043	total	_	
237-13	50044-50055	ventricular	_	
237-14	50056-50062	system	_	
237-15	50063-50067	were	_	
237-16	50068-50078	calculated	_	
237-17	50079-50084	using	_	
237-18	50085-50088	raw	_	
237-19	50089-50096	volumes	_	
237-20	50097-50098	(	_	
237-21	50098-50101	cm3	_	
237-22	50101-50102	)	_	
237-23	50102-50103	.	_	

#Text=Values for the remaining regions
#Text=were analyzed as a percentage of cerebrum volume.
238-1	50104-50110	Values	_	
238-2	50111-50114	for	_	
238-3	50115-50118	the	_	
238-4	50119-50128	remaining	_	
238-5	50129-50136	regions	_	
238-6	50137-50141	were	_	
238-7	50142-50150	analyzed	_	
238-8	50151-50153	as	_	
238-9	50154-50155	a	_	
238-10	50156-50166	percentage	_	
238-11	50167-50169	of	_	
238-12	50170-50178	cerebrum	_	
238-13	50179-50185	volume	_	
238-14	50185-50186	.	_	

#Text=The 95% confidence
#Text=interval (CI) of the slope is expressed as the percentage of the mean volume for
#Text=each of the regions.
239-1	50187-50190	The	_	
239-2	50191-50194	95%	_	
239-3	50195-50205	confidence	_	
239-4	50206-50214	interval	_	
239-5	50215-50216	(	_	
239-6	50216-50218	CI	_	
239-7	50218-50219	)	_	
239-8	50220-50222	of	_	
239-9	50223-50226	the	_	
239-10	50227-50232	slope	_	
239-11	50233-50235	is	_	
239-12	50236-50245	expressed	_	
239-13	50246-50248	as	_	
239-14	50249-50252	the	_	
239-15	50253-50263	percentage	_	
239-16	50264-50266	of	_	
239-17	50267-50270	the	_	
239-18	50271-50275	mean	_	
239-19	50276-50282	volume	_	
239-20	50283-50286	for	_	
239-21	50287-50291	each	_	
239-22	50292-50294	of	_	
239-23	50295-50298	the	_	
239-24	50299-50306	regions	_	
239-25	50306-50307	.	_	

#Text=Partial r2 was calculated with the formula:
#Text=SSterm/(SSterm + SSerror).
240-1	50308-50315	Partial	_	
240-2	50316-50318	r2	_	
240-3	50319-50322	was	_	
240-4	50323-50333	calculated	_	
240-5	50334-50338	with	_	
240-6	50339-50342	the	_	
240-7	50343-50350	formula	_	
240-8	50350-50351	:	_	
240-9	50352-50358	SSterm	_	
240-10	50358-50359	/	_	
240-11	50359-50360	(	_	
240-12	50360-50366	SSterm	_	
240-13	50367-50368	+	_	
240-14	50369-50376	SSerror	_	
240-15	50376-50377	)	_	
240-16	50377-50378	.	_	

#Text=See
#Text=Supplemental Table
#Text=4 for all analyses.
241-1	50379-50382	See	_	
241-2	50383-50395	Supplemental	_	
241-3	50396-50401	Table	_	
241-4	50402-50403	4	_	
241-5	50404-50407	for	_	
241-6	50408-50411	all	_	
241-7	50412-50420	analyses	_	
241-8	50420-50421	.	_	

#Text=All ALC (N=60)\tALC Women (N=30)\tALC Men (N=30)\t \t\t \t\t\t95% CI\tPartial r2\t95% CI\tPartial r2\t95% CI\tPartial r2\t \tDaily Drinks (percent / ounces ethanol per\t \tday)\t\t\t\t\t\t\t\t \t\tTotal Cerebrum\t[0.0, 0.7]\t0.07\t[-0.1, 1.2]\t0.11\t[-0.4, 0.4]\t0.00\t \t\tTotal Cerebral Cortex\t[0.0, 0.7]\t0.07\t[-0.1, 1.1]\t0.10\t[-0.4, 0.6]\t0.01\t \t\tAnterior Cingulate Cortexa\t[-0.8, 0.6]\t0.00\t[-1.9, 0.0]\t0.12\t[-0.3, 1.7]\t0.07\t \t\tHippocampus\t[-0.8,\t \t-0.1]\t0.09\t[-1.0, 0.2]\t0.07\t[-0.7, 0.2]\t0.03\t \tDuration of Heavy Drinking (percent/year)\t\t\t\t\t\t\t\t \t\tTemporal Polea\t[-1.1, 0.1]\t0.04\t[-0.1, 1.6]\t0.11\t[-1.4,\t \t-0.3]\t0.26\t \tLength of Sobriety (percent/year)\t\t\t\t\t\t\t\t \t\tTotal Ventricular Systemb\t[-3.4,\t \t-0.1]\t0.08\t[-2.7, 4.4]\t0.01\t[-3.4,\t \t-0.2]\t0.17\t \t
#Text=Interaction significant for drinking variable by gender (p
#Text=< 0.05).
242-1	50424-50427	All	_	
242-2	50428-50431	ALC	_	
242-3	50432-50433	(	_	
242-4	50433-50434	N	_	
242-5	50434-50435	=	_	
242-6	50435-50437	60	_	
242-7	50437-50438	)	_	
242-8	50439-50442	ALC	_	
242-9	50443-50448	Women	_	
242-10	50449-50450	(	_	
242-11	50450-50451	N	_	
242-12	50451-50452	=	_	
242-13	50452-50454	30	_	
242-14	50454-50455	)	_	
242-15	50456-50459	ALC	_	
242-16	50460-50463	Men	_	
242-17	50464-50465	(	_	
242-18	50465-50466	N	_	
242-19	50466-50467	=	_	
242-20	50467-50469	30	_	
242-21	50469-50470	)	_	
242-22	50478-50481	95%	_	
242-23	50482-50484	CI	_	
242-24	50485-50492	Partial	_	
242-25	50493-50495	r2	_	
242-26	50496-50499	95%	_	
242-27	50500-50502	CI	_	
242-28	50503-50510	Partial	_	
242-29	50511-50513	r2	_	
242-30	50514-50517	95%	_	
242-31	50518-50520	CI	_	
242-32	50521-50528	Partial	_	
242-33	50529-50531	r2	_	
242-34	50534-50539	Daily	_	
242-35	50540-50546	Drinks	_	
242-36	50547-50548	(	_	
242-37	50548-50555	percent	_	
242-38	50556-50557	/	_	
242-39	50558-50564	ounces	_	
242-40	50565-50572	ethanol	_	
242-41	50573-50576	per	_	
242-42	50579-50582	day	_	
242-43	50582-50583	)	_	
242-44	50594-50599	Total	_	
242-45	50600-50608	Cerebrum	_	
242-46	50609-50610	[	_	
242-47	50610-50613	0.0	_	
242-48	50613-50614	,	_	
242-49	50615-50618	0.7	_	
242-50	50618-50619	]	_	
242-51	50620-50624	0.07	_	
242-52	50625-50626	[	_	
242-53	50626-50627	-	_	
242-54	50627-50630	0.1	_	
242-55	50630-50631	,	_	
242-56	50632-50635	1.2	_	
242-57	50635-50636	]	_	
242-58	50637-50641	0.11	_	
242-59	50642-50643	[	_	
242-60	50643-50644	-	_	
242-61	50644-50647	0.4	_	
242-62	50647-50648	,	_	
242-63	50649-50652	0.4	_	
242-64	50652-50653	]	_	
242-65	50654-50658	0.00	_	
242-66	50662-50667	Total	_	
242-67	50668-50676	Cerebral	_	
242-68	50677-50683	Cortex	_	
242-69	50684-50685	[	_	
242-70	50685-50688	0.0	_	
242-71	50688-50689	,	_	
242-72	50690-50693	0.7	_	
242-73	50693-50694	]	_	
242-74	50695-50699	0.07	_	
242-75	50700-50701	[	_	
242-76	50701-50702	-	_	
242-77	50702-50705	0.1	_	
242-78	50705-50706	,	_	
242-79	50707-50710	1.1	_	
242-80	50710-50711	]	_	
242-81	50712-50716	0.10	_	
242-82	50717-50718	[	_	
242-83	50718-50719	-	_	
242-84	50719-50722	0.4	_	
242-85	50722-50723	,	_	
242-86	50724-50727	0.6	_	
242-87	50727-50728	]	_	
242-88	50729-50733	0.01	_	
242-89	50737-50745	Anterior	_	
242-90	50746-50755	Cingulate	_	
242-91	50756-50763	Cortexa	_	
242-92	50764-50765	[	_	
242-93	50765-50766	-	_	
242-94	50766-50769	0.8	_	
242-95	50769-50770	,	_	
242-96	50771-50774	0.6	_	
242-97	50774-50775	]	_	
242-98	50776-50780	0.00	_	
242-99	50781-50782	[	_	
242-100	50782-50783	-	_	
242-101	50783-50786	1.9	_	
242-102	50786-50787	,	_	
242-103	50788-50791	0.0	_	
242-104	50791-50792	]	_	
242-105	50793-50797	0.12	_	
242-106	50798-50799	[	_	
242-107	50799-50800	-	_	
242-108	50800-50803	0.3	_	
242-109	50803-50804	,	_	
242-110	50805-50808	1.7	_	
242-111	50808-50809	]	_	
242-112	50810-50814	0.07	_	
242-113	50818-50829	Hippocampus	_	
242-114	50830-50831	[	_	
242-115	50831-50832	-	_	
242-116	50832-50835	0.8	_	
242-117	50835-50836	,	_	
242-118	50839-50840	-	_	
242-119	50840-50843	0.1	_	
242-120	50843-50844	]	_	
242-121	50845-50849	0.09	_	
242-122	50850-50851	[	_	
242-123	50851-50852	-	_	
242-124	50852-50855	1.0	_	
242-125	50855-50856	,	_	
242-126	50857-50860	0.2	_	
242-127	50860-50861	]	_	
242-128	50862-50866	0.07	_	
242-129	50867-50868	[	_	
242-130	50868-50869	-	_	
242-131	50869-50872	0.7	_	
242-132	50872-50873	,	_	
242-133	50874-50877	0.2	_	
242-134	50877-50878	]	_	
242-135	50879-50883	0.03	_	
242-136	50886-50894	Duration	_	
242-137	50895-50897	of	_	
242-138	50898-50903	Heavy	_	
242-139	50904-50912	Drinking	_	
242-140	50913-50914	(	_	
242-141	50914-50921	percent	_	
242-142	50921-50922	/	_	
242-143	50922-50926	year	_	
242-144	50926-50927	)	_	
242-145	50938-50946	Temporal	_	
242-146	50947-50952	Polea	_	
242-147	50953-50954	[	_	
242-148	50954-50955	-	_	
242-149	50955-50958	1.1	_	
242-150	50958-50959	,	_	
242-151	50960-50963	0.1	_	
242-152	50963-50964	]	_	
242-153	50965-50969	0.04	_	
242-154	50970-50971	[	_	
242-155	50971-50972	-	_	
242-156	50972-50975	0.1	_	
242-157	50975-50976	,	_	
242-158	50977-50980	1.6	_	
242-159	50980-50981	]	_	
242-160	50982-50986	0.11	_	
242-161	50987-50988	[	_	
242-162	50988-50989	-	_	
242-163	50989-50992	1.4	_	
242-164	50992-50993	,	_	
242-165	50996-50997	-	_	
242-166	50997-51000	0.3	_	
242-167	51000-51001	]	_	
242-168	51002-51006	0.26	_	
242-169	51009-51015	Length	_	
242-170	51016-51018	of	_	
242-171	51019-51027	Sobriety	_	
242-172	51028-51029	(	_	
242-173	51029-51036	percent	_	
242-174	51036-51037	/	_	
242-175	51037-51041	year	_	
242-176	51041-51042	)	_	
242-177	51053-51058	Total	_	
242-178	51059-51070	Ventricular	_	
242-179	51071-51078	Systemb	_	
242-180	51079-51080	[	_	
242-181	51080-51081	-	_	
242-182	51081-51084	3.4	_	
242-183	51084-51085	,	_	
242-184	51088-51089	-	_	
242-185	51089-51092	0.1	_	
242-186	51092-51093	]	_	
242-187	51094-51098	0.08	_	
242-188	51099-51100	[	_	
242-189	51100-51101	-	_	
242-190	51101-51104	2.7	_	
242-191	51104-51105	,	_	
242-192	51106-51109	4.4	_	
242-193	51109-51110	]	_	
242-194	51111-51115	0.01	_	
242-195	51116-51117	[	_	
242-196	51117-51118	-	_	
242-197	51118-51121	3.4	_	
242-198	51121-51122	,	_	
242-199	51125-51126	-	_	
242-200	51126-51129	0.2	_	
242-201	51129-51130	]	_	
242-202	51131-51135	0.17	_	
242-203	51139-51150	Interaction	_	
242-204	51151-51162	significant	_	
242-205	51163-51166	for	_	
242-206	51167-51175	drinking	_	
242-207	51176-51184	variable	_	
242-208	51185-51187	by	_	
242-209	51188-51194	gender	_	
242-210	51195-51196	(	_	
242-211	51196-51197	p	_	
242-212	51198-51199	<	_	
242-213	51200-51204	0.05	_	
242-214	51204-51205	)	_	
242-215	51205-51206	.	_	

#Text=Data from one woman exerted disproportionate influence (Cook's D
#Text=> 1.0), and therefore was removed from the analysis.
243-1	51207-51211	Data	_	
243-2	51212-51216	from	_	
243-3	51217-51220	one	_	
243-4	51221-51226	woman	_	
243-5	51227-51234	exerted	_	
243-6	51235-51251	disproportionate	_	
243-7	51252-51261	influence	_	
243-8	51262-51263	(	_	
243-9	51263-51269	Cook's	_	
243-10	51270-51271	D	_	
243-11	51272-51273	>	_	
243-12	51274-51277	1.0	_	
243-13	51277-51278	)	_	
243-14	51278-51279	,	_	
243-15	51280-51283	and	_	
243-16	51284-51293	therefore	_	
243-17	51294-51297	was	_	
243-18	51298-51305	removed	_	
243-19	51306-51310	from	_	
243-20	51311-51314	the	_	
243-21	51315-51323	analysis	_	
243-22	51323-51324	.	_	

#Text=Highlights
#Text=The volume of the brain's reward system was smaller in alcoholic men, but not alcoholic women.
244-1	51325-51335	Highlights	_	
244-2	51336-51339	The	_	
244-3	51340-51346	volume	_	
244-4	51347-51349	of	_	
244-5	51350-51353	the	_	
244-6	51354-51361	brain's	_	
244-7	51362-51368	reward	_	
244-8	51369-51375	system	_	
244-9	51376-51379	was	_	
244-10	51380-51387	smaller	_	
244-11	51388-51390	in	_	
244-12	51391-51400	alcoholic	_	
244-13	51401-51404	men	_	
244-14	51404-51405	,	_	
244-15	51406-51409	but	_	
244-16	51410-51413	not	_	
244-17	51414-51423	alcoholic	_	
244-18	51424-51429	women	_	
244-19	51429-51430	.	_	

#Text=These gender differences were most evident in dorsolateral prefrontal cortex and ventral diencephalon.
245-1	51431-51436	These	_	
245-2	51437-51443	gender	_	
245-3	51444-51455	differences	_	
245-4	51456-51460	were	_	
245-5	51461-51465	most	_	
245-6	51466-51473	evident	_	
245-7	51474-51476	in	_	
245-8	51477-51489	dorsolateral	_	
245-9	51490-51500	prefrontal	_	
245-10	51501-51507	cortex	_	
245-11	51508-51511	and	_	
245-12	51512-51519	ventral	_	
245-13	51520-51532	diencephalon	_	
245-14	51532-51533	.	_	

#Text=The volumes of several reward regions were related to drinking history.
246-1	51534-51537	The	_	
246-2	51538-51545	volumes	_	
246-3	51546-51548	of	_	
246-4	51549-51556	several	_	
246-5	51557-51563	reward	_	
246-6	51564-51571	regions	_	
246-7	51572-51576	were	_	
246-8	51577-51584	related	_	
246-9	51585-51587	to	_	
246-10	51588-51596	drinking	_	
246-11	51597-51604	history	_	
246-12	51604-51605	.	_	
